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Abstract 
Activity  based  alterations  in  synaptic  connectivity  are  thought  to  underlie  the 
processes involved in learning and memory.    Measurable  changes  in  neuronal 
activation by long-term potentiation (LTP) are widely investigated as a possible 
cellular correlate of this phenomenon, as it can be induced quickly to elicit long-
lasting modifications.  These long-term changes in the activity of neuronal circuits 
are sustained by an altered pattern of gene expression and protein synthesis.  The 
inducible transcription factor zif268 has been implicated in almost all models of 
neuronal plasticity.  Downstream targets of zif268 are widely believed to contribute 
to the duration and stabilisation of NMDA receptor dependent LTP which, in turn, 
can  be  linked  to  various  models  of  learning  and  memory.  However,  these 
downstream targets are only just starting to receive attention.   
By  utilising  a  wide  range  of  contemporary  neuroscience  techniques  covering 
molecular &  cell  biology  approaches,  this  thesis  proposes  two  known  proteins, 
gephyrin and ubiquilin, as well as a novel gene (urma), as potential downstream 
targets  of  zif268.    Both  gephyrin  and  ubiquilin  are  associated  with  GABAA 
receptors  at  inhibitory  synapses.    Gephyrin  is  thought  to  cluster  and  anchor 
GABAA  receptors  at  postsynaptic  sites  whilst  ubiquilin  is  reported  to  regulate 
receptor  surface  expression.  We  found  that  gephyrin  mRNA  and  protein 
expression levels were downregulated in response to increased levels of zif268 by 
transient  transfection  in  PC-12 cells  and  NMDA  stimulation  in primary  cultured 
cortical  neurones.    In  addition,  ubiquilin  mRNA  and  protein  levels  were  also 
downregulated  within  the  same  experimental  paradigms,  implying  that  both 
gephyrin  and  ubiquilin  are  downstream  transcriptional  targets  of  this  plasticity-
related gene. 
A previously reported microarray experiment (James et al. 2005) contained 144 
ESTs significantly affected by the transient transfection of zif268 in PC-12 cells 
compared to control.  Bioinformatic analyses of these tags revealed interesting 
genomic areas pertaining to little published information.  After further investigation, 
EST AI169020 revealed a novel transcript that was downregulated in response to 
NMDA treatment of primary cortical neurones.  Additional data mining suggests 3 
that urma may be a rarely expressed transcription factor.  Basal levels of urma 
mRNA  were  also  decreased  in  the  zif268  knockout  mouse,  as  were  ubiquilin 
mRNA levels. 
Zif268 is a regulatory immediate early gene, activating or suppressing downstream 
targets that play a role in the duration and stabilisation of LTP.  These results 
indicate  that  gephyrin  and  ubiquilin  are  potential  mediators  of  NMDA  receptor-
dependent  plasticity,  by  modifying  inhibitory-signalling.    In  addition,  zif268  may 
actively  suppress  a  novel  plasticity-related  transcription  factor,  urma.    These 
findings may underlie important processes in learning and memory. 
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ERK      extracellular-signal related kinase 
EST      expressed sequence tag 18 
GABA     -aminobutyric acid 
GABAAR    -aminobutyric acid type A receptor 
GABARAP     GABAAR-associated protein 
GAP      GTPase-activating protein 
GAPDH    glyceraldehyde-3-phosphate dehydrogenase 
GDP      guanosine diphosphate 
GEF      guanyl nucleotide exchange factors 
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GTP      guanosine triphosphate 
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IEG      immediate early gene 
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LTP      long-term potentiation 
MAPK     mitogen-activated protein kinase 
MEK      MAPK/ERK kinase 
Mena/VASP    (mammalian enabled)/vasodilator-stimulated phosphoprotein 
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Mg
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MoCo       molybdenum cofactor  
mTOR      mammalian target of rapamycin 
MTP      microtitre plate 
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+      sodium 
NMDA      n-methyl-D-aspartate 
NMDAR    NMDA receptor 
PBS      phosphate buffered saline 
PC-12     pheochromocytoma cell line 
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PDI      protein-disulfide isomerase 
pERK     phosphorylated ERK 
PKA      cAMP-dependent protein kinase 
PKC      protein kinase C 19 
PKG      cGMP-dependent kinase 
PNMT     phenylethanolamine N-methyltransferase 
polyQ     polyglutamine  
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PVDF     polyvinyldifluoride 
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RT      room temperature 
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t-ERK     total ERK 
T-TBS     tris-tween buffered saline 
TH      tyrosine hydroxylase 
UIM      ubiquitin interacting motif 
XTT      tetrazolium salt 
Zif268     Zinc finger binding protein clone 268 
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1.1   Introduction 
This thesis identifies 3 novel target genes of the plasticity related immediate early 
gene zif268: gephyrin, ubiquilin and the novel gene, urma.  Zif268 is implicated in 
many different forms of neuronal plasticity.  Long-term potentiation (LTP) is a type 
of synaptic plasticity thought to be the cellular mechanism of memory formation.  
Like memory, synaptic plasticity can occur in short-term and long-lasting forms.  
Downstream targets of zif268 are widely believed to contribute to the duration and 
stabilisation of LTP and, therefore, to learning and memory.  These downstream 
targets of zif268 are only just starting to receive attention; a description follows in 
the text. 
Long-term changes in the activity of neuronal circuits are sustained by an altered 
pattern  of  gene  expression  and  protein  synthesis.    The  importance  of  protein 
degradation is starting to emerge as an area of intense research, and therefore I 
will  briefly  introduce  the  proteasome  (a  protein  complex  that  digests  proteins 
marked for degradation) and its proposed involvement in LTP.  Intriguingly, zif268 
was recently linked to the neuroproteasome, a subject that will be addressed. 
In addition, I will introduce two GABAA receptor (GABAAR) associated proteins: 
ubiquilin,  which  regulates  cell  surface  expression,  and  gephyrin,  a  scaffolding 
protein thought to cluster and anchor GABAARs at the postsynaptic membrane. 
1.1.1  Neuronal Plasticity 
Neuronal plasticity is a term used to describe the many and varied changes that 
occur within the brain as a result of internal and external stimuli i.e. development, 
injury and/or learning and memory.  These phenomena can lead to changes in the 
structure and function of synapses, neurones and neural networks.   
Animal models of neuronal plasticity include neuronal development in the visual 
cortex  after  light  stimulation  (Wiesel  &  Hubel  1963),  spatial  learning  in  the 
hippocampus (Bliss & Lomo 1973), long-term habituation in Aplysia (Dale et al. 
1988), fear conditioning in the amygdala (Rogan et al. 1997), olfactory memory 
formation in the olfactory bulb (Matsuoka et al. 1997), procedural memory in the 
striatum and cerebellum (Karachot et al. 2001) and eyeblink conditioning in the 
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1.1.2  Long Term Potentiation 
LTP is widely believed to be a form of plasticity involved in learning and memory, 
thus  providing  an  important  key  to  understanding  the  cellular  and  molecular 
mechanisms that underlie memory formation and storage.  Long-lasting, activity-
dependent  changes in  the  weight  or  strength  of  synaptic  communication  could 
constitute  a  basic  mechanism  underlying  the  brain  translating  experiences  into 
memories (Walton et al. 1999). 
The  most  investigated  form  of  synaptic  plasticity  –  a  measurable  change  in 
synaptic connections, is LTP.  It can be induced within fractions of seconds using 
short  bursts  of  tetanic  high  frequency  electrical  stimulation  to  the  connection 
between two neurones, eliciting modifications that can last for periods of weeks or 
even months.  This results in a semi-permanent trace of the past activation of the 
synapse.  Ultimately, upon induction of LTP and appropriate activation of specific 
neurones,  it  is  generally  believed  that  synapses  can  be  strengthened  by  the 
production  and  persistence  of  long-term  changes  in  the  activity  of  neuronal 
circuits, developing and incorporating into a memory network. 
In 1894, Santiago Ramon y Cajal proposed that learning was not due to new cell 
growth, but to a strengthening of connections between existing neurones.  This 
was  further  elaborated  by  Hebb‘s  Postulate  (1949),  which  describes  how  the 
connection  from  pre-synaptic  neurone  A  to  post-synaptic  neurone  B  can  be 
modified.    He  proposed  that  such  a  mechanism  could  stabilise  the  specific 
neuronal activity patterns in the brain, stating that: 
―When an axon of cell A is near enough to excite cell B and repeatedly 
or persistently takes part in firing it, some growth process or metabolic 
change takes place in one or both cells such that A‘s efficiency, as one 
of the cells firing B, is increased.‖ 
Several rules must be adhered to for successful LTP induction: a) Co-operativity: 
the existence of an intensity threshold for induction, b) Associativity: a weak input 
can  be  potentiated  if  active  at  the  same  time  as  a  strong  stimulus,  c)  Input 
Specificity: if an input is not active at the time of the tetanus, it will not share the 
potentiation (Bliss & Collingridge 1993). 
There are distinct phases of LTP in which the early phases seem to be controlled 
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approximately 1 to 3 hours. The late phases of LTP depend on immediate early 
gene initiation of gene transcription and new protein synthesis, which starts after 
approximately 4 hours and can be maintained for weeks in vivo (Morris 2004). 
1.1.2.1  The hippocampus 
The hippocampal formation is found within the limbic system and comprises the 
entorhinal cortex, subiculum, dentate gyrus and  the hippocampus proper.  The 
hippocampus itself is separated into 4 regions cornu ammonis (CA) 1, CA2, CA3 
and CA4 (Lorente de No 1934) (see figure 1.1). 
The perforant pathway is the major afferent projection into the hippocampus and 
originates from different layers of the entorhinal cortex.  It consists of a lateral and 
medial component: the lateral path begins in layers III and V and travels to the 
subiculum and the pyramidal cells of the CA1, whilst the medial section begins in 
layers II and IV and travels to the granule cells of the dentate gyrus and pyramidal 
cells of the CA3. 
Within the hippocampal formation, as a simplification, the major projections are the 
mossy fibre pathway and the Schaffer collateral pathway.  The mossy fibres link 
the granule cells of the dentate gyrus to the CA3 pyramidal neurones and the 
Schaffer collateral pathway projects from the CA3 to the CA1 cells.  In addition 
there are a myriad of other minor pathways that interlink all the regions of the 
hippocampal  formation,  although  the  CA3  neurones  only  innervate  the  CA1 
neurones (reviewed in Amarel & Witter, 1989). Donna M McDade, 2007    Chapter 1, 24 
 
 
Figure 1.1: Diagram of the hippocampal formation.  The entorhinal cortex layers II/IV gives rise 
to the medial perforant path (MPP) which extends to the dentate gyrus (DG) and CA3.  The mossy 
fibres (MF) also send information from the DG to CA3.  CA3 innervates CA1 via the Schaffer 
Collateral Pathway (SC) and to the CA1 region of the contralateral hippocampus via the 
Associational Commissural Pathway (AC).  The lateral perforant path travels to the subiculum (Sb) 
and CA1.  CA1 innervates the subiculum which, in turn, return to the lateral (LEC) and medial 
(MEC) entorhinal cortex.  Taken from 
http://www.bris.ac.uk/Depts/Synaptic/info/pathway/hippocampal.htm 
 
In  accordance  with  Hebb‘s  Postulate,  Bliss &  Lomo  (1973)  elicited  long-lasting 
strong responses in postsynaptic granule cells of rabbits after tetanic stimulation of 
the presynaptic fibres of the perforant pathway.  It can be generated in a variety of 
brain  regions,  but  the  induction  of  LTP  within  the  perforant  path  of  the 
hippocampus shows a clear relationship with endogenous learning and memory 
(Bliss  &  Collingridge  1993).  Memory  deficits  can  be  observed  using 
electrophysiological procedures to saturate LTP within the hippocampal formation 
before  learning,  in  a  manner  that  prevents  the  capacity  for  further  synaptic 
changes during learning (Barnes et al. 1994).  It can be produced throughout the 
limbic forebrain with few exceptions, however, pathways within the hippocampus 
show  significantly  greater  LTP  effects  compared  with  pathways  outwith  the 
hippocampal formation (Racine et al. 1983). 
In addition to hippocampal LTP, other structures within the brain that can display 
LTP include the striatum, amygdala, cerebellum and cerebral cortex (Salin et al. 
1996; Charpier & Deniau 1997; Rogan et al. 1997). Donna M McDade, 2007    Chapter 1, 25 
1.1.3  Long Term Depression 
Another  form  of  synaptic  plasticity  is  long  term  depression  (LTD).    This 
phenomenon  can  present  itself  in  two  separate  forms:  de  novo  LTD  and 
depotentiation.  Depotentiation has the capability to reverse the effects of LTP at 
synapses after low frequency stimulation within the hippocampus (Barrionuevo et 
al. 1980).  De novo LTD may contribute to memory formation and consists of a 
use-dependent weakening of synaptic conductivity (reviewed in Linden & Connor 
1995).  LTD at the excitatory synapse between parallel fibres and Purkinje cells in 
the  cerebellum  has  been  attributed  to  the  acquisition  of  classically  conditioned 
eye-blink responses (Ekerot & Kano 1985). 
The induction of LTD can occur with high frequency and prolonged low frequency 
stimulation,  depending  on  the  brain  region.    Area  CA1  of  the  hippocampus 
requires low frequency stimulation over long periods of time for the induction of 
LTD (Dudek & Bear 1992).  In contrast, high frequency stimulation can induce LTD 
in  the  cerebellar  cortex,  neocortex,  striatum  and  nucleus  accumbens  (Artola  & 
Singer 1993).  LTP and LTD can be activated using similar stimulation parameters 
but  LTP  requires  a  stronger  depolarisation  and  greater  increase  in  Ca
2+ 
concentration than LTD (Artola et al. 1990).   
LTD typically requires the NMDA receptor, although this is not essential (Mulkey & 
Malenka  1992;  Anwyl  2006).    In  contrast  to  LTP,  LTD  can  occur  at  inactive 
synapses  (anti-Hebbian  or  heterosynaptic  LTD)  as  well  as  active  synapses 
(Hebbian or homosynaptic LTD), and is generally regarded as the 'inverse' of LTP 
(Bolshakov & Siegelbaum 1994; Bear & Abraham 1996; Oliet et al. 1997). 
1.1.4  NMDA Receptor-dependent LTP 
LTP-inducing stimuli progressively depolarise the postsynaptic cell by  releasing 
glutamate  from  the  presynaptic  cell.    A  magnesium  ion  gates  the  calcium-
permeable  glutamate-activated  N-methyl-D-aspartate  (NMDA)-type  receptor 
(Nowak et al. 1984), necessitating a voltage-dependent activation.  Therefore, the 
NMDA receptor (NMDAR) contributes little to basal postsynaptic responses during 
low frequency synaptic transmission at most glutamatergic synapses.  However, 
once glutamate has evoked a large excitatory postsynaptic potential (EPSP), via 
activation of another glutamate receptor subtype, the  -amino-3-hydroxy-5-methyl-
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postsynaptic  cell  by  an  influx  of  Na
+  and  K
+  (McLennan  1983)  is  sufficient  to 
relieve the magnesium ion from the NMDAR channel.  Activation of the NMDAR 
therefore may only occur once the cell is sufficiently depolarised and glutamate 
has bound, allowing Ca
2+ to enter the cell (Mayer & Westbrook 1987).  The flood 
of Ca
2+ through the receptor channel increases the intracellular Ca
2+ concentration 
giving the necessary signal for LTP induction (Harvey & Collingridge 1992).  As 
well as entering the cell via NMDAR, calcium also enters through voltage gated 
calcium channels and is released from intracellular stores.   
1.1.4.1  NMDAR-dependent LTP and the hippocampus 
The NMDAR is assembled from a combination of subunits designated NR1 and 
NR2A–D.  NR1, the essential receptor subunit of the NMDAR, has eight alternative 
splice  variants  that  have  different  expression  patterns  within  the  human
  brain 
(Rigby et al. 1996). In the cerebral cortex and the hippocampus, NMDARs
 are 
assembled from NR1, NR2A, and NR2B subunits (Conti et al. 1997; Kaczmarek et 
al.  1997).    NR3  subunits  are  also  likely  to  be  present,  at  least  at  some 
developmental  stages.    The  hippocampus  is  one  of  the  most  NMDAR  dense 
regions  of  the  brain.  The  Schaffer  collateral/CA1  synapses  and  the  perforant 
path/dentate gyrus synapses comprise two major hippocampal pathways involved 
in NMDA-dependent LTP.  NMDAR-dependent plasticity in the CA3-CA1 region of 
the hippocampus is the most intensively studied connection for synaptic plasticity.  
Rat in vivo and in vitro studies have implicated NMDAR as a necessary factor for 
LTP induction and maintenance in the CA1 region of the hippocampus (Harris et 
al. 1984; Wigstrom & Gustafsson 1986; Collingridge et al. 1988).  Specific NMDAR 
antagonists  completely  block  the  generation  of  associative  LTP,  but  minimally 
effect  basal  synaptic  transmission  (Teyler  1987;  Collingridge  et  al.  1983).  In 
addition, transgenic mice overexpressing the NR2B subunit of the NMDAR were 
shown  to  have  enhanced  LTP  in  the  hippocampus,  and  superior  learning 
performances in several tasks when compared to wildtypes (Tang et al. 1999). 
LTP requires a postsynaptic calcium increase, and the rise of NMDAR-dependent 
intracellular calcium seems to be the critical trigger.  Increases in the uptake and 
retention  of  Ca
2+  after  tetanic  stimulation  in  the  hippocampus  have  been 
demonstrated  (Baimbridge  &  Miller  1981;  Kuhnt  et  al.  1985).    In  addition, 
increasing the extracellular concentration of Ca
2+ can increase LTP in the CA1 
region  of  the  rat  hippocampus  (Mulkeen  et  al.  1988),  whilst  decreasing  levels Donna M McDade, 2007    Chapter 1, 27 
surrounding rat hippocampal slices prevents LTP (Dunwiddie & Lynch 1979).  LTP 
induction can be blocked by EGTA, which binds free calcium ions (Lynch et al. 
1983), and anti-S-100, a calcium binding protein, prevents LTP in the CA1 of the 
hippocampus (Lewis & Teylor 1986).  In contrast, directly raising the amount of 
postsynaptic calcium by photolysis of caged calcium can increase LTP (Malenka 
et al. 1988).  It is unknown whether an increase in calcium alone is sufficient to 
trigger  LTP  or  whether  additional  factors  are  required,  probably  provided  by 
additional synaptic activity.  
1.1.5  LTP in the Cerebral Cortex 
Memories  of  sensory  experiences  are  thought  to  form  within  the  areas  that 
process  the  sensory  information,  and  therefore  any  synaptic  neurone  activated 
within the sensory cortices of the cerebral cortex would be permanently modified 
by  that  sensory  event  (Bear  1996).    In  support  of  this,  it  has  been  found  that 
neurones  within  the  primary  auditory  cortex  display  altered  responses  once  an 
auditory  discrimination  task  has  been  learnt  (Weinberger  &  Diamond  1987; 
Edeline et al. 1993), and neurones of the inferior temporal cortex display altered 
responses after face recognition tasks in primates (Rolls et al. 1989).  
The neocortex is the major site for storage of nonspatial declarative memory (i.e. it 
stores memories of facts and events that do not require spatial information).  Using 
the same high frequency stimulation that induces LTP in the CA1 region of the 
hippocampus, stimulation of neocortical layer IV induces LTP in neocortical layer 
III in mouse, rat and cat visual cortex and rat somatosensory cortex (Kirkwood et 
al.  1993;  Castro-Alamancos  et  al.  1995).    LTP  has  also  been  induced  in  the 
human inferotemporal cortex, a region thought to accommodate visual memories 
(Chen et al. 1996).  Critical factors for these types of cortical LTP are the levels of 
NMDAR activation and availability (Markram et al. 1995).  
1.1.6  LTP in the Striatum 
Specific forms of associative learning and reward produce long-term changes in 
synaptic efficiency within the striatum (Reynolds et al. 2001; Schultz 2002).  In this 
area, dopamine mainly acts on D1 receptors, found on dynorphin and substance P 
containing spiny neurones that project to the substantia nigra, and D2 receptors, 
found on enkephalin containing spiny neurones that project to the globus pallidus 
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of equal number and comprise approximately 90% of the total number of striatal 
neurones (Gerfen & Young 1988; Kawaguchi et al. 1990). 
D2  receptors,  found  presynaptically,  inhibit  the  release  of  glutamate  from 
corticostriatal synapses (Maura et al. 1988; Bamford et al. 2004), activation of D2 
receptors attenuates NMDA responses in the striatum (Cepeda et al. 1993) and 
inhibits calcium currents in isolated spiny striatal neurones (Surmeier et al. 1996).  
High frequency stimulation of the striatum unpredictably induces both LTP and 
LTD in vivo (Charpier & Deniau 1997; Reynolds & Wickens 2000; Reynolds et al. 
2001) and in vitro (Akopian et al. 2000; Partridge et al. 2000).  However, after 
chronic  haloperidol  administration,  which  blocks  D2  receptors,  high  frequency 
stimulation of corticostriatal fibres invariably induces LTP, which is blocked by MK-
801 (Centonze et al. 2004).  Tetanic stimulation of cortical fibres projecting to the 
striatum in D2 receptor-null mice produces LTP which is blocked by the addition of 
D(-)-2-amino-5-phosphonoaleric  acid  (APV  -  an  NMDAR  antagonist  that 
competitively inhibits the receptor binding site), suggesting a regulatory function 
for D2 receptors on synaptic plasticity expressed in striatal areas (Calabresi et al. 
1997). 
1.1.7  Cellular Cascades involved in LTP 
Once  AMPARs  have sufficiently  depolarised  the  cell  and  released  the  voltage-
dependent  Mg
2+  block  in  the  NMDAR,  the  resultant  Ca
2+
  influx  is  probably 
restricted to the vicinity of the activated spines (Regehr & Tank 1990; Sabatini et 
al. 2002).   
A  key  component  of  LTP  seems  to  be  calcium-calmodulin-dependent  protein 
kinase II (CaMKII) (Madison et al. 1991; Lisman 1994) which is activated by Ca
2+ 
bound to calmodulin.  CaMKII, an oligomeric protein consisting of 10-12 subunits, 
is a major constituent of the postsynaptic density (PSD), and is therefore found in 
high  concentrations  close  to  the  glutamate  receptors  that  mediate  synaptic 
transmission  (Malenka  et  al.  1989).    Upon  activation,  it  can  translocate  to 
synapses (Strack et al. 1997; Shen & Meyer 1999) and bind to NMDARs (Leonard 
et  al.  1999).    CaMKII  is  able  to  undergo  long  term modification,  resulting  in a 
calcium  influx  by  binding  to  the  region  around  serine  1303  in  the  cytoplasmic 
domain of the NMDAR NR2B subunit  (Leonard et al. 1999; Strack et al. 2000; 
Bayer  et  al.  2001).    This  locks  CaMKII  in  an  activated  state  that  cannot  be Donna M McDade, 2007    Chapter 1, 29 
reversed by phosphatases (Bayer et al. 2001), leading to the generation of Ca
2+-
independent  activity,  which  increases  after  LTP  induction.    Transgenic  mice  in 
which  threonine  286  has  been  mutated  to  alanine  have  normal  basal  synaptic 
transmission,  but  do  not  exhibit  LTP  (Giese  et  al.  1998).    Persistently  active 
CaMKII can mimic LTP (Pettit et al. 1994; Lledo et al. 1995), inhibitors of CaMKII 
prevent  the  induction  of  LTP  (Malinow  et  al.  1989)  tetanic  stimulation  of  CA1 
increases  CaMKII  activity  (Miyamoto  &  Fukunaga  1996)  and  APV  blocks  LTP-
associated CaMKII autophosphorylation (Fukunaga et al. 1996), indicating a key 
role for CaMKII in the early phases of LTP.  Behaviourally, mice with no alpha 
subunit of CaMKII display a deficit in learning (Silva et al. 1992), and mice with a 
point mutation at threonine 286 show no spatial learning in the Morris water maze 
(a spatial learning task) (Giese et al. 1998). 
The critical substrates of CaMKII within LTP are poorly understood.  One known 
substrate of CaMKII however, is the AMPAR.  AMPARs are tetrameric receptors, 
comprised of 2 subunits selected from GluR1–GluR4; these receptors allow Na
+ to 
enter  the  cell,  and  play  a  major  role  in  glutamate-induced  membrane 
depolarization  (Doble  1995).    After  NMDA  stimulation  and  calcium  influx  in 
cultured  hippocampal  cells,  CaMKII  autophosphorylates  at  threonine  286  and 
anchors to the NMDAR  (Tan et al. 1994), phosphorylating AMPAR in the CA1 
region  after  the  induction  of  LTP  in  this  area  (Barria  et  al.  1997b)  and 
phosphorylates the GluR1 AMPAR at Ser831 in HEK293 cells (Barria et al. 1997a; 
Mammen et al. 1997).  It may also assemble insertion slots for newly delivered 
AMPARs (Lisman et al. 2002).  GluR1 knockout mice show normal basal synaptic 
transmission however, associative LTP is absent in region CA1 (Zamanillo et al. 
1999).  Phosphorylation of AMPAR results in potentiation of whole cell AMPAR 
mediated currents due to an increase in single channel conductance of existing 
receptors, or by recruiting new high-conductance-state AMPARs (Derkach et al. 
1999).   
CaMKIV  is  also  transiently  upregulated  after  LTP-inducing  stimuli.    It  is 
phosphorylated  by  CaMK  kinase  and  acts  on  cyclic  AMP-responsive  element-
binding protein (CREB) at serine 133 which, in turn, leads to the expression of c-
Fos  protein.    During  LTP  in  the  rat  CA1,  CREB  and  c-Fos  expressions  are 
increased;  an  effect  that  can  be  inhibited  with  the  use  of  CaMK  inhibitors 
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CaMKII  can  activate  the  calcium-dependent  adenylyl  cyclase  (Chetkovich  & 
Sweatt 1993),  which leads to local increases in cAMP, a possible downstream 
mediator  of  NMDA-dependent  LTP  (Chetkovich  et  al.  1991).  Deficits  in 
hippocampal LTP and memory tests can be found in mutant mice lacking adenylyl 
cyclase (Wu et al. 1995), and the early phase of LTP has been shown to rely on 
postsynaptic levels of cAMP (Blitzer et al. 1995).   
cAMP-dependent  protein  kinase,  also  known  as  protein  kinase  A  (PKA) 
phosphorylates inhibitor-1, an endogenous protein phosphatase inhibitor, indirectly 
boosting CaMKII activity (Blitzer et al. 1998).  Like CaMK, PKA can phosphorylate 
CREB  at  serine  133  in  response  to  elevated  levels  of  cAMP  (Gonzalez  & 
Montminy 1989), and inhibition of PKA blocks the expression of LTP (Frey et al. 
1993; Matthies & Reymann 1993).  The timecourse of PKA actions in LTP seem 
rather  controversial  as  the  PKA  inhibitor,  H89,  suppresses  early  phase  LTP 
(Otmakhova et al. 2000), whereas Frey et al. (1993) found that inhibition of PKA 
specifically  blocked  late  phase  LTP.    Transgenic  mice  with  a  mutation  in  the 
regulatory subunit of PKA display a marked reduction of late phase LTP in area 
CA1 with concomitant deficiencies in spatial memory and contextual fear (Abel et 
al. 1997). 
PKC has also been implicated in LTP through the use of transgenic mice.  PKC 
gamma-mutant mice have a reduced capability for LTP in the hippocampus and 
display  mild  deficits in learning  tasks  (Abeliovich  et  al.  1993a,  b).    In  addition, 
reduced levels of PKC in the hippocampus decrease performance in the Morris 
water  maze,  effectively  linking PKC  and  spatial  memory  (Wehner  et  al.  1990).  
Specific inhibitors of PKC decrease the potentiation of synaptic responses and can 
reduce the proportion of PKC associated with the membrane (Wang & Feng 1992; 
Reymann  et  al.  1988).    Again,  there  is  controversy  over  the  timings  of  LTP 
disruption with the use of differing PKC inhibitors and results suggest that it may 
be involved in both the early and late phases (Wang & Feng 1992).  Injecting PKC 
into the pyramidal cells of the CA1 elicits long lasting enhancement of synaptic 
transmission in a manner similar to LTP (Hu et al. 1987), and PKC seems to target 
many proteins with proposed LTP involvement.  One such protein, F1 (also known 
as  B-50  and  GAP-43)  shows  increased  phosphorylation  in  the  hippocampus 
immediately after, 1 hour after and even 3 days after the induction of LTP as well 
as after a spatial learning task (Lovinger et al. 1986); effects that are blocked by 
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NMDAR activation, and the ensuing increase in intracellular calcium, causes an 
increase in activity of guanyl nucleotide exchange factors (GEFs), catalysing the 
exchange of GDP for GTP on low molecular weight GTPases such as Ras.  At the 
same time, the activity of the GTPase-activating proteins (GAPs), which aid the 
hydrolysis  of  GTP  to  GDP,  is  decreased.    The  increase  and  corresponding 
decrease  in  activity  of  the  GEFs  and  GAPs  subsequently  leads  to  an  overall 
increase in Ras activity.  In addition, the activated kinases CaMK and PKC can 
both phosphorylate Ras.  KO mice deficient in Ras-GRF1 (Ras-guanine-nucleotide 
releasing factor 1) show a loss of LTP in the amygdala (Brambilla et al. 1997), and 
Ras activation is necessary for delivering AMPARs to the synapse during NMDAR-
dependent LTP in the hippocampus (Zhu et al. 2002). 
Ras can activate the tyrosine kinase src, which may participate in LTP induction by 
enhancing NMDA receptor function (Lu et al. 1998).  Src activity is increased by 
LTP induction, and blocking src prevents LTP within the CA1 of the hippocampus 
(Lu et al. 1998).  However, O'Dell et al. (1992) found that mutations in the src gene 
did not affect the induction or maintenance of LTP.  Ras also activates Raf, a 
serine/threonine  protein  kinase  that  phosphorylates  the  enzyme  MAPK/ERK 
kinase (MEK).  Inhibition of MEK prevents hyperphosphorylation of extracellular 
signal-regulated kinase (ERK) (also known as mitogen-activated protein kinases 
(MAPK)), blocks LTP induction in the hippocampus (English & Sweatt 1997), and 
impairs the learning and memory of animals in spatial learning, fear conditioning 
and conditioned taste aversion (Atkins et al. 1998; Selcher et al. 1999; Schafe et 
al. 2000).  In addition, LTP-induced increases in AMPAR transmission via CaMKII 
are also disrupted by MEK inhibition, linking ERK activation and CaMKII activity 
(Zhu et al. 2002). 
The  ERK  isoforms  -1  and  -2  (ERK1  and  ERK2),  are  widely  expressed  in  the 
mammalian nervous system (Boulton et al. 1991; Fiore et al. 1993a), have been 
localised in neurones to the nucleus, cytoplasm and dendrites  (Patterson et al. 
2001; Yuan et al. 2002), and are activated by glutamatergic signalling (Fiore et al. 
1993b;  Xia  et  al.  1996).    LTP-inducing  high  frequency  stimulation  of  the 
hippocampus activates ERK (English & Sweatt 1996), as does LTP in the dentate 
gyrus (Coogan et al. 1999), amygdala (Schafe et al. 2000) and cortex (Di Cristo et 
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The  induction of LTP in  the dentate  gyrus  in  vivo  causes  phosphorylation  and 
nuclear translocation of ERK (Davis et al. 2000; Patterson et al. 2001), which then 
activates two sets of kinases – ribosomal protein S6 kinases (RSKs) and mitogen- 
and  stress-activated  kinases  (MSKs).    With  reference  to  area  CA1  of  the 
hippocampus,  evidence  suggests  the  cAMP-responsive  element-binding  protein 
(CREB)  kinase,  Rsk2,  is  critical  for  the  maintenance  of  LTP  within  this  area 
(Guzowski  &  McGaugh  1997;  Bourtchuladze  et  al.  1994).    PKA  and  CaMKIV 
phosphorylate the transcription factor CREB at serine 133 (Dash et al. 1991; Deak 
et al. 1998) leading to the activation of several IEGs by binding to the CRE sites 
present in their promoter regions and, ultimately, regulating gene transcription.  In 
contrast, CaMKII can phosphorylate CREB at serine 142 which reduces CREB-
mediated  transcription  (Matthews  et  al.  1994; Wu  et  al.  2001).    LTP  induction 
increases  CREB  phosphorylation  (Bito  et  al.  1996)  and  transcription  regulation 
requires the maintenance of CREB phosphorylation at serine 133, which has been 
attributed to Rsk2 via ERK (Hardingham et al. 2001; Wu et al. 2001).  However, 
Rsk2 targeted deletion does not seem to alter CREB phosphorylation (Sassone-
Corsi et al. 1999; Bruning et al. 2000).  More recently, Msk1, rather than Rsk2, has 
been linked to CREB phosphorylation in neurones (Arthur et al. 2004; Rakhit et al. 
2005).    Evidence  from  Aplysia,  Drosophila,  mice  and  rats  demonstrates  that 
region-specific cAMP-responsive transcription mediated by CREB is crucial in the 
establishment of long term, but not short-term, memory (Kaang et al. 1993; Yin et 
al. 1994; Bourtchuladze et al. 1994; Lamprecht et al. 1997; Yin & Tully 1996).  In 
addition,  MEK  inhibitors  block  CREB  targeted  gene  transcription  after  LTP 
induction and fear dependent learning (Impey et al. 1998; Athos et al. 2002), and 
in CREB deficient mice, LTP induction decreases more rapidly than in control mice 
(Bourtchuladze et al. 1994).   
1.1.8  LTP Maintenance 
The stimulation of cell-surface receptors (e.g. NMDA receptors), and subsequent 
activation  of  cytoplasmic  second-messenger  systems,  eventually  results  in  an 
early wave of immediate early gene transcription.  The expression of these genes 
at  the  mRNA  level  rises  markedly  and  transiently  in  the  cell  shortly  after 
stimulation and in the absence of de novo protein synthesis.  Once translated, 
these  inducible  transcription  factors  re-enter  the  nucleus  and  regulate  the 
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neurones during transient memory formation that subsequently alter transcription 
are important in the conversion of short-term to long-term memory. 
Evidence  suggests  that  all models  of  neuronal  plasticity  comprise  3  sequential 
LTP phases.  Phase 1 is dependent on existing protein modification and can last 
for the initial 2 hours after an LTP-inducing stimulus.  This phase is unaffected by 
transcriptional  and  translational  inhibition.   Phase  2 is  dependent  on increased 
mRNA translation, subsequently synthesising new protein, and is present between 
2 and 8 hours after the initial stimulus.  Phase 3 is the most sustained phase of 
LTP and is dependent on increased gene transcription, as well as further protein 
and mRNA synthesis, allowing  specific synapses to alter the  efficiency of their 
transmission  in  order  to  become  more  effective  (Morris  2004).    These  distinct 
temporal phases can be seen experimentally in each of the major hippocampal 
excitatory  synaptic  pathways  (Huang  et  al.  1996)  and  stable  LTP,  lasting  for 
months, has been obtained for both medial and lateral perforant path synapses 
(Abraham et al. 2002). 
Pharmacological  inhibition  of  activity-induced  translation,  and  the  speedy 
synthesis  of  de  novo  marker  and  reporter  proteins  in  response  to  LTP,  have 
determined that long-lasting forms of LTP require protein synthesis (Stanton and 
Sarvey 1984; Deadwyler et al. 1987; Frey et al. 1988; Mochida et al. 2001).  RNA 
synthesis inhibitors impair late phase LTP in the CA1 in vitro and in the dentate 
gyrus in vivo (Frey et al. 1996), and protein (and RNA) synthesis inhibitors impair 
long term memory formation whilst keeping short term memory intact (Squire et al. 
1980;  Davis  &  Squire  1984).    Thus,  protein  synthesis  is  important  for  the 
mechanisms of memory consolidation to occur. 
The most problematic issues regarding LTP maintenance are the localisation of 
definitive  synaptic  modifications  providing  the  foundation  for  enhanced 
transmission  and  the  understanding  of  the  mechanisms  by  which  these 
modifications are made persistent.  Alterations observed include an increase in the 
amount of transmitter released, implying the necessity for a retrograde messenger 
(Dolphin et al. 1982), an increase in the density of glutamate receptors (Lynch et 
al. 1982), an increase in size of dendritic spines (Fifkova & Van Harreveld 1977) 
,and  an  increase  in  protein  synthesis  (Duffy  et  al.  1981).    Altered  glutamate 
transporter levels have also been suggested to contribute to LTP and memory 
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Synaptic plasticity relies on input and synapse specificity, so localisation of protein 
products  for  modifications  and  stabilisation  in  synaptic  strength  is  an  inherent 
need.  There are several schools of thought that attempt to explain how alterations 
in transcription lead to synapse specific modifications.  A definitive model has not 
been  elucidated  however,  theories  include  the  specific  targeting  of  RNAs  and 
proteins  from  the  nucleus  to  activated  synapses;  the  existence  of  a  virtual 
conveyer belt that delivers proteins throughout the cell, but only increases synaptic 
strength in those synapses activated and ‗tagged‘; or the ability of synapses to 
translate  their  own  mRNAs locally  (Goelet  et  al.  1986;  Sossin  1996;  Schuman 
1997; Frey & Morris 1998). 
mRNA  can  be  translated  at  synapses,  as  indicated  by  the  presence  of  golgi 
elements,  rough  endoplasmic  reticulum,  polyribosomes,  translation  factors  and 
large populations of mRNAs within dendrites and dendritic spines (Job & Eberwine 
2001;  Bradshaw et al. 2003; Inamura et al. 2003).  Glutamate receptor agonists 
induce the synthesis of new proteins in isolated dendrites and synaptoneurosomes 
(Weiler et al. 1997; Bagni et al. 2000; Yin et al. 2002).  LTP induction causes 
polyribosomes  to  move  from  dendritic  shafts  into  spines  (Ostroff  et  al.  2002), 
allowing local protein synthesis and translation in synaptic plasticity.  An hour after 
LTP-inducing high frequency stimulation (HFS), the  total number of ribosomes, 
polysomes, and number of membrane bound ribosomes increase significantly in 
hippocampal  CA1  pyramidal  neurones  (Wenzel  et  al.  1993).    In  addition,  local 
application of a protein synthesis inhibitor only impairs LTP in those local dendrites 
rather  than  dendrites  found  further  down  the  cell  in  Schaffer-commissural 
synapses on CA1 pyramidal neurones in the murine hippocampus (Bradshaw et 
al.  2003).    MEK  inhibitors  effect  LTP  within  20  to  30  minutes  following  high 
frequency stimulation, and therefore ERK is probably unable to translocate to the 
nucleus, activate transcription and translation, then send the new gene product to 
potentiated synapses in such a short space of time (Ohno et al. 2001; Rosenblum 
et al. 2002; Selcher et al. 2003).  However, separating apical dendrites from their 
cell  bodies  allows  the  induction  of  LTP  that  lasts  for  approximately  3  hours, 
compared to 8-10 hours in intact slices.  This suggests that protein synthesis in 
isolated dendrites is sufficient for the early expression of translation dependent 
LTP but mRNA transcription in the soma is required for longer lasting potentiation 
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1.1.9  The Immediate Early Gene Zif268  
Zinc finger binding protein clone 268 (zif268) (Christy et al. 1988), also known as 
Krox24 (Lemaire et al. 1988, Lemaire et al. 1990), nerve growth factor-induced 
gene  A  (NGFI-A)  (Milbrandt  1987),  early  growth  response  gene-1  (Egr-1) 
(Sukhatme et al. 1988), tetradecanoyl phorbol acetate-induced sequence 8 (TIS8) 
(Lim et al. 1987), and ZENK (an acronym of zif268, egr-1, NGFI-A, Krox24), is an 
immediate early gene (IEG) that encodes an 82 and an 88kDa regulatory protein 
(depending on the initiator sequence) (Lemaire et al. 1990).  The gene is present 
in the mammalian genome as a single copy gene located on mouse chromosome 
18, and belongs to a multi-gene family of closely related transcription factors, the 
Egr proteins. 
As the name implies, zif268 is a zinc finger protein; it contains 3 zinc fingers in the 
DNA binding domain that allow the protein to control directly the transcription of 
other genes (Christy & Nathans 1989; Swirnoff & Milbrandt 1995).  There is a high 
homology  in  the  3  zinc  finger  sequences  in  all  members  of  the  Egr  family 
suggesting that the proteins may bind to the same consensus sequence of 5‘-
GCG(G/T)GGGCG-3‘  (Christy  &  Nathans  1989;  Cao  et  al.  1993;  Swirnoff  & 
Milbrandt 1995) found in the promoter regions of downstream target genes.  The 
other members of the Egr family are Egr-2, also known as Krox 20, Egr-3, also 
known as PILOT, and Egr-4, also known as NGFI-C and pAT133 (Joseph et al. 
1988; Crosby et al. 1991; Patwardhan et al. 1991; Mages et al. 1993).  Zif268 
protein has a modular organisation; there are distinct areas for DNA binding, and 
the activation or repression of transcription.  As befits a transcription factor, the 
zif268  protein  has  a  nuclear  localisation  within  the  neurone,  due  to  a  bipartite 
signal in the DNA-binding domain, which is located in either the second or third 
zinc  finger  (Gashler  et  al.  1993).    In  addition  to  the  DNA  binding  site,  zif268 
contains  an  activation  domain  that  has  not  been  fully  characterised  and  an 
inhibitory domain located between the two.  This allows zif268 expression to be 
regulated  by  binding  of  the  transcriptional  co-factor  proteins  NGFI-A  binding 
proteins  1  and  2  (NAB1  and  NAB2)  which  interact  with  the  inhibitory  domain 
(Russo et al. 1995; Svaren et al. 1996).  Both NAB1 and NAB2 block the biological 
activity of zif268 (Russo et al. 1995; Svaren et al. 1996; Thiel et al. 2000), and 
interestingly, zif268 has been shown to control the expression of NAB2, allowing 
for autoregulation via a negative feedback loop (Ehrengruber et al. 2000).  Zif268 
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CREB-binding proteins (Ramirez et al. 1997), NFĸB (Chapman & Perkins 2000), 
NFAT  (Decker  et  al.  2003)  or  C/EBP  (Zhang  et  al.  2003)  can  all  modify  the 
transcriptional  actions  of  zif268,  suggesting  that  zif268  can  exert  a  variety  of 
effects depending on which other transcription factors are active at that time. 
In, or adjacent to, the promoter region of the zif268 gene are several different 
regulatory  sites,  including  cyclic-AMP-responsive  element  (CRE)  sites,  serum 
response  element  (SRE)  sites,  activator  protein  1  like  motifs (AP-1),  AP-2  like 
binding  sequences,  specificity  protein  1  element  (Sp1)  -like  motifs,  and,  in 
humans, an Egr/Zif268 response element (ERE) (Tsai-Morris et al. 1988; Christy & 
Nathans 1989; Sakamoto et al. 1991; Alexandropoulos et al. 1992b; Schwachtgen 
et al. 2000).  This abundance of regulatory sites allows several different signalling 
pathways and kinases to induce and modulate zif268, including Elk-1 binding to 
the SRE sites, CREB binding to the CRE sites and the Fos-Jun dimerised protein 
binding to the AP-1 site.  In addition, its own family members can bind to the ERE 
site and, for enhanced autoregulation, zif268 itself can also bind. 
During  development,  zif268  is  expressed  in  the  endothelial  system,  thymus, 
muscle, cartilage, bone and parts of the central and peripheral nervous system 
(McMahon  et  al.  1990;  Watson  and  Milbrandt  1990).    In  the  rat  brain,  basal 
constitutive  expression  of  zif268  mRNA  is  found  in  many  areas  including  the 
primary visual cortex, entorhinal cortex, olfactory cortex, neocortex, and several 
subcortical  regions including  the  hippocampus  and  striatum.    In  the  neocortex, 
zif268  is  mainly  expressed  in  layers  IV  and  VI,  and  in  the  hippocampus  it  is 
expressed  at  its  highest  levels  in  CA1,  to  a  lesser  extent  in  CA2-CA4  and  is 
virtually  absent  in  the  dentate  gyrus  (Schlingensiepen  et  al.  1991).    Protein 
expressions display a very similar pattern to that of mRNA  (Beckmann & Wilce 
1997). 
Zif268 was initially identified as a nerve growth factor response gene product in rat 
PC-12  cells,  and  an  immediate-early  serum  and  growth  factor  response  gene 
product in mouse fibroblasts, before similar genes were identified in other species 
(Sukhatme et al. 1988; Milbrandt 1987; Christy et al. 1988; Suggs et al. 1990; Lau 
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1.1.10  Zif268 activation in Long Term Potentiation 
As  an  inducible  transcription  factor,  zif268  can  be  activated  by  a  variety  of 
pharmacological  and  physiological  stimuli  including  growth  factors, 
neurotransmitters,  depolarization,  peptides,  nitric  oxide,  ischaemia,  seizures, 
neurodegeneration,  apoptosis  and  cellular  stress  (reviewed  in  Hughes  & 
Dragunow 1995; Beckmann & Wilce 1997; Herdegen & Leah 1998).  Immediate 
early genes are rapidly and transiently activated after LTP induction, and therefore 
possibly  constitute  an  early  genomic  response  for  triggering  the  mechanisms 
underlying persistent cell modification.  An important biological function of these 
modifications in neurones may be to underlie the maintenance or stabilisation of 
neuronal plasticity and the formation of long-term memories.  With reference to 
LTP, it has been shown that glutamate, as well as synthetic agonists targeted to 
specific types of glutamate receptors, are effective in activating zif268 (Condorelli 
et al. 1994).  The administration of NMDA and kainate to the cerebral cortex and 
hippocampus of rats in vivo effectively increases zif268 activity (Beckmann et al. 
1997).  The resultant increase in Ca
2+ within the cytosol can also induce zif268 
expression (Murphy et al. 1991; Ghosh et al. 1994). 
Ras can be activated by the protein tyrosine kinase Src in response to an increase 
in  intracellular  calcium  within  PC-12  cells.    Src  activation,  which  triggers  the 
formation  of  an  Shc/Grb2  complex  (an  adaptor  protein/growth-factor-receptor 
binding protein 2), leads to Ras activation in PC-12 cells (Rusanescu et al. 1995), 
which, in turn, activates Raf and further downstream, ERK and zif268 (Qureshi et 
al. 1991; Alexandropoulos et al. 1992a).  Raf activates MAPK/ERK kinase (MEK) 
by  phosphorylation  which,  in  turn,  phosphorylates  the  serine/threonine  kinases 
ERK1  and  ERK2,  leading  to  their  activation,  and  ultimately  the  modification  of 
many different types of proteins, including transcription factors, like CREB.  In vivo 
stimulation  of  the  glutamatergic  corticostriatal  pathway  induces  a  transient 
activation of ERK, which is spatially coincident with the onset of zif268 expression 
in the lateral striatum (Sgambato et al. 1998).  Infusion of MEK inhibitors prior to 
LTP  can  prevent  (Davis  et  al.  2000),  or  attenuate  (Rosenblum  et  al.  2002), 
transcription of zif268 in the dentate gyrus.  However, zif268 activation in dentate 
granule  cells  by  LTP  induction  of  the  perforant  pathway  did  not  produce  a 
concurrent increase in the level of phosphorylated CREB in one study (Walton et 
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(Blendy  et  al.  1995).  This  may  suggest  that  CREB  activity  is  not  the  major 
determinant of zif268 expression in hippocampal neurones. 
Another  possible  activator  of  zif268,  Elk-1,  binds  to  the  SRE  in  upstream 
regulatory regions of IEGs (Wasylyk et al. 1998) and is activated simultaneously 
with ERK, CREB, and zif268 induction in vivo (Sgambato et al. 1998).  Elk-1 is 
activated  by  ERK  and  the  c-Jun  N-terminal  protein  kinase  (JNK),  leading  to 
enhanced  DNA-binding  activity  (Treisman  1995;  Whitmarsh  et  al.  1995).    LTP 
induction in  the  dentate  gyrus  leads  to  the  phosphorylation  of  ERK,  Elk-1  and 
CREB and the transcriptional activation of zif268, whilst MEK inhibitors prevent the 
cascade, resulting in rapidly decaying LTP (Davis et al. 2000).  This points towards 
two parallel and possibly co-operating signalling pathways.  It remains unknown 
whether  zif268  regulation  is  dictated  by  CRE  or  SRE-mediated  transcription, 
although the contradictory CREB evidence coupled with the presence of 6 SRE 
sites compared to 2 CRE sites strongly suggests zif268 is controlled by SRE via 
MAPK-mediated Elk-1 activation.  A simplified schematic representation of zif268 
induction during LTP is presented in figure 1.2. 
1.1.11  Zif268 and Long Term Depression 
LTD is a synaptic mechanism of neuronal plasticity that involves a long-lasting 
decrease in synaptic efficiency following synaptic stimulation.  LTD can be induced 
by similar stimulus conditions, can persist as long as LTP (Abraham et al. 1994), 
and can be blocked by inhibitors of transcription and translation.  Behaviourally, 
spontaneous recovery of conditioned fear is associated with sustained prefrontal 
LTD  (Herry  &  Garcia  2002,  2003).    Zif268  mRNA  is  upregulated  after  LTD 
induction  at  CA3/CA1  synapses  (Lindecke  et  al.  2006),  and  increased  protein 
levels  correlate  strongly  with  the  persistence  of  heterosynaptic  LTD  in  the 
perforant path (Abraham et al. 1994).  Therefore, zif268 induction may be a key 
factor in inhibitory (LTD) as well as excitatory (LTP) learning paradigms (Herry & 
Mons 2004). 
1.1.12  Zif268 & synaptic plasticity in the dentate gyrus 
Zif268 is a regulatory IEG, activating (or suppressing) downstream target genes 
that presumably play a role in the duration and stabilisation of LTP, in particular 
the production of LTP phase III.  The induction of long-lasting LTP in the dentate 
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1989; Wisden et al. 1990), but, in contrast, continuous low frequency stimulation 
does not (Cole et al. 1989; Richardson et al. 1992; Worley et al. 1993).  Tetanic 
stimulation of the perforant path, inducing LTP at dentate gyrus synapses, results 
in ipsilateral upregulation of zif268 mRNA which is more prevalent in the dorsal 
than the ventral hippocampus (Cole et al. 1989; Richardson et al. 1992; Abraham 
et al. 1993; Williams et al. 2000).  The threshold for inducing zif268 expression is 
similar to the threshold intensity necessary to induce LTP phase III, but not phases 
I or II (Abraham et al. 1993; Worley et al. 1993). 
Zif268 upregulation correlates with the persistence of LTP rather than magnitude 
of induction (Richardson et al. 1992) and, after LTP induction, zif268 DNA binding 
activity to its response element rapidly increases in an NMDAR-dependent manner 
(Williams et al. 2000).  Conversely, blocking the induction of LTP by stimulation of 
the  inhibitory  commissural  input  to  the  dentate  gyrus  during  perforant  path 
tetanization  blocks  the  LTP-associated  increase  in  zif268  expression,  as  does 
NMDAR antagonism (Cole et al. 1989; Wisden et al. 1990; Worley et al. 1993; 
Salin et al. 2002). 
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Figure  1.2:  A  simplified  schematic  representation  of  zif268  activation  during  LTP.    The 
release of glutamate into the synaptic gap between neurones activates glutamate receptors and, in 
NMDAR-dependent LTP, the NMDA receptor.  This leads to several signal transduction cascades 
that ultimately activate zif268. 
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After perforant pathway tetanization, zif268 mRNA levels in the dentate gyrus peak 
with a 6 to 9 fold increase after around 20 minutes, but return to base-line within 2 
hours  (Cole  et  al.  1989;  Wisden  et  al.  1990).    Zif268  immunoreactivity  peaks 
around  2  hours  and  returns  to  baseline  after  8  hours.    This  timecourse is  too 
prolonged for the initial stages of LTP, which peaks within a couple of  minutes 
following tetanization (Richardson et al. 1992), but is consistent with zif268 target 
genes contributing to phase III of LTP.  
1.1.13  Zif268 and neuronal plasticity throughout the brain 
Evidence pertaining to zif268‘s involvement in LTP within other areas of the brain 
suggests that it is not vital for all types of plasticity in all brain regions.  There are 
very  few  publications  regarding  zif268  activation  coupled  with  LTP  induction in 
regions  other  than  the  perforant  path-granule  cell  synapse.    Zif268  mRNA  is 
upregulated in the primary visual cortex after tetanic stimulation of the dorsolateral 
geniculate  nucleus  (Heynen  &  Bear  2001),  and  in  the  insular  cortex  after 
stimulation of the basolateral amygdala, although this was also induced by low 
frequency stimulation and was apparent throughout the entire cortex (Jones et al. 
1999).  Zif268 induction in the CA1 pyramidal cells of the rat hippocampus after 
LTP  has  been  reported  (Roberts  et  al.  1996)  although,  French  et  al.  (2001) 
detected no changes in zif268 in the CA1 pyramidal cells of the hippocampus after 
induction of LTP by high-frequency stimulation of the commissural projection in 
freely moving rats, even though the LTP detected lasted for 5 days.  However, 
they did show zif268 could be modulated in response to electroconvulsive shock 
and  their  detection  assay  was  rather  insensitive  (Prof.  B.  J.  Morris,  personal 
communication) so the negative result after LTP induction should be viewed with 
caution.  Overall therefore, zif268 may be region-specific and not LTP-specific in 
some  systems,  although  zif268  induction  in  learning  has  been  relatively 
widespread.  
1.1.14  Zif268 regulation during learning 
A rapid increase in zif268 expression has been associated with some, but not all, 
forms  of  learning  and  long-term  memory  in  many  different  species.    In  the 
macaque monkey, visual paired associative learning increases zif268 protein in 
the  anterior  temporal  lobe,  a  finding  that  was  not  repeated  in  a  simple  visual 
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et al. 2002).  Zif268 is also rapidly regulated during associative learning in other 
species,  such  as  song  learning  in  birds  (Mello  et  al.  1992),  whereby  the 
upregulation is induced when song birds hear their own conspecies songs.  In 
addition, when a song is presented with a shock, there is a greater increase of 
zif268 in the caudomedial auditory telencephalon compared to the delivery of a 
song or a shock by themselves (Jarvis et al. 1995).  This implies a learning-related 
aspect to the zif268 induction. 
Within rats, associated learning tasks (Malkani & Rosen 2000) and spatial learning 
tasks (Fordyce et al. 1994) have displayed increases in zif268 expression.  After 
20  minutes  training  to  locate  the  platform  within  a  water  maze,  zif268  is 
upregulated in the hippocampus (Guzowski et al. 2001).  However, after extended 
spatial learning over several days, no overexpression of zif268 can be located, 
providing further evidence for the rapid and transient nature of zif268 activation 
(Richter-Levin & Segal 1988; Wisden et al. 1990).  C57 mice have a genetically-
defined higher basal level of zif268 compared to the DBA strain of mouse, and the 
C57 mice perform better in the water maze task than the DBA mice (Fordyce & 
Wehner  1993).    Animals  housed  in  an  enriched  environment,  which  improves 
cognitive function (Hebb 1949), display a significant increase in zif268 mRNA in 
the CA3 and CA4 areas of the hippocampus compared to those raised in isolation.  
In addition, these animals performed better in a spatial learning task compared to 
controls (Toscano et al. 2006). Induction of zif268 within the acquisition phase of 
two-way avoidance training has been demonstrated with a marked accumulation 
of  zif268  occurring  within  the  hippocampus  and  visual  cortex  (Nikolaev  et  al. 
1992). 
Learning-related  increases  in  zif268  expression  have  also  been  seen  in  the 
accessory olfactory bulb of female mice in response to pheromone signals and 
putative pheromonal constituents (Brennan et al. 1992; Brennan et al. 1999), and 
in  the  hippocampus  after  active  avoidance  learning  (Nikolaev  et  al.  1992)  or 
brightness  discrimination  (Grimm  &  Tischmeyer  1997).    In  addition,  zif268 
expression is elevated in the nucleus of the solitary tract, the parabrachial nucleus, 
the hypothalamic paraventricular nucleus and the central nucleus of the amygdala 
in animals trained in conditioned taste aversion (Lamprecht & Dudai 1995). 
Fear conditioning is rapidly acquired and has been shown to rely on the amygdala 
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contextual conditioning (Kim & Fanselow 1992; Maren & Fanselow 1996; Rogan & 
LeDoux  1996;  Frankland  et  al.  1998).    Contradictory  results  regarding  the 
involvement of zif268 within the experimental paradigm of associating footshock 
with  a  tone  or  particular  environment  have  been  published.    Malkani  &  Rosen 
(2000), and Hall et al. (2000) both report an increase in zif268 mRNA in area CA1 
of  the  hippocampus  following  contextual  fear  conditioning  in  both  controls  and 
experimental groups, indicating that the result is not learning specific and merely 
due  to  novelty.    In  the  amygdala  however,  Malkani  &  Rosen  (2000)  noted  an 
increase of zif268 in the lateral nucleus of the amygdala specifically in response to 
learning.  Hall et al. (2000) on the other hand, also noted a similar increase in the 
control  group  exposed  to  the  training  chamber  relative  to  naïve  controls.    In 
addition, a retention test 24 hours after learning reportedly produced no change in 
zif268 levels in the CA1 or amygdala in the experiment by Malkani & Rosen (2000) 
but did produce an increase in these areas in the experiment by Hall et al. (2001).  
Therefore, with regard to contextual fear learning, one group state that zif268 is 
involved  in  learning,  but  not  retrieval  (Malkani  &  Rosen  2000),  and  the  other 
concludes that zif268 is involved in retrieval, but not learning (Hall et al. 2000).  
However, the latter group noted zif268 may also be involved in retrieval in the 
nucleus accumbens and cingulate cortex (Thomas et al. 2002).  Following on from 
their earlier work, Malkani & Rosen (2001) administered APV, an NMDA receptor 
antagonist known to block the acquisition of fear conditioning (Kim et al. 1991; 
Maren & Fanselow 1996; Lee & Kim 1998), and discovered that it also stopped the 
learning-induced  increase  in  zif268  expression  found  by  them  in  the  lateral 
nucleus of the amygdala.  Lee et al. (2004) reported that zif268 was not required 
for memory consolidation in hippocampus-dependent contextual fear conditioning, 
but  essential  for  reconsolidation  (whereby  a  recalled  memory  is  reinforced  to 
become permanent).  Further studies are required to elucidate the exact role of 
zif268 in this particular mode of learning. 
Zif268 is also activated in simpler forms of learning.  In vitro, classical conditioning 
of the brainstem in turtles increases zif268 protein, which can be reversed with the 
application of APV, illustrating a dependency for NMDARs (Mokin & Keifer 2006). 
1.1.15  The effects of zif268 gene targeted deletion 
Topilko et al. (1997) generated mutant zif268 null mice by inserting the lacZ gene 
upstream of the initiation codon, with an additional frameshift mutation upstream of Donna M McDade, 2007    Chapter 1, 43 
the  DNA  binding  domain,  ensuring  that  zif268  was  neither  transcribed  nor 
translated.  The pups were born normally and capable of survival to adulthood, but 
both male and female mice homozygous for mutation had a reduced body size 
and were sterile.  Analysis of tissues and organs revealed numerous deficits in the 
anterior pituitary and reproductive system. 
Comparing zif268 -/- mutant mice to wildtype littermates after induction of LTP in 
the dentate gyrus displays a comparable potentiation for 50 – 60 minutes after 
tetanisation.  However, measuring 24 and 48 hours after tetanus demonstrates 
that  late  LTP  in  the  homozygous  and  heterozygous  mutants  decayed  back  to 
basal levels within 24 hours after induction. This demonstrates the necessity of 
activation of zif268 in the stabilisation of long-term LTP in the dentate gyrus (Jones 
et al. 2001). 
Behavioural  analysis  performed  on  zif268  -/-  mutant  mice  has  shown  a  strong 
deficiency in long-term memory formation tested on a variety of behavioural tasks, 
including  olfactory  discrimination,  novel  object  recognition,  conditioned  taste 
aversion and the Morris water maze.  This effect was not exhibited during normal 
short-term  retention  evaluations,  namely  spatial  behaviour  in  a  T  maze,  object 
recognition and social transmission of food preference (Jones et al. 2001).  These 
data show that the deficits encountered in zif268 knockout mice are not specific to 
a particular task, but to a general deficit in the consolidation of memories. 
1.1.16  Downstream targets of zif268  
The gene products of zif268 can act as nuclear transcription factors to regulate the 
transcription  of  target  genes.    Translation  of  both  newly  transcribed  and  pre-
existing mRNAs occurs within hours of LTP induction and plays an important role 
in maintaining LTP.  Up until 2005 and the publication by James et al. (2005), very 
few  genes  had  been  suggested  as  possible  CNS  targets  for  LTP-induced 
regulation by zif268.   
Synapsin I and synapsin II gene transcription is activated by an increase in zif268 
(Thiel  et  al.  1994;  Petersohn  et  al.  1995).    In  particular,  the  gene  encoding 
synapsin I is found to be upregulated in the dentate gyrus granule cells after LTP 
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regulation of a pre-synaptic protein downstream of zif268 activation suggests the 
propagation of plasticity through neural networks. 
Tyrosine  Hydroxylase  (TH),  the  enzyme  involved  in  the  biosynthesis  of  the 
catecholamines,  was  recently  shown  to  contain  an  Egr-1  motif  in  its  promoter 
region (Papanikolaou & Sabban 1999).  Transiently transfecting zif268 into PC-12 
cells  is  sufficient  to  drive  the  proximal  rat  TH  promoter  as  measured  by  the 
increased  activity  of  the  CAT  reporter  gene  (Papanikolaou  &  Sabban  2000).  
Phenylethanolamine  N-methyltransferase  (PNMT)  catalyses  the  conversion  of 
noradrenaline  to  adrenaline  and  has  two  potential  ERE  sites.    PNMT  gene 
expression  is  enhanced  when  RS1  cells  are  transiently  transfected  with  zif268 
(Ebert et al. 1994) or administered with phorbol 12-myristate 13-acetate (PMA), 
which stimulates endogenous zif268 (Morita et al. 1995).  However, PNMT has not 
been observed to change in models of learning behaviour.  Other specific target 
genes  of  zif268  include  adenosine  deaminase  (Ackerman  et  al.  1991), 
acetylcholine esterase  (Li et al. 1993), the  -myosin heavy chain  (Gupta et al. 
1991) and the cdk5-regulator, p35 (Harada et al. 2001).  
In  2005,  James  et  al.  published  a  microarray  experiment  that  identified  153 
differentially  expressed  known  genes  as  neuronal  targets  of  zif268,  the  vast 
majority  of  which  were  significantly  downregulated.    These  included 
neurotransmitters  and  modulators,  receptors,  signalling  genes,  pre-synaptic 
elements and genes involved in synapse formation, the proteasome, the major 
histocompatability  complex,  the  immune  response,  vesicle  trafficking,  the 
cytoskeleton,  translation,  chromaffin  cell  function  and  metabolic  processes.  
Rigorous statistical analysis revealed that only 8 of these genes were likely to be 
false positives.  A random selection of candidate genes was verified in two CNS 
plasticity models in vitro and in vivo, as representative authentication of the cell 
line results.   
It seems that zif268 may be an activator or suppressor of transcription depending 
on the context in which the data is gathered.  James et al. (2005) found that the 
pattern of altered gene expression was different in differing areas of the brain, 
namely the hippocampus and the striatum.  In addition, TH was downregulated in 
the PC-12 cells, but has been reported as upregulated (Papanikolaou & Sabban 
2000) and indeed downregulated in other reports (Maharjan et al. 2005).  Also, 
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(Wang et al. 1999).  Most strikingly, in a single cell type – prostate carcinoma cells 
– zif268 mediates increased transcription of CREB-binding protein (CBP) after one 
stimulus (serum) and reduced CBP transcription after another stimulus (UV) (Yu et 
al.  2004).    The  ability  of  zif268  to  act  as  either  a  transcriptional  activator  or 
repressor may therefore depend on factors such as its phosphorylation state and 
interaction with other transcription factors. 
Within  the  many  known  genes  identified  by  the  microarray  experiment  as 
downstream targets of zif268 were gephyrin and ubiquilin (James  et al. 2005).  
Gephyrin  displayed  a  negative  fold  change  of  1.36  and  ubiquilin  showed  a 
negative fold change of 1.57.  These proteins are interesting as they have both 
been associated with the GABAAR, an inhibitory ligand-gated chloride channel.  
1.1.17  The GABAAR 
Whilst  glutamate  is  the  major  excitatory  neurotransmitter  in  the  brain,  gamma-
aminobutyric acid (GABA) is the major inhibitory neurotransmitter.  There are 3 
GABA  receptor  subtypes:  A,  B  and  C.    GABAA  and  GABAC  are  ionotropic 
receptors, allowing Cl
- ions to enter the cell, resulting in hyperpolarisation and a 
reduction in cell excitability.  On the other hand, GABAB is a metabotropic-type 
receptor,  allowing  K
+  to  enter  and  reducing  presynaptic  levels  of  Ca
2+  after 
activation of the associated G-protein.   
GABAARs are ligand gated inhibitory receptors that are distributed throughout the 
CNS.  They are arranged in a pentameric stoichiometry with subunits recruited 
from a range of 21 (currently known) different subunits ( 1-6,  1-4,  1-4,  ,  ,  ,   and 
1-3) (Bonnert et al. 1999; Whiting 1999; Burt 2003).  The  1 2/3 2 combination is 
the  predominantly  expressed  receptor  isoform  (Fritschy  &  Mohler  1995)  and 
2 :2 :1  is the most likely ratio (Chang et al. 1996; Tretter et al. 1997; Farrar et al. 
1999).  Gephyrin and the  2 subunit are required for the clustering of GABAARs at 
postsynaptic  sites  (Essrich  et  al.  1998),  gephyrin  may  bind  to  the  3  subunit 
(Kirsch  et  al.  1995),  and  can  be  co-localised  with  the  1,  2,  3,  3  and  2 
subunits  in  rat  brain  and  dissociated  cultures  (Sassoe-Pognetto  et  al.  2000; 
Danglot et al. 2003).  Ubiquilin binds to the  1,  2,  3,  6,  1,  2 and  3 subunits 
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Synaptically localised GABAARs allow phasic GABA-mediated transmission, which 
is produced by 0.3mM GABA within the synaptic cleft for less than 1 millisecond 
(Mody et al. 1994; Cherubini & Conti 2001; Nusser et al. 2001).  Once activated, 
GABAARs  produce  inhibitory  postsynaptic  potentials  (IPSPs),  the  magnitude  of 
which is determined by the number, and properties, of the receptors present, and 
the concentration and duration of GABA release.  In addition to phasic activation is 
tonic  neurotransmission,  produced  by  continuous  activation  of  extrasynaptic 
receptors by micro-molar GABA levels, spilt from the synaptic cleft and always 
present in the extracellular space (Scanziani 2000; Semyanov et al. 2004; Mody & 
Pearce  2004).    Tonic  inhibition  may  play  a  crucial  role  in  regulating  neuronal 
excitability by setting the threshold for action potential generation (Petrini et al. 
2004).  
1.1.18  Gephyrin  
Gephyrin is widely expressed throughout the mammalian CNS (Prior et al. 1992; 
Kirsch et al. 1993), binds to polymerised tubulin (Kirsch et al. 1991), and is co-
purified with the inhibitory glycine receptor (Langosch et al. 1992).  Its association 
with microtubules may aid the development of a subsynaptic lattice, or scaffold, 
below the plasma membrane anchoring receptors at the cytoplasmic face of the 
cell membrane, by binding directly, or possibly indirectly, to the cytoplasmic loops 
of  receptor  subunits  (Kneussel et  al.  1999b;  Meier  et  al.  2001).    The  synaptic 
anchoring  of  inhibitory  receptors  was  established  by  antisense  oligonucleotide 
depletion  (Kirsch  et  al.  1993;  Essrich  et  al.  1998),  and  gene  knockout  in mice 
(Feng  et  al.  1998;  Kneussel  et  al.  1999a),  which  prevented  the  localisation  of 
GlyRs and GABAARs to the synapse.  The role of gephyrin in GlyR clustering will 
be dealt with in more depth in chapter 4.  
1.1.19  Gephyrin and the Cytoskeleton 
The postsynaptic density (PSD) lines the cytoplasmic face of the cell membrane 
and comprises microtubules, neurofilaments and their associated proteins.  At the 
PSD  of  inhibitory  synapses,  gephyrin  interacts  with  components  of  the 
cytoskeleton, and is thought to connect the cytoplasmic domain of glycine receptor 
and GABAAR polypeptides to 2 cytoskeletal systems, the microtubules (tubulin) 
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An intact microtubular cytoskeleton seems to be essential for the stabilisation of 
postsynaptic gephyrin clusters.  Gephyrin clusters are enriched with G-actin (actin 
monomers) but there is no direct association between the two (Giesemann et al. 
2003),  and  gephyrin  puncta  are  aligned  with  filamentous  actin  (F-actin)  in 
dendrites, and are localised to inhibitory synapses (Bausen et al. 2006).  Mena 
(mammalian  enabled)/VASP  (vasodilator-stimulated  phosphoprotein),  the  f-actin 
uncapping  protein  (Bear  et  al.  2002),  directly  interacts  with  G-actin  (Walders-
Harbeck  et  al.  2002)  and  profilin  (Reinhard  et  al.  1992;  Reinhard  et  al.  1995; 
Gertler  et  al.  1996),  an  actin  monomer  binding  protein  that  stimulates  actin 
polymerization by increasing ADP/ATP exchange (Sohn & Goldschmidt-Clermont 
1994).  Therefore, Mena/VASP can recruit profilin/actin monomer complexes to 
actin  filaments  in  order  to  allow  further  filament  generation  (Huttelmaier  et  al. 
1999; Bear et al. 2002).  Actin microfilaments are thought to control the inhibitory 
receptor density at postsynaptic sites.  Mena/VASP was found to precipitate and 
co-localise with gephyrin (Giesemann et al. 2003), and gephyrin also binds with 
profilin  (Mammoto  et  al.  1998).    Both  gephyrin  and  profilin  colocalise  and 
physically interact at inhibitory synapses in cultured neuronal cells and spinal cord 
sections  (Giesemann  et  al.  2003).    Cultured  spinal  cord  neurones  treated  with 
cytochalasin D (a drug that severs the actin cytoskeleton) show a reduction in 
postsynaptic  gephyrin  cluster  size  with  an  increase  in  packing  density,  whilst 
demecolcine (which disrupts microtubules) decreases the density of postsynaptic 
gephyrin clusters, increasing the cluster size (Kirsch & Betz 1995).  In addition, the 
lateral  mobility  of  the  inhibitory  GlyR  is  restricted  at  postsynaptic  sites  by  an 
interaction  with  the  microtubules,  and  demecolcine  decreases  GlyR 
immunoreactivity  apposed  to  presynaptic  terminals  (Kirsch  &  Betz  1995).  
However,  depolymerisation  of  microtubules  has  no  effect  on  the  distribution 
pattern of GABAARs; they remain intact and maintain a synaptic localisation in 
mature  hippocampal  cultures  (Allison  et  al.  2000),  suggesting  that  some 
mechanism other than microtubules is required to anchor gephyrin and GABAAR 
at  inhibitory  synapses  after  synaptogenesis.    In  addition,  in  HEK293  cells, 
intracellular gephyrin clusters do not appear to interact with, or depend on, actin 
filaments (Bausen et al. 2006). 
Gephyrin binds to dynein light chain-1 and –2 (Dlc-1 and –2) as determined by 
yeast dihybrid screening and biochemical assays.  Dlc-1 and –2 are components 
of  microtubule  motor  proteins,  and  seem  to  interact  with  gephyrin  whilst  co-
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gephyrin transport (Fuhrmann et al. 2002).  The subcellular localisation of gephyrin 
at the synapse may therefore depend on motor proteins.  In addition, disrupting 
microtubules with nocodazole or dynamitin, a dynein transport inhibitor, interferes 
with gephyrin‘s transport by dynein intermediate and heavy chains (Maas et al. 
2006). 
The Rho family small G proteins regulate various actin cytoskeleton-dependent 
cell functions including cell shape change, cell motility and cytokinesis.  Collybistin 
(from Greek  : to exchange) is predominantly a brain specific GEF for 
small  GTPases  of  the  Rho/Rac-family  thought  to  constitute  an  essential 
component  of  the  signalling  machinery  that  directs  gephyrin  to  the  developing 
postsynaptic  membrane  (Kins  et  al.  2000).    The  splice  variants  I  and  II  were 
detected  as  binding  partners  of  the  C-terminal  domain  of  gephyrin  by  yeast 
dihybrid  screening  of  newborn  rat  brain.    Collybistin  I  was  redistributed  to 
gephyrin-rich  cytoplasmic  aggregates  when  co-transfected  into  HEK293  cells.  
Collybistin II was able to induce submembrane gephyrin microaggregates, which 
recruited   subunit containing GlyRs (Kins et al. 2000).  In addition, a mutation in 
exon  2  of  the  human  collybistin  gene  results  in  hyperekplexia  and  epilepsy, 
possibly due to the misdirected localisation of gephyrin and associated GlyR and 
GABAARs.    Therefore,  collybistin  could  be  a  key  protein  for  the  postsynaptic 
localisation of gephyrin (Harvey et al. 2004). 
1.1.20  Gephyrin and GABARAP 
GABAAR-associated protein (GABARAP) has a tubulin-binding motif (Wang et al. 
1999;  Wang  &  Olsen  2000),  and  colocalises  with  GABAAR  in  cultured  cortical 
neurones  (Wang  et  al.  1999),  specifically  binding  its  N-terminal  domain  to  the 
GABAAR  2  subunit.    In  addition  GABARAP  binds  to  gephyrin;  however,  in 
cultured neurones of gephyrin deficient mice, no difference is seen in GABARAP 
puncta localisations compared to wildtypes (Kneussel et al. 2000).  GABARAP is 
not  localised  at  inhibitory  postsynaptic  sites  but  is  found  in  intracellular 
compartments,  particularly  concentrated  at  the  ends  of  the  Golgi  stacks  where 
transport vesicles bud and fuse (Kittler et al. 2001).  Therefore, it could interact 
with GABAAR subunits, and gephyrin before they reach the synapse and ultimately 
play a role in receptor trafficking.  In addition, binding of the GABARAP C-terminus 
to tubulin, and the N-terminus to GABAAR, suggests a role in linking the receptor 
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evidence has shown that overexpression of GABARAP in hippocampal neurones 
increases GABAARs at the cell surface (Leil et al. 2004).  However, GABARAP 
knockout  mice  show  no  differences  in  the  number  or  synaptic  distribution  of 
GABAARs containing  2 subunits at gephyrin positive postsynaptic sites compared 
to  wildtypes,  suggesting  that  it  may  not  be  essential  for  trafficking  or  synaptic 
localisation after all (O'Sullivan et al. 2005). 
1.1.21  Gephyrin and the GABAA Receptor 
Gephyrin was originally linked to glycine receptors alone, however, it is found in 
brain  regions  known  to  contain  little  or  no  evidence  of  glycinergic  synapses 
(Malosio et al. 1991; Kirsch et al. 1993).  Gephyrin immunoreactivity can be found 
in GABAergic synapses in cultured hippocampal (Craig et al. 1996), and cortical 
neurones (Essrich et al. 1998), as well as in areas such as the retina, olfactory 
bulb and spinal cord (Todd et al. 1996; Sassoe-Pognetto & Wassle 1997; Giustetto 
et al. 1998).  All presently available data, including gene depletion and knockout 
experiments, strongly indicates that gephyrin is associated with and essential for 
clustering of not only glycine receptors but specific GABAAR subtypes (Essrich et 
al.  1998;  Betz  1998;  Feng  et  al.  1998;  Kneussel  et  al.  1999a).    However, 
biochemical evidence for a direct association of GABAARs subunits and gephyrin 
has  not  been  demonstrated  (Meyer  et  al.  1995),  leading  to  the  notion  of  a 
hypothesised  linker  protein  that  mediates  the  association  of  gephyrin  with 
GABAARs.    Gephyrin  is  concentrated  in  the  postsynaptic  membrane  at  many 
inhibitory  synapses,  and  is  proposed  to  mediate  clustering  and/or  synaptic 
anchoring  of  GABAAR  through  indirect  binding  to  the  3  subunit  (Kirsch  et  al. 
1995).    It  has  also  been  shown  that  gephyrin  is  essential  for  the  postsynaptic 
clustering of GABAARs containing  1 or  2 and  2 subunits (Essrich et al. 1998; 
Kneussel et al. 1999a; Kneussel et al. 2001; Levi et al. 2004). 
There is evidence that infers some interdependence for the synaptic localisation of 
gephyrin  and  specific  subtypes  of  the  GABAAR.    Gephyrin  antisense 
oligonucleotide treatment of cultured cortical and cultured hippocampal neurones 
displays a reduction in punctate synaptic staining for GABAAR  2 and  2 subunits.  
In addition, the generation of mice with a targeted loss of the GABAAR  2 subunit 
resulted in a loss of postsynaptic gephyrin and GABAAR clusters (Essrich et al. 
1998;  Schweizer  et  al.  2003).    This  can  be  reversed  by  the  transgenic 
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regions within the subunit sequences.  Danglot et al. (2003) observed a decrease 
in the number of gephyrin clusters that did not contain GABAAR  2 subunits during 
maturation in hippocampal neurones.  Gephyrin deficient mice also display a total 
loss  of  postsynaptic  clusters  of  GABAAR  2  and  2  subunits  in  cultured 
hippocampal  neurones  (Kneussel  et  al.  1999a),  providing  further  evidence  that 
suggests these subunits are essential for clustering.  However, Levi et al. (2004) 
utilised  gephyrin  -/-  mice  to  assess  the  GABAergic  phenotype  of  cultured 
hippocampal neurones and observed surface synaptic clusters of  1,  2 and  2 
subunits  in  gephyrin  deficient  neurones.    In  spinal  cord,  GABAAR  3,  2/3,  2 
subunit  receptor  clustering  has  been  described,  in  an  impaired  manner,  in 
gephyrin  knockout  mice  (Kneussel  et  al.  2001)  suggesting  that  this  clustering 
might be independent of gephyrin.  It is likely that there are probably gephyrin-
dependent and -independent mechanisms for GABAAR clustering. 
Surface labelling by immunohistochemistry of gephyrin knockout mice indicates 
that  gephyrin  contributes  in  part  to  clustering,  but  not  surface  insertion  or 
stabilisation, of GABAAR  2 and  2 subunits (Levi et al. 2004).  Danglot et al. 
(2003) argue that gephyrin is more involved in synaptic stabilisation rather than 
cluster formation; they found that GABAAR  2 subunit clusters were observed in all 
hippocampal  neurones  before  10DIV,  even  when  gephyrin  clusters  were  only 
detected in a few neurones.  
The gephyrin gene is highly mosaic (Prior et al. 1992) increasing the likelihood of  
splice  variant  generation  which  may  go  some  way  to  explain  the  receptor 
selectivity on postsynaptic gephyrin. 
1.1.22  GABAA receptor trafficking 
Receptor ion channels, specialised for chemotransmission between neurones, are 
highly  concentrated  at  postsynaptic  densities  apposed  to  the  appropriate 
presynaptic nerve terminals.  GABAAR density and localisation at the postsynaptic 
cell  membrane  determines  neuronal  excitability  and  can  be  affected  by  many 
factors,  including  neuronal  activity.    The  trafficking  of  receptors  at  inhibitory 
synaptic  sites  is  an  important  feature  of  neuronal  plasticity.    During  periods  of 
neuronal plasticity and development, the numbers of GABAARs is subject to large 
alterations (Fritschy & Brunig 2003).  Insulin can increase the number of GABAAR 
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synaptic number (Wan et al. 1997; Brunig et al. 2001).  GABAARs are subject to 
continuous turnover: quick recovery and reinsertion of GABAARs that have been 
endocytosed or have been synthesised de novo and stored intracellularly allows 
the  rapid  adaptation  of  neural excitability  (Luscher  &  Keller  2001).    Figure  1.3 
displays a simplified diagram of GABAAR trafficking and targeting at the synapse. 
 
Figure 1.3: A simplified diagram of GABAA receptor trafficking and targeting at the synapse.  
Subunits of the GABAA receptor are synthesised in the endoplasmic reticulum and assembled into 
heteropentameric structures, predominantly from  ,   and   subunits, most likely with the ratio of 
2 :2 :1 .  Assembled receptors are then targeted by the Golgi apparatus to the plasma membrane, 
whilst unassembled subunits are degraded.  Receptors at the cell surface are localised to the 
synapse, or are targeted to clathrin coated pits and removed from the membrane by endocytosis. 
Receptors within the endosomes can be either recycled to the cell surface or degraded by the 
proteasome.  Diagram adapted from Barnes (2000). 
 
GABAAR assembly occurs in the endoplasmic reticulum (ER), and an investigation 
within HEK293 cells revealed that receptors require the  1 and  2 subunits for ER 
exit and cell surface expression, with the aid of chaperone proteins (Connolly et al. 
1996b).  The   subunit can also determine the route to the surface (Connolly et al. 
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whilst the δ subunit targets extrasynaptic sites (Jones et al. 1997; Brickley et al. 
1999; Sassoe-Pognetto et al. 2000).   It is suggested  that synaptic targeting of 
GABAAR relies on gephyrin as well (Essrich et al. 1998).  Some of the subunits 
also  undergo  alternate  splicing,  generating  additional  heterogeneity  (Burt  & 
Kamatchi 1991).  For instance, the short  2 subunit ( 2S) is able to reach the 
plasma membrane when expressed alone, but the long form ( 2L), which differs by 
8 amino acids, remains in the ER (Connolly et al. 1999a).  Either splice variant, 
when expressed with  1 and  2, is necessary for receptor endocytosis (Connolly 
et al. 1999b). 
Once  a  GABAAR  has  reached  the  synaptic  membrane,  and  remained  for  the 
requisite  amount  of  time,  the  receptor  may  be  mono-ubiquitinated,  and  those 
composed  of  /   or  / /   subunits  are  recruited  to  clathrin  coated  pits  and 
internalised by dynamin dependent constitutive endocytosis (Chapell et al. 1998; 
Connolly  et  al.  1999a;  Connolly  et  al.  1999b;  Ghansah  &  Weiss  2001;  van 
Rijnsoever et al. 2005).  The   and   GABAAR subunits interact with the   and   
adaptins; components of the AP2 complex that recruits proteins into the clathrin 
pits (Marsh & McMahon 1999; Kittler et al. 2000).  Once internalised, GABAAR are 
located to a subsynaptic intracellular pool that stains positively for gephyrin (van 
Rijnsoever et al. 2005).  Approximately 70% of receptors are then recycled to the 
cell surface, and the remainder are degraded (Connolly et al. 1999b;  Kittler et al. 
2004), a fate that may be decided by ubiquilin (Bedford et al. 2001).  The constant 
cycling of receptors between the cell membrane and internal structures has been 
shown  by  blocking  endocytosis;  after  20  to  40  minutes  the  mIPSC  amplitude 
increases  by  50-100%  (Kittler  et  al.  2000),  and  the  formation  of  intracellular 
receptor clusters is impaired (van Rijnsoever et al. 2005).  In addition, blocking the 
interaction  between  the  AP2  complex  and  the    GABAAR  subunit  confers  an 
increased cellular response to the application of GABA (Herring et al. 2003). 
In addition to impaired receptor localisation in gephyrin knockout mice compared 
to wildtype, an increased accumulation of intracellular GABAAR immunoreactive 
microclusters is observed, suggesting an enhanced receptor internalisation in the 
absence of gephyrin, and hence a defect in intracellular trafficking (Kneussel et al. 
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1.1.23  The ubiquitin-proteasome pathway  
Ubiquitin is a small 76 amino acid protein that exists in cells singly or covalently 
conjugated to other proteins. It may act as a sorting signal in early endosomes to 
target receptors and proteins for degradation by the lysosomal and proteasomal 
pathways.  
The  ubiquitin  proteasome  system  is  the  major  non-lysosomal  pathway  in 
eukaryotes for cellular protein degradation.  A poly-ubiquitin chain formed from 
ubiquitin  monomers  is  covalently  attached  to  proteins  targeted  for  destruction.  
The  ubiquitylation  process  involves  E1  (Ub-activating  enzyme),  E2  (Ub-
conjugating enzyme), and E3 (Ub-ligase) enzymes (Hershko & Ciechanover 1998; 
Voges et al. 1999; Glickman & Ciechanover 2002).  Ubiquitin is ATP-dependently 
activated  by  E1  forming  a  thioester  bond  between  a  cysteine  residue  and 
ubiquitin‘s C-terminal.  Ubiquitin is then conjugated to E2 which binds to E3 with 
the target protein.  Ubiquitin is attached from its c-terminus glycine to the protein, 
or  previous  ubiquitin,  through  the  -amino  group  of  a  lysine  residue  (most 
commonly K48 of ubiquitin if creating a chain).  Proteins can also be ubiquitylated 
on the  -amino group of the N-terminal residue (Glickman & Ciechanover 2002). 
E2 and E3 then lengthen the ubiquitin chain, sometimes with the help of E4, an 
accessory factor (Koegl et al. 1999).  These multi-ubiquitin tagged substrates are 
recognised  and  delivered  to  the  2.5  MDa  proteasome  holoenzyme,  the  26S 
proteasome.  
The  ubiquitin-26S  proteasome  degrades  target  proteins  ATP-dependently  into 
short polypeptides and recycled ubiquitin.  It is comprised of a 20S core chamber 
with a 19S regulatory cap, which can assemble at each end.  Poly-ubiquitylated 
proteins are first recognised by an interaction with the 19S regulatory complex, 
which then appears to unfold them and guide them through the 20S catalytic core 
for degradation (Glickman & Ciechanover 2002). 
The 19S regulatory particle is comprised of approximately 18 subunits, and forms 
two structures, a lid and a base.  Within the base are six homologous ATPases 
(Rpt1-6)  which  are  probably  responsible  for  protein  unfolding  and  guidance 
through 20S, via a gated channel (Groll et al. 1997; Braun et al. 1999; Horwich et 
al. 1999).  The base also contains three non-ATPases, Rpn1/S2, Rpn2/S1 and 
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lid  and  base,  and  is  the  only  known  subunit  that  binds  tightly  to  poly-ubiquitin 
chains,  but  not  mono-ubiquitin  (Deveraux  et  al.  1995;  Takeuchi  et  al.  1999; 
Wilkinson et al. 2000).  However, Rpn1 and 2 may be additional polyubiquitin or 
UBL binding sites  (Davy et al.  2001; Saeki et al. 2002).  The lid seems to be 
important for effective ubiquitinated protein degradation, although its purpose is 
unclear (Glickman et al. 1998), and consists of a further eight non-ATPases, Rpn3, 
-5, -6, -7, -8, -9, -11 and -12. 
The 20S core particle comprises two structural   protein rings, which surround two 
catalytic   protein rings.  The   subunits interact with the ATPases found in the 
19S base, effectively attaching the two 26S particles together (Davy et al. 2001; 
Fu et al. 2001).  The   subunits contain the proteolytic active sites with each   ring 
containing a post-glutamyl site, a tryptic site and importantly, a chymotryptic site.  
The  chymotryptic  site  plays  a  key  role  as  blocking  the  catalytic  activity  of  this 
protein can block all of the proteasomal activity (Kisselev et al. 1999). 
The  multiple  conjugating  enzymes  regulate  the  number  of  ubiquitin  molecules 
conjugated to a target protein (Ciechanover & Schwartz 1998) however; at least 4 
isopeptide-bonded ubiquitins are needed for recognition by 26S  (Thrower et al. 
2000).  Additional cellular regulation can be exerted by the removal of ubiquitins by 
deconjugating proteins (D'Andrea & Pellman 1998).  Conjugation of less than 4 
isopeptide-bonded ubiquitins can be referred to as mono-ubiquitination, which is a 
reversible  post-translational  modification  that  may  play  a  role  in  receptor 
endocytosis at the plasma membrane (Hicke & Dunn 2003). 
Many,  but  not  all  of  the  known  functions  of  ubiquitin  conjugation  involve  the 
targeted  degradation  of  the  modified  protein,  which  in  turn  can  control  many 
processes  like  cell  cycle  progression,  development  and  apoptosis.    Covalently 
attached ubiquitin to proteins can also be used as a post-translational modification 
that  can  be  identified  by  downstream  protein  receptors/interactors  in  non-
degradation  cellular  processes,  for  example,  DNA  repair,  transcription,  signal 
transduction and sorting of receptors (Hershko & Ciechanover 1998). 
There is also a non-ubiquitin proteasomal pathway that will not be dealt with in this 
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1.1.24  Ubiquilin is an Ubiquitin-like protein 
A highly conserved feature between ubiquilin and its homologous proteins (dealt 
with in more detail in chapter 5) is the inclusion of the ubiquitin-like (UBL) domain 
at  the  N-terminal  and  ubiquitin-associated  (UBA)  domain  positioned  at  the  C-
terminal.  Both the UBA and UBL domains have been implicated in the targeting 
and degradation of proteins by the ubiquitin-proteasome pathways. 
UBA domains are commonly occurring sequence motifs, present in one or two 
copies  in  some  members  of  the  ubiquitination  pathway  including  ubiquitin 
conjugating  enzymes,  ubiquitin-carrier  proteins  and  ubiquitin  carboxy-terminal 
hydrolases.    They  are  also  present  in  UV  excision  repair  proteins,  DNA  repair 
enzymes,  signal  transduction  proteins  and  certain  protein  kinases  (Hofmann  & 
Bucher  1996).    Fifteen  of  the  40  core  residues  within  the  domain  are  highly 
conserved,  suggesting  they  are  critical  in  determining  the  overall  structure 
(Hershko & Ciechanover 1998).  In ubiquilin, the UBA domain serves to bind poly 
ubiquitin chains in vitro suggesting that it blocks ubiquitin chain elongation in vivo 
(Massey et al. 2004). 
UBL proteins are designated either Type 1 or Type 2.  Type 1 UBL proteins can be 
covalently  linked  to  target  proteins  in  the  same  way  as  ubiquitin  and  may  be 
implicated  in  post-transcriptional  modifications.    Type  2  UBL  proteins  are  not 
ligated to other proteins, and are not fully understood  (Hershko & Ciechanover 
1998).  However, they may be involved in ubiquitin dependent proteolysis due to 
interactions with the proteasome (see below).  Ubiquilin is a type 2 UBL protein 
(Ko et al. 2002).  
1.1.25  Ubiquilin and the proteasome pathway 
There is much speculation that ubiquilin is involved in the ubiquitin-proteasome 
pathway.  Kleijnen et al. (2000) were the first to show direct evidence that ubiquilin 
associates  with  both  proteasomes  and  ubiquitin  ligases  in  large  complexes.  
Ubiquilin  was  found  to  complex  with  E6AP,  a  human  E3  ligase,  and  the  20S 
catalytic core of the proteasome. This interaction with the proteasome was via the 
UBL domain of ubiquilin.  In addition, overexpression of ubiquilin increased the 
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type  ligase,  TRCP.    Ubiquilin  overexpression  had  no  effect  on  ubiquitin-
independent proteasome substrates however.  
Ko et al. (2004) demonstrated that the UBA of ubiquilin interacts with poly-ubiquitin 
chains as overexpression of ubiquilin led to increased accumulation of large poly-
ubiquitin chains, compared to a mutant lacking a C-terminus.  They also found that 
the N-terminus UBL interacted with the 19S subunits Rpn3, Rpn10a and Rpn10e, 
but  not  Rpn1  or  -2.    Dsk2  (a  yeast  homologue  of  ubiquilin)  also  binds  to 
polyubiquitylated substrates through the UBA domain of the C-terminus, and to 
subunits of the 19S and 20S particles of the proteasome through the N-terminus 
(Funakoshi et al. 2002).  
1.1.26  Ubiquilin, the Proteasome and GABAARs 
Ubiquitination of neural surface receptors is generally regarded as a cellular signal 
for endocytosis of these proteins, allowing for rapid downregulation of receptors at 
the plasma membrane.  Altering the number of GABAARs present at postsynaptic 
sites would effectively alter the response to GABA. Therefore, constant receptor 
insertion  into  the  plasma  membrane  would  maintain  the  overall  cell  surface 
receptor number.  Dynamin dependent constitutive endocytic removal of GABAARs 
at synapses via clathrin coated pits requires the  2 subunit of GABAARS and the 
linker protein AP2 (Connolly et al. 1999a; Kittler et al. 2000).  However, membrane 
trafficking  to  replenish  the  synapse  with  either  recycled  or  newly  synthesised 
receptors at the membrane is poorly understood, and in the case of GABAARs it is 
unknown whether ubiquitination is a necessary requirement.   
Bedford et al. (2001) used a series of experiments to isolate ubiquilin, a novel 
binding partner of the majority of GABAAR   and   subunits, the most commonly 
expressed GABAAR subunits in the CNS.  They located ubiquilin to intracellular 
compartments  including  the  golgi  apparatus  and  clathrin-coated  pits.    Utilising 
ELISA, they monitored the effect of introducing a synthetic peptide, which would 
compete for ubiquilin binding with the GABAARs.  This decreased the number of 
receptors at the cell surface without effecting receptor internalisation.  Conversely, 
overexpression of ubiquilin dramatically increased the number of receptors located 
on  the  cell  surface.    The  same  effect  was  witnessed  after  treatment  with  a 
proteasome inhibitor in A293 cells expressing either  1 or  3 subunits.  Ubiquilin 
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increase  the  half-life  of  receptor  subunits.    These  findings  could  implicate  the 
ubiquitin proteasome pathway as a modulator of synaptic function and plasticity. 
1.1.27  Long Term Potentiation and the Proteasome 
In different brain regions, the subunit composition of the proteasome varies (Noda 
et al. 2000; Ding & Keller 2001) with the pyramidal neurones of the cerebral cortex 
and hippocampus showing the highest proteasome levels (Mengual et al. 1996).  
In hippocampal neurones, proteins of the proteasome complex are localised in the 
dendrites near synapses, whilst displaying a higher density in the soma (Ehlers 
2003;  Rezvani  et  al.  2003;  Bingol  &  Schuman  2006)  which,  circumstantially, 
implicates the proteasome in synaptic signalling.  Indeed, an emerging concept is 
that the regulated degradation of proteins by the ubiquitin proteasome pathway is 
an important modulator of synaptic function and plasticity.  However, the precise 
role  of  the  proteasome  in  synaptic  plasticity  requires  elucidation  as  published 
reports point to both a facilitatory and suppressive function. 
In the ubiquitin-dependent proteasome pathway, once a target protein has been 
ubiquitinated, it is delivered to the proteasome.  However, recent evidence has 
shown  an  interaction  of  proteasomes  with  proteins  physically  proximal  to 
degradation  targets,  suggesting  that  the  proteasome  moves  towards  the  target 
protein (Glickman & Raveh 2005).  A persistent redistribution of proteasomes from 
dendritic shafts to functionally active spines, minutes after synaptic stimulation by 
KCl, has been observed (Bingol & Schuman 2006).  APV blocked KCl-induced 
movements of 19S and 20S, indicating that NMDAR activation is required.  NMDA 
perfusion  into  a  localised  site  revealed  a  spatially  restricted  increase  in 
proteasomal activity, which led to an increase in protein degradation.  The long-
lasting effects suggest the involvement of the actin cytoskeleton, which was found 
to  be  associated  with  50%  of  the  proteasomes  in  dendrites.    In  addition, 
proteasomes  have  been  reported  to  associate  with  the  cytoplasmic  tails  of 
receptor  complexes  (Ferrell  et  al.  2000),  suggesting  a  capacity  for  rapid 
remodelling  of  membrane-associated  receptor  complexes  and  for  local  and 
persistent  remodelling  of  spines  through  on-site  coordinated  synthesis  and 
degradation of proteins (Burbea et al. 2002; Ehlers 2003; Colledge et al. 2003; Juo 
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The late phase of most, if not all, forms of synaptic plasticity  is dependent on 
enhanced  protein  synthesis  (Morris  2004),  and  complementary  to  this,  protein 
degradation has emerged as a mechanism to control synaptic protein composition 
(Colledge et al. 2003).  Proteasome inhibitors lead to deficits in LTP and attenuate 
learning and memory (Jiang et al. 1998; Chain et al. 1999; Foley et al. 2000), 
whereas compromised proteasome function has been linked to aging and memory 
impairment in humans (Keller et al. 2000).  Karpova et al. (2006) found that the 
use  of  Cbz-leu-leu-leucinal  (MG132),  a  cell  permeable  peptide  aldehyde 
proteasome inhibitor, blocked late phase LTP by reducing the magnitude of fEPSP 
slope potentiation, suggesting that late LTP specifically depends on proteasome 
activity.  In addition, induction of LTP dramatically accelerates the degradation of 
proteins  in  the  presence  of  anisomycin,  which  blocks  translational  activity, 
compared  to  a  non-LTP  control.    This  effect  was  reduced  in  the  presence  of 
MG132.  Using time-lapse imaging, Karpova et al. (2006) were able to show that 
proteasome  mediated  protein  degradation  was  induced  very  quickly  after 
tetanization of the Schaffer collateral CA1 synapses, consistent with the idea that 
fast proteasome-mediated degradation of scaffolding proteins occurs soon after 
tetanization.  In cultured hippocampal neurones, internalisation of the glutamate 
receptors GluR1 and GluR2, induced by AMPA, requires protein degradation via 
the  proteasome  system  (Colledge  et  al.  2003;  Patrick  et  al.  2003).    The 
proteasome system effects PKA and MAPK-dependent signalling pathways in the 
sensory neurone synapses of Aplysia (Chain et al. 1999). 
In contrast to the above evidence, published reports have shown that inhibition of 
proteasome  activity  facilitates  various  forms  of  plasticity;  it  augments  neurite 
outgrowth,  increases  presynaptic  neurotransmitter  release  and  enhances 
postsynaptic glutamate receptor sensitivity, (Obin et al. 1999; Speese et al. 2003; 
Zhao et al. 2003) suggesting that the proteasome suppresses plasticity.  There 
seems to be no explanation for this discrepancy at present. 
1.1.28  Regulation of the neuronal proteasome by zif268 
The link between the proteasome and LTP has recently been strengthened further 
by  the  finding  that  zif268  regulates  some  component  genes  of  the  neuronal 
proteasome.    James  et  al.  (2006)  monitored  proteasome  activity  in  zif268 
transfected  PC-12  cells,  and  found  a  significant  decrease  over  time  when 
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control.  The truncated (control) form of zif268 is efficiently  translocated to the 
nucleus, but does not bind to the Egr DNA recognition site.  The zif268 mutant 
displays  an  inhibitory  effect  on  wildtype  zif268-dependent  gene  transcription 
through an unknown mechanism (Gosslar et al. 1999).  
James et al. (2006) also found that proteasome activity was significantly elevated 
in zif268 knockout mice compared to control mice.  In particular they investigated 
psmb9,  an  inducible  proteolytic  β  subunit  of  the  20S  core  and  psme2,  an 
interferon-induced subunit of the 19S regulator; transcriptional expression of which 
increases  proteasome  activity  in  the  immunoproteasome  (Harris  et  al.  2001; 
Cascio et al. 2002).  In addition, they also looked at SGK, a proteasomal kinase 
that  protects  synaptic  glutamate  receptors  from  proteasomal  degradation 
(Boehmer et al. 2003; Boehmer et al. 2004; Schniepp et al. 2004), and Tap1, a 
subunit of the proteasome-associated antigen peptide transporter (Tap) complex, 
whose targeted deletion contributes to deficits in synaptic plasticity in mice (Huh et 
al. 2000).  In a series of experiments, they determined that mRNA levels of all 4 
genes  were  downregulated  in  PC-12  cells  after  transfection  of  zif268,  and 
overexpressed in zif268 knockout mice when compared to wildtype controls.  In 
addition they found that the promoter activities of psmb9, Tap1 and SGK were 
suppressed in zif268 transfected PC-12 cells, and that all 3 genes were affected in 
an in vivo model of synaptic plasticity: dopamine antagonist-induced plasticity in 
the striatum via haloperidol administration.  Interestingly, it was discovered that 
striatal zif268 induction was associated with downregulated psmb9 and Tap1 but 
upregulated SGK. 
These findings are the first to uncover the important role of zif268 in regulating the 
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1.2  Study Aims & Objectives 
The main aims of this study were as follows: 
  To  upregulate  zif268  in  physiologically  relevant  conditions  in  order  to 
investigate the induction of genes in response to cellular activation.  
  To extend the findings of James et al. (2005) and verify two of the known 
genes identified as downstream targets of zif268: gephyrin and ubiquilin. 
  To data mine the ESTs identified in the microarray experiment performed by 
James et al. (2005) to highlight areas of interest within the genome that have 
not yet been fully characterised. 
  To  perform  any  necessary  experimentation  required  to  confirm  suspected 
unknown transcripts that may to be regulated by zif268. 
  To theorise the downstream effects of LTP within the whole cell by monitoring 
the cellular actions of zif268 targets at synapses that are not activated by 
tetanically-induced glutamate. 61 
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2  Materials and Methods 
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2.1   Bioinformatics 
A selection of putative zif268 target EST (expressed sequence tag) genes were 
characterised using various bioinformatic tools.  In order to do this, EST nucleotide 
sequences were retrieved using the National Center for Biotechnology Information 
database (NCBI, Bethesda, MD, USA; http://www.ncbi.nlm.nih.gov/), and similarity 
searches of the sequences with the Rattus norvegicus genome were carried out 
using BLAST (Basic Local Alignment Tool) at Ensembl (www.ensembl.org).  A 3-
phase  approach  was  used  to  catalogue  and  annotate  these  cDNA  fragments.  
Firstly,  a  search  was  performed  for  any  known  gene  located  at  the  same 
chromosomal point.  Any EST not in the vicinity of an Ensembl known annotated 
gene,  but  within  approximately  4kb  to  an  Ensembl  predicted  or  genscan  gene 
(Burge  &  Karlin  1997)  and/or  several  other  ESTs  was  put  forward  for  further 
investigation.    In  the  second  phase,  the  relationship(s)  of  the  gene  predictions 
were examined using the orthologous sequences.  If a gene prediction had been 
derived from hypothetical data, and not from any known genes of any organism, it 
suggested that any findings in this area would be novel.  Thirdly, any area that was 
related  to  mental  retardation  in  the  comparable  chromosomal  area  in  Homo 
sapiens  was  of  particular  interest.    This  approach  gleaned  4  ESTs  for  further 
experimental  study  (using  the  PC-12  cell  line  and  verifying  in  primary  cortical 
neurones): AA998964, AI169020, AI112362 and AI176839.   
2.2   Cell Culture Preparation 
2.2.1  Primary dissociated cortical cell cultures 
All cell culture reagents were purchased from Invitrogen PLC, Paisley, UK unless 
otherwise stated.   Pregnant Wistar rats (300-400 g, gestation  day 17-18 (E17-
E18)) were euthanized with an intraperitoneal injection of sodium pentobarbitone 
(Euthatal, Vericore Ltd., Dundee, UK) (1300 mg/kg).  Embryos were removed by 
Caesarean section; decapitated and placed in ice-cold Minimum Essential Media 
(MEM) supplemented with 5  g/mL penicillin-streptomycin.  Brains were separated 
from the crania and the cortex removed, minced and washed three times in ice-
cold MEM.  Thereafter, the cortical tissue was dissociated in 5 mLs of a 2.5% 
trypsin solution for 30 minutes at 37
oC (in a 5% CO2 incubator).  The trypsin was 
inactivated by  the addition of 5 mls foetal bovine serum (FBS), and the  tissue 
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trituration (through a sterile  pasteur pipette) three times in ice-cold MEM.  The 
resulting dissociated neurones were re-suspended in Dulbecco‘s Modified Eagle‘s 
Media  (DMEM,  containing  GlutaMAX   I  and  4500  mg/L  D-Glucose 
(supplemented with 20% FBS and 5  g/mL penicillin-streptomycin)) and seeded 
onto  6-well  plates  (Corning,  Fisher  Scientific,  Loughborough,  UK)  or  8-well 
multichamber slides (Nunc, Fisher Scientific, Loughborough, UK), which had been 
previously coated with poly-D-lysine (4  g/mL) (Sigma-Aldrich, Dorset, UK) and 
mouse laminin (6  g/ L).  The neurones were incubated at 37
oC in 5% CO2 for up 
to 48 hours, after which they were incubated in 2 mLs per well of Neurobasal  
media  containing  penicillin-streptomycin  (5  g/mL)  and  20%  B27  serum-free 
supplement at 37
oC in 5% CO2.  The Neurobasal  media was partially changed 
every 2 - 3 days until the primary cortical cultures were used for further study.  A 
residual 500 µL of media was left covering the cells during media changes in order 
to minimise cellular stress. 
2.2.2  PC-12 Cell Line 
The PC-12 rat pheochromocytoma cell line (CRL-1721™, American Type Culture 
Collection, VA, USA) was cultured in
 DMEM (containing GlutaMAX  I and 4500 
mg/L  D-Glucose)  supplemented  with  10%  heat-inactivated  FBS  and  5  g/mL 
penicillin-streptomycin (Invitrogen, Paisley, UK).  Cells were maintained in a 75 
cm
2  cell  culture  flask  at  37
oC  in  5%  CO2,  and  passaged  every  7  days  using 
trypsin-EDTA (0.25% trypsin, 1 mM EDTA) (Invitrogen, Paisley, UK). 
2.3  In Vitro Culture Treatments 
2.3.1  NMDA Stimulation Time-course 
Primary cortical neurones were utilised at varying times in vitro depending on the 
assay.  For western blotting and RT-PCR procedures, primary neurone cultures 
were harvested at 7-10 DIV.  For immunocytochemistry, although technically very 
challenging, cells were used at 21 DIV.  At this developmental stage (21 DIV), the 
majority  of  gephyrin  clusters  are  synaptic  and  a  large  proportion  of  these  are 
associated with GABAARs (Danglot et al. 2003).  The neurones were seeded in 
either 8-well multichamber slides or 6-well plates and were treated with either 100 
µM N-methyl-D-aspartate (NMDA) in 20 mM KCl (added as 20 μL of a 10 mM 
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for differing time periods.  The time-course involved cell stimulation for 3 hours, 6 
hours or 24 hours.  Treatment and control cells were always processed in parallel 
from  a  single  culture.    Neurones  were  either  fixed  with  formaldehyde  (Fluka, 
Sigma-Aldrich,  Dorset,  UK)  for  immunofluorescence  (see  section  2.5),  RNA 
extracted for RT-PCR (see section 2.4), or protein extracted for Western blotting 
(see section 2.6). 
2.3.2  Transient Transfection 
PC-12 cells, 72 hours after passage and seeded in either 6-well plates or 8-well 
multichamber  slides,  were  pre-incubated  for  2  hours  in
  DMEM  (containing 
GlutaMAX  I and 4500mg/L D-Glucose) supplemented with 10% heat-inactivated 
FBS  and  50  ng/mL  NGF-7S  (Sigma-Aldrich,  Dorset,  UK).    This  facilitated  the 
differentiation of the cells into a neuronal-like cell type (Greene & Tischler 1976). 
The murine  zif268  cDNA  expression  vectors,  pzif268 and  ptrzif268,  have  been 
described previously (James et al. 2005).  Both plasmids are based on the pCMV5 
(Genbank accession number AF239249) plasmid vector.  pzif268 expressed full 
length zif268, whereas ptrZif268 is an N-terminally deleted ( N3-372) version of 
zif268.   Separately, 2  g of endotoxin-free pzif268 plasmid or 2  g of ptrzif268 
DNA was added to PC-12 cells or primary cortical neurones when seeded in 6-well 
plates.  In 8-well multichamber slides, 0.5  g of the plasmid vectors was added.  
Cells were transiently transfected using the cationic lipid reagent Lipofectamine™ 
2000 (Invitrogen, Paisley, UK) (2  l per 1  g of DNA).  The required amounts of 
DNA  and  Lipofectamine™  2000  were  separately  diluted  in  Opti-MEM
®  with 
GlutaMAX™  (Invitrogen,  Paisley,  UK)  for  5 minutes  at  room  temperature  (RT).  
The diluted DNA and diluted Lipofectamine™ 2000 were then mixed together and 
incubated  at  RT for  20  minutes  before  addition  to  the  wells.    The  transfection 
efficiencies of primary neurones with Lipofectamine 2000 is reported at 20-30% 
(Dalby  et  al.  2004)  and  for  PC-12  cells  is  85% 
(http://www.invitrogen.com/Content/SFS/ProductNotes/F_Lipofectamine%202000b
-040923-RD-MKT-TL-HL050602.pdf).    PC-12  cells  also  received  2  M  of  the 
adenyl cyclase activator, forskolin, before all cells were incubated for 48 hours at 
37
oC in 5% CO2.  James et al. (2005) discovered that forskolin was required in 
order for zif268 to transactivate target gene transcription in PC-12 cells. Neurones 
were either fixed for immunofluorescence (see section 2.5), RNA extracted for RT-
PCR (see section 2.4) or protein extracted for Western blotting (see section 2.6). Donna M McDade, 2007    Chapter 2, 65 
2.4  Reverse Transcriptase Polymerase Chain Reaction 
2.4.1  RNA Extraction 
The protocol for animal tissues in the RNeasy  Mini Kit (Qiagen, Crawley, UK) 
was  utilised,  and  directions  followed  as  per  manufacturer‘s  instructions.    For 
cultured  neuronal  (7-10  DIV)  or  PC-12  cells,  the  cell  media  was  removed 
thoroughly from plated cells by washing with ice cold 0.1 M phosphate buffered 
saline (PBS) (Sigma-Aldrich, Dorset, UK), before covering with 600  l of lysing 
buffer  RLT  (containing  -Mercaptoethanol  ( -ME)).    Cells  were  immediately 
scraped into a BioPulveriser Tube, containing Lysing Matrix D, and homogenised 
using the Hybaid Ryboliser (Thermo Electron Corporation, Cheshire, UK).   
For whole tissue (see section 2.8.2, page 81), 30 mg of an adult female Wistar rat 
brain was removed, mechanically disrupted with a mortar and pestle containing 
600  l  buffer  RLT  (containing  -ME),  then  placed  in  a  BioPulveriser  Tube, 
containing Lysing Matrix D tube and homogenised using the Hybaid Ryboliser.  
For either preparation the resultant mixture was carefully removed, placed in a 
clean Eppendorf and 600  l of 70% ethanol added and mixed.  Samples were 
loaded onto RNeasy mini columns and centrifuged for 15 seconds at 9,000 g in a 
5804 R centrifuge (Eppendorf, Cambridge, UK).  This was followed by the addition 
of 700 l Buffer RW1, spun for 15 seconds at 9,000 g, then two times 500 l Buffer 
RPE (containing ethanol) was added, the first centrifuged for 15 seconds and the 
second for 2 minutes.  Elution was performed by placing the column in a fresh 
eppendorf with the addition of 30  l RNase-free water added to the membrane and 
the column spun for 1 minute at 9,000 g.  Samples were either then stored at –
20 C or used immediately to synthesise first strand cDNA. 
2.4.2  First Strand cDNA Synthesis 
First  strand  cDNA  synthesis  from  total  RNA  was  performed  using  the 
Superscript  First-Strand Synthesis System for RT-PCR (Invitrogen, Paisley, UK).  
Firstly, RNA samples were quantified using the RNA/DNA calculator GeneQuant 
(Pharmacia Biotech, Amersham, Buckinghamshire, UK).  cDNA was synthesised 
from  1  g  or  500  ng  of  total  RNA  from  PC-12  cells  or  primary  neurones 
respectively.  RNA was placed in a DNase, RNase-free eppendorf tube with 1  L Donna M McDade, 2007    Chapter 2, 66 
10  mM  dNTP  (Deoxynucleotide-triphosphate)  mix,  1  L  random  hexamers  (50 
ng/ L) and DEPC-treated water up to 10  L.  Each sample was incubated at 65 C 
for  5 minutes and  placed  on  ice.    Then,  2  L  10x  RT  (Reverse  Transciptase) 
buffer, 4  L 25 mM Mg2Cl2, 2  L 0.1 M DTT (Dithiothreitol) and 1  L RnaseOUT  
Recombinant RNase Inhibitor was prepared, vortexed, added to each sample and 
controls and mixed thoroughly.  All samples and controls were incubated at 25 C 
for 2 minutes before the addition of 1  L SuperScript  II RT (50 U/ L) to each 
tube.  All tubes were mixed and incubated at 25 C for 10 minutes, 42 C for 50 
minutes followed by 15 minutes at 72 C, then placed on ice.  After the addition of 1 
L RNase H to each tube to degrade residual RNA, all samples were incubated at 
37 C for 20 minutes.  The resultant 20  L cDNA sample was then diluted with 80 
L DNase-free water. 
2.4.3  Amplification of Target DNA 
As an initial step, PCR tubes and equipment were UV irradiated for a minimum of 
10  minutes,  denaturing  any  DNA  present  and  therefore  removing  any  possible 
contaminants.  Each tube was then filled with 18  L ultrapure water, 5  L 5x PCR 
buffer (500  L 10x PCR Buffer [containing Tris·Cl, KCl, (NH4)2SO4,15 mM MgCl2; 
pH 8.7 (Qiagen, Crawley, UK), 10  L each of 100 mM dATP, dTTP, dGTP, dCTP 
(Promega,  Southampton,  UK)  and  460  L  ultrapure  water],  1.25  L  20  M 
appropriate primer (see table 2.5; section 2.11), 0.25  L HotStarTaq™ (5 U/ L) 
(Qiagen, Crawley, UK) and 0.5  L cDNA.  GAPDH was used as a steady state 
control  for  normalisation.    The  PCR  program  employed  involved  an  initial  Taq 
activating step of 95 C for 15 minutes, followed by cycles of 94 C for 45 seconds 
(DNA  denaturing),  60 C  for  45  seconds  (annealing  of  the  primers  to 
complementary DNA), and extension at 72 C for 1 minute.  The number of cycles 
was  empirically  determined  for each  DNA  sequence  of interest  (detailed  within 
table 2.6; section 2.11, page 89). 
2.4.4  Gel Electrophoresis & Analysis 
After the addition of 5  L Blue/Orange 6x Loading Buffer (Promega, Southampton, 
UK),  samples  were  electrophoresed  on  1.5%  agarose  (Roche  Diagnostics, 
Sussex, UK) gels prepared with 0.5xTBE buffer (Invitrogen, Paisley, UK) and 1  L 
GelStar®  Nucleic  Acid  Gel  Stain  (Cambrex,  Berkshire,  UK)  per  10  mL  gel.  Donna M McDade, 2007    Chapter 2, 67 
Samples  were  typically  electrophoresed  at  100  V  for  1  hour.    Images  were 
captured with a GelCam, attached to a GH10 0.8x electrophoresis hood (BioRad, 
Hertfordshire,  UK),  or  examined  and  processed  using  a  MCID  image  analysis 
system  (MCID  5,  Canada).    In  this  paradigm  we  adjusted  for  variances  by 
employing ANCOVA (analysis of co-variance), with GAPDH pixel intensity as the 
co-variate.  This statistical procedure is capable of measuring and removing the 
effects  of  pre-existing  individual  differences  in  samples,  for  example  different 
efficiencies of mRNA extraction, cDNA synthesis and treatment. 
2.5  Immunocytochemistry 
2.5.1  Fixation & Staining 
Primary cortical cultured neurones, 21 DIV,  were fixed using 4% formaldehyde 
(Fluka,  Sigma-Aldrich,  Dorset,  UK)  in  0.1  M  PBS  (see  section  2.12.3)  for  20 
minutes at 4
oC.  After three washes with 0.1 M PBS, blocking serum (0.1 M PBS 
with 15% normal goat serum (Vector, Peterborough, UK)) was added to the cells 
for one hour at RT.  The blocking serum was removed, whereupon cells were 
immersed  in  a  solution  of  0.1  M  PBS  and  0.5%  Triton-X100  (Sigma-Aldrich, 
Dorset,  UK)  containing  3%  normal  goat  serum  and  either  1:100  mouse  anti-
Gephyrin  (Cat.  No.  610585,  BD  Biosciences,  Oxford,  UK),  1:100  rabbit  anti-
Ubiquilin  (Cat.  No.  662052,  Calbiochem,  Merck  Biosciences,  Nottingham,  UK), 
1:100 mouse anti-GABAA receptor  -chain (Cat. No. MAB341, Merck Biosciences, 
Nottingham,  UK)  or  1:200  rabbit  anti-GABAA  receptor  2  (Cat.  No.  AGA-005, 
Alomone Labs Ltd., Jerusalem, Israel) over night at 4
oC.  
After washing the cells three times with 0.1M PBS, neurones were incubated for 
60 minutes at RT in the dark with either Alexa 594 goat anti-mouse or goat anti-
rabbit (Cat. No. A11032 and A11037 respectively, Molecular Probes, Invitrogen, 
Paisley,  UK)  diluted  1:100  with  0.1M  PBS  containing  5%  normal  goat  serum.  
Following a further three washes with 0.1M PBS, the slides were left until almost 
dry  before  being  preserved  using  the  ProLong  Antifade  Kit  (Molecular  Probes, 
Invitrogen, Paisley, UK), which is specifically designed to protect fluorescence for 
long periods of time.  1 mL of component B (mounting medium) is added to a vial 
of component A (antifade reagent), mixed carefully and applied to the slide with 
the coverslip placed on top.  Once the mounting medium had dried overnight the 
coverslip was sealed with nail varnish and the slides stored at -20
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2.5.2  Confocal Microscopy, Image Analysis and Statistics 
A Bio-Rad MRC 1024 confocal microscope (Bio-Rad, Hertfordshire, UK) mounted 
on a Nikon microscope (Nikon, Surrey, UK), utilising LaserSharp 2000 software 
(Bio-Rad, Hertfordshire, UK), for image viewing was used to capture images.  The 
parameters  for  each  set  of  images  were  uniform  for  the  protein  stained.  
Immunofluorescence was captured with a x40 oil immersion objective, box size 
1024 x 1024, x2.0 digitally zoomed, z-stack images with steps of 0.5-1.0μm and 
Kalman N=4.  Gephyrin and GABAA receptors were detected with the red laser 
power at 30, while ubiquilin was detected with a red laser power of 3 due to the 
intensity of staining.  All images were stacked using Confocal Assistant version 
4.02 (Freeware, Build 101, Todd Clark Brelje, University of Minnesota, USA), and 
analysed using Image J (Freeware, 1.34s, National Institute of Health, USA).  All 
results were analysed 'blind', without knowledge of the sample treatment.  The 
threshold for each individual z-stack was assessed, and set when background was 
at a minimum with diffuse staining throughout the cell.  Each neurite was then 
isolated and the particles counted, mean intensity of punctate staining determined, 
and  the  punctate  and  neurite  areas  measured.    Cell  body  puncta  were  not 
included in case results were skewed due to target protein variablilities in this area 
compared to neurites. 
2.6  Western Blot 
2.6.1  Sample Preparation 
Adherent PC-12 or primary cortical cultured cells (7-10 DIV) were initially washed 
with ice-cold 0.1 M PBS, then lysed with ice-cold RIPA buffer (see section 2.12.1), 
scraped  into  clean  eppendorf  tubes  and  agitated  on  ice  for  15  minutes.    Cell 
extracts were centrifuged at 11,700 g for 15 minutes at 4
oC, and the supernatants 
stored at -20
oC. 
2.6.2  Assessment of Total Protein Content 
The  Bradford  (Bio-Rad)  Protein  Assay  (Bradford  1976)  was  employed  to 
determine  the  total  protein  concentration  of  each  sample.    Duplicate  standard 
solutions were created from a stock solution of 2.0 mg/mL BSA (see table 2.1) in 
order to create a standard curve.   Donna M McDade, 2007    Chapter 2, 69 
Cortical  neurone  and  PC-12  samples,  defrosted  and  kept  on  ice,  were  mixed 
thoroughly before 10  L was removed and diluted with de-ionised water 1:100 and 
1:200 respectively.  Differing dilutions were used for the different cell types as PC-
12 cells were generally twice as confluent as the primary neurones.  Two aliquots 
of 400  L of either sample were then placed in a clean eppendorf tube.  Bio-Rad 
Protein Assay Dye Reagent Concentrate (Bio-Rad, Hertfordshire, UK) was allowed 
to reach room temperature then diluted 1:1 with de-ionised water.  200  L of the 
dye  solution  was  added  to  each  sample,  mixed  thoroughly,  and  allowed  to 
incubate at room temperature for 5 minutes.  After vortexing again, 200  L of each 
duplicate standard and sample was pipetted into a 96 well plate, the absorbance 
read at 595 nm on an Opsys MR photometer (Dynex Technologies, West Sussex, 
UK), and protein concentration calculated by linear regression using Revelation™ 
QuickLINK software v4.03 (Dynex Technologies, West Sussex, UK).  A successful 
assay  was determined by a straight-line generated from the standard solutions 
(where r
2 ≥ 0.99), variations between the sample and standard duplicates was less 
than 20%, and all sample protein determinations fell within the set 0.0 - 2.0 mg/mL 
concentrations (i.e. protein concentration determination by extrapolated data was 
repeated).  All samples were then normalised, by dilution with lysis buffer, to the 
lowest  registered  protein  concentration  before  continuing  with  further 
experimentation, or storing at -20
oC. 
Tube  BSA Volume 
( L) 
De-ionised Water 
Volume ( L) 
Final Concentration 
(mg/mL) 
A  0  400  0.00 
B  50  350  0.25 
C  100  300  0.50 
D  200  200  1.00 
E  300  100  1.50 
F  400  0  2.00 
Table 2.1 Protein Standards for the Bradford (Bio-Rad) Protein Assay 
2.6.3  NuPAGE® Bis-Tris Electrophoresis 
Instructions  were  followed  as  per  the  NuPAGE®  Electrophoresis  System 
instruction  booklet  (Invitrogen,  Paisley,  UK).    Each  normalised  sample  was 
deforested on ice and prepared using 65  L normalised protein, 25  L NuPAGE  
LDS Sample Buffer and 10 l NuPAGE  Reducing Agent (0.5 M DTT) and heated Donna M McDade, 2007    Chapter 2, 70 
to 70
oC for 10 minutes.  After loading 10  L of Full Range Rainbow recombinant 
protein  molecular  weight  marker  (RPN  800,  Amersham  Biosciences, 
Buckinghamshire,  UK),  equal  amounts  of  total  protein  (20  L  maximum)  were 
loaded onto NuPAGE  pre-cast 4-12% Bis-Tris polyacrylamide gels housed in an 
XCell SureLock™ Mini-Cell (Invitrogen, Paisley, UK).  The gel was submerged in 
1x  SDS  NuPAGE   MOPS  Running  Buffer  with  0.25%  NuPAGE   Antioxidant 
within the inner buffer chamber (all NuPAGE  products, Invitrogen, Paisley, UK).  
The  samples  were  then  electrophoresed  at  200  V  using  a  PowerPac  Basic™ 
power supply (Bio-Rad, Hertfordshire, UK) for 45 minutes if the protein of interest 
was less than 50 kDa, or 1 hour if the protein was more than 50 kDa. 
2.6.4  NuPAGE® Transfer 
After electrophoresis, the gel was transferred to an Invitrolon™ PVDF membrane, 
in a filter paper sandwich (Invitrogen, Paisley, UK).  All blotting pads and filter 
papers  were  initially  soaked  in  700mLs  of  a  1L  solution  made  from  50mLs 
20xNuPAGE  Transfer buffer, 100mLs methanol, 1mL NuPAGE  Antioxidant and 
850mLs deionised water.  The PVDF membrane was placed in methanol before 
rinsing in the transfer buffer in order to improve antigen binding.  Next, the transfer 
blot was assembled within the cathode core by assembling 3 blotting pads, a filter 
paper, the gel, the PVDF membrane, a second filter paper and a further 3 blotting 
pads.  After ensuring no air bubbles were present between any of the layers, the 
anode core was placed on top, the blot module wedged into the XCell II™ Blot 
Module chamber (Invitrogen, Paisley, UK), and filled with the remaining 300 mLs 
of  transfer  buffer.   The  outer  chamber  of  the module  was  filled  with  deionised 
water and transfer was performed at 30 V using PowerPac Basic™ power supply 
(Bio-Rad, Hertfordshire, UK) for 45 minutes. 
2.6.5  Blot Efficiency Test 
A  visual  inspection  of  the  membrane  to  ensure  the  uniformity  of  transfer, 
normalisation of proteins and accuracy of gel sample loading, was achieved by 
submerging the membranes in Ponceau S Solution (Sigma-Aldrich, Dorset, UK) 
immediately  after  transfer.  After  5  minutes  the  membrane  was  agitated  in 
deionised water, and the transferred protein bands visualised and scrutinised.  If 
the bands appeared consistent, specifically within the expected size range of the 
protein, the membrane was briefly submerged in 0.1 M sodium hydroxide (BDH Donna M McDade, 2007    Chapter 2, 71 
Laboratory Supplies, Poole, UK), then placed in clean deionised water for a few 
minutes until the staining was removed. 
2.6.6  Immunodetection 
The membranes were blocked in 3% non-fat dried milk powder (Marvel, Premier 
International Foods (UK) Ltd., Lincolnshire, UK) for 2 hours, and then soaked in 
the appropriate primary antibody in 1% milk powder in T-TBS (see section 2.11.2 
for buffer ingredients).  Antibodies used, and their dilutions, were as follows: anti-
gephyrin,  1:500  (Cat.  No.  610585,  BD  Biosciences,  Oxford,  UK),  anti-ubiquilin, 
1:500 (Cat. No. 662052, Calbiochem, Merck Biosciences, Nottingham, UK), anti-
zif268 (Egr-1 (588)), 1:250 (Cat. No. sc-110, Santa Cruz Biotechnology, Calne, 
UK),  rabbit  anti-p70  S6  Kinase,  1:500,  (Cat.  No.  9202L),  rabbit  anti-p4E-BP1 
(Thr37/46),  1:1,000,  (Cat.  No.  9459L),  mouse  anti-pERK  (p44/42  MAP  Kinase; 
Thr202/Tyr204), 1:2,000, (Cat. No. 5120), rabbit anti-total ERK, 1:2,000 (Cat. No. 
9102)  and  rabbit  anti-pCREB  (Ser133),  1:250  (Cat.  No.  9191),  (all  from  Cell 
Signalling, Hertfordshire, UK).  Membranes were incubated with the antibody at 
4 C overnight before washing 3 times for 15 minutes in T-TBS, then placed in the 
appropriate  secondary  antibody,  either  peroxidase-conjugated  AffiniPure  anti-
mouse IgG 1:10,000 or anti-rabbit IgG 1:10,000 (Cat. No. 115-035-166 and 111-
035-144 respectively, Jackson Laboratories, Stratech, Suffolk, UK) for 1 hour with 
agitation at RT.  Thereafter, the membrane was washed 3 times for 15 minutes in 
T-TBS before covering with ECL plus Western Detection System (Amersham Plc, 
Buckinghamshire,  UK)  as  per  the  manufacturer‘s  instructions.    Briefly,  after 
equilibrating to RT, 100  L of solution B was added to 4 mLs of solution A and 
placed on the membrane, protein side up, for 5 minutes at RT with agitation.  The 
exception was the zi268 antibody, which was probed with a goat anti-rabbit, HRP-
conjugate 1:10,000, and protein bands visualised with the Visualizer™ Western 
Blot  Detection  Kit  (both  from  Upstate  Signalling,  Hampshire,  UK).    The 
manufacturer‘s  instructions  were  followed,  combining  Detection  Reagent  A  and 
Detection Reagent B in a 1:2 ratio, allowing 3 mLs overall.  The solution was then 
allowed  to  equilibrate  to RT  before  covering  the membrane for  5  minutes  with 
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2.6.7  Imaging 
The  blot  was  developed  using  Hyperfilm™  ECL  high  performance 
chemiluminescence  film  and  a  HyperProcessor,  automatic  autoradiography  film 
processor  (both  Amersham  Plc,  Buckinghamshire,  UK).    Photographs  of  blots 
were taken using a Panasonic WV-BP500 camera (Berkshire, UK).  Film analysis 
was  performed  on  a  Macintosh  computer  using  the  public  domain  NIH  Image 
program (developed at the U.S. National Institutes of Health and available on the 
Internet at http://rsb.info.nih.gov/nih-image/).  All measurements were performed 
by  hand  and  reported  by  the  NIH  program.    Each  lane  density  and  area  was 
measured  three  times  for  an  average  reading,  the  background  density  was 
subtracted from the lane density, and this value was multiplied by the area of the 
band.  For normalisation, each value was then transformed to a percentage of 
control. 
2.7   Promoter-Reporter Assay 
2.7.1  Gephyrin Promoter Primer Design 
The sequences for the gephyrin promoter primer pair were designed to target the 
cDNA sequence of Rattus norvegicus provided by NCBI and utilising information 
provided  by  Ramming  et  al.  (1997).    The  primers  were  designed  using  the 
sequence of the M.  musculus gephyrin 5‘ untranslated region (UTR) (Genbank 
accession numbers Y10882 and Y10883).  The primers were predicted to flank a 
region of 882 base pairs of the mouse gephyrin UTR.  The primer pair sequences 
'Gephyrin Promoter Fwd' and 'Gephyrin Promoter Rev' are described in Table 2.5; 
see section 2.11. 
A second set of mouse gephyrin specific primers were designed to amplify, from 
the  product  of  the  first  round  PCR,  the  DNA  sequence  containing  recognition 
sequences for restriction endonucleases subsequently used directionally to clone 
the  gephyrin  promoter  into  pBLCAT3  (a  promoter-less  CAT  vector,  Genbank 
accession number X64409).  Inspection of the pBLCAT3 plasmid map revealed 
adjacent SalI and XbaI restriction enzyme sites situated within the multiple cloning 
site (MCS) of the vector.  Neither of these restriction sites were predicted to be 
present within the sequence amplified during the first round of PCR amplification 
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The primer pair sequences, called 'Gephyrin Promoter Fwd SalI' and 'Gephyrin 
Promoter  Rev  XbaI',  whereby  bold  letters  denote  the  palindromic  6  base  pair 
recognition sequences for the SalI and XbaI restriction enzymes, are shown in 
table 2.5; see section 2.11. 
2.7.2  Genomic DNA Isolation 
Total DNA  was  isolated  from  cultured  PC-12  cells,  using  the DNeasy   Tissue 
Handbook  (Qiagen,  Crawley,  UK),  and  the  manufacturer‘s  protocol  followed.  
Briefly, PC-12 cells were rinsed in 0.1 M PBS before scraping from the wells in 
200  L of fresh 0.1 M PBS and placing into an eppendorf tube.  200  L Buffer AL 
and  20  L  Proteinase  K  were  added  to  the  cell  suspensions  before  mixing 
thoroughly by vortexing and heating at 70 C for 10 minutes.  200  L of 96-100% 
ethanol was then added, and the mixture applied to a DNeasy Mini Spin Column in 
a collection tube and centrifuged at 7,200 g for 1 minute.  The flow-through was 
discarded and 500  L Buffer AW1 added to the spin column, centrifuged at 7,200 
g for 1 minute and the flow through discarded again.  500  L Buffer AW2 was 
added, and the column centrifuged at 12,600 g for 3 minutes, before discarding 
the flow through.  The column was then placed in a clean fresh eppendorf tube 
and 200  L Buffer AE added to the membrane to elute the genomic DNA.  This 
was incubated at room temperature for 1 minute before centrifuging for 1 minute at 
7,200 g. 
2.7.3  Polymerase Chain Reaction (PCR) 
Two  rounds  of  PCR  were  performed  to  prepare  the  gephyrin  promoter  for 
directional cloning into pBLCAT3.  In the first round the reaction contained 12.5  L 
DNase and RNase-free water, 5  L 5x PCR buffer, 3  L of PC-12 genomic DNA, 1 
L of an equimolar mixture of the forward and reverse primers (10  M of Gephyrin 
Promoter Fwd & 10  M Gephyrin Promoter Rev; see table 2.5), 0.5  L 50x dNTP 
mix, 2.5  L GC Melt and 0.5  L advantage-GC2 polymerase (BD Biosciences, 
Oxford, UK).  The PCR program employed was 94 C for 3 minutes followed by 30 
cycles of 94 C for 30 seconds, 68 C for 3 minutes with a final extension of 68 C 
for  3  minutes.    In  order  to  validate  the  presence  of  a  single  amplicon  at  the 
predicted size, 5  L of the PCR reaction was co-electrophoresed on an ethidium 
bromide stained 0.5x TBE 1% agarose gel with 100 base pair markers (Promega, Donna M McDade, 2007    Chapter 2, 74 
Southampton, UK).  To remove unincorporated dNTPs and primers the remaining 
20  L  of  the  reaction  was  PCR  purified  using  Qiagen's  PCR  Purification  Kit 
(Qiagen,  Crawley,  UK).    Instructions  were  followed  as  per  the  manufacturer‘s 
handbook.  Briefly, 100  L of buffer PB was added to the PCR sample mix (5 
volumes  buffer  to  1  volume  sample)  and  the  resulting  mixture  applied  to  a 
QIAquick  column  and  centrifuged.    All  centrifugation  steps  were  carried  out  at 
11,700 g for 60 seconds.  The flow-through was discarded and the membrane 
washed with 750  L Buffer PE, centrifuged and the flow-through discarded.  After 
an additional spin the QIAquick column was placed in a fresh eppendorf tube and 
the DNA eluted from the column after centrifugation for 1 minute, with 50 l Buffer 
EB. 
The second round of PCR used the same PCR reaction mixture, but contained 3 
L of a dilute amount of the DNA synthesised during the first round of PCR.  An 
estimate of the concentration of template synthesised during the first round of PCR 
was  determined  using  the  DNA/RNA  calculator,  GeneQuant  as  previously 
described.  Subsequently, the PCR product was diluted to approximately 1 fg/ L 
and this solution used as a source of DNA template for a second round of PCR 
using  an  equimolar  mixture  of  10  M  Gephyrin  Promoter  Fwd  SalI  &  10  M 
Gephyrin  Promoter  Rev  XbaI  primers  (as  detailed  in  table  2.5).    The  PCR 
programme  was  repeated,  and  the  resultant  PCR  product  purified  using  the 
Qiagen PCR Purification Kit as before.  The purified DNA was quantified using 
GeneQuant as previously described. 
2.7.4  Restriction Endonuclease Digestion 
Separately, approximately 160 ng of the gephyrin 5‘UTR PCR product (the ‗insert‘) 
and  100  ng  of  pBLCAT  (the  ‗vector‘)  were  digested  with  the  restriction 
endonucleases SalI and XbaI (Promega, Southampton, UK).  The recognition sites 
for  these  enzymes  are  5‘-GTCGAC-3‘  and  5‘-TCTAGA-3‘  for  SalI  and  XbaI 
respectively.    Digests  (20  L)  were  performed  in  1x  Buffer  D  containing 
approximately 2 g acetylated bovine serum albumin (BSA) (both from Promega, 
Southampton, UK).  Digest mixtures were vortexed before incubating overnight at 
37 C, whereupon 4 l of 6x loading dye (Promega, Southampton, UK) was added 
to each eppendorf tube and mixed.  Both the ‗insert‘ and ‗vector‘ digests were 
electrophoresed on a 1% agarose 0.5x TBE buffer gel with 1  L GelStar® Nucleic Donna M McDade, 2007    Chapter 2, 75 
Acid Gel Stain (Cambrex, Berkshire, UK) per 10 mL gel, for 1 hour at 100 V.  The 
vector  and  insert  products  were  excised  from  the  gel,  placed  in  the  same 
eppendorf and purified using the QIAquick Gel Extraction Kit (Qiagen, Crawley, 
UK).    Instructions  were  followed  as  per  the  manufacturer‘s  handbook.    Three 
volumes of Buffer QG were added to 1 volume of combined vector and insert gels 
before incubating at 50ºC for 10 minutes, with periodic vortexing.  One gel volume 
of  isopropanol  was  then  added,  mixed  and  the  sample  placed  in  a  QIAquick 
column.  After centrifuging at 11,700 g for 1 minute, 0.5 mL of Buffer QG was 
added to the column and centrifuged again at 11,700 g for 1 minute.  The column 
was  washed  with  0.75  mLs  Buffer  PE  before  centrifugation  at  11,700  g  for  1 
minute, the flow through discarded, and the centrifugation repeated.  The column 
was placed in a clean eppendorf tube and the DNA eluted with 50  L Buffer EB, 
incubated at room temperature for 1 minute and centrifuged for 1 minute at 11,700 
g. 
2.7.5  Ligation & Transformation 
The  Quick  Ligation   Kit  (New  England  BioLabs  Inc.,  Hertfordshire,  UK)  was 
utilised, and instructions followed from the manufacturer‘s directions.  10  L of 
2xQuick Ligation Buffer was added to 10  L of the combined vector and insert 
DNA sample and vortexed.  After the addition of I  L of Quick T4 DNA Ligase the 
sample was incubated for 5 minutes at room temperature before placing on ice.  
One Shot® TOP10 Chemically Competent E.coli cells (Invitrogen, Paisley, UK), 
previously stored at –80 C were thawed and 50  L added to 2  L of the DNA 
sample and mixed.  The mixture was placed on ice for 30 minutes before heat 
shock at 42 C for 30 seconds.  250  L of room temperate S.O.C. media was then 
added and the mixture incubated for 1 hour at 37 C, shaking at 200 rpm.  After 
spreading 50  L of the sample on warmed imMedia™ ampicillin agar (Invitrogen, 
Paisley, UK) for recombinant E.coli strains, the plates were incubated overnight at 
37 C. 
2.7.6  Plasmid Purification 
Successful transformation of the E.coli cells with the gephyrin promoter was then 
determined.    Plasmid  DNA  was  isolated  from  transformed  TOP10  E.coli  cells 
(Invitrogen, Paisley, UK), using QIAprep Miniprep columns and reagents (Qiagen, 
Crawley,  UK).    The  manufacturer‘s  protocol  was  followed.    Briefly,  cells  were Donna M McDade, 2007    Chapter 2, 76 
pelleted by centrifugation and re-suspended in 250  L Buffer P1, then 250  L P2 
and inverted 6 times. Buffer N3 (350  L) was then added, and the tube inverted 6 
times  gently  before  centrifuging  at  11,700  g  for  10  minutes.    All  further 
centrifugation  steps  were  also  carried  out  at  11,700  g.    The  supernatant  was 
applied  to  the  QIAprep®  Spin  Column  and  centrifuged  for  60  seconds.    The 
column membrane was then washed with 0.5 mL of Buffer PB and centrifuged for 
60  seconds.    After  the  flow  through  had  been  discarded,  the  membrane  was 
washed again using 0.75 mL Buffer PE and centrifuged for 60 seconds.  The flow 
through was discarded and the column centrifuged again to remove any additional 
wash buffer.  The QIAprep® column was then placed in a clean centrifuge tube.  
To elute the DNA, 50  L of Buffer EB was pipetted directly onto the membrane, 
incubated for 1 minute at room temperature and centrifuged for 1 minute.  From 
the resultant plasmid DNA sample, 5  L was digested with 0.2  L BSA Acetylated 
(10  mg/mL),  1  L  SalI  (10  U/ L),  1  L  XbaI  (10 U/ l),  2  L 10x  Buffer D  (All 
Promega, Southampton, UK), 10.8  L ultrapure water and incubated overnight at 
37 C.  The following day, 20 l of the restriction endonuclease digests were mixed 
with 4  L 6x loading buffer (Promega, Southampton, UK) and electrophoresed on 
a 1% agarose 0.5x TBE buffer gel with 1  L GelStar® Nucleic Acid Gel Stain 
(Cambrex, Berkshire, UK) to every 10 mL gel, for 1 hour at 100 V. 
2.7.7  Endotoxin-Free Plasmid Purification 
Endotoxin-free plasmid preparations were prepared using the EndoFree® Plasmid 
Maxi Kit (Qiagen, Crawley, UK), and the manufacturer‘s protocol followed.  Briefly, 
a single E.coli colony was used to inoculate a starter culture of 5mL imMedia™ 
ampicillin broth (Invitrogen, Paisley, UK).   After incubation for 8 hours at 37 C 
shaking at 200 rpm, 0.1 mL of this starter culture was diluted into 100 mL fresh 
imMedia™ ampicillin broth (Invitrogen, Paisley, UK) and incubated overnight at 
37 C vigorous shaking at 200rpm.  The next day, the cultures were centrifuged at 
4,500  g  for  10  minutes  at  4 C,  after  which  the  supernatant  was  removed  and 
discarded.  The bacterial pellet was resuspended in 10 mLs Buffer P1 (containing 
100  g/mL  RNase  A)  and  10  mLs  Buffer  P2,  mixed  by  inverting  6  times  and 
incubated  at  room  temperature  for  5  minutes.    The  QIAfilter  cartridge  was 
assembled and placed in a clean 50 mL tube.  After incubation, ice cold Buffer P3 
was added to the lysate, inverted 6 times, poured into the cartridge and incubated 
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into the cartridge and the lysate filtered. Buffer ER (2.5 mLs) was then added; the 
sample inverted  10  times and incubated  on  ice  for  30 minutes.    Meanwhile,  a 
QIAGEN-tip 500 was equilibrated with the addition of 10 mLs Buffer QBT, which 
then  passed  through  the  column  by  gravity.    After  incubation,  the  sample  was 
added to the equilibrated column and allowed to pass through by gravity.  The 
QIAGEN-tip was then washed twice with 30 mLs Buffer QC and finally eluted with 
15 mLs Buffer QN; all solutions were allowed to filter of their own accord.  DNA 
precipitation  was  achieved  by  the  addition  of  10.5  mLs  room  temperature 
isopropanol, which was then mixed and centrifuged immediately at 4,500 g for 1 
hour at 4 C.  The supernatant was discarded and the pelleted DNA washed with 5 
mLs of room temperature endotoxin-free 70% ethanol and centrifuged at 4,500 g 
for 30 minutes.  The resulting DNA pellet was carefully dried before re-dissolving 
in 100  L endotoxin-free Buffer TE.  The plasmid DNA concentration was then 
determined by GeneQuant. 
2.7.8  Co-Transfection  
PC-12 cells, seeded in 6 well plates, were pre-incubated with 50 ng/mL NGF-7S 
(Sigma-Aldrich, Dorset, UK) in DMEM (containing GlutaMAX  I and 4500 mg/L D-
Glucose) supplemented with 10% heat-inactivated FBS for 2 hours.  The test well 
then  received  3.5  g  of  the  cloned  gephyrin  promoter,  2  g  of  endotoxin-free 
pzif268 and 0.2  g of β-GAL cloned into a pCMV vector.  β-GAL was used to 
correct  for  variations  in  transfection  efficiencies.    Four  control  wells  were  also 
transiently transfected; control 1 received 3.5  g of the cloned gephyrin promoter, 
2  g of endotoxin-free ptrzif268 and 0.2  g of β-GAL, control 2 received 3.5  g of 
the cloned gephyrin promoter, 2  g of pCMV5 empty vector and 0.2  g of β-GAL, 
control 3 received 3.5  g of the pBLCAT3 empty vector, 2  g of endotoxin-free 
pzif268 and 0.2  g of β-GAL and finally, control 4 received 3.5  g of the pBLCAT3 
empty vector, 2  g of pCMV5 empty vector and 0.2  g of β-GAL.  Transfection 
was achieved using 2  L of Lipofectamine™ 2000 (Invitrogen, Paisley, UK) per 1 
g DNA, and performed as per the previous description (see section 2.3.2).  The 
experiment was performed in duplicate with only one set of PC-12 cells receiving 2 
M forskolin to determine the different effects with and without the adenyl cyclase 
activator.  All wells were then incubated for 48 hours at 37
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2.7.9  CAT & β-GAL Enzyme-Linked Immunosorbant Assay 
2.7.9.1  Sample Preparation 
Cells were washed 3 times in ice cold PBS before lysing with 1 part Lysis Buffer 
provided in the CAT & β-GAL ELISA kits (Roche Diagnostics, Sussex, UK) mixed 
with 4 parts ultra pure water.  To allow for co-transfection studies, the lysis buffer 
provided  is  optimised  for  full  compatibility  between  CAT  and  β-GAL  ELISA's.  
Firstly, 400  L of the buffer was added to each well and left to stand for 30 minutes 
at  room  temperature.    Cells  were  then  scraped  into  an  eppendorf  tube  and 
centrifuged at 12,600 g for 10 minutes at 4 C.  A 100  L aliquot of the supernatant 
was then removed and transferred to a clean eppendorf for protein determination.  
The remaining 300  L was transferred to a separate clean eppendorf tube and 
snap-frozen on dry ice before storage at -70 C. 
2.7.9.2  BCA (Bicinchoninic Acid) Protein Assay 
This copper-based assay was used to quantify the total amount of proteins found 
in  each  sample.    Directions  were  followed  as  per  manufacturer‘s  instructions 
(BCA™ Protein Assay Kit, Pierce, Northumberland, UK).  The instructions for the 
microplate procedure with 3 replicates of standards and samples were adhered to.  
Firstly, protein standards were prepared using the supplied 2.0 mg/mL BSA diluted 
with the same diluent as the samples; solution 8 of either the CAT or β-GAL ELISA 
kit (Roche Diagnostics, Sussex, UK) diluted 1 part to 5 parts ultra-pure water.  See 
table  2.2  for  the  dilution  scheme  of  protein  standards  used  to  determine  the 
standard curve. 
The BCA™ working reagent (WR) was then prepared using the following equation: 
(9 standards + # unknowns) x (3 replicates) x (200 l WR per sample) = total volume 
WR required 
Preparation of WR involved mixing 50 parts of BCA™ Reagent A to 1 part BCA™ 
Reagent B and vortexing.  25  L of each standard and pure undiluted sample was 
pipetted in triplicate into a 96 well plate before the addition of 200  L of WR to 
each well.  The plate was then mixed thoroughly on a shaker for 30 seconds after 
which it was incubated at 37 C for 30 minutes, and then allowed to cool to room 
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photometer  (Dynex  Technologies,  West  Sussex,  UK),  calculated  by  quadratic 
regression  using  Revelation  QuickLINK  software  v4.03  (Dynex  Technologies, 
West Sussex, UK) and all samples normalised. 
2.7.9.3  Preparation of CAT & β-GAL Enzyme Standards 
All  ELISA  kit  solutions  were  equilibrated  to  room  temperature  before 
experimentation.  CAT and β-GAL enzyme standards were prepared as per the 
manufacturer's  instructions  (see  table  2.3  and  2.4)  before  loading  200  L  in 
duplicate of each standard into the wells of the microtitre plate (MTP) provided.  
200  L of the samples was then added to the CAT ELISA plate.  The remaining 
sample was diluted 1:5 and 200  L of the diluent added to the β-GAL ELISA plate. 
2.7.9.4  ELISA Assay 
Both MTP modules were covered and incubated at 37 C for 1 hour after which the 
solutions were removed and the wells rinsed with washing buffer.  The CAT ELISA 
wells were washed 5 times and the β-GAL wells 3 times for 30 seconds each.  200 
L  of  a  freshly  prepared  solution  of  digoxigenin-labelled  (DIG)  CAT  or  β-GAL 
antibody,  anti-CAT-DIG  (2  g/mL)  or  anti-β-GAL-DIG  (0.5  g/mL),  was  then 
applied to the respective MTP modules, covered and incubated at 37 C for 1 hour.  
The modules were washed as before, after which 200  L of a freshly prepared 
solution of an antibody to digoxigenin conjugated to peroxidase (POD), anti-DIG-
POD (150 mU/mL), was then applied to both MTP modules, before covering and 
incubation at 37 C for 1 hour.  Both MTP modules were then washed again as 
before.  The β-GAL module received 200  L of the peroxidase substrate ABTS to 
each well for approximately 5 minutes before being read on an MRX photometer 
(Dynex Technologies, West Sussex, UK) at 405 nm (reference wavelength 490 
nm)  linked  to  Revelation™  software  (Dynex  Technologies,  West  Sussex,  UK).  
The CAT module received 200  L of the peroxidase substrate ABTS including 
substrate enhancer for approximately 45 minutes with agitation.  The CAT ELISA 
module was then read on the same photometer. Donna M McDade, 2007    Chapter 2, 80 
 
Tube  BSA Volume 
( L) 
Lysis Buffer Volume 
( L) 
Final Concentration 
( g/mL) 
A  300 of stock  0  2000 
B  375 of stock  125  1500 
C  325 of stock  325  1000 
D  175 of tube B  175  750 
E  325 of tube C  325  500 
F  325 of tube E  325  250 
G  325 of tube F  325  125 
H  100 of tube G  400  25 
I  0  400  0 
Table 2.2: Protein Standards for the BCA Protein Assay 
 
Step  CAT Enzyme 
working dilution 
(approx. 1 ng/mL) 
Sample Buffer   Approx. CAT Enzyme 
concentration  
(ng/mL) 
0  0  1000  L  0 
1  1000  L  0  1.0 
2  500  L of Step 1  500  L  0.5 
3  500  L of Step 2  500  L  0.25 
4  500  L of Step 3  500  L  0.125 
Table 2.3: Standards for the CAT ELISA, used to produce a calibration curve for the CAT 
enzyme 
Step  β-GAL Stock 
Solution  
(approx. 25 ng/mL) 
Sample Buffer  Approx. β-GAL 
enzyme concentration 
(pg/mL) 
0  0  1000  L  0 
1  50  l  950  L  1250 
2  500  L of Step 1  500  L  625 
3  500  L of Step 2  500  L  312 
4  500  L of Step 3  500  L  156 
5  500  L of Step 4  500  L  78 
Table 2.4: Standards for the β-GAL ELISA, used to produce a calibration curve for the β-GAL 
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2.8  Identification of the Novel Gene related to EST AI169020 
2.8.1  Product Verification 
Bioinformatically, it was discovered that EST AI169020 could be associated with 
the predicted transcript ENSRNOT00000012253 (www.ensembl.org), located on 
chromosome 4 of Rattus norvegicus.  Therefore, exon-intron boundary spanning 
primers  of  this  transcript  were  designed  (designated  Tr12253;  see  table  2.5; 
section 2.11). 
Differentiated  PC-12  cells  cDNA  was  used  in  a  PCR  reaction  to  validate  the 
Tr12253 Fwd & Tr12253 Rev primers. In addition, the EST AI169020 Fwd primer 
was  combined  with  the  Tr12253  Fwd  primer  (as  they  were  designed  on 
complementary  DNA  strands)  in  order  to  verify  that  a  single  product  could  be 
produced.  The PCR reaction and PCR programme were performed as previous 
experiments (see section 2.4.3) with the AI169020 Fwd & AI169020 Rev primers, 
Tr12253  Fwd  &  Tr12253  Rev  primers  or  Tr12253  Fwd  &  EST  Ai169020  Fwd 
primers.  Two controls were also performed using 2 of the same sets of primers, 
but replacing PC-12 cDNA with ultrapure water.  Products were then separated on 
a 1.5% agarose gel as previously described (section 2.4.4). 
2.8.2  Product Generation and Sequencing 
The next stage involved verifying a single product with the Tr12253 Fwd & EST 
Ai169020  Fwd  primers  using  adult  Wistar  rat  cerebral  cortex.    The  RNA  was 
extracted as previously described (section 2.4.1) and first strand cDNA synthesis 
achieved  using  Superscript   First-Strand  Synthesis  System  for  RT-PCR 
(Invitrogen, Paisley, UK).  After quantifying the total RNA present by GeneQuant, 
cDNA synthesis was performed using 1  L Oligo(dT)12-18 (0.5  g/ L), 1  L 10 mM 
dNTP mix and 8  L (1.37  g) RNA.  The suggested controls were also performed, 
namely  No  RT  Control  (No  Superscript   II  RT  added  in  the  later  stage)  and 
Control RNA (the supplied RNA was used instead of the primary cortical RNA).  
The sample and controls were incubated at 65 C for 5 minutes and placed on ice.  
2  L 10xRT buffer, 4  L 25mM Mg2Cl2, 2  L 0.1M DTT and 1  L RnaseOUT  
Recombinant RNase Inhibitor was then added to the sample and controls, mixed 
thoroughly and incubated at 42 C for 2 minutes.  After the addition of 1  L of 
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tubes were mixed gently and incubated at 42 C for 50 minutes followed by 15 
minutes at 72 C, then placed on ice.  1  L RNase H was added to each tube and 
all eppendorf tubes incubated at 37 C for 20 minutes.  cDNA samples were then 
quantified using the RNA/DNA calculator GeneQuant instrument. 
The sequencing was carried out by Geneservice (Cambridge, UK), who required 
10  L of 20 ng/ L concentration of purified product per reaction and 10  L of 3.2 
pmol/ L primers with a GC content of 50-55% and Tm 55-60 C.  To this end, the 
cDNA sample was diluted 1 in 5 with ultrapure water, and PCR performed with 
three  eppendorf  tubes  containing  9  L  adult  rat  cerebral  cortical  cDNA,  5  L 
5xPCR  buffer,  1.25  L  Tr12253  Fwd  &  EST  AI169020  Fwd  primers,  0.25  l 
HotStar Taq and 9.5  L dH2O.  In addition, extra PCR reactions were carried out 
using 9  L cDNA of the two controls, No RT Control and Control RNA.  The PCR 
programme  was  as  previously  described  (section  2.4.3;  45  cycles),  and  the 
products electrophoresed on a 1.5% agarose as detailed in section 2.4.4.  The 
cDNA  of  the  samples  (not  controls)  were  excised  from  the  gel  and  separately 
purified using the QIAquick Gel Extraction Kit (Qiagen, Crawley, UK).  To ensure 
the required concentration and quantity of product was reached, 3 of the purified 
PCR  reactions  were  combined.    Primers  were  designed  bioinformatically  using 
Ensembl (www.ensembl.org) utilising the predicted sequence of the novel gene 
ascertained from EST and predicted gene information, allowing the design of 3 
additional  primers  producing  approximately  500  base  pair  product  sizes  with 
approximately 100 base overlaps (see table 2.5 for details). 
2.8.3  Novel Gene Cloning 
Once the sequence had been determined and returned from Geneservice, it was 
submitted  to  two  websites  predicting  initiation  codons  and  protein  sequences 
(http://www.hri.co.jp/atgpr/ and http://ca.expasy.org/tools/dna.html), both of which 
returned the same data.  From this information, new primers were designed to 
flank the coding region in order to clone the novel gene sequence into the pCR
®II-
TOPO
® vector (Invitrogen, Paisley, UK). 
The primer sequences were designed to anneal upstream of the ATG start codon, 
but not to include the TAG stop codon, in order that any later cloning into tagged 
vectors would include any tag positioned downstream of the multiple cloning site.  
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reaction was prepared as previously described (section 2.4.3) with 0.5  L purified 
cDNA from Wistar adult rat cortex.  The PCR programme (previously described in 
section 2.4.3; 30 cycles) was followed by sample electrophoresis on a 1% agarose 
gel (see section 2.4.4) at 100V for 1.5 hours, allowing full separation of bands.  
The 724 base pair band was then excised and purified using the QIAquick Gel 
Extraction Kit (Qiagen, Crawley, UK) as described in section 2.7.4.  
The TOPO TA Cloning® Version P manual was used to clone the novel gene 
insert into the pCR®II-TOPO vector.  4  L of purified PCR product was added to 
the provided 1  L Salt Solution and 1  L TOPO® vector (both Invitrogen, Paisley, 
UK),  mixed  gently  and  incubated  at  room  temperature  for  5  minutes,  before 
placing on ice.  2  L of this reaction was then added to thawed One Shot® TOP10 
Chemically  Competent  E.Coli  cells  (Invitrogen,  Paisley,  UK),  gently  mixed  and 
incubated on ice for 30 minutes.  After heat shock for 30 seconds at 42 C, 250  l 
of room temperate S.O.C. media was added and the mixture incubated for 2 hours 
at 37 C, shaking at 200 rpm.  75  L from the transformation was then spread on 
pre-warmed  imMedia™  Kan  agar  (Invitrogen,  Paisley,  UK)  and  incubated 
overnight at 37 C.   
From  the  resultant  transformants,  3  colonies  were  used  to  inoculate  5  mLs 
imMedia™ Kan broth (Invitrogen, Paisley, UK), placed on an orbital shaker at 200 
rpm, and incubated overnight at 37 C.  The plasmid DNA was then isolated and 
purified using the QIAprep® Miniprep Handbook for purification of plasmid DNA 
(Qiagen, Crawley, UK) as before (section 2.7.6).  To verify the clones contained 
the novel gene insert, the plasmid was digested with the endonuclease restriction 
enzyme EcoR1.  This involved 5  L plasmid DNA, 0.2  L BSA Acetylated (10 
mg/mL), 1  L EcoR1 (10 U/ L), 2  L 10x Buffer H (All Promega, Southampton, 
UK), 11.8  L ultrapure water incubated overnight at 37 C.  The following day, 20 
L of the digests were mixed with 4  L 6x loading buffer (Promega, Southampton, 
UK) and electrophoresed on a 1.5% agarose 0.5x TBE buffer gel for 1 hour at 
100V, then soaked in 5  L GelStar® Nucleic Acid Gel Stain (Cambrex, Berkshire, 
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2.9  Genotyping 
2.9.1  Purification of DNA from rodent tails 
Zif268 null mice are sterile, therefore breeding heterozygous zif268 mutant mice 
(donated by P. Charnay, Paris, France) provided mice with a targeted inactivation 
of  the  zif268  gene,  as  well  as  additional  heterozygotes  and  wildtypes.    The 
DNeasy   Tissue  Handbook  provided  the  protocol  for  purifying  total  DNA  from 
rodent tails, and the instructions followed.  Approximately 0.5 cm length of mouse-
tail, harvested at 4-6 weeks old, was placed in a centrifuge tube and fully covered 
with 180  L of Buffer ATL.  After the addition of 20  L proteinase K, tubes were 
vortexed to mix, and the tails incubated at 55 C on a rocking platform overnight.  
400  L of Buffer AL-ethanol mixture was then added and the sample thoroughly 
mixed.  To bind DNA, the sample was pipetted into a DNeasy Mini spin column 
with  collection  tube,  centrifuged  at  7,200  g  for  1  minute  and  the  flow-through 
discarded.  To wash the DNeasy membrane and bound DNA, 500  L of buffer 
AW1  followed  by  500  L  of  buffer  AW2  were  added  to  the  spin  column, 
centrifuging at 7,200 g for 1 minute after buffer AW1, and for 3 minutes at 11,700 g 
after AW2.  The spin column was placed in a clean eppendorf tube and 200  L of 
Buffer AE pipetted directly onto the membrane.  After incubation for 1 minute at 
room  temperature,  the  sample  was  centrifuged  at  7,200  g  for  1  minute.    The 
elutant containing the DNA was then removed from the eppendorf tube and placed 
back onto the membrane before centrifuging again. 
2.9.2  Polymerase Chain Reaction 
Firstly, all equipment was UV irradiated for 30 minutes.  Then, to each PCR tube 
was  added:  5  L  5xPCR  mixture,  1.25  L  100 M  mix  of  zif268  forward  and 
reverse primers including the LacZ forward (as described in Topilko et al. (1997), 
and detailed in table 2.5), 0.25  L HotStar Taq, 10  L mouse DNA and 8.5  L 
distilled water.  The PCR programme consisted of 35 cycles of 1 minute at 94 C, 2 
minutes at 55 C and 2 minutes at 72 C.  Samples were then separated on a 1.5% 
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2.10  In Situ Hybridisation 
2.10.1  Tissue preparation 
In  this  study,  11  knockouts  and  11  wildtypes,  matched  for  age  and  sex,  were 
selected  for  experimentation.    Five  each  of  the  wildtypes  and  knockouts  were 
treated with 1 mg/kg haloperidol (Sigma-Aldrich, Dorset, UK) (dissolved in 0.5% 
hydroxypropyl  methyl  cellulose  (HPMC))  (Fisher  Scientific,  Loughborough,  UK) 
intraperitoneally and 6 of each were treated with the same volume of 0.5% HPMC 
(vehicle).  All animals were humanely killed 6 hours after injection and according to 
UK Home Office guidelines governing the ethical use of animals.  The brains were 
removed and rapidly frozen on dry ice and stored at -80ºC.  20  m sections were 
cut on a cryostat through Bregma 1.00 mm and -0.40 mm, thaw-mounted onto 
frosted poly-L-lysine-coated slides and air-dried.  Sections were fixed in fresh, ice 
cold 4% paraformaldehyde in 1x PBS for 5 minutes.  Following a 3 minute rinse in 
DEPC-treated PBS, sections were transferred to 70% ethanol for 3 minutes and 
then stored in 95% ethanol at 4ºC. 
2.10.2  Preparation of probes 
DNA antisense oligonucleotide probes were designed to be complimentary to the 
mouse mRNA sequence of enkephalin as haloperidol has been shown to increase 
enkephalin  and  zif268  levels  in  the  striatum  (Morris  et  al.  1988).    The 
oligonucleotide sequence was: 
Enkephalin:    TGCATCCTTCTTCATGAAGCCGCCATACCTCTTGGCAAGGATCTC 
Homology analysis using BLASTn searches of the databases available through 
Ensembl (www.ensembl.org) identified no known mouse sequences to which this 
probe was likely to hybridise other than the desired mRNA sequence.  A working 
stock solution of 0.3 pmol/ L was made using TE buffer, and the concentration of 
this  working  solution  checked  by  GeneQuant  (Pharmacia  Biotech,  Amersham, 
Buckinghamshire, UK) as before.  Radioactive probes were made by end-labelling 
the oligonucleotides (MWG Biotech, Ebersberg, Germany) with [
35S]dATP (Perkin 
Elmer, Buckinghamshire, UK) using terminal deoxynucleotidyl transferase (Roche 
Diagnostics, Sussex, UK).  This involved mixing 2  L of oligonucleotide with 2  L 
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[
35S]dATP  to  an  eppendorf  tube,  vortexing  the  solution  and  adding  2  L  TdT 
enzyme (800 U/reaction).  This was mixed by pipetting and incubated on a heat 
block for 1 hour at 37ºC, after which 60  L DEPC-treated H2O was added.  To 
remove  unincorporated  nucleotides,  the  QIAquick  Nucleotide  Removal  Kit 
(Qiagen,  Crawley,  UK)  was  utilised  and  the  instructions  followed  as  per  the 
manufacturer‘s protocol.  Briefly, 467  L of buffer PN was added to the labelled 
oligonucleotide eppendorf tube and mixed.  The solution was then applied to a 
provided column and centrifuged at 5,400 g for 1 minute before the column was 
washed with 2 x 500  L buffer PE (including ethanol), centrifuging for 1 minute at 
5,400 g, then for 1 minute at 11,700 g after the second wash.  To elute the probe, 
the column was placed in an RNAse-free eppendorf tube, 100  L of buffer added 
to  the  column  and  then  centrifuged  for  1  minute  at  11,700  g.    The  labelled 
oligonucleotide  was  then  counted  on  an LSA-2200  Liquid  Scintillation  Analyser 
(Perkin Elmer, Buckinghamshire, UK) to ensure a count range of 50,000 dpm/ L to 
200,000  dpm/ L,  after  which  1  L  of  1M  DTT  (dithiothreitol)  was  added  to 
preserve the probe from oxidation. 
2.10.3  Hybridisation 
Slides were removed from ethanol and allowed to air dry for up to 1 hour.  1.5  L 
of  labelled  oligonucleotide  and  1.5  L  of  1mM  DTT  were  added  to  150 l  of 
hybridisation buffer (see 2.12.5), applied to the slides and covered with Parafilm® 
"M",  laboratory  film  (American  National  Can™  Company,  IL,  USA)  avoiding 
bubbles.  The slides were placed in a dish with a towel soaked in 4x SSC (see 
2.12.4) for humidity and incubated at 42
oC overnight.  The next day slides were 
submerged in 1x SSC for 30 minutes at room temperature followed by 1x SSC at 
55
oC for 30 minutes with agitation, before washing in 0.1x SSC, followed by 70% 
ethanol then 100% ethanol.  Slides were allowed to air dry for 30 minutes before 
exposing to BioMax MR Emulsion film (Kodak, London, UK) for approximately 1 
week.  Films were developed using a HyperProcessor, automatic autoradiography 
film processor (Amersham Plc, Buckinghamshire, UK).   
2.10.4  Imaging 
Photographs  of  sections  were  taken  using  a  Panasonic  WV-BP500  camera 
(Berkshire, UK).  Film analysis was performed on a Macintosh computer using the 
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2.11  PCR Primers and Cycle Details 
Each  primer  was  designed  to  be  exon-intron  boundary  spanning,  except  for 
GAPDH, in order to preclude genomic amplification from DNA.  Primers were also 
designed to have similar melting temperatures (Tm) of no more than 65 C and a 
GC (guanine and cytosine) content of approximately 40%-60%.  All the primers 
designed for use within this thesis are detailed in table 2.5. 
In order to obtain the maximum amount of information from the log linear phase of 
the RT-PCR reaction (described in section 2.4), the  results from every second 
cycle number was utilised.  Three of the cycles were then used to create a straight 
line.    The  novel  gene  PCR  reaction  was  monitored  over  3  consecutive  cycles 
however, as the log linear phase was too short to monitor over 5 cycles.  The cycle 
numbers for each amplicon in each cell type examined are detailed in table 2.6. Donna M McDade, 2007    Chapter 2, 88 
 
Primer Name  Sequence  Orientation 
Section 2.4.3     
Ubiquilin Fwd:  5'-CTCGGTCCAGCAGTTCAAAGAGGAAAT-3'  sense 
Ubiquilin Rev:  5'-TCCTCCAAGTCCACCTAAACCAAAGGAG-3'  anti-sense 
Gephyrin Fwd:  5'-CTTGCTGCAAAGATTCCAGACTCCATC-3'  sense 
Gephyrin Rev:  5'-CTCGCCCCATTCCATCTCGGTAAT-3'  anti-sense 
EST AI169020 Fwd:  5'-CAAAATGAATTCAAATGACGCAACA-3'  sense 
EST AI169020 Rev:  5'-ACTTTGTCGTAAGCTGCTTGGAATG-3'  anti-sense 
EST AI176839 Fwd:  5'-CAAGAATAGACCAACACTGGCATCC-3'  sense 
EST AI176839 Rev:  5'-GATATTCATTTGCAGATGGCTGGAC-3'  anti-sense 
GAPDH Fwd:  5'-CCGCTGATGCCCCCATGTTTGTGAT-3'  sense 
GAPDH Rev:  5'-GGCATGTCAGATCCACAACGGATAC-3'  anti-sense 
Section 2.7.1     
Gephyrin Promoter Fwd:   5'-GTTCTGCCACCCATGCCGCTT-3'  sense 
Gephyrin Promoter Rev:   5'-GATCATTCCCTCGGTCGCCATG-3'  anti-sense 
Gephyrin Promoter Fwd SalI:   5‘-ATGTCGACGTTCTGCCACCCATG-3‘  sense 
Gephyrin Promoter Rev XbaI:   5‘-GTTCTAGAGATCATTCCCTCGGTCGC-3‘  anti-sense 
Section 2.8     
Tr12253 Fwd:   5'- AGACAATCGCGTGGCCTACATG -3'   sense 
Tr12253 Rev:  5'-GCTTTTTATCCTCCTCCTCAGAATCTG-3'  anti-sense 
EST Ai169020 Fwd:  5'-CAAAATGAATTCAAATGACGCAACA-3'   sense 
Sequence 2:   5'-GGATCCAGATTCAGTTCCTG-3'  sense 
Sequence 3:   5'-GCTCTTCACCGCTTTTCTTC-3'  sense 
Sequence 4:   5'-TCCGGAGACTTATGGCAATG-3'  sense 
Novel Gene Fwd:   5'-AGACAATCGCGTGGCCTACAT-3'   sense 
Novel Gene Rev:   5'-CGGCGAGTCTGAGCTTGAACT-3'   anti-sense 
Section 2.9     
Krox24 Fwd:  5'-GAGTGTGCCCTCAGTAGCTT-3'  sense 
Krox24 Rev:   5'-GGTGCTCATAGGGTTGTTCGCT-3'  anti-sense 
LacZ Rev:   5'-AACGACTGTCCTGGCCGTAACC-3'  anti-sense 
Table 2.5: Details of all the primers designed for this thesis.  The table is split into relevant 
sections for ease of use and are detailed as described in the text. Donna M McDade, 2007    Chapter 2, 89 
 
 
Amplicon   Cell Type  Cycle Number 
GAPDH  PC-12  24 
  Primary Cortical Neurones  22-26 
  Adult Cerebral Cortex  25-29 
Gephyrin  PC-12  30 
  Primary Cortical Neurones  30-34 
  Adult Cerebral Cortex  33-37 
Ubiquilin  PC-12  25 
  Primary Cortical Neurones  28-32 
  Adult Cerebral Cortex  31-35 
AI176839  PC-12  30 
  Primary Cortical Neurones  32-36 
AI169020  PC-12  35 
Urma  Primary Cortical Neurones  29-31 
  Adult Cerebral Cortex  30-34 
Table 2.6: Details of PCR cycle numbers monitored for each amplicon in each of the cell 
types examined. 
 
2.12  Solutions & Buffers 
2.12.1  Radioimmunoprecipitation (Ripa) Buffer 
  Concentration  Quantity*  Supplier 
Trizma Base  0.5 M  60 mg  Sigma-Aldrich, Dorset, UK 
NaCl  0.15 M  87.6 mg  BDH, VWR, Poole, UK 
Igepal  1%  100  L  Sigma-Aldrich, Dorset, UK 
Triton  0.5%  50  L  Sigma-Aldrich, Dorset, UK 
SDS  0.1%  10 mg  BDH, VWR, Poole, UK 
Protease Inhibitor 
Cocktail 
  1 tablet  Roche Diagnostics, Sussex, UK 
* Dissolved in 10 mLs de-ionised water.  Stored at 4 C.  pH 7.4 Donna M McDade, 2007    Chapter 2, 90 
 
2.12.2  T-TBS 
  Concentration  Quantity*  Supplier 
NaCl  1 M  58.44 g  BDH, VWR, Poole, UK 
Trizma Base  0.1 M  12.1 g  Sigma-Aldrich, Dorset, UK 
* Dissolved in 1L de-ionised water.  10x stock solution.  pH 7.5.  Dilute 100 mLs in 1L de-
ionised water then add 0.5mLs Tween-20.  Stored at room temperature. 
2.12.3  10x PBS 
  Concentration  Quantity*  Supplier 
NaCl  1.3 M  75.79 g  BDH, VWR, Poole, UK 
Na2HPO4  70m M  9.93 g  BDH, VWR, Poole, UK 
NaH2PO4  30m M  4.68 g  BDH, VWR, Poole, UK 
* Dissolved in 1L de-ionised water.  Filter, DEPC treat and autoclave.  Stored at room 
temperature. 
2.12.4  20x SSC 
  Concentration  Quantity*  Supplier 
NaCl  3 M  175.32 g  BDH, VWR, Poole, UK 
Na Citrate  0.3 M  88.23 g  BDH, VWR, Poole, UK 
* Dissolved in 1L de-ionised water.  Filter, DEPC treat and autoclave.  Stored at room 
temperature. 
2.12.5  Hybridisation Buffer 
  Concentration  Quantity*  Supplier 
Formamide  100%  25 mL  Fluka, Sigma-Aldrich, Dorset, UK 
SSC  20x  10 mL  See 2.11.4 
Na3PO4  0.5 M  2.5 mL  BDH, VWR, Poole, UK 
Na4P2O7  0.1 M  0.5 mL  BDH, VWR, Poole, UK 
Polyadenylic Acid  5 mg/mL  1 mL  Sigma-Aldrich, Dorset, UK 
Dextran Sulfate    5 g  Fisher Scientific, Loughborough, UK 
* Dissolved in 50mLs DEPC-treated water.  Stored at 4 C. 91 
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3  Induction of LTP-related Proteins in Cultured Cortical 
Neurones Donna M McDade, 2007    Chapter 3, 92 
3.1  Introduction 
Under experimental conditions, inducing LTP usually involves the maintenance of 
brain  slices  in  a  constant  stream  of  artificial  cerebrospinal  fluid  (aCSF)  with 
continual oxygen perfusion whilst applying electrical LTP-inducing tetanic stimuli 
via capillary electrodes along neural pathways or across neuronal membranes.  In 
2001,  a  new  and  simple  pharmacological  methodology  was  developed  that 
allowed the chemical induction of NMDAR-dependent LTP within murine cultured 
primary  hippocampal  neurones  (Lu  et  al.  2001).    This  involved  the  selective 
activation of synaptically located NMDARs, which are physiologically stimulated by 
glutamate release from presynaptic terminals.  This was achieved by applying an 
extracellular  solution,  which  was  similar  to  aCSF
1  but contained an increased 
glucose concentration, presumably reflecting the increased glucose requirement of 
cultured  ne urones  (typical  glucose  concentrations  within  culture  media  are 
approximately 20-30 mM).  Importantly, the extracellular solution contained no 
Mg
2+, which is usually present at approximately 3 mM in aCSF, or at 1 mM for 
electrophysiological LTP inducing  experimental paradigms  (within  Neurobasal™ 
culture media, this is 0.38 mM).  The extracellular solution did contain glycine, the 
co-agonist of NMDAR, with the addition of strychnine to block the activation of 
non-NMDA  related  glycine  receptors,  as  well  as  other  pharmacological  agents 
(detailed  in  the  methods).    This  was  reported  as  a  significant  advance  over 
previous approaches.  For example, application of NMDA may not reliably produce 
LTP, possibly reflecting the activation of extra-synaptic NMDA receptors,  which 
have been linked to LTD (Lu et al. 2001). 
Spontaneous miniature excitatory postsynaptic currents (mEPSCs) measured from 
single  neurones  can  represent  one  or  two  quanta  of  transmitter  release.    An 
increase in the amplitude of the mEPSCs can be indicative of LTP (Manabe et al. 
1992; Oliet et al. 1996).  Lu et al. (2001), and subsequently Man et al. (2003), 
found  that  a  three  minute  application  of  glycine  perfused  with  the  extracellular 
solution, and then washed out, rapidly increased the amplitude and frequency of 
mEPSCs.  This phenomenon was eliminated when synaptic NMDARs, activated 
by the spontaneous release of glutamate, were selectively blocked by pre-treating 
cultures  for  10  minutes  with  MK-801  (an  open  channel  blocker  of  NMDAR 
                                         
 
1 aCSF contains approximately (mM): NaCl, 120; NaHCO3, 26; KCl, 3; NaH2PO4, 1.25; Glucose, 
10; CaCl2, 2; and MgSO4, 1-3. Donna M McDade, 2007    Chapter 3, 93 
(MacDonald  &  Nowak  1990;  Rosenmund  et  al.  1993)).    The  subsequent 
application of glycine for 3 minutes then failed to enhance mEPSCs. 
Using the same method, but with an increased exposure to glycine of 15 minutes, 
Ehlers (2003) looked at changes in the post synaptic density (PSD) and protein 
turnover within cultured cortical synapses and the effects these had on CREB and 
ERK phosphorylation (pCREB and pERK respectively).  He found that activation of 
synaptic NMDARs with the application of the extracellular solution, including 200 
M glycine for 15 minutes, induced a 2 to 3 fold increase in induction of both 
CREB and ERK proteins when analysed by immunoblotting.  
ERK is significantly activated after glutamate treatment, NMDA treatment or high 
frequency stimulation sustained for 3 to 15 minutes and CREB is activated after 5 
to 15 minutes (Kurino et al. 1995; Iida et al. 2001; Liu et al. 1999; Sgambato et al. 
1998).  In 2003, Ehlers stimulated cultured rat hippocampal neurones (14 – 30 
DIV), for 15 minutes with glycine in order to allow phosphorylation of ERK and 
CREB, as measured by western blot. 
Arachadonic acid (AA) mimetics, such as ETYA, may also chemically induce LTP.  
LTP  inducing  tetanic  stimulation  of  the  hippocampal  CA1  region  induces  the 
release of AA via the activation of ionotropic glutamate receptors and can alter 
synaptic transmission alone by increasing the slope of field excitatory postsynaptic 
potentials in a manner similar to LTP (Nishizaki et al. 1999).  In addition, AA has 
been  shown  to  induce  LTP  in  0.1mM  magnesium  (Kato  et  al.  1991)  and  can 
increase the amplitude of EPSPs (Ramakers & Storm 2002).   
In the series of experiments presented in this chapter, an attempt was made to 
repeat  and  optimise  the  above  protocols  to  permit  the  induction  of  LTP  within 
cultured cortical neurones.  The basic paradigm involved the application of the 
extracellular (control) solution and the addition of glycine for 15 minutes, which 
was  subsequently  removed  and  the  neurones  harvested  for  immunoblotting  to 
detect phosphorylation levels of CREB and ERK proteins.  The ability to produce 
neurochemical changes characteristic of LTP in cultured neurones would greatly 
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3.2  Aims and Objectives 
  Optimise the experimental protocol to suit available laboratory conditions. 
  Pharmacologically induce LTP in cultured primary cortical neurones. 
  Repeat the experiment described in Ehlers (2003) by measuring ERK and 
CREB phosphorylation levels during pharmacologically induced LTP. Donna M McDade, 2007    Chapter 3, 95 
3.3  Method Development 
3.3.1  Experiment 1: LTP in culture 
3.3.1.1   Control Salt Solution 
The following control salt solution was prepared using the description in Lu et al. 
(2001).  The solution is composed of, NaCl, KCl, Glucose and CaCl2, which are all 
present in aCSF.  In addition it contains HEPES, a buffer, strychnine, which blocks 
glycine  receptors,  bicuculline,  a  competitive  antagonist  of  GABARs  and  TTX, 
which blocks voltage-gated sodium channels. 
  Concentration  Quantity*  Supplier 
NaCl  140mM  0.4g  BDH, VWR, Poole, UK 
CaCl2  1.3mM  65μl
a  Fisher Scientific, Loughborough, UK 
KCl  5mM  750μl
b  BDH, VWR, Poole, UK 
25mM HEPES  25mM  0.3g  Sigma-Aldrich, Dorset, UK 
Glucose  33mM  0.3g  Fisher Scientific, Loughborough, UK 
Strychnine  1μM  375μl
c  Fisher Scientific, Loughborough, UK 
Bicuculline  20μM  1ml
d  Tocris, Avonmouth, UK 
Tetrodotoxin  0.5μM  7.5μl
e  Tocris, Avonmouth, UK 
* Dissolved in 50mls de-ionised water.  Stored at 4 C. 
a of a 1M stock solution 
b of a 333.3mM stock solution (2.485g in 100mls de-ionised water) 
c of a 133μM stock solution (4.45mg in 100mls de-ionised water) 
d of a 1mM stock solution (25mg bicuculline in 4.9mls de-ionised water, diluted 
1:10 with de-ionised water) 
e of a 3.3mM stock solution 
3.3.1.2  Protocol 
As Ehlers (2003) used cultured primary cortical neurones at 14-30 DIV, we utilised 
primary cortical neurones of similar ages (15 - 25 DIV).  These were seeded in 3 
wells of a 6 well plate and denoted sample 1, 2 or 3.  Sample 1 received the 
control  salt  solution,  sample  2  the  LTP  test  and  sample  3  an  MK-801  control 
(figure  3.1).    Firstly,  the  Neurobasal   media  (Invitrogen,  Paisley,  UK)  was 
removed and replaced with 2 mLs control salt solution (detailed above in section 
3.3.1.1) for all samples.  Immediately thereafter, 10 μM  MK-801 was added to 
sample 3 and the plate incubated at 37
oC in 5% CO2 for 10 minutes.  After this Donna M McDade, 2007    Chapter 3, 96 
period, 200 μM glycine was added to the LTP test well (sample 2) and to the MK-
801 control (sample 3) and the plate incubated for 15 minutes at 37
oC in 5% CO2.  
An  additional  culture  plate  was  simultaneously  stimulated  and  incubated  for  2 
hours at 37
oC in 5% CO2.  Samples were then harvested, the protein normalised 
and a western blot performed as per the western blotting procedure described in 
section 2.6 (including ponceau S staining to check for equal levels of total protein). 
 
Figure 3.1: Diagram of a stylised 6 well plate illustrating the conditions of LTP in cultured 
cortical neurone experiments.  Each plate contained a control (sample 1), LTP test (sample 2) 
and MK-801 control (sample 3) wells and the composition of each solution is detailed. 
3.3.1.3  Results 
In  this  first  experiment,  the  published  materials  and  methods  in  Ehlers  (2003) 
provided the protocol.  A 15-minute 200 μM glycine stimulation in the presence of 
the control salt solution (which contained no Mg
2+) was followed by a western blot 
to  assess  ERK  1/2  (p44/42  MAPK)  dual  phosphorylation  at  threonine  202  and 
tyrosine 204, as an indicator of LTP.  In addition, cultured neurones stimulated for 
2 hours were assessed for zif268 activation.  As can be seen in figure 3.2, there 
was  no  significant  difference  between  pERK  levels  in  control  and  LTP  test 
samples.  There did seem to be an increase in pERK protein levels in cells pre-
treated for 10 minutes with MK-801, however.  Zif268 immunoreactivity was not 
affected by experimentation (see figure 3.2). 
3.3.2  Experiment 2: The effect of phosphatase inhibitor, okadaic acid, 
on LTP in culture 
Okadaic Acid is an inhibitor of protein phosphatase type-1 and type-2a, which de-
phosphorylate  phosphoproteins  (Haystead  et  al.  1989).    Protein  phosphatases 
were therefore addressed as possible mediators of the unchanged phosphorylated 
proteins within this experimental paradigm.  The experiment was conducted in the 
same way as experiment 1 however, 100 nM of the phosphatase inhibitor, okadaic 
acid (Tocris Cookson Ltd., Avonmouth, UK), was added to each well at the same Donna M McDade, 2007    Chapter 3, 97 
time as the control salt solution.  The experiment then proceeded as previously 
detailed. 
3.3.2.1  Results 
Applying 100 nM okadaic acid to all samples before the addition of 200 μM glycine 
had  no  obvious  effect  on  CREB  phosphorylation  at  serine  133  or  ERK  1/2 
phosphorylation in either controls (sample 1 and 3) or the test well (sample 2) 
(figure 3.3, n=2).   
 
 
 
Figure 3.2: Experiment 1 - LTP in culture.  Representative western blots of pERK and zif268 
immunoreactivity from cultured cortical neurones after sample 3 was pre-incubated with 10 μM MK-
801 for 10 minutes followed by the addition of 200 μM glycine to samples 2 & 3 for 15 minutes (for 
pERK) or 2 hours (for zif268), as described in experiment one.  Lanes displayed: Sample 1, control; 
Sample 2, LTP test; Sample 3, MK-801 control.   pERK, n=3, zif268, n=1. 
 
 
 
 
Figure 3.3: Experiment 2 – The effect of okadaic acid.  Representative western blots of pERK 
and pCREB immunoreactivity from cultured cortical neurones after all samples received 100 nM 
okadaic acid with the control solution.  Sample 3 was then pre-incubated with 10 μM MK-801 for 10 
minutes followed by the addition of 200 μM glycine to samples 2 & 3 for 15 minutes, as described 
in experiment 2. Lanes displayed: Sample 1, control; sample 2, LTP test; Sample 3, MK-801 
control. n=2. 
3.3.3  Experiment 3: The effect of phosphatase inhibitor, cantharidin, 
on LTP in culture 
This experiment was conducted as experiment 1, however, 0.38 mM Mg
2+ was 
added to the control well (sample 1) with the addition of the control salt solution.  
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This  served  to  lower  the  baseline  of  LTP-induced  protein  phosphorylation.    All 
subsequent experiments (i.e. experiments 4 to 10) included 0.38 mM Mg
2+ in the 
control (sample 1) well.  Cantharidin (Tocris Cookson Ltd., Avonmouth, UK) (2 μM) 
an inhibitor of protein phosphatase 2a, was also applied to each well (sample 1, 2 
and  3).    The  experiment  then  proceeded  as  before,  with  a  10  minute  pre-
incubation period of 10 μM MK-801 for sample 3, followed by the addition of 200 
µM glycine to the LTP test and MK-801 control for 15 minutes before the samples 
were harvested for western blotting. 
3.3.3.1.1 Results 
In  this  experiment,  total  ERK  (tERK)  protein  was  also  probed  to  confirm  the 
normalisation of ERK protein in all experimental paradigms.  Overall, there was no 
apparent difference between pERK or pCREB protein levels in both controls and 
the test well (figure 3.4, n=2). 
 
 
 
 
Figure 3.4: Experiment 3 – the effect of cantharidin.  Representative western blots of tERK, 
pERK and pCREB immunoreactivity from cultured cortical neurones after treatment with 2 μM 
cantharidin with the control solution.  Sample 3 was then pre-incubated with 10 μM MK-801 for 10 
minutes followed by the addition of 200 μM glycine to samples 2 & 3 for 15 minutes, as described 
in experiment 3.  Lanes displayed: Sample 1, control; Sample 2, LTP test; Sample 3, MK-801 
control. n=2. 
3.3.4  Experiment 4: The effect of osmolarity on LTP in culture 
Osmolarity refers to the total molar concentration of the solutes.  Rapid changes in 
extracellular  osmolarity  can  have  profound  effects  on  cell  homeostasis.    The 
published  data  from  Invitrogen  Plc  (Paisley,  UK)  regarding  the  Neurobasal  
media, to which was added penicillin-streptomycin (5  g/mL) and 20% B27 serum-
free supplement, allowed the calculation of the overall osmolarity used in neuronal 
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cells maintenance to be approximately 210 – 250 mosmol
-1.  The salt solution was 
325  –  345  mosmol
-1  (Lu  et  al.  2001),  requiring  an  adjustment  period  for  the 
cultured cells in which the osmolarity could be raised and allow the cells to adapt.  
In order to increase the osmolarity of the media, 100 mM sucrose was added to 
the cultured primary cortical neurones overnight by removing the Neurobasal  
media from all the samples and replacing it with Neurobasal  media containing 
1.71g sucrose per 50mls media.  The next day, the experiment proceeded as per 
experiment  3,  with  the  control  salt  solution  application  occurring  immediately 
before the application of 2 μM cantharidin to all samples. 
3.3.4.1  Results 
The Neurobasal  media bathing the neurones was fortified with 100mM sucrose, 
and  the  cells  incubated  at  37
oC  in  5%  CO2  overnight  in  order  to  raise  the 
osmolarity of the extracellular solution.  The protein levels of pERK and pCREB 
remained  unchanged  in  the  LTP  test  well  (sample  2)  after  raising  the  resting 
osmolarity of the media before treating with 2 μM cantharidin, when compared to 
both the control well (sample 1) and MK-801 control (sample 3), as determined by 
western blotting (figure 3.5, n=2). 
 
 
 
Figure  3.5:  Experiment  4  –  the  effect  of  osmolarity  on  LTP  in  culture.    A  representative 
western blot of pERK & pCREB immunoreactivity from cultured cortical neurones after increasing 
the osmolarity of the media and treating with 2 μM cantharidin and control solution simultaneously. 
Sample 3 was then pre-incubated with 10 μM MK-801 for 10 minutes followed by the addition of 
200 μM glycine to samples 2 & 3 for 15 minutes, as described in experiment 4. Lanes displayed: 
Sample 1, control; Sample 2, LTP test; Sample 3, MK-801 control. n=2. 
3.3.5  Experiment 5: The effect of decreasing glycine cell solution 
bathing time on LTP in culture 
On the advice of Professor Mike Ehlers and Dr Mikyoung Park, (Howard Hughes 
Medical  Institute,  Duke  University),  the  glycine  bathing  time  was  reduced.  
Therefore, as before, the Neurobasal  media for all cultured cortical neurones 
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was fortified with 100 mM sucrose the night prior to experimentation.  The next 
day, all neurones received the control solution and sample 1 also received 0.38 
mM  Mg
2+.    Then,  200  μM  glycine  was  applied  to  samples  2  and  3,  with  the 
simultaneous addition of 10 μM MK-801 to sample 3, and cells incubated at 37
oC 
in  5%  CO2  for  3  minutes.    After  this  period,  all  solutions  were  removed.  
Immediately thereafter, fresh control solution was added to all samples.  Sample 1 
also received 0.38 mM Mg
2+,
 sample 3 received 10 μM MK-801 and the plate was 
incubated for 12 minutes at 37
oC in 5% CO2.  Samples were then harvested, the 
protein  normalised  and  a  western  blot  performed  as  per  the  western  blotting 
procedure described in section 2.6. 
3.3.5.1  Result 
After direct contact with Professor Mike Ehlers and Dr Mikyoung Park, Howard 
Hughes  Medical  Institute,  Duke  University  the  protocol  for  inducing  LTP  was 
adjusted.    The  addition  of  glycine  for  3  minutes  to  the  LTP  test  well  had  no 
significant effect on ERK protein phosphorylation compared to controls (see figure 
3.6,  n=2).    CREB  phosphorylation  did  seem  to  increase  in  the  LTP  test  well 
compared to sample 1 control, however there was no obvious difference between 
the LTP test well and the MK801 control. 
 
 
 
 
Figure 3.6: Experiment 5 – the effect of decreased glycine cell bathing time.  Representative 
western blots of tERK, pERK and pCREB immunoreactivity from cultured cortical neurones after 
increasing the osmolarity of the media and treating with control solution in all samples with the 
addition of 0.38 mM Mg
2+ to sample 1, 200 μM glycine to samples 2 & 3 and 10 μM MK-801 to 
sample 3 simultaneously for 3 minutes.  This was followed by the removal of all solutions and 
replacement of fresh control solution to all 3 samples, with the addition of 0.38 mM Mg
2+ to sample 
1 and 10 μM MK-801 to sample 3, as described in experiment 6.  Lanes displayed: Sample 1, 
control; Sample 2, LTP test; Sample 3, MK-801 control. n=2. 
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3.3.6  Experiment 6: The effect of decreased glycine concentration on 
LTP in culture 
High concentrations of glycine could be counteractive to LTP induction (Lu et al. 
2001)  and  therefore  the  effects  of  a  decreased  glycine  concentration  were 
investigated.  This experiment was repeated as per experiment 5 however, only 50 
μM glycine was added to sample 2 (LTP test) and sample 3 (MK-801 control) wells 
for 3 minutes. 
3.3.6.1  Result 
The addition of 50 μM glycine to the LTP test well and MK-801 control well instead 
of  200  μM  glycine  had  no  effect  on  the  level  of  activation  of  ERK  protein  as 
measured by dual phosphorylation at threonine 202 and tyrosine 204, as seen in 
figure  3.7  (n=2).    There  was  also  no  apparent  difference  in  pERK  protein 
phosphorylation  levels  between  the  sample  1  control  and  the  LTP  test  well 
(sample 1). 
 
 
Figure 3.7: Experiment 6 – the effect of decreased glycine concentration.  Representative 
western blots of tERK and pERK immunoreactivity from cultured cortical neurones after increasing 
the osmolarity of the media and treating with control solution in all samples with the addition of 0.38 
mM Mg
2+ to sample 1, 50 μM glycine to samples 2 & 3 and 10 μM MK-801 to sample 3 
simultaneously for 3 minutes.  This was followed by the removal of all solutions and replacement of 
fresh control solution to all 3 samples, with the addition of 0.38 mM Mg
2+ to sample 1 and 10 μM 
MK-801 to sample 3, as described in experiment 7.  Lanes displayed: Sample 1, control; Sample 2, 
LTP test; Sample 3, MK-801 control. n=2. 
3.3.7  Experiment 7: The effect of decreased glycine concentrations 
with unchanged cell culture media osmolarity 
This was a repeat of experiment 6 using 50 μM glycine however, the Neurobasal  
media remained unchanged and was not fortified with sucrose the night prior to 
experimentation. 
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3.3.7.1  Result 
In this experiment, the media was not fortified with sucrose to elevate osmolarity in 
the wells of the cultured cortical neurones.  Applying 50 μM glycine for 3 minutes 
to samples 2 and 3 with the addition of the control solution has slightly decreased 
the level of phosphorylated ERK protein compared to the sample 1 control and 
MK-801 sample 3 control (see figure 3.8, n=2). 
 
 
 
 
Figure 3.8: Experiment 7 – the effect of decreased glycine concentration with unchanged 
cell culture media.   Representative western blots of tERK, pERK and pCREB immunoreactivity 
from cultured cortical neurones after treating with control solution in all samples with the addition of 
0.38 mM Mg
2+ to sample 1, 50 μM glycine to samples 2 & 3 and 10 μM MK-801 to sample 3 
simultaneously for 3 minutes.  This was followed by the removal of all solutions and replacement of 
fresh control solution to all 3 samples, with the addition of 0.38 mM Mg
2+ to sample 1 and 10 μM 
MK-801 to sample 3, as described in experiment 8.  Lanes displayed: Sample 1, control; Sample 2, 
LTP test; Sample 3, MK-801 control. n=2. 
3.3.8  Experiment 8: The effect of ETYA on LTP in culture 
ETYA is an analogue of AA, which has been implicated in LTP induction.  We 
therefore investigated the effects of ETYA on levels of phospo-ERK protein levels 
in cultured cortical neurones.  Firstly, 100 mM sucrose was added to the cultured 
primary cortical neurones the night prior to experimentation.  The next day, sample 
1 received the control salt solution (fortified with 0.38 mM Mg
2+), whilst sample 2 
and sample 3 received the control salt solution only.  Immediately thereafter, 200 
μM glycine was added to samples 2 and 3 and 5 μM ETYA (Alexis Biochemicals, 
Nottingham,  UK),  an  AA  analogue,  applied  to  sample  3.    The  plate  was  then 
incubated for 15 minutes at 37
oC in 5% CO2, and the experiment completed as 
before. 
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3.3.8.1  Result 
The  addition  of  ETYA  to  sample  3  with  the  glycine  application  provided  no 
observable  differences  between  total  ERK  proteins  and  phosphorylated  ERK 
proteins in the LTP test wells compared to both the sample 1 control and MK-801 
sample 3 control (see figure 3.9, n=2). 
 
 
Figure 3.9: Experiment 8 – the effect of ETYA on LTP in culture.  A representative western blot 
of tERK & pERK immunoreactivity from cultured cortical neurones after increasing the osmolarity of 
the media and treating the cells with the addition of 0.38 mM Mg
2+ to sample 1, 200 μM glycine to 
samples 2 & 3 and 5 μM ETYA to sample 3 for 15 minutes, as described in experiment 9.  Lanes 
displayed: Sample 1, control; Sample 2, LTP test; Sample 3, LTP and ETYA test. n=2. 
3.3.9  Experiment 9: The effect of a modified salt solution on LTP in 
culture 
A new control solution was prepared which contained the original ingredients (see 
section 3.3.1.1), with the exception of TTX and bicuculline, in order to maximise 
any possible LTP-like activity.  The night prior to experimentation, the Neurobasal
 media was fortified with 100 mM sucrose and applied to all the sample wells 
containing cultured cortical neurones.  The next day the new control solution was 
applied to all samples with the simultaneous addition of 0.38 mM Mg
2+ to sample 
1, 50 μM glycine to samples 2 and 3 and 10 μM MK-801 to sample 3.  All samples 
were  then  incubated  at  37
oC  in  5%  CO2  for  3  minutes.    After  this  period,  the 
solutions were removed and fresh control solution added to all wells.  Sample 1 
then received 0.38 mM Mg
2+,
 sample 3 received 10 μM MK-801 and the plate was 
incubated for 12 minutes at 37
oC in 5% CO2.  Samples were harvested, the protein 
normalised and a western blot performed as per the western blotting procedure 
described in section 2.6. 
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3.3.9.1  Result 
Removing  0.5  μM  TTX  and  20  μM  Bicuculline  from  the  control  solution  and 
stimulating NMDAR with 200 μM glycine for 3 minutes simultaneously did not alter 
the phosphorylation state of ERK protein when compared to cells treated with the 
addition of MK-801 or cells that had not been exposed to glycine (see figure 3.10, 
n=2). 
 
 
Figure 3.10:  Experiment 10 – the effect of removing TTX and bicuculline from the LTP salt 
solution.  Representative western blots of tERK and pERK immunoreactivity from cultured cortical 
neurones after treating with control solution lacking TTX and Bicuculline in all samples with the 
addition of 0.38 mM Mg
2+ to sample 1, 50 μM glycine to samples 2 & 3 and 10 μM MK-801 to 
sample 3 simultaneously for 3 minutes.  This was followed by the removal of all solutions and 
replacement of fresh control solution lacking TTX and Bicuculline to all 3 samples, with the addition 
of 0.38 mM Mg
2+ to sample 1 and 10 μM MK-801 to sample 3, as described in experiment 10.  
Lanes displayed: Sample 1, control; Sample 2, LTP test; Sample 3, MK-801 control. n=2. 
3.3.10  Zif268 is NMDAR dependently upregulated in cultured 
cortical neurones 
In  order  to  upregulate  zif268  in  a  physiologically  relevant  paradigm,  primary 
cortical  neurones  (10DIV)  were  stimulated  with  100  μM  NMDA.    In  the  first 
instance,  neurones  were  treated  with  either  (1)  vehicle,  (2)  100  μM  NMDA  in 
20mM KCl, (3) 10 µM MK-801, or (4) 100 μM NMDA in 20mM KCl and 10 µM MK-
801 for 6 hours (see figure 3.11, n=1).  Cytosolic proteins were then harvested and 
a western blot performed to visualise zif268 levels.  Basal levels of zif268 protein 
were not detectable in the vehicle treated sample.  After 6 hours, zif268 was not 
changed  in  the  sample  treated  with  MK-801  alone  when  compared  to  vehicle.  
There was a very small increase in zif268 protein levels in the sample treated with 
NMDA and MK-801, however, a noticeable increase was detected in the sample 
treated with 100 μM NMDA in 20mM KCl. 
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Figure  3.11:    Zif268  upregulation  after  NMDA  stimulation.    A  western  blot  of  zif268 
immunoreactivity from cultured cortical neurons (10 DIV) treated for 6 hours with either (1) vehicle, 
(2) 100 µM NMDA in 20 mM KCl, (3) 10 µM MK-801, or (4) 100 µM NMDA in 20 mM KCl and 10 
µM MK-801. n=1. 
 
82 kDa 
1            2        3               4 Donna M McDade, 2007    Chapter 3, 106 
3.4  Discussion 
In these experimental paradigms, the results obtained by others for the induction 
of LTP in cultured neurones could not be reproduced.  Lu et al. (2001) used the 
perfusing  solution  as  a  control,  which  contained  the  same  components  as  the 
control solution used in the experiments contained within this thesis (apart from 
the addition of Mg
2+ in experiments 4 - 10).  In Ehlers (2003), when measuring the 
phosphorylation of ERK and CREB, the control was the culture media alone (Dr 
Mikyoung  Park,  personal  communication).    We  observed  no  changes  in 
phosphorylation states of ERK or CREB when compared to control in any of the 
experiments performed.  Lu et al. (2001) presented evidence that MK-801 pre-
treatment could block the induction of LTP within cultured cells however, there 
were no changes in the activation of ERK or CREB when treated with MK-801, 10 
minutes  before  or  at  the  same  time  as  glycine,  compared  to  the  LTP  solution 
alone. 
In the first experiment an increase in pERK could only be seen by the addition of 
MK-801 to the cultured neurones.  This could be due to a problem with protein 
normalisation, as total ERK was not measured providing a measurable basal level 
of  protein  within  the  cells.    MK-801  blocks  synaptic  NMDARs;  therefore  it  is 
possible to assume that non-synaptic NMDARs could be involved in the increased 
ERK  activation  relative  to  non-MK-801  treated  cells.    However,  both  ERK  and 
CREB are shut off by the activation of extrasynaptic NMDAR (Ivanov et al. 2006; 
Hardingham, 2006) and in Ehlers (2001) a separate solution is used to specifically 
activate  these  receptors,  which  includes  CNQX  (an  AMPAR/kainate  receptor 
antagonist), nifedipine (a calcium channel blocker) and 100 µM NMDA. 
All the experimental samples were maintained on ice from lysis to denaturation for 
western  blotting.    This  maintains  a  low  temperature,  causing  phosphatase 
inhibition.  However, as there were no phosphatase inhibitors in the lysis buffer, 
we therefore addressed the possible problem of phosphatases by the addition of 
different compounds in the experimental paradigm.  Okadaic acid binds to and 
inhibits  serine/threonine  protein  phosphatases,  allowing  the  accumulation  of 
phosphorylated  substrates  (Tachibana  et  al.  1981;  Guy  et  al.  1992).  
Serine/threonine protein phosphatase type 1 (PP1) and protein phosphatase type 
2a  (PP2a)  are  the  dominant  protein  phosphatases  acting  on  phosphoproteins 
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in vivo (Sontag et al. 1993).  Okadaic acid treatment of PC-12 cells has been 
shown to cause an increased phosphorylation of ERK (Miyasaka et al. 1990), in 
addition, evidence suggests that CREB can be regulated by PP1 (Hagiwara et al. 
1992; Alberts et al. 1994) and/or PP2 (Wadzinski et al. 1993; Wheat et al. 1994).  
Therefore, the addition of okadaic acid to all samples was an attempt to decrease 
any dephosphorylating actions of the phosphatases present in the cell extracts.  
However, as the results show, this approach was unsuccessful in allowing us to 
promote  activation  of  either  ERK  or  CREB  in  the  LTP-inducing  cultures  when 
compared to controls. 
As a further attempt to address the possible effects of phosphatases acting on 
CREB and ERK phosphorylation states, cantharidin was added to cultures along 
with the control solution.  This protein phosphatase inhibitor, like okadaic acid, also 
suppresses the activities of both PP1 and PP2a (Honkanen 1993; Li et al. 1993b; 
Knapp et al. 1998).  As with previous experiments, the addition of cantharidin did 
not assist ERK and/or CREB protein phosphorylation  in the LTP test samples.  
Any future experiments would probably benefit from the addition of phosphatase 
inhibitors in the RIPA buffer, rather than altering the experimental solution. 
An increased extracellular osmolarity causes decreases in cell volume and can 
cause neurotransmitter release (Basarsky et al. 1994).  Cell shrinkage can lead to 
changes  in  cellular  functions  by  concentrating  intracellular  macromolecules, 
leading  to  increased  macromolecular  activity,  and  activation  of  membrane 
transporters (Parker & Colclasure 1992).  It can also lead to protein and glycogen 
inhibition  as  well  as  stimulating  glycogenolysis  and  proteolysis,  (whereas  cell 
swelling  has  the  opposite  effect)  (Haussinger  et  al.  1994).    The  cellular 
homeostasis  was  maintained  therefore  by  increasing  the  osmolarity  of  the  cell 
culture media  the  night  prior  to  experimentation,  allowing  the cells  to  adjust  to 
environmental  changes  outwith  the  critical  experimental  time  period.    Testing 
cellular responses to the LTP inducing solution with or without sucrose fortification 
of the cell culture media displayed no differences in ERK or CREB activation when 
compared to controls. 
Professor Mike Ehlers and Dr Mikyoung Park, (Howard Hughes Medical Institute, 
Duke University) advised that the control solution, glycine and MK-801 should be 
added  to  the  wells  simultaneously,  as  the  addition  of  the  control  salt  solution 
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preincubation.  They also recommended that the glycine activation should only be 
for  a  total  of  3  minutes.    Incorporating  these  changes  into  the  experimental 
procedure  produced  no  differences  in  the  phosphorylation  of  ERK  or  CREB 
between the control, MK-801 control or LTP samples.  There is a possibility that 
the  pre-incubation  of  MK-801  is  a  necessary  step  for  the  effective  blocking  of 
NMDAR channels and therefore any further attempts may require the addition of 
MK-801 to the culture media 10 minutes before the addition of the control solution 
and glycine. 
Applying 200 µM of glycine to cells is a suprasaturating level (Lu et al. 2001), and 
it has been reported that saturating the NMDAR at the synapse will induce glycine-
primed endocytosis and therefore leave a lower number of receptors available to 
engage in LTP (Nong et al. 2003; Martina et al. 2004).  Therefore, we decided to 
decrease  the  glycine  concentration  to  50  µM  to  look  at  LTP  induction  within 
cultured cells.  This had no effect on the phosphorylated proteins involved in the 
LTP signalling pathway. 
ETYA (5,8,11,14-eicosatetraynoic acid) is a polyunsaturated fatty acid analogue of 
AA  and  current  published  results  indicate  that  AA  can  facilitate  LTP  induction 
(Williams  et  al.  1989;  Drapeau  et  al.  1990;  O'Dell  et  al.  1991).    However, 
application of ETYA at a concentration sufficient to mimic AA actions (Ramakers & 
Storm 2002) did not elevate pERK or pCREB levels. 
The LTP inducing solution (control solution with the addition of glycine) contained 
strychnine  to  block  glycine  receptors.    In  addition,  it  contained  bicuculline,  a 
competitive antagonist of, primarily, the ionotropic GABA receptors.  These would 
serve to limit inhibitory actions on the cell.  HEPES is an organic chemical buffer 
that maintains physiological pH and TTX selectively blocks voltage-gated sodium 
channels, therefore blocking the passage of action potentials.  TTX was removed 
from  the  solution  in  order  to  allow  the  passage  of  action  potentials  along  the 
neurones and because of evidence that it could cause a large decrease in the 
levels of pERK (Chandler et al. 2001).  Bicuculline was also removed to reduce 
any excessive activity in control culture wells.  This produced no effect on the 
activation of ERK or CREB after the addition of glycine when compared to the non-
glycine control or MK-801 control.  Donna M McDade, 2007    Chapter 3, 109 
The experiments described in the results section involved the manual removal and 
application  of  all  solutions.    However,  in  Lu  et  al.  (2001)  each  well  was 
continuously superfused (1 mL/min) from a single barrel of a computer-controlled 
multibarreled  perfusion  system,  with  glycine  supplementation  applied  from  an 
alternate barrel.  This small, but significant, alteration could be a major factor in the 
failure of ERK and CREB phosphorylation.  There is a possibility that solutions 
were not entirely removed, leaving residual unwanted compounds within the wells.  
If  they  were  indeed  completely  removed,  this  would  lead  to  rapid  homeostatic 
changes within the cells, and possibly oxygen and electrolyte starvation between 
solution changes.  In addition, cultured cortical neurones were utilised in this study 
rather  than  cultured  hippocampal  neurones  in  the  literature.    However,  the 
mechanisms of synaptic plasticity are believed to show extensive commonalities 
between the cortex and the hippocampus. 
English & Sweatt (1996), investigating the role of ERK in hippocampal LTP, found 
that p42 ERK, but not p44, is activated in area CA1 after direct activation of PKC 
and NMDAR, and after LTP inducing high frequency stimulation.  We found no 
evidence to support this within cultured cortical neurones. 
Zif268 protein levels were also unchanged by application of the LTP salt solution.  
Therefore,  NMDA  stimulation  was  used  to  induce  zif268  in  order  to  gauge 
downstream effects.  The caveat with this technique is that it causes changes not 
only to zif268, but also to many other genes, proteins and processes within the 
cells.  Nevertheless, it is a physiologically relevant paradigm and consistent with 
the NMDAR-dependent LTP involved in synaptic plasticity.  In order to show zif268 
induction, NMDA in KCl was applied to cultured cells and the results compared 
with several controls.  KCl was used to depolarise the cell in order to relieve the 
magnesium  block  within  the  NMDAR,  which  activated  zif268  as  detected  by 
western  blot.    This  effect  was  attenuated  with  the  addition  of  MK-801.    As 
additional controls, the effects of the experimental vehicle and MK-801 alone were 
separately  analysed  and  were  found  not  to  induce  zif268.    Therefore,  NMDA 
activates  a  profusion  of  cellular  targets,  which  also  includes  increasing  zif268 
expression.  In this particular western blot the Visualiser system was used as it 
seemed  to  detect low  levels  of  protein more effectively  than  ECL.   The  zif268 
antibody  is  directed  towards  the  C-terminal,  and  has  been  characterised  and 
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In summary, phosphorylation states of the ERK and CREB proteins did not differ 
from total ERK amounts or either of the controls suggesting that these proteins 
were  not  activated  in  any  paradigms  tested.    The  results  suggest  that  the 
described protocols, while possibly capable of inducing a short term facilitation of 
synaptic  transmission,  may  not  induce  the  pattern  of  change  in  signalling 
pathways  that  are  characteristic  of  LTP  in  hippocampal  or  cortical  tissue.  
However, NMDA and KCl treatment of cortical neurones in culture increases pERK 
levels (Rakhit et al. 2005) and pCREB levels (Conway & Morris, unpublished) in 
an MK-801 sensitive manner.  The evidence that zif268 levels are also increased 
(figure  3.12)  suggests  that  exposure  of  cultured  neurones  to  NMDA,  in  the 
presence of a mild depolarising agent such as 20 mM KCl, produces many of the 
biochemical changes associated with LTP.  NMDA application can induce LTP in 
the presence of ACPD, an mGluR agonist, which was APV dependent (Fujii et al. 
2003).  In addition, it can potentiate synaptic transmission in the hippocampus 
(Kauer et al. 1988; Broutman & Baudry 2001).  Lee et al (2001) found that a 3-
minute application of 20 μM NMDA induced LTD in the CA1, which was measured 
for  1  hour.    Broutman  &  Baudry  (2001),  describe  a  5  minute  50  μM  NMDA 
application initially inducing LTD, which then increases EPSP amplitudes above 
baseline  after  1  hour.    Therefore,  the  duration  of  NMDA  application,  and 
subsequent  measurement  of  activity,  may  be  time  sensitive  for  LTP  induction.  
However,  whether  or  not  NMDA/KCl  induces  LTP,  it  appears  to  activate  a 
plasticity-signalling pathway of ERK - CREB - zif268 and hence is of use to study 
events downstream of zif268 induction. 
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4  Gephyrin as a downstream target of zif268 
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4.1   Introduction  
Gephyrin (Prior et al. 1992) was originally identified as a peripheral membrane 
protein (Schmitt et al. 1987) and is a ubiquitously expressed 93 kDa receptor-
associated  protein.    In  mouse the  gephyrin  gene  spans  457 kb,  containing  30 
exons, and is located on chromosome 12D2.  In humans it is 668 kb with 27 exons 
located on chromosome 14q23.3 (Rees et al. 2003).  The gene encodes a protein 
containing  an  N-terminal  G-domain,  a  C-terminal  E-domain  (which  show  high 
similarity to and are therefore named after, the E.Coli proteins MogA and MoeA 
respectively) and a proline-rich linker region in the centre.  The N-terminal domain 
forms a trimer and the C-terminal forms a dimer leading to the synaptic assembly 
of a gephyrin hexagonal submembrane lattice, onto which receptors are anchored 
(Kneussel & Betz 2000; Schwarz et al. 2001; Sola et al. 2001). 
4.1.1  Gephyrin Splice Variants 
Gephyrin is a highly mosaic gene due to the numerous exons in both mouse and 
human; many gephyrin gene variants have been identified.  Splicing occurs in all 
three domains with each domain containing at least 3 variable exons. Alternative 
splicing  has  been  found  to  affect  the  functions  of  gephyrin  in  mouse,  but  not 
human, and is ideal for dealing with the diverse functional demands of this protein.   
In mouse there are ten exons that can be spliced out, denoted C1-C7 and C4 -C6  
(Paarmann et al. 2006).  The C7 cassette contains a stop codon (Sola et al. 2004) 
effectively truncating the protein at the C-terminus, interfering with the interaction 
of many of gephyrin‘s binding partners.  Nova proteins, neuronal regulators of pre-
mRNA splicing, control the C3 cassette in neurones (Ule et al. 2003), indicating 
the possible importance of C3 in the periphery.  The inclusion of C5  may interfere 
with GlyR anchoring in hippocampal and spinal cord neurones (Meier & Grantyn 
2004).  Cassette 1 does not produce detectable hybridisation results within rat 
adult  and developing  brains  (Kirsch  et  al.  1993),  suggesting little  or  no mRNA 
signals for this particular exon.  This evidence led to the avoidance of cassette 1 
when  designing  in  situ  hybridisation  oligonucleotide  probes  for  experimentation 
within this thesis. 
Alternative splicing may be tissue specific suggesting that gephyrin‘s function may 
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in the liver (Prior et al. 1992), whilst C5 seems more abundant in muscle than 
other tissues (Ramming et al. 2000). 
4.1.2  Regional & Cellular Distribution of Gephyrin 
Gephyrin  and  its  variants  are  found  in  peripheral  tissues  in  the  heart,  muscle, 
retina,  testis,  spleen,  kidney,  lung  and  liver,  as  well  as  in  the  central  nervous 
system (Hermann et al. 2001; Prior et al. 1992). 
Immunoreactivity of gephyrin in the brain is widely distributed and can largely be 
found at its most intense in layers III, V and VI of the neocortex.  The hippocampal 
formation  shows  high  levels  of  immunoreactivity,  especially  in  the  granule  cell 
layer of the dentate gyrus.  The amygdaloid nuclei show varying amounts, while 
the  thalamic  nuclei  show  high  to  moderate  amounts.    It  is  distributed 
heterogeneously throughout the medulla and shows intense labelling in the pons 
(Waldvogel et al. 2003). 
At a cellular level, gephyrin immunoreactivity is found on the plasma membrane of 
the  soma  and  dendrites,  probably  representing  postsynaptic  sites.  
Immunoreactivity  is  also  found  intracellularly,  presumably  reflecting  the 
intracellular localisation of recently formed protein, which is en route to receptor 
membrane sites (Waldvogel et al. 2003). 
4.1.3  The role of Gephyrin & Glycine Receptors 
Gephyrin co-purifies with the mammalian glycine receptors (GlyRs) found in rat 
spinal cord (Pfeiffer et al. 1982; Graham et al. 1985).  Gephyrin binds via its MoeA 
domain to an 18-amino-acid amphipathic sequence in the large intracellular loop 
connecting transmembrane segments 3 and 4 of the GlyR   subunit (Meyer et al. 
1995; Kneussel et al. 1999b).   As mentioned in the introduction, gephyrin seems 
to  play  a  crucial  role  in  the  postsynaptic  clustering  of  GlyRs  and  GABAARs, 
although information regarding the relationship between GABAARs and gephyrin 
can often be contradictory.  The role of gephyrin at glycinergic synapses can point 
towards a possible generalized mechanism for inhibitory receptor accumulation at 
synapses by gephyrin. 
Both GlyRs and GABAARs belong to a superfamily of ligand-gated ion channels 
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transmembrane topologies (Moss & Smart 2001; Schrader et al. 2004).  The GlyR 
is composed of the   and   subunits, 2 glycosylated integral membrane proteins 
which have a stoichiometry of either three   to two   subunits (Langosch et al. 
1988) or two   to three   subunits (Grudzinska et al. 2005).  Four genes encode 
the    subunits  (GLRA1-4)  together  with  a  single    polypeptide  gene  (GLRB).  
GlyRs  allow  the  passage  of  chloride  ions  through  the  central  pore  of  the 
pentameric  receptor  formed  by  the  M2  -helical  segments  of  the  individual 
subunits.    This  hyperpolarizes  the  cell  in  mature  neurones,  thereby  preventing 
action potentials.  Glycine is the major inhibitory neurotransmitter in the spinal cord 
and brainstem. 
Gephyrin binds to heteromeric GlyR with high affinity (Kirsch et al. 1995), and in 
cultured  spinal  neurones  anchors  and  immobilises  GlyRs  on  the  subsynaptic 
cytoskeleton  (Kirsch  &  Betz  1995)  suggesting  that  gephyrin  organises  the 
development,  localisation  and  clustering  of  GlyRs  at  inhibitory  post-synaptic 
membrane specialisations (Kirsch et al. 1996).  It has been shown that the loss of 
gephyrin  expression  via  antisense  depletion  of  primary  neurones  (Kirsch  et  al. 
1993)  or  by  gene  knockout  in  mice  (Feng  et  al.  1998),  prevents  the  synaptic 
clustering of GlyRs.  Single expression of GlyR   (but not  ) subunits targeted to 
intracellular gephyrin aggregates in HEK293 cells show that gephyrin binding is 
mediated  by  the    subunit  (Kirsch  et  al.  1995).    In  addition,  the    subunit  is 
responsible for receptor assembly and channel properties (Kirsch 2006). 
During embryonic development, gephyrin accumulates at spinal postsynaptic sites 
prior to the GlyR (Kirsch et al. 1993; Bechade et al. 1996), and promotes receptor 
clustering  in  an  activity  dependent  manner  (Kirsch  &  Betz  1998).  It  has  been 
proposed  that  glycine  induces  calcium  signals,  triggering  transmitter  release  in 
embryonic  cultured  neurones  (Kirsch  &  Betz  1998).    This  causes  gephyrin  to 
accumulate  at  the  cytoplasmic  face  of  nerve  terminal-postsynaptic  cell 
specialisations in spinal cord and other regions of the CNS  (Triller et al. 1985; 
Altschuler et al. 1986).  Gephyrin binds with high affinity to polymerised tubulin 
(Kirsch et al. 1991) and microfilaments (Kirsch & Betz 1995; Giesemann et al. 
2003) as well as to the GlyR (Meyer et al 1995; Kneussel et al. 1999).  Gephyrin 
clusters  could  then  trap  GlyRs  creating  a  postsynaptic  GlyR  matrix  increasing 
gephyrin cluster size further, possibly by way of local cytoskeleton reorganisation.  
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removed.    Similar  information  regarding  the  accumulation  of  GABAARs  and 
gephyrin at postsynaptic specialisations still requires clarification. 
In young cultured neurones (early DIV), spontaneous formation of gephyrin-GlyR 
clusters at non-innervated plasma domains are consistently observed (Kirsch & 
Betz  1995)  (Levi  et  al.  1999).    However,  these  accumulations  may  precede 
gephyrin-dependent clustering, creating a two-step process (Meier et al. 2000b).  
In spinal interneurones, newly synthesised GlyRs diffuse in the plasma membrane 
as  stable  clusters  (Rosenberg  et  al.  2001)  and  the  interaction  of  GlyR  with 
gephyrin  increases  its  rate  of  accumulation  at  synapses.  During  development, 
gephyrin is associated with intracellular somatic and dendritic vesicles both in vitro 
and in vivo (Colin et al. 1996; Colin et al. 1998).  After partial glycine denervation, 
gephyrin is detected with vesicles in the area of the golgi apparatus (Seitanidou et 
al. 1992).  
Transfecting gephyrin-GFP reveals that many GlyR puncta are co-localised with 
gephyrin around the nucleus and throughout the cytoplasm in COS-7 cells and 
3DIV  spinal  cord  neurones  (Hanus  et  al.  2004).    This  interaction  alters  the 
behaviour  of  intracellular  aggregates  of  gephyrin-GFP-GlyR  compared  to 
aggregates of gephyrin-GFP alone.  When in the presence of the GlyR binding 
domain, aggregates are seen to move more rapidly, with a directed movement 
away  from  or  toward  the  centre  of  the  cell  compared  to  the  gephyrin-GFP 
aggregates.    It  was  also  found  that  microtubule  depolymerisation  by  1 M 
nocodazole dramatically reduced the displacements of gephyrin-GFP aggregates 
associated with the binding domain, suggesting that they usually travel along the 
microtubules  along  the  secretory  pathway.    Movements  of  gephyrin-GFP 
aggregates were not affected.  Moreover, by using temperature changes to block 
GlyR  in  and  then  release  it  from  the  trans-golgi  network,  it  was  shown  that 
gephyrin  accelerates  the  accumulation  of  GlyR  and  increases  the  number  of 
receptors at the plasma membrane of the soma, followed by the neurites.   
4.1.4  Additional functions of Gephyrin 
Homozygous disruption of the murine gephyrin gene is lethal at birth (Feng et al. 
1998), and autoimmunity to gephyrin has been reported in a patient with Stiff-Man 
Syndrome (SMS) (Butler et al. 2000).  In addition, gephyrin knockout mice display 
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intestine  and  share  the  same  phenotype  as  human  hereditary  hyperekplexia 
(Johnson  et  al.  1989),  a  neurological  disorder  caused  by  mutations  to  glycine 
receptors  (Shiang  et  al.  1993; Rees  et  al.  1994; Rees  et  al. 2002)  and  MoCo 
deficiency  (Reiss  et  al.  2001).    Gephyrin  catalyses  crucial  steps  in  MoCo 
biosynthesis, specifically in the incorporation of molybdenum, which is important 
for the activity of different oxidoreductases (Johnson et al. 1989) and is a highly 
conserved process from bacteria to mammals.  There are significant sequence 
similarities  between  gephyrin  and  MoCo  biosynthesis  proteins  from  bacteria 
(Nohno et al. 1988), invertebrates (Kamdar et al. 1994) and plants (Stallmeyer et 
al.  1995).    Indeed,  transfection  of  rat  gephyrin  has  been  shown  to  rescue  the 
phenotype of MoCo biosynthesis mutants in E.Coli and plants (Stallmeyer et al. 
1999).  This is a novel non-neuronal catalytic function of gephyrin in intermediary 
metabolism that is not connected to synaptogenesis, and is a possible explanation 
for the ubiquitous expression and distinct splice variants of the gephyrin gene in all 
mammalian tissue (Prior et al. 1992). 
Gephyrin has also been found to interact with RAFT1, the rapamycin and FKBP12 
target  protein  (Sabatini  et  al.  1999).    This  could  regulate  the  subsynaptic 
translational  machinery  thought  to  initiate  protein  synthesis  in  dendritic 
subcompartments and will be dealt with in more depth in chapter 6. 
Overall there is considerable evidence that gephyrin is widely expressed and has 
the  capacity  to  form  many  isoforms  with  distinct  functions.    This  may  enable 
gephyrin  to  perform  multiple  functions  in  relation  to  synapse  formation  and 
maintenance.    As  detailed  previously,  gephyrin  is  linked  to  the  postsynaptic 
clustering of GlyRs as well as GABAARs and therefore may play a key role in 
inhibitory neurotransmission.  This chapter attempts to expand our knowledge of 
gephyrin  with  reference  to  synaptic  plasticity  and  introduces  this  scaffolding 
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4.2  Aims & Objectives 
  Identify and verify the presence of gephyrin within the PC-12 cell line. 
  Validate the original microarray experiment by transfecting PC-12 cells with 
full length or truncated zif268 and investigating any changes in gephyrin 
RNA and protein levels. 
  Extend the findings found in PC-12 cells by using primary cortical neurones 
stimulated  with  either  NMDA  or  vehicle  over  24  hours  and  investigating 
gephyrin expression at the RNA and protein levels. 
  Look at Gephyrin RNA and protein levels harvested from zif268 knockout 
and wildtype mice to investigate the effects of genetic manipulation. 
  Investigate whether gephyrin mRNA levels are altered after administration 
of haloperidol, which induces zif268 in striatal neurones, in wildtype mice 
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4.3  Results 
4.3.1  PC-12 cells stain positively for gephyrin 
Identification of gephyrin expression within the PC-12 cell line was achieved using 
immunocytochemistry on partially differentiated and undifferentiated cells using a 
mouse anti-gephyrin antibody. Secondary antibody staining alone was essentially 
used as a control to illustrate that there is no non-specific staining in cells treated 
with or untreated with nerve growth factor (figure 4.1 A & B).  There is a marked 
difference  in  cells  probed  with  anti-gephyrin.    In  undifferentiated  cells,  distinct 
puncta can be seen throughout the cytoplasm (figure 4.1C).  Nerve growth factor 
treated PC-12 cells show a neuronal-like shape with the appearance of processes.  
Gephyrin immunoreactivity can be seen throughout the cell and processes and 
displays stronger staining than undifferentiated PC-12 cells (figure 4.1D). 
4.3.2  Gephyrin is downregulated in PC-12 cells after transient 
transfection with zif268 
RT-PCR was performed using GAPDH primers and exon-intron spanning primers 
for  gephyrin.    Gephyrin  RNA  was  significantly  downregulated  after  transient 
transfection of 1 μg/mL full-length zif268 cDNA in PC-12 cells pre-treated with 50 
ng/mL nerve growth factor when compared to cells transfected with 1 μg/mL of 
truncated zif268 cDNA (p<0.05, one sample t-test, n=5; see figure 4.2).  Gephyrin 
displays a decrease of 28% in RNA levels of PC-12 cells transfected with full-
length zif268 compared to controls. 
Figure 4.3 is a representative blot of a PVDF membrane stained with Ponceau S 
solution directly after protein transfer and immediately prior to blocking.  Uniformity 
of protein bands allowed the continuation of the western blot. 
Gephyrin protein levels display a significant downregulation of 7% in PC-12 cells 
transiently  transfected  with  full-length  zif268 compared  to  control  (p<0.05,  one-
tailed one sample t-test, n=6; see figure 4.4 A & B).   
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Figure 4.1: Confocal images of gephyrin in PC-12 cells. A, undifferentiated PC-12 cells stained 
only with 1:100 anti-mouse Alexa 594 secondary antibody. B, PC-12 cells pre-incubated for 2 hours 
with 50ng/mL NGF-7S and stained only with anti-mouse Alexa 594 secondary antibody. C, 
undifferentiated PC-12 cells stained with 1:100 anti-gephyrin and 1:100 anti-mouse Alexa 594. D: 
PC-12 cells pre-incubated for 2 hours with 50ng/mL NGF-7S and stained with 1:100 anti-gephyrin 
and 1:100 anti-mouse Alexa 594 secondary antibody.  Scale bar 15 m. 
4.3.3  Gephyrin is time-dependently downregulated in cultured cortical 
neurones after NMDA treatment 
As  mentioned  in  Chapter  2,  cultured  cortical  neurones  prepared  for  western 
blotting and RT-PCR were 7-10 DIV.  Neurones treated immunocytochemically 
were 21 DIV.  It was reasoned that whole cell measures of gephyrin did not require 
localisation at the synapse, and therefore did not need to be aged for 21 days, 
which was technically very challenging.   
Throughout this thesis, three statistical tests are performed.  The one sample t-test 
is used when comparing treated PC-12 cells to control and analyses the mean 
value of the sample to a known value, which, in this thesis, is 100% (the control 
value).    In  addition,  the  ANOVA  was  used  when  comparing  primary  neurones 
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between groups and is preferable to performing numerous t-tests.  The ANCOVA 
is utilised when there is a shared covariate (in this case, GAPDH) and a control 
and  treated  group.    This  compares  two  linear  regressions  and  is  a  statistical 
control for the variability found in some reference genes (Bond et al. 2002). 
 
Figure 4.2: The effect of zif268 on gephyrin mRNA levels in PC-12 cells.  Graph comparing 
gephyrin mRNA levels from PC-12 cells transiently transfected with either truncated or full-length 
zif268, as assessed by signal intensities at a single RT-PCR cycle.  Results are presented as 
gephyrin normalised pixel intensity after normalisation to the corresponding GAPDH.  All data 
expressed as a mean percentage of control (mean signal after expression of truncated zif268)   
SEM, *p<0.05, one sample t-test, n=5. 
 
 
 
Figure 4.3: Representative image of a western blot of a PVDF membrane stained with 
Ponceau S solution directly after transfer.  This blot contains two lanes of cytosolic lysates from 
PC-12 cells transiently transfected with truncated zif268 (Tr) and two lanes of cytosolic lysates from 
PC-12 cells transiently transfected with full-length zif268 (Fl). 
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Figure 4.4: The effect of zif268 on gephyrin protein levels in PC-12 cells.  A, Representative 
western blot comparing gephyrin immunoreactivity in PC-12 cells transiently transfected with either 
truncated or full-length zif268. B, Graph comparing gephyrin protein levels from PC-12 cells 
transiently transfected with either truncated or full-length zif268 as determined by western blotting. 
Results are presented as gephyrin normalised pixel intensity. All data expressed as a mean 
percentage of control (mean signal after expression of truncated zif268)   SEM, *p<0.05, one-tailed 
one sample t-test, n=6. 
Gephyrin mRNA harvested from 6 hour NMDA stimulated primary neurones (7-10 
DIV) was significantly downregulated in the RT-PCR reaction when compared to 
neurones treated with vehicle for 6 hours (p<0.01, F (1,16) = 11.69, ANCOVA, 
n=4; see figure 4.5).  In contrast, at 24 hours gephyrin mRNA was not significantly 
altered in primary cortical neurones stimulated with NMDA compared to neurones 
stimulated with vehicle (p>0.05, F(1,15) = 1.84, n=4; figure 4.6).  It can be seen 
within the graph that the regression lines do not touch and that the 3 datasets 
(representing information taken at 3 different cycle numbers) are clearly defined.  
The log values have been used within the statistical analysis as this can decrease 
the variability found when comparing various arbitrary numbers (pixel intensity), 
without changing the relationship between the numbers. 
Utilising immunocytochemistry, an overall effect of NMDA stimulation was found 
on gephyrin immunoreactivity when compared to vehicle treated primary cultured 
cortical neurones (p<0.01 F(1,30) = 15.67, 3-way ANOVA (factors: time, treatment 
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and  culture),  n=6;  see  figure  4.7).    In  particular,  gephyrin  protein  levels  are 
downregulated when stimulated for 3 hours with NMDA, displaying 29.83% ± 8.39 
less  immunoreactivity  per  square  micron  compared  to  vehicle-treated  cells 
(p<0.05,  Tukeys  post  hoc  test).    Figure  4.8  shows  representative  images  of 
neurones stimulated for 3 hours with either with 100 μM NMDA in 20 mM KCl or 
vehicle.  There was no overall effect of time (p = 0.283, F(2,30) = 1.32) and no 
interaction  between  treatment  and  time  (p  =  0.522,  F(2,30)  =  0.67).    For 
normalisation and resultant statistical analysis, the log value of pixel intensities 
was used.  For graphical representation all values are presented as percentages 
of control (vehicle treatment). 
Gephyrin  protein  levels  determined  by  western  blotting  of  cultured  cortical 
neurones  also  show  an  overall  effect  of  NMDA  stimulation  when  compared  to 
vehicle treated cells (p<0.01, F (1,23) = 28.12, 3-way ANOVA (factors: culture, 
time and treatment); see figure 4.9 A & B).  Specifically, there was a significant 
downregulation  of  gephyrin  immunoreactivity  of  primary  cortical  neurones 
stimulated for 3 hours with 100μM NMDA in 20mM KCl showing 37.82% ± 10.19 of 
immunoreactivity compared to vehicle treated cells (p<0.01, Tukeys post hoc test).  
There was also an overall effect of the duration of NMDA stimulation compared to 
vehicle treated cells and a significant effect of the interaction between treatment 
and  duration  of  treatment  compared  to  control  (p<0.01,  F(2,  23)  =  5.82  and 
p<0.05, F(2,23) = 4.20 respectively, 3-way ANOVA).   
4.3.4  Gephyrin RNA and protein levels are not effected in zif268 
knockout mice 
Figure  4.10  is  a  representative  DNA  genotyping  agarose  gel  of  wildtype, 
heterozygous, and zif268 knockout mice.  When genotyped, zif268
+/+ mice show a 
wildtype  allele  of  362  base  pairs,  zif268
+/-  display  the  wildtype  allele  and  a 
disrupted allele of 520 base pairs, whereas zif268
-/- only have the disrupted allele 
present (Topilko et al. 1997).   
A comparison of mRNA levels of gephyrin from zif268 knockout and wildtype mice 
by  RT-PCR  show  no  significant  differences  (p>0.05  F(1,13)  =  0.08,  ANCOVA, 
wildtype,  n=3,  zif268  knockout,  n=4;  see  figure  4.11).    In  addition,  comparing 
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either wildtype or zif268 knockout mice also show no effects of a zif268-targeted 
deletion (see figure 4.12 A & B). 
 
Figure 4.5: The effect of 6 hours NMDA stimulation on gephyrin mRNA in cultured neurones.  
Graph illustrating gephyrin log pixel intensity as a function of GAPDH log pixel intensity, determined 
by RT-PCR of primary cultured cortical neurones stimulated for 6h with either 100μM NMDA in 
20mM KCl or vehicle.  #p<0.01 F(1,16)=11.69, ANCOVA, n=4. 
 
 
Figure 4.6: The effect of 24 hours NMDA stimulation on gephyrin mRNA in cultured 
neurones. Graph illustrating gephyrin log pixel intensity as a function of GAPDH log pixel intensity, 
as determined by RT-PCR of primary cultured cortical neurones stimulated for 24h with either 
100μM NMDA in 20mM KCl or vehicle. ANCOVA revealed no significant effect of NMDA treatment, 
p>0.05, F(1,15) = 1.84, n=4. Donna M McDade, 2007    Chapter 4, 124 
 
Figure 4.7: The effect of NMDA stimulation on gephyrin protein levels in cultured neurones.  
Graph illustrating the effect of treatment of 3, 6 or 24 hour stimulation of 100μM NMDA in 20mM 
KCl or vehicle on gephyrin immunoreactivity of 21 DIV primary cultured cortical neurones as 
detected by immunocytochemistry. Results are presented as the number of puncta measured per 
square micron and expressed as a mean percentage of the signal in control (vehicle-treated) cells 
 SEM.  Effect of NMDA #p<0.01 F(1,30) = 15.67, 3-way ANOVA, *p<0.05, Tukeys post hoc test, 
n=6. 
 
 
 
Figure 4.8: Images of gephyrin within cultured neurones after 3 hours NMDA stimulation.  
Representative  primary cultured cortical neurones (21 DIV) treated for 3 hours  with vehicle (A) 
compared to those treated with 100 μM NMDA in 20 mM KCl (B), probed with anti-gephyrin and 
visualised with a confocal microscope as per the immunocytochemistry protocol.  When measuring 
the number of puncta, the particles present in the cell, visualised within a z-stacked image, were 
analysed  by  Image  J,  before  the  dendritic  measurement  area  was  defined  and  the  number  of 
puncta counted.  Scale bar 15 μm. 
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Figure 4.9: The effect of NMDA stimulation on gephyrin protein levels in cultured neurones 
by western blot.  A, Representative western blot of cultured cortical neurones stimulated with 
100μM NMDA in 2mM KCl or vehicle for either 3, 6 or 24 hours. B, Graph comparing gephyrin 
immunoreactive signal intensities from western blots of primary cortical neurones (7-10 DIV) 
stimulated for 3, 6 or 24 hours with 100μM NMDA in 20mM KCl or vehicle. Results are presented 
as normalised pixel intensity and expressed as a mean percentage of control (vehicle treatment)   
SEM.  Effect of NMDA #p<0.01, F (1,23) = 28.12, effect of time p<0.01, F(2, 23) = 5.82, interaction 
of treatment and time p<0.05, F(2,23) = 4.20, effect of culture p<0.01, F(5,23) = 18.58, 3-way 
ANOVA,  **p<0.01, Tukeys post hoc test, n=6. 
 
 
 
Figure 4.10: Representative image of genotyping results for the zif268 knockout colony. The 
wildtype allele is a 362 base pair band.  The disrupted allele is 520 base pairs long and is found in 
zif268 knockout mice.  Heterozygotes display both a wildtype and a disrupted allele.  WT = 
wildtype, HZ = heterozygote, KO = zif268 knockout mouse. 
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Figure 4.11: The effect of a zif268 targeted deletion on gephyrin mRNA in the adult cortex.  
Graph illustrating gephyrin log pixel intensity as a function of GAPDH log pixel intensity, as 
determined by RT-PCR of adult cerebral cortex tissue from either wildtype or zif268 knockout mice.  
ANCOVA found no significant effect of zif268 targeted gene deletion, p>0.05 F(1,13) = 0.08.  
Wildtype, n=3, zif268 knockout, n=4. 
 
 
 
Figure 4.12: The effect of a zif268 targeted deletion on gephyrin protein levels in the adult 
cortex.  A, Representative western blot comparing gephyrin immunoreactivity in adult cortical 
tissue from wildtype and zif268 knockout mice. B, Graph comparing gephyrin immunoreactivity 
signal intensities from western blots of adult cerebral cortex tissue extracted from either wildtype or 
zif268 knockout mice. Results are presented as normalised pixel intensity and expressed as a 
mean percentage of control (wildtype tissue)   SEM.  Wildtype, n=5, zif268 knockout, n=3.  
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4.3.5  Haloperidol administration to zif268 knockout and wildtype mice 
effectively induces enkephalin in the striatum 
Haloperidol administration in vivo increases glutamate release from corticostriatal 
terminals and produces LTP of corticostriatal transmission (Calabresi et al. 1997; 
Cepeda et al. 2001) by D2 receptor blockade.  This model of CNS plasticity also 
significantly  increases  zif268  and  enkephalin  within  the  striatum  (Morris  et  al. 
1988;  Nguyen  et  al.  1992;  Simpson  &  Morris  1994;  Keefe  and  Gerfen  1995; 
Cochran et al. 2002).  Haloperidol-induced responses within zif268 knockout mice 
were therefore measured indirectly by way of enkephalin mRNA levels.   
Enkephalin  mRNA  levels  in  the  striatum  were  determined  by 
35S  in  situ 
hybridisation after intraperitoneal administration of 1 mg/kg haloperidol or vehicle 
in zif268 knockout or wildtype mice.  Figure 4.13A shows a representative image 
of enkephalin upregulation in the striatum.  Approximately 6 hours after treatment, 
no  animals  showed  signs  of  catalepsy.    Enkephalin  mRNA  was  significantly 
increased  by  7%  in  all  mice  administered  with  haloperidol  when  compared  to 
vehicle  treated  animals  (p<0.01,  F(1,17)  =  10.70,  3-way  ANOVA  (factors: 
treatment,  genotype  and  sex),  haloperidol  treated,  female  n  =  4,  male  n  =  6, 
vehicle treated, female n = 4; male n = 8, see figure 4.13B).  There was also a 
significant effect of sex (p<0.05, F(1,17) = 7.36, 3-way ANOVA; not shown).  There 
was  no  effect  of  genotype  on  the  mRNA  levels  of  enkephalin  in  the  striatum 
(p>0.05, F(1,17) = 2.33, 3-way ANOVA).  
Gephyrin  oligonucleotide 
35S  and 
33P  labelling  was  unfortunately  unsuccessful 
within the time constraints of the PhD.  This, therefore, means that the gephyrin 
mRNA  levels  of  wildtype  and  zif268  knockout  throughout  the  brain  after 
administration of haloperidol or vehicle will not be presented in this thesis. 
4.3.6  Zif268 interacts with the promoter region of the gephyrin gene in 
PC-12 cells 
A promoter reporter assay was performed to investigate the activity of the gephyrin 
promoter in response to increased zif268 levels.  This experiment involved cloning 
the gephyrin promoter into a vector expressing chloramphemiol acetyl transferase 
(CAT).  The CAT reporter construct was transiently co-transfected into PC-12 cells 
with plasmid vectors expressing either full length zif268 (pzif268) or a truncated 
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on  putative  cis-binding  elements  of  the  gephyrin  promoter,  thereby  influencing 
gephyrin  gene  expression.    Cells  were  co-transfected  with  a  -Gal  expression 
vector to control for any variation in transfection efficiency.   
The murine gephyrin promoter (described in Ramming et al. (1997)) was used to 
perform a BLAST search of the Rattus norvegicus genome (www.ensembl.com).  
This had significant similarity to rat gephyrin RNA X66366, which then provided 
more of the 5‘ upstream sequence for the gephyrin promoter within rat.  Firstly, 
flanking  promoters  were  designed,  and  a  PCR  reaction  amplified  the  targeted 
gephyrin promoter from genomic DNA.  This produced the predicted amplicon of 
approximately 882 base pairs.   
 
 
Figure 4.13: The effect of haloperidol on enkephalin mRNA in the striatum of zif268 
knockout and wildtype mice.  A, Localisation of enkephalin mRNA by in situ hybridisation in 
wildtype mouse brain - coronal section at striatal level.  B, Graph illustrating the effect of 1 mg/kg 
haloperidol administration to zif268 knockout and wildtype mice on enkephalin mRNA levels in the 
striatum compared with vehicle administration as detected by in situ hybridisation. Results are 
expressed as mean pixel intensity   SEM.  Effect of haloperidol treatment **p<0.01, F(1,17) = 
10.70, effect of sex p<0.05, F(1,17) = 7.36, 3-way ANOVA.  No significant effect was found for 
genotype p>0.05, F(1,17) = 2.33.  Haloperidol, n= 10 (wildtype, n= 5, zif268 knockout n= 5), 
vehicle, n= 12 (wildtype, n= 6, zif268 knockout, n= 6).  
Using the PCR product as a DNA pool for the second round of PCR,  primers, 
containing restriction endonuclease recognition sites, were used to generate DNA 
strands  containing  both  the  gephyrin  promoter  and  digestion  sites  for  future 
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directional ligation with the vector.  pBLCAT3 is a promoter-less vector allowing a 
synthetically inserted non-native promoter to drive transcription (see figure 4.14).  
Investigation  of  the  MCS  and  gephyrin  promoter  region  revealed  2  restriction 
enzyme recognition sites (SalI and XBaI) which were present in the MCS but not in 
the promoter.  Primers were therefore designed to bind to the gephyrin promoter 
region, with the additional 6 base restriction enzyme recognition sites added to the 
5‘ end of each primer, allowing incorporation of the SalI site at the 5‘ end and the 
XBaI site at the 3‘ end of the promoter during the elongation phase of the PCR 
reaction (see figure 4.15).  The 4.3 kb vector and promoter were then separately 
digested with the restriction enzymes and electrophoresed to ensure the correct 
molecular weights were obtained.  After ligation, TOP10 cells were transformed 
with  the  gephyrin  promoter-containing  vector  and  the  clones  were  verified  by 
doubly  digesting  with  the  SalI  and  XbaI  restriction  enzymes  followed  by 
electrophoresis of the resultant products (see figure 4.16). 
PC-12 cells were transiently  transfected with  the β-GAL expression vector and 
either  the  empty  vector  (pBLCAT3)  or  the  gephyrin  promoter-driven  pBLCAT3 
(pGPHN),  and  either  full-length  zif268  (pzif268),  truncated  zif68  (ptrzif268)  or 
empty vector (pCMV5).  The experiment was performed both in the presence and 
absence of forskolin.  All previous transient transfections were conducted in the 
presence of forskolin after the finding that elevated cAMP, usually present during 
neuronal plasticity, was required for the modulation of synapsin1 expression by 
zif268  (James  et  al.  2004).    For  the  purposes  of  the  promoter  reporter  assay, 
transient transfections were performed in the presence and absence of forskolin in 
order to delineate the necessity of this adenyl cyclase activator for the modulation 
of  gephyrin  expression  by  zif268.  The  subsequent  ELISA  results  prominently 
show  that  β-gal  activity  is  significantly  decreased  when  cells  are  treated  with 
forskolin (p<0.01, one-way ANOVA, see figure 4.17).  The following CAT results 
are therefore presented in their raw form and not normalised to β-gal transfection 
efficiencies.  Results are presented as a percentage of control (empty vector or 
ptrzif268 as detailed). 
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Figure  4.14:  A  diagram  of  the  promoter-less  CAT  vector  pBLCAT3.    In  the  top  right  hand 
corner the MCS is clearly detailed, including the SalI and XbaI sites which were used directionally 
to  clone  the  gephyrin  promoter  into  the  vector.    Taken  from 
http://www.addgene.org/pgvec1?f=d&cmd=genvecmap&vectorid=5260&format=html&mtime=1143
220471 
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Figure 4.15: Diagram of the double stranded DNA gephyrin promoter with annealed primers 
designed to each contain restriction enzyme sites at the 5’ ends.  During the elongation phase 
of the PCR, DNA polymerase within the reaction will synthesise new strands of DNA incorporating 
the restriction enzyme sites onto the ends of the newly formed complementary strand. 
 
 
Figure 4.16: An image of an agarose gel containing the gephyrin promoter insert with the 
pBLCAT3 vector electrophoresed for 1 hour after restriction enzyme digestion with SalI and 
XbaI.  Numbers denote base pairs.  The contrast has been adjusted to reverse the polarity of the 
image for enhanced visualisation of the molecular weight bands. 
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Figure 4.17: The effect of forskolin on β-gal activity.  Graph illustrating β-gal activity in PC-12 
cells transiently transfected with β-gal in the presence or absence of 2 µM forskolin for 48 hours as 
detected by ELISA.  Results are presented as optical density (OD) values   SEM. **p<0.01 one-
way ANOVA, F(1, 28) = 174.43, n=3. 
Co-transfecting pzif268 had little effect on pBLCAT3 as measured by CAT activity 
in the presence of forskolin, compared to the CAT activity of the pBLCAT3 when 
co-transfected  with  pCMV5.    However,  in  the  absence  of  forskolin,  the  ELISA 
detected a significant decrease in pBLCAT3 CAT activity in cells co-transfected 
with  pzif268  compared  to  pBLCAT3  activity  when  co-transfected  with  pCMV5 
(one-sample t-test, p<0.05; see figure 4.18) suggesting zif268 action on the CAT 
empty vector independent of the gephyrin insert.  However, expressing pzif268 
and pGPHN relative to pzif268 co-transfected with pBLCAT3 revealed a significant 
suppressive action in the presence of forskolin (p<0.05, one sample t-test, n=3, 
see figure 4.19) suggesting zif268 action on gephyrin.  There was no significant 
effect in the absence of forskolin. 
Comparing the effect of pzif268 to ptrzif268 on the gephyrin insert, the effect of 
pzif268  on  pGPHN  was  not  significantly  different  to  the  effect  of  ptrzif268  on 
pGHPN  in  the  presence  of  forskolin.    In  the  absence  of  forskolin,  pzif268 
significantly decreased pGPHN activity, compared to pGPHN co-transfected with 
ptrzif268 (p<0.05, one sample t-test, n=3, see figure 4.20).  Inserting the gephyrin 
promoter  into  pBLCAT3  significantly  affects  the  CAT  activity  as  measured  by 
ELISA  in  the  absence  of  forskolin  (p<0.05,  one  sample  t-test,  n=3;  see  figure 
4.21).  A similar tendency was observed in the presence of forskolin, although it 
did not reach statistical significance. 
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Figure 4.18: The effect of pzif268 on CAT activity.  Graph illustrating CAT activity in PC-12 cells 
transiently co-transfected with pzif268 and pBLCAT3 in the presence or absence of 2 µM forskolin 
for 48 hours as detected by ELISA.  Results are presented as optical density values and expressed 
as a percentage of the optical density values of corresponding control cells (transiently co-
transfected with pCMV5 and pBLCAT3 in the presence or absence of forskolin)   SEM. *p<0.05, 
one sample t-test, n=3. 
 
 
Figure 4.19: Effect of the gephyrin promoter on CAT activity in the presence of zif268.  Graph 
illustrating CAT activity in PC-12 cells transiently co-transfected with pzif268 and pGPHN in the 
presence and absence of 2 µM forskolin for 48 hours as detected by ELISA.  Results are presented 
as  optical  density  values  and  expressed  as  a  percentage  of  the  optical  density  values  of 
corresponding control cells (transiently co-transfected with pzif268 and pBLCAT3 in the presence 
or absence of forskolin)   SEM. *p<0.05, one sample t-test, n=3. 
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Figure 4.20: The effect of zif268 on the gephyrin promoter.  Graph illustrating CAT activity in 
PC-12 cells transiently co-transfected with pzif268 and pGPHN in the presence and absence of 2 
µM forskolin for 48 hours as detected by ELISA.  Results are presented as optical density values 
and  expressed  as  a  percentage  of  the  optical  density  values  of  corresponding  control  cells 
(transiently co-transfected with ptrzif268 and pGPHN in the presence or absence of forskolin)   
SEM. *p<0.05, one sample t-test, n=3. 
 
 
Figure 4.21: The effect of gephyrin on CAT activity.  Graph illustrating CAT activity in PC-12 
cells transiently co-transfected with pCMV5 and pGPHN in the presence and absence of 2 µM 
forskolin for 48 hours as detected by ELISA.  Results are presented as optical density values and 
expressed as a percentage of the optical density values of corresponding control cells (transiently 
co-transfected  with  pCMV5  and  pBLCAT3  in  the  presence  or  absence  of  forskolin)    SEM. 
*p<0.05, one sample t-test, n=3. Donna M McDade, 2007    Chapter 4, 135 
4.4  Discussion 
The data presented in this thesis is the first to implicate gephyrin as a downstream 
target gene of the plasticity-related zif268 transcription factor.  The results show 
that increased amounts of zif268 within neurones decrease gephyrin mRNA and 
protein levels. 
The  gephyrin  antibody  used  throughout  is  directed  against  the  C-terminal  E-
domain, an area crucial for many of gephyrin's binding partners, and has been 
frequently  cited  in  the  literature  as  being  highly  specific  for  use  with  western 
blotting  (Feng  et  al.  1998;  Kneussel  &  Betz  2000)  and  immunofluorescence 
(Giesemann et al. 2003).   
In the first instance, gephyrin was localised within the PC-12 cell line.  A brief 
period of nerve growth factor stimulation differentiated the cells partially.  PC-12 
cells  become  a  neuronal-like  cell  type  once  treated  with  NGF  and  can  stop 
dividing, extend processes from the cell body and become electrically excitable.  
The  cells  were  probed  with  anti-gephyrin  and  subsequently  displayed  distinct 
puncta  when  compared  to  cells  probed  only  with  the  secondary  antibody  as 
control.  This provided evidence that gephyrin protein is expressed in PC-12 cells.  
The punctate labelling is consistent with previous reports in neurones (Craig et al. 
1996), and in PC-12 cells may relate to the non-receptor clustering functions of 
gephyrin. 
We then verified findings from the original microarray data presented by James et 
al. (2005).  Confirmatory analysis involved the transient transfection of PC-12 cells 
with either a full length or a truncated version of zif268.  The truncated form of the 
zif268  transcription  factor  is  inactive  due  to  an  N-terminal  deletion  ( N3-372), 
inhibiting  endogenous  full-length  zif268.    Harvesting  mRNA  after  48  hours  and 
utilising RT-PCR displayed a decrease in gephyrin expression in the presence of 
full-length zif268 when compared to truncated zif268.  This was mirrored in the 
findings  when  investigating  gephyrin  protein  levels  by  western  blot  after  zif268 
transient  transfection,  revealing  a  small,  but  significant,  decrease  in  gephyrin 
expression.  In this particular experiment, a one-tailed one-sample t-test was used 
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Ponceau  S  was  used  in  all  western  blotting  experiments  (PC-12  and  primary 
cultured  cortical  neurones)  to  check  the  uniformity  of  protein  transfer,  the 
normalisation of protein concentration starting material and loading of lysate onto 
the polyacrylamide gel.  If all the sample lanes stained equally, especially within 
the sizing area expected for the protein, then the experiment was continued.  If an 
uneven distribution of stained proteins was witnessed, the samples were either re-
assayed  for  normalisation  of  protein  concentration  or  re-loaded  onto  the  gel 
depending on the nature of variation.  Hence, it is very unlikely that the differences 
in protein levels detected could result from uneven loading or transfer of protein 
samples.    Blotting  with  an  antibody  against  a  ―housekeeping"  protein,  such  as 
actin or GAPDH, would also have helped to confirm protein loading was consistent 
for each lane. 
It  seems  somewhat  surprising  that  a  transcription  factor  would  suppress  gene 
expression  rather  than  activate  transcription,  especially  when  considering  the 
pivotal  role  of  zif268  in  learning  and  memory.    However,  as  demonstrated  in 
James et al. (2005), it is becoming increasingly evident that zif268 target genes 
are generally down regulated (Fukada & Tonks 2001; Bahouth et al. 2002; Davis 
et al. 2003; Zhang & Liu 2003).  The findings presented in this chapter therefore 
reinforce the suppressive nature of this particular transcription factor as previously 
published.   
Transient  transfection  of  zif268  into  neuronal  cells  was  attempted  for 
immunocytochemistry however, this was technically very challenging.  There is an 
increased  tendency  for  neurones  to  migrate  towards  each  other  and  'clump' 
together  the  longer  the  cells  are  in  vitro.  Combined  with  the  low  transfection 
efficiency, which necessitates the use of assay methods with cellular resolution, 
such as immunocytochemistry, this can make it very difficult to find measurable 
cells, especially when the cell to be measured is dictated arbitrarily by transfection 
success within viable cells.   
The RT-PCR results were derived from information gleaned over three data points 
as this allows for a high degree of confidence in the results obtained.  GAPDH is 
treated as a steady state control that is not affected by treatment (Spanakis 1993; 
Spanakis & Brouty-Boye 1994), however, when dealing with PCR over time there 
is a need to adjust for the effect of independent biological variables, as reference 
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allows for an improvement in the sensitivity of analysis and enables the variation 
common to both test and reference gene to be explained and removed from the 
analysis (Bond et al. 2002). 
After 6 hours of NMDA stimulation, gephyrin mRNA levels in cortical neurones (7-
10 DIV) are significantly decreased compared to controls.  By 24 hours, mRNA 
levels have returned to basal levels.  By western blot detection, gephyrin protein 
levels  are  not  significantly  different  from  controls  at  3  or  6  hours  of  NMDA 
stimulation  but  are  significantly  downregulated  at  24  hours  in  cultured  cortical 
neurones (7-10 DIV).  These results are consistent, whereby an increase in zif268 
expression would decrease gephyrin mRNA levels, which would eventually lead to 
a  decrease  in  gephyrin  protein.    In  contrast  are  the  results  found  by 
immunocytochemistry.  In this experiment, gephyrin protein levels are found to be 
downregulated at 3 hours in cultured cortical neurones (21 DIV) stimulated with 
NMDA, but not significantly after 6 or 24 hours, when compared to controls.  There 
are several reasons for this seeming discrepancy.  Firstly, and most obviously, the 
techniques  used  are  very  different.    Whilst  measurements  obtained  from 
immunocytochemistry can be localised appropriately, in this case within dendrites, 
western blotting and RT-PCR harvests all proteins within all cells giving a more 
global idea of the effects of experimentation.  Secondly, the length of time the 
cultures spent in vitro was dramatically different for each experiment.  Cultured 
cortical  neurones  treated  immunocytochemically  were  approximately  14  days 
more mature than the cultured cells processed for western blotting and RT-PCR.  
Although  it  was  reasoned  that  whole  cell  measures  of  gephyrin  protein  didn‘t 
require localisation at the synapse, this could have a marked effect on the results.  
At 21 DIV approximately 90% of gephyrin clusters are synaptic and 85% of these 
are  co-localised  with  GABAARs  at  synaptic  sites.  However,  at  7-10  days,  the 
number of gephyrin clusters associated with GABAARs is decreased dramatically 
to approximately 25% (Danglot et al. 2003).  In addition, there is a clear tendency 
for the dendritic gephyrin immunoreactivity to be suppressed by NMDA treatment 
at both 6 and 24 hours as well as 3 hours, implying that there may be a sustained 
suppression  of  gephyrin  expression.    It  is  also  possible  that  the  early  fall  in 
gephyrin  levels  are mediated  by  some  non-transcriptional mechanism,  such  as 
increased degradation.   
The NMDA treatment experiments within this thesis used a concentration of 100 
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increased  intracellular  calcium  concentrations,  excitotoxicity  and  neuronal  cell 
death, an XTT assay (Roehm et al. 1991) was performed (Professor B.J. Morris, 
personal communication).  This colorimetric assay,  based  on  the  reduction  of a 
tetrazolium  salt  (XTT),  showed  no  change  in  the  number  of  viable  striatal  or 
cortical neurones in primary culture after 24 and 48 hours treatment with 100 µM in 
20mM KCl.  Further tests of this nature, for longer periods of time, would ensure 
that  the  zif268  results  reported  here  were  true  results  of  a  plasticity-related 
pathway and not the beginnings of an excitotoxic pathway. 
RT-PCR of adult cerebral tissue from zif268 knockout mice shows no difference 
detected  in  gephyrin  expression  when  compared  to  wildtype  controls;  a  result 
reflected in the western blotting results.  This is most likely due to the fact that 
zif268  is  a  member  of  the  large  Egr  family,  generating  the  potentiality  of 
compensation.  Egr-2, egr-3 and egr-4 for instance encode proteins that can bind 
to the zif268 binding motif and there is considerable overlap in their binding sites 
and  functional  roles  (Crosby  et  al.  1992;  Vesque  &  Charnay  1992;  Swirnoff  & 
Milbrandt 1995).  In fact, it is known that egr-4 can compensate for zif268 in the 
zif268 knockout mouse (Tourtellotte et al. 2000) and egr-3 has been found to co-
localise with zif268, suggesting the possibility of further compensation (Yamagata 
et al. 1994).  Egr 2 and egr3 are also regulated by the induction of LTP (Yamagata 
et  al.  1994;  Williams  et  al.  1995).  Indeed,  gephyrin  is  an  essential  cellular 
component, as homozygous disruption of the murine gephyrin gene is lethal at 
birth,  suggesting  that  gephyrin  is  dispensable  for  embryonic  development  but 
absolutely  essential  for  postnatal  survival  (Feng  et  al.  1998).  Therefore  the 
knockout mice would need to be developmentally effective at compensating for 
zif268 loss.  Hence the lack of any detectable change in gephyrin expression in 
the zif268 knockout mice does not preclude an important role for zif268 as the 
transcriptional regulator of the gephyrin gene.   
A model of CNS plasticity was used to increases zif268 and enkephalin within the 
striatum by way of haloperidol administration in vivo (Morris et al. 1988; Nguyen et 
al. 1992; Simpson & Morris 1994; Keefe and Gerfen 1995; Cochran et al. 2002).  
Haloperidol-induced  responses  within  zif268  knockout  mice  were  measured 
indirectly by way of enkephalin mRNA levels, which showed a significant increase 
when compared with animals treated with vehicle.  The induction of enkephalin 
was smaller than expected.  This may reflect the genetic background of the mice, 
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neurones to haloperidol treatment (Patel et al. 1998).  In addition, it may be that 
the  desired  effect  of  increased  glutamate  at  synapses  did  not  occur  due  to 
haloperidol antagonistic actions on NR2B-containing NMDARs (Gallagher  et al. 
1998).    There  were  no  effects  of  genotype  within  the  results  confirming  that 
enkephalin levels are not altered by the presence or absence of zif268.  This is 
consistent with previous studies in the hippocampus (Johnston & Morris 1994).  It 
was hypothesised that, even in the absence of any change in the basal level of 
gephyrin expression in the zif268 knockout mice, there might be an impairment in 
any response to haloperidol treatment.  Unfortunately, measuring gephyrin levels 
by in situ hybridisation could not be completed within the time constraints imposed. 
The mouse gephyrin promoter is described by Ramming  et al. (1997) and was 
used to identify the rat gephyrin promoter region with the use of bioinformatics.  
Once the likely promoter region had been identified it was cloned for transfecting 
into PC-12 cells with either full length or truncated zif268.  Within this promoter 
region, there were 3 potential zif268 sites, 3 potential Sp1 sites and a general zinc 
finger transcription factor known to enhance promoter activity (Dynan et al. 1986), 
amongst  other  transcription  factor  binding  sites  (www.genomatix.de).    The 
promoter reporter assay, a CAT ELISA, is used quantitatively to measure CAT 
expression in eukaryotic cells transfected with a plasmid bearing a CAT encoding 
reporter gene.   
A  -gal ELISA was performed in order to monitor transfection efficiencies, but it 
was found that  -gal is significantly affected by the presence of forskolin.  This can 
be explained either by the fact that forskolin is decreasing the rate of transfection 
or that forskolin is causing the enzyme to decrease its activity.  Since there are 
reports suggesting that forskolin may increase  -galactosidase activity (Löser et al. 
1998),  the  latter  explanation  is  likely,  and  any  differences  in  cell  types  may 
contribute to the reversal of effect.  This effect negates the use of this protein as a 
means to normalise for any variation in transfection efficiencies and so data were 
analysed without further normalisation. 
The results from the CAT ELISA were several fold.  Firstly, we looked at the effect 
that  transfecting  zif268  into  the  cell  had  on  CAT  activity.    Full-length  zif268 
significantly  decreased  CAT  expression,  which  is  puzzling  as  pBLCAT3  is  a 
promoter-less  vector  and  therefore  should  not  have  been  affected.    Although 
zif268 was suppressing the CAT empty vector, transfecting gephyrin with zif268 Donna M McDade, 2007    Chapter 4, 140 
led to a further significant decrease in CAT activity, suggesting regulation of the 
gephyrin promoter by full-length zif268.  This effect was also significantly reduced 
when compared to truncated (control) zif268.   
The surprising result that pGHPN displays less CAT activity than pBLCAT3 led to 
further  data  mining  (using  MatInspector)  of  the  targeted  promoter  region.    A 
diagrammatic overview (figure 4.22) displays a few of the pertinent transcription 
factor  binding  sites.    Of  particular  interest  is  the  potential  Neural  Restrictive 
Silencer  Element  (NRSE)  site, which  is  found  in  promoters  which  binds NRSF 
(Neural Restrictive Silencer Factor)/REST (Repressor Element-1 silencing factor), 
a  known  endogenous  transcriptional  repressor  of  several  genes  encoding 
neurotransmitter  receptors  and  ion  channels  in  neurones  (Chong  et  al.  1995; 
Schoenherr & Anderson 1995; Schoenherr et al. 1996; Shimojo & Hersh 2006).  
This NRSE is conserved in human, rat and mouse upstream regions at equivalent 
positions, relative to the gephyrin transcriptional start site.  In PC-12 cells, NRSF 
transcriptionally represses the Na+ channel type II (Tapia-Ramirez et al. 1997).  It 
has been proposed that NRSF is localised to the nucleus PKA dependently as, in 
environments which lack PKA, NRSF remains in the cytosol, repressing overall 
NRSF activity and allowing increased target gene expression (Shimojo & Hersh 
2006).  Therefore, there may be an influence of cAMP levels in NRSF function, 
which might predict less suppression of promoter activity by NRSF in the presence 
of  forskolin.    There  are  some  suggestions  that  this  may  be  the  case  in  these 
results (figure 4.21). 
  
 
 
 
 
Figure 4.22  Diagram of the targeted gephyrin promoter cloned into the pBLCAT3 promoter-
less  vector  plasmid.    Positions  of  some  of  the  known  binding  sites  are  annotated.  Zif268 
recognition sequences are located at positions -408 to -392, -294 to -278 and -22 to -6 relative to 
the end of the cloned gephyrin sequence and putative CAT transcription start site (at 0).  Sp1 
(Stimulating protein 1) recognition sequences are located at positions -193 to -179, -42 to -28 and -
24 to -10 relative to the end of the cloned  gephyrin sequence.  The NRSE (Neural Restrictive 
Silencer Element) recognition site is at position -316 to -296.  
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It can be proposed that the introduction of the gephyrin ‗promoter‘ region upstream 
of the CAT coding sequence suppresses expression via this NRSE.  Ramming et 
al. (1997) observed increased expression of their reporter gene downstream of the 
mouse gephyrin promoter, but they used a longer ‗promoter‘ fragment that may 
contain other elements that interact with the NRSE.  The promoter-reporter results 
also  confirm  our  earlier  findings  that  full-length  zif268  decreases  gephyrin 
expression when compared to truncated zif268. 
Zif268 expression decreased the activity of the cloned gephyrin promoter, relative 
to  both  empty  vector  and  the  truncated  zif268  expression  vector.    This  is 
consistent with a direct action of zif268 on one or more of the potential zif268 
binding sites shown in figure 4.22, to suppress transcriptional activity.  The effect 
was more marked in the absence of forskolin than in the presence of forskolin.  
However, the original microarray detection of gephyrin transcripts being modulated 
by  zif268  and  the  confirmatory  studies  monitoring  gephyrin  mRNA  and  protein 
levels in PC-12 cells after zif268 transfection, were performed in the presence of 
forskolin.    A  likely  explanation  for  this  apparent  discrepancy  is  that  complete 
endogenous  gephyrin  promoter  is  not  fully  represented  by  the  ~1  kb  fragment 
studies here.  It is well known that functionally important promoter elements are 
frequently  located  more  than  1  kb  upstream  of  the  transcription  start  site,  or 
downstream,  in  coding  or  intronic  regions.    Such  elements  in  the  endogenous 
gene may modify the response to zif268. 
The  'promoter'  region  cloned  in  our  study  also  contained  an  overlapping 
recognition site for Sp1 and zif268.  Competition or interaction of Sp1 and zif268 
binding is considered important for gene regulation and occurs in many promoters 
(Huang et al. 1997; Srivastava et al. 1998; Fukada and Tonks 2001; Davis et al. 
2003).  The  ability  of  zif268  to  modulate  gephyrin  expression  could  therefore 
involve competitive binding with Sp1. 
Overall, we have presented strong evidence that gephyrin is a direct downstream 
target of zif268 and is generally suppressed during periods of neuronal plasticity 
(Chhatwal  et  al.  2005).    Gephyrin‘s  interactions  with  the  cytoskeleton  and 
GABAARs, introduced in the general introduction, will be discussed with relevance 
to zif268-induced downregulation in the general discussion. 142 
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5.1  Introduction  
5.1.1  Ubiquilin and related homologues 
In humans there are currently four known ubiquilin genes: ubiquilin 1 (Mah et al. 
2000), ubiquilin 2 (originally called Chap1) (Kaye et al. 2000), ubiquilin 3 (Conklin 
et al. 2000) and ubiquilin 4 (A1Up) (Davidson et al. 2000).  Ubiquilin and its forms 
are also known as Plic-1 and Plic-2 (Proteins that Link IAP (integrin-associated 
protein) with the cytoskeleton) in mouse (Wu et al. 1999), DA41 in rat (Ozaki et al. 
1997a), XDRP1 in frog (Funakoshi et al. 1999) and Dsk2 in yeast (Biggins et al. 
1996).  In addition, alternative names in humans are hPlic-1 and hPlic-2, (Kleijnen 
et al. 2000) and human DA41 (Hanaoka et al. 2000). 
Ubiquilin 1 was discovered in humans by  Mah  et al. (2000) as a novel 66kDa 
interactor  with  presenilin  proteins,  which  are  linked  to  early  onset  Alzheimer's 
Disease  (AD),  a  property  that  will  be  discussed later  in  this  chapter.    It  has 2 
transcript variants, one with exon 8 (transcript 1) and one without (transcript 2) and 
was found to have a 60% homology with XDRP1 (Xenopus Dsk2-related protein 1) 
discovered  in  Xenopus  laevis  (Funakoshi  et  al.  1999).    XDRP1  is  a  nuclear 
phosphoprotein  and  binds  to  cyclin  A1  and  A2,  proteins  that  seem  to  be 
importantly involved in mitosis, as their degradation is necessary to enter the next 
cell cycle and is highly regulated.  This interaction requires the N-terminal UBL 
domain of XDRP1 and inhibits cyclin A degradation, allowing overall involvement 
of XDRP1 with the spindle function in mitosis, and therefore cell cycle regulation.  
Dsk2, human Chap1 and DA41 have also been implicated as regulators of the cell 
cycle (Biggins et al. 1996; Kaye et al. 2000; Ozaki et al. 1997b). 
Plic-1  and  Plic-2  were  discovered  in  1999  by  Wu  et  al.  and  share  over  80% 
sequence identity.  Plic-1 displays 84% homology to ubiquilin 1 and Plic-2 shows 
60% homology.  It has since been found that ubiquilin 1 is more closely related to 
Plic-1, and ubiquilin 2 more close to Plic-2.  They were found by yeast dihybrid 
screening  using  two  isoforms  of  IAP  with  distinctly  different  cytoplasmic  tails.  
Integrins  associate  with  microfilaments,  and  IAP  is  thought  to  mediate  the 
interaction of both Plic-1 and -2 with integrin  v 3.  In addition, Plic proteins were 
found to interact with IAP and vimentin, anchoring the intermediate filaments to the 
plasma membrane.  Moreover, the transfection of either Plic-1 or -2 into a stable 
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to  control.    Therefore,  the  affiliation  of  the Plic  proteins  and  IAP  could lead  to 
alterations in the cytoskeleton. 
Kliejnen  et  al.  (2000)  also  utilised  yeast  dihybrid  screening,  to  find  cDNAs 
encoding human Plic-2 and Plic-1.  As mentioned in the Chapter 1, this was the 
first  paper  to  propose  that  the  Plic  proteins  had  an  association  with  the 
ubiquitination machinery and the proteasome. 
Ubiquilin  staining  pattern  is  variable  in  different  cell  types  (Mah  et  al.  2000).  
However,  analysis  of  tissue  distribution  in  mouse  Plic-1,  rat  DA41  and  human 
DA41 show that it is ubiquitously expressed (Ozaki et al. 1997a; Wu et al. 1999; 
Hanaoka et al. 2000).  Northern blot analysis of human tissues found that ubiquilin 
is  highly  expressed  in  the  brain  and  pancreas.  In  addition,  in  adult  human 
neurones,  ubiquilin  localises  to  the  nucleus,  cytoplasm  and  to  long  axonal 
processes (Mah et al. 2000). 
5.1.2  The Role of Ubiquilin in Neurodegenerative Disease 
5.1.2.1  General Aggresomal Diseases 
Massey  et  al.  (2004)  located  ubiquilin  proteins  within  the  inner  core  of 
aggresomes, structures involved with the sequestration of misfolded proteins in 
cells.  This could suggest a role for ubiquilin within general aggresomal disease 
states.  Small protein aggregates singularly form throughout the cytoplasm and are 
quickly  dynein-dependently  transported  on  microtubules  to  form  a  large 
aggresome  (Johnston  et  al.  1998;  Garcia-Mata  et  al.  1999).    In  an  attempt  to 
dispose  of  the  aggresome,  chaperones,  the  ubiquitination  machinery  and  the 
proteasome  arrive,  closely  followed  by  autophagosomes  and  lysosomes 
(Mortimore et al. 1996).  The many known aggresome-related diseases provide 
circumstantial evidence that aggresomes are involved in cellular degeneration in 
disease states.  Possible mechanisms for cell death include the sequestration of 
chaperones and proteasomes, a disruption of cellular trafficking (Johnston et al. 
2000), and the ability of aggresomes to attract other proteins on a ‗like for like‘ 
basis, whereby aggresomal proteins attract structurally similar proteins (Huang et 
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5.1.2.2  Alzheimer’s Disease 
The  majority  of  recent  publications  regarding  ubiquilin  have  argued  over  the 
relevance  and  role  it  may  play  in  Alzheimer‘s  disease  (AD).    AD  is  a 
neurodegenerative disorder responsible for the majority of dementia cases found 
in the elderly.  It is characterised by amyloid plaques and neurofibrillary tangles 
formed in various brain areas.  The majority of cases are found in individuals over 
the age of 65, however, the less common early-onset AD can affect approximately 
5% of the overall number of AD patients (Farrer et al. 1997). 
So far three genetic mutations have been related to early onset familial (FAD) AD: 
-amyloid  precursor  protein  (APP),  presenilin-1  (PSEN1)  and  presenilin-2 
(PSEN2) (Hardy 1997; Price et al. 1998), and only one genetic mutation has been 
related  to  late-onset  AD  in  the  ε4  allele  of  apolipoprotein  E  (APOE)  (Kamboh 
2004).  However, there are genetic variations found in AD, so many more genes 
probably  need  to  be  identified  (Daw  et  al.  2000),  in  addition,  it  is  not  fully 
understood how mutations in these known genes can cause AD. Ubiquilin was 
found as a novel interactor of both PSEN1 and PSEN2 (Mah et al. 2000).  An in 
vitro  binding  assay  provided  evidence  that  only  the  UBA  containing  COOH-
terminal of ubiquilin was able to bind the presenilins.  Co-expression of ubiquilin 
with  PSEN2  resulted  in  a  marked  increase  of  PSEN2  protein  accumulation, 
compared with overexpression of PSEN2 alone, in the presence and absence of 
proteasome inhibitors. In addition, they discovered by immunohistochemistry that 
neurones containing neurofibrillary tangles (from AD patients) had more intense 
ubiquilin staining than control neurones. 
The catalytic core of the  -secretase complex is formed from presenilin proteins 
and is responsible for  cleaving APP, leading to a build up of fragments in the 
extracellular space (Edbauer et al. 2003; Kimberly et al. 2003; De Strooper 2003).  
In  order  for  the  catalytic  core  to  form,  the  presenilins  must  undergo 
endoproteolysis by ‗presenilinase‘ to create C-terminal and N-terminal fragments 
(Thinakaran et al. 1996; Kim et al. 1997; Thinakaran et al. 1997; Ratovitski et al. 
1997),  which  interact  with  each  other  and  are  responsible  for  the  -secretase 
activity  (Esler  et  al.  2000;  Li  et  al.  2000).   Ubiquilin is  thought  to  promote  the 
accumulation of presenilin full-length proteins, and to regulate its endoproteolysis 
by  blocking  access  to  the  ‗presenilinase‘,  an  unknown  activity.    Ubiquilin  also 
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pen2 and nicastrin (Massey et al. 2005).  Further evidence linking ubiquilin with 
the  presenilin  proteins  includes  the  co-localisation  of  ubiquilin  and  PSEN1  in 
primary cultured neurones.  In addition, evidence suggests an interaction between 
the two proteins at the cell surface.  However, this interaction was not significantly 
different in AD patients compared to controls (Thomas et al. 2006). 
The  first  clinical  study  linking  ubiquilin  with  AD  was  by  Bertram  et  al.  (2005) 
utilising two family-based samples.  They used neural tissue from 25 late-onset AD 
patients and 17 controls and studied a single nucleotide C/T polymorphism located 
within the ubiquilin gene (UBQ-8i) that they state was consistently mutated in AD 
brains.  They also found that the level of ubiquilin transcript 2 was increased in AD 
brains.  However, genotyping the transcript 2 sample for the UBQ-8i risk allele did 
not reveal significant linkage to AD, possibly due to their small sample size.  This 
article created a wave of responses, most of which disagreed with the findings 
(Bensemain et al. 2006; Brouwers et al. 2006; Slifer et al. 2006; Smemo et al. 
2006). 
5.1.2.3  Huntingdon’s Disease 
The fatal, hereditary, neurodegenerative Huntingdon‘s Disease (HD) is caused by 
the expansion of a CAG repeat found in exon 1 of the gene encoding huntingtin 
protein.    This  gene  product is then  translated  with  an  expanded  polyglutamine 
(polyQ) stretch, which is thought to cause intracellular nuclear aggregates to form 
(Scherzinger et al. 1997; Michalik & Van Broeckhoven 2003).  Numerous proteins 
interact  with  the  aggregates,  which  are  ubiquilin  rich,  but  it  is  unclear  whether 
these aggregates are protective or toxic.  Doi et al. (2004) identified ubiquilin 1, as 
well as ubiquilin 2, as novel proteins that interact with aggregates, in addition to 
their interaction with ubiquitin.  PolyQ aggregates have been reported to contain 
several  UBA  domain-containing  proteins,  as  well  as  ubiquitin  interacting  motif 
(UIM)  domain-containing  proteins  (Donaldson  et  al.  2003;  Wang  et  al.  2000; 
Davidson  et  al.  2000).    PolyQ  aggregates  are  thought  to  sequester  ubiquitin-
interacting proteins through these domains, disrupting normal neuronal function.  
Recently, Wang et al. (2006) co-transfected ubiquilin into neuronal cells with a 
GFP-tagged protein containing 74 polyQ repeats (GFP-Htt(Q74-3)) and found that 
overexpression of ubiquilin promotes increased cell survival.  They also showed 
that  cells  stably  expressing  GFP-Htt(Q74-3)  were  more  sensitive  to  oxidative Donna M McDade, 2007    Chapter 5, 147 
stress  induced  by  exposure  to  H2O2  or  serum  deprivation  than  a  lower  polyQ 
repeat protein, GFP-Htt(Q28-2).  The GFP-Htt(Q74-3) cell death was reduced by 
approximately  80%  and  50%  respectively  when  ubiquilin  was  transiently 
transfected into the cells.  They also investigated the effects of reducing ubiquilin 
by siRNA in the GFP-Htt(Q74-3) stably expressing HeLa cells.  They observed a 
corresponding  halt  in  cell  proliferation,  an  increase  in  cell  death  and  the 
accumulation of expanded GFP-immunoreactive aggregates when knocking down 
ubiquilin.   
5.1.3  Additional Functions of Ubiquilin 
Prolonged exposure to nicotine can upregulate the surface expression of nicotinic 
acetylcholine  receptors  (nAChRs)  in  neurones  (Wonnacott  1990;  Darsow  et  al. 
2005).  Ubiquilin was found to bind to the mouse  3 subunit of nAChRs by yeast 
dihybrid screening (Ficklin et al. 2005).  By co-transfecting ubiquilin and the  3 
nAChR subunit into COS-7 cells they found that ubiquilin redistributed the subunit 
to  the  20S  proteasome  subunit.    They  also  found  that  ubiquilin  decreased  the 
surface expression of receptors in a stably expressed  3 and  2 subunit HEK293 
cell line.  In addition, ubiquilin was able to reduce the number of surface nAChRs 
upregulated by nicotine in cultured mouse superior cervical ganglion cells.  Taken 
together, this may mean that ubiquilin can limit nAChR subunits for assembly and 
trafficking.  
Protein-disulfide isomerase (PDI) forms and rearranges disulfide bonds within the 
rough endoplasmic reticulum (RER) in order to aid the folding of proteins (Lyles & 
Gilbert 1991).  An increase in the amount of unfolded proteins within the ER can 
lead to a stress response (Sidrauski et al. 1998), which in mild cases, can be dealt 
with by stress proteins like PDI.  PDI has been shown to up-regulate in response 
to hypoxia in vitro and brain ischemia in vivo in glial cells (Tanaka et al. 2000). 
Ubiquilin has been identified as a PDI-interacting protein and therefore a possible 
protective factor against hypoxia.  Ubiquilin binds in vitro and in vivo to PDI‘s C-
terminus and, when over-expressed, could be found localised to the ER.  Ubiquilin 
mRNA and proteins levels were increased in response to hypoxia in astrocytes 
and co-expression of ubiquilin and PDI had a protective effect against hypoxia in 
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Ubiquilin  also  interacts  with  Eps15  (epidermal  growth  factor  (EGF)  receptor 
pathway substrate 15) a protein that interacts with AP2, the linker protein involved 
in clathrin coated pit formation (Benmerah et al. 1995; Morgan et al. 2003).  The 
UIM (ubiquitin-interacting motif) domains of Eps15, Eps15R (Eps15-related) and 
another  endocytic  protein,  Hrs,  interact  with  ubiquilin  through  the  UBL  domain 
although  this  interaction  was  not  related  to  endocytic  compartments  (Regan-
Klapisz et al. 2005). 
Overall, there is considerable evidence that ubiquilin is involved in the cell cycle, 
the cytoskeleton, proteasome activity and ligand gated ion channel receptors and 
signalling molecules and is implicated in certain neurodegenerative diseases.  This 
chapter  introduces  ubiquilin  as  a  downstream  target  of  zif268,  implicating  this 
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5.2  Aims & Objectives 
  Identify and verify the presence of ubiquilin within the PC-12 cell line. 
  Validate the original microarray experiment by transfecting PC-12 cells with 
full length or truncated zif268 and investigating ubiquilin expression at RNA 
and protein levels. 
  Extend  the  findings  found  within  the  cell-line  by  utilising  primary  cortical 
neurones  stimulated  with  either  NMDA  or  vehicle  over  24  hours  and 
investigating ubiquilin expression at the RNA and protein levels. 
  Look at ubiquilin RNA and protein levels harvested from zif268 knockout 
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5.3  Results 
5.3.1  PC-12 cells stain positively for ubiquilin 
To assess ubiquilin expression within the PC-12 cell line, immunocytochemistry 
was performed on partially differentiated and undifferentiated cells using a rabbit 
anti-ubiquilin antibody. As illustrated in Figure 5.1A & 5.1B, using only a secondary 
antibody as a control shows very little or no staining on cells treated or untreated 
with  nerve  growth  factor.    In  contrast,  undifferentiated  cells  stained  with  anti-
ubiquilin  show  diffuse  staining  and  distinct  puncta  (figure  5.1C).    PC-12  cells 
treated with nerve growth factor for 2 hours before fixing with formaldehyde show 
the  appearance  of  dendrite-like  processes.    In  addition,  they  show  ubiquilin 
immunoreactivity  throughout  the  cells,  including  punctuate  staining  along 
processes,  and  display  stronger  staining  than  the  undifferentiated  cells  (figure 
5.1D). 
5.3.2  Ubiquilin is downregulated in PC-12 cells after transient 
transfection with zif268 
Transient transfection of 1  g/mL full-length zif268 into PC-12 cells treated with 50 
ng/mL nerve growth factor showed a statistically significant reduction in ubiquilin 
RNA  when  compared  to  cells  transfected  with  1  g/mL  of  a  truncated  control 
zif268 (p<0.05, one sample t-test, n=5; see figure 5.2).  RT-PCR was performed 
using GAPDH primers and exon-intron spanning primers for ubiquilin.  A single 
cycle within the logarithmic linear phase was taken for each transcript and the log 
GAPDH  normalised  pixel  intensity  value  subtracted  from  the  log  ubiquilin 
normalised pixel intensity value.  This revealed a 13% reduction in ubiquilin RNA 
in PC-12 cells transiently transfected with full length zif268 compared to control.  
Utilising  western  blotting,  it  was  found  that  protein  levels  of  ubiquilin  were  not 
significantly downregulated within the same experimental paradigm, with full length 
transiently transfected zif268 PC-12 cells displaying a non-significant 8% reduction 
in normalised pixel intensity when compared to control (n=6; see figure 5.3 A & B). 
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Figure 5.1: Confocal images of ubiquilin staining in PC-12 cells.  A, undifferentiated cells 
stained only with 1:100 anti-rabbit Alexa 594.  B, PC-12 cells pre-incubated for 2 hours with 
50ng/mL NGF-7S and stained only with 1:100 anti-rabbit Alexa 594.  C, undifferentiated PC-12 
cells stained with 1:100 anti-ubiquilin and 1:100 anti-rabbit Alexa 594.  D, PC-12 cells pre-
incubated for 2 hours with 50ng/ml NGF-7S and stained with 1:100 anti-ubiquilin and 1:100 anti-
rabbit Alexa 594.  Scale bar 15 m. 
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Figure 5.2: The effect of zif268 on ubiquilin mRNA in PC-12 cells.  Graph comparing ubiquilin 
RNA levels as assessed by signal intensities at a single RT-PCR cycle from differentiated PC-12 
cells transiently transfected with either full length or truncated zif268.  Results are presented as 
ubiquilin normalised pixel intensity after normalisation to corresponding GAPDH values.  All data 
expressed as mean percentage of control   SEM. *p<0.05 one sample t-test, n=5. 
 
 
 
 
Figure 5.3: The effect of zif268 on ubiquilin protein levels in PC-12 cells A, Representative 
image of western blot comparing ubiquilin protein levels from PC-12 cells transfected with either full 
length or truncated zif268. B, Graph comparing protein levels of differentiated PC-12 cells 
transiently transfected with either full length or truncated zif268, as determined by western blotting.  
Results are presented as ubiquilin normalised pixel intensity.  All data expressed as a mean 
percentage of control   SEM, n=6.   
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5.3.3  Ubiquilin is time-dependently downregulated in cultured cortical 
neurones after NMDA treatment 
NMDA  stimulation  (100µM  NMDA  in  20mM  KCl)  of  cultured  primary  cortical 
neurones  for  6  hours  displayed  a  statistically  significant  downregulation  of 
approximately  23%  in  ubiquilin  RNA  levels  when  compared  to  vehicle  as 
determined by RT-PCR (p<0.01, ANCOVA, n=4; see figure 5.4).  Statistically, we 
employed  the  ANCOVA  in  order  to  adjust  for  variances,  with  GAPDH  as  the 
covariate.  Looking at protein levels, ubiquilin is significantly downregulated when 
stimulated with NMDA for 3 hours (29.8   5.8% of control) and 6 hours (30.9   
7.3%  of  control)  as  determined  by  immunocytochemistry  (p<0.05  and  p<0.01 
respectively, two-way ANOVA with Tukeys post-hoc test; see figure 5.6).  Figure 
5.7 contains representative confocal images of primary cultured neurones treated 
for 3 hours with NMDA or control. 
In contrast, when comparing RNA and protein levels after 24-hour stimulation with 
NMDA, ubiquilin is not significantly different from primary cortical neurones treated 
with vehicle for 24 hours (see figures 5.5 and 5.6).  Western blotting of protein 
levels after 3 hours, 6 hours or 24 hours NMDA stimulation showed no significant 
differences when compared with controls (see figure 5.8A & B). 
5.3.4  Ubiquilin RNA is downregulated in zif268 knockout mice 
A comparison of RNA extracted from zif268 knockout mice and their associated 
wildtype  counterparts  by  RT-PCR  show  that  ubiquilin  is  significantly 
downregulated (ANCOVA p<0.01; see figure 5.9).  At the protein level however, 
western blotting shows no significant difference between zif268 knockout mice and 
the wildtypes (figures 5.10 A & B). 
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Figure 5.4: The effect of 6 hours NMDA stimulation on ubiquilin mRNA in cultured neurones. 
Graph illustrating ubiquilin log pixel intensity as a function of GAPDH log pixel intensity, as 
determined by RT-PCR of cultured primary cortical neurones stimulated for 6 hours with either 
100µM NMDA in 20mM KCl or Vehicle.  Effect of NMDA treatment #p<0.01, F(1,15)=8.45, 
ANCOVA n=4. 
 
 
 
Figure 5.5: The effect of 24 hours NMDA stimulation on ubiquilin mRNA in cultured 
neurones.  Graph illustrating ubiquilin log pixel intensity as a function of GAPDH log pixel intensity 
as determined by RT-PCR of cultured primary cortical neurones stimulated for 24 hours with either 
100µM NMDA in 20mM KCl or Vehicle.  n=4. 
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Figure 5.6: The effect of NMDA stimulation on ubiquilin protein levels in cultured neurones. 
Graph illustrating the effect of treatment of cultured cortical neurones (21DIV) for either 3 hours, 6 
hours or 24 hours with either 100µM NMDA in 20mM KCl or vehicle on ubiquilin immunoreactivity, 
as detected by immunocytochemistry.  Results are presented as the number of particles measured 
per square micron and expressed as a mean percentage of the signal in control (vehicle treated) 
cells   SEM.  Effect of treatment, #p<0.01, F(1,27) = 22.44, two-way ANOVA.  Effect of time 
**p<0.01, *p<0.05, Tukeys post hoc test, n=5 
 
 
Figure 5.7: Images of ubiquilin within cultured neurones after 3 hours NMDA stimulation.  A 
representative image comparing primary cultured cortical neurones (21 DIV) treated for 3 hours 
with vehicle (A) or with 100 μM NMDA in 20 mM KCl (B), probed with anti-ubiquilin and visualised 
with a confocal microscope as per the immunocytochemistry protocol.  Arrows depict the measured 
puncta within cells A and B.  Scale bar 15 μm. 
 
A  B Donna M McDade, 2007    Chapter 5, 156 
 
 
 
 
 
 
Figure 5.8: The effect of NMDA stimulation on ubiquilin protein levels in cultured neurones 
by western blot A: Representative western blot of ubiquilin immunoreactivity in cultured cortical 
neurones stimulated for either 3 hours, 6 hours or 24 hours with either 100µM NMDA in 20mM KCl 
or vehicle and  probed with anti-ubiquilin. B: Graph comparing ubiquilin immunoreactive signal 
intensities from western blots of cultured cortical neurones (7-10 DIV) stimulated for either 3 hours, 
6 hours or 24 hours with either 100µM NMDA in 20mM KCl or vehicle.  Results are presented as 
normalised pixel intensity and expressed as a mean percentage of control (vehicle treatment)   
SEM.  ANOVA revealed no significant effect of NMDA treatment and no significant interaction with 
time.  Effect of NMDA F(1,18) = 2.07, p>0.05, interaction of time and treatment F(2,18) = 0.55, 
p>0.05, n=4. 
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Figure 5.9: The effect of a zif268 targeted deletion on ubiquilin mRNA in the adult cortex. 
Graph illustrating ubiquilin log pixel intensity as a function of GAPDH log pixel intensity, as 
determined by RT-PCR of adult cerebral cortex tissue from either wildtype or zif268 knockout mice.  
#p<0.01 F(1,11) = 11.90, ANCOVA, n=3. 
 
 
 
 
Figure 5.10: The effect of a zif268 targeted deletion on ubiquilin protein levels in the adult 
cortex.    A:  Representative  western  blot  comparing  ubiquilin  immunoreactivity  signal  in  cortical 
tissue from wildtype and zif268 knockout mice.  B: Graph comparing ubiquilin immunoreactivity 
signal intensities from western blots of adult cerebral cortex tissue extracted from either wildtype or 
knockout zif268 mice.  Results are presented as normalised pixel intensity and expressed as a 
mean percentage of total control (wildtype tissue)   SEM.  Wildtype, n=7, knockout zif268, n=5. 
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5.4  Discussion 
This  is  the  first  study  to  identify  ubiquilin  as  a  downstream  target  gene  of  the 
inducible  transcription  factor  zif268.    Ubiquilin  RNA  and  protein  levels  are 
downregulated  by  increased  amounts  of  zif268  and  ubiquilin  mRNA  levels  are 
decreased in cortical tissue from zif268 knockout mice, implying that ubiquilin is a 
transcriptional target of this plasticity related gene. 
Initial experiments used a pheochromocytoma derived cell line in order to establish 
the validity of the original microarray experiment (James et al. 2005).  In the first 
instance,  PC-12  cells  were  partially  differentiated  with  nerve  growth  factor.  
Applying  an  anti-ubiquilin  antibody  revealed  punctate  staining  throughout  the 
cytoplasm  and  processes,  confirming  the  presence  of  ubiquilin  protein.    The 
ubiquilin antibody used has not been widely cited, however, it is directed towards 
amino acid residues 2-18 of ubiquilin and displayed a high level of specificity in 
western blot experiments. 
The upregulation of zif268 by transient transfection in the presence of forskolin 
produced a significant decrease in ubiquilin RNA when compared with a truncated 
control form of zif268.  This validated the significant result achieved previously by 
James  et  al.  (2005).    At  the  protein  level  however,  no  significant  result  was 
achieved.  Western blotting has changed very little since its development in 1979 
(Towbin  et  al.  1979).    Among  this  technique's  limitations  is  the  problem  of 
restricted quantitative capability and PCR is generally a more sensitive method of 
detection (Liu et al. 2004). 
We next looked at the effect increasing zif268 had on cultured dissociated primary 
cortical  neurones.    Zif268  protein  levels  peak  at  2  hours  after  stimulation 
(Richardson et al. 1992) whereby it enters the nucleus to regulate downstream 
targets.  Therefore, cells were harvested at 2 time points in order to delineate any 
time dependent effects of zif268 stimulation.  At 6 hours, ubiquilin RNA levels were 
significantly decreased in cells stimulated with NMDA when compared to vehicle-
stimulated  cells.    This  result  is  echoed  in  the  protein  levels,  which  are  also 
significantly  decreased  when  looking  at  the  immunocytochemistry  results.    An 
additional time point of 3 hours stimulation was examined with the protein levels 
allowing a further insight into ubiquilin actions after zif268 induction.  At 3 hours, 
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However, at 24 hours both RNA and protein levels have returned towards a basal 
level, inferring that zif268's actions could be time-dependent.  This is consistent 
with the ubiquilin gene being regulated by transient induction of zif268 following 
NMDA receptor stimulation.  
Changes  in  ubiquilin  protein  levels  were  apparent  using  immunocytochemical 
techniques.    The  paraformaldehyde  fixation  stage  of  immunofluorescence 
procedures  can  produce  artefacts  in  immunocytochemistry.    In  addition, 
unfortunately,  optimal antibody  concentrations  were  determined  by  visualisation 
with an inverted light microscope, before the availability of image capture with the 
confocal microscope.  The specific laser used in the confocal microscope has a 
wavelength  of  568nm,  which  means  that  the  fluorescent  Alexa  594  secondary 
antibody is only reaching 50% excitation.  This required an increase in laser power 
which uniformly increased background and could have created less than optimal 
conditions  for  ubiquilin  immunoreactivity  detection.    However,  we  attempted  to 
circumvent  any  possible  problems  with  generic  staining  by  using  the  Image  J 
program.    This  allows  a  certain  threshold  to  be  set  in  order  to  minimise  any 
background noise, which can be individually altered for each image, and all the 
results  were  performed  blind.    Hence,  the  data  obtained  can  be  viewed  with 
considerable confidence.  Earlier data from our laboratory (McDermot & Morris, 
unpublished) showed no evidence of apoptosis or necrosis at extended times after 
this NMDA treatment protocol.  It is also encouraging to note that the return of 
ubiquilin RNA and protein to basal levels after 24 hours suggests that any changes 
at earlier time points were due to a genuine downregulation in ubiquilin and not to 
cell death. 
Western  blotting  to  detect  protein  levels  of  ubiquilin  after  zif268  induction  by 
NMDA stimulation produced no significant results at 3 hours, 6 hours or 24 hours.  
However, contradictory results in protein levels detected by western blot compared 
to immunocytochemistry have been obtained by others (Salvador-Silva et al. 2001; 
Lindahl & Keifer 2004) and may reflect the fundamental difference between the 
techniques:  western  blotting  detects  whole  cell  proteins  whilst 
immunocytochemistry has a more directed approach.   
When comparing RNA levels of zif268 knockout mice compared to wildtypes a 
significant reduction in ubiquilin was detected.  This result was surprising, as an 
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inherent problems with knockout mice however, especially those that deal with 
immediate  early  genes  (Prof.  Hugh  Piggins,  Manchester  University;  personal 
communication).    There  is  an element  of  redundancy  in  many  control  systems 
allowing for developmental compensation.  In particular, there is strong evidence 
that another member of the Egr family, Egr4 can compensate for the absence of 
zif268  in  these  knockout  mice  (Tourtellotte  et  al.  2000).    Propitiously,  it  does 
demonstrate that ubiquilin is ultimately a target of zif268, as ubiquilin's expression 
is significantly affected by zif268's absence.  The western blot did not detect any 
changes in ubiquilin protein levels in zif268 knockout mice compared to wildtypes, 
possibly  due  to  limitations  inherent  in  the  technique.    As  a  complimentary 
experiment to the RNA work and to extend protein detection, we had hoped to 
culture zif268 knockout and wildtype cortical tissues for 21 days, genotype the 
cultures  by  removing  additional  tissue  at  dissection,  and  perform 
immunocytochemistry with the ubiquilin antibody.  Unfortunately, colony breeding 
was  intermittent,  delivering  minimal  litter  sizes  and  creating  time  constraint 
problems.  Ubiquilin  labelling  in  zif268  knockout  and  wildtype  mice  treated  with 
haloperidol to produce an in vivo model of synaptic plasticity sadly did not produce 
results.    More  time  would  be  needed  to  optimise  the  oligonucleotide  labelling.  
Overall,  however,  these  results  provide  strong  support  for  the  hypothesis  that 
ubiquilin expression is regulated by zif268. 
The overall hypothesis of the effect zif268 has on ubiquilin concerns the effects 
this may produce in GABAARs at the synapse, which will be discussed later.  The 
number of cellular functions in which ubiquilin has been implicated leads to further 
consequences of ubiquilin downregulation that could affect a myriad of different 
systems.  Ubiquilin is localised to neuropathological inclusions in AD, PD (Mah et 
al.  2000)  and  HD  (Doi  et  al.  2004)  and  has  been  shown  to  modulate  the 
accumulation  of  presenilin  proteins  (Mah  et  al.  2000).    This  suggests  that 
increased  ubiquilin  levels  are  involved  in  or  associated  with  neuronal  disease.  
Zif268 expression is decreased in AD transgenic mouse models modelling amyloid 
deposition (APP+PS1) (Dickey et al. 2003; Dickey et al. 2004), although zif268 
actions  still  remain  controversial  in  neurodegenerative  diseases  (Rensink  et  al. 
2002).   
In  addition,  ubiquilin  is  upregulated  in  response  to  hypoxia  (Ko  et  al.  2002), 
whereas zif268 mRNA expression is inhibited (Hung et al. 2000).  Zif268 has many 
different roles, as it is induced by DNA damaging agents (Quinones et al. 2003), Donna M McDade, 2007    Chapter 5, 161 
and may have a role in the cellular reaction to hyperoxia (Jones and Agani 2003) 
and  apoptosis  (Pignatelli  et  al. 2003).    Chaperones  assist  the folding of  newly 
synthesised  proteins  and  refolding  of  proteins  damaged  by  stress  and  cellular 
injuries.    Incorrectly  folded  proteins  are  delivered  to  the  ubiquitin-proteasome 
system,  and  ubiquilin  is  known  to  act  post  transcriptionally  like  a  molecular 
chaperone (Funakoshi et al. 1999; Davidson et al. 2000; Kaye et al. 2000).  A 
decrease  in  ubiquilin  therefore  may  increase  the  number  of  misfolded  and 
unrepaired proteins within the cell, increasing the number of proteins delivered to 
the proteasome.   
At the level of the cytoskeleton, mouse Plic-1 and Plic-2 have an involvement in 
linking integrins via integrin-associated proteins to the intermediate filaments (Wu 
et al. 1999).  Ubiquilin, therefore, could connect the plasma membrane and the 
cytoskeleton  and  may  be  involved  in  regulating  adhesion  and  migration,  an 
important property for synaptic plasticity.  
In  summary,  the  diversity  of  studies  leave  it  unclear  exactly  what  the 
consequences  of  altered  ubiquilin  expression  will  be.    Clearly,  a  lot  more 
experimentation is required to find out the many and varied roles of this protein.  
Nevertheless, the data provides strong evidence that expression of the ubiquilin 
gene is regulated during plasticity by zif268. 
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6  Potential downstream effects of the modulation of 
gephyrin & ubiquilin expression by zif268 
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6.1   Introduction  
Gephyrin  and  ubiquilin  have  been  functionally  linked  to  both  the  GABAAR  and 
mTOR (mammalian target of rapamycin).  In order to gain a greater understanding 
of  the  possible  downstream  consequences  in  response  to  altered  zif268 
expression, the effects potentially resulting from changes in gephyrin and ubiquilin 
levels were the subjects of a preliminary investigation. 
6.1.1  The GABAAR at the synapse 
GABAARs  are  ligand-gated  chloride  channels  that  exist  in  numerous  distinct 
subunit  combinations,  but  the  1 2 2  combination  is  the  most  predominantly 
expressed  receptor  multimers,  followed  by  2 3 2  and  3 3 2  (Fritschy  et  al. 
2003).  GABAARs containing   and   subunits can reach the cell surface (Connolly 
et  al.  1996b)  however,  there  is  a  necessity  for  the    subunit  for  synaptic 
localisation (Essrich et al. 1998).  Gephyrin has been linked with the  1-3,  3 and 
2 subunits of the GABAARs at postsynaptic sites (Kirsch et al. 1995; Essrich et al. 
1998; Sassoe-Pognetto et al. 2000; Danglot et al. 2003), and ubiquilin binds to the 
1-3,  6  and  1-3  subunits  of  the  GABAAR  (Bedford  et  al.  2001).    Reduced 
gephyrin expression is predicted to decrease the number of GABAARs clustered at 
synaptic  sites,  while  decreased  ubiquilin  expression  is  predicted  to  reduce 
GABAAR number via enhanced proteasomal degradation. 
6.1.2  Downstream effectors of mTOR  
mTOR,  also  known  as  FRAP  (FKBP-rapamycin-associated  protein),  RAFT1 
(rapamycin and FKBP target) and RAPT1 (rapamycin target) (Brown et al. 1994; 
Chiu et al. 1994; Sabatini et al. 1994; Sabers et al. 1995) is a highly conserved 
serine-threonine  kinase  regulated  by  growth  factors,  and  is  involved  in  the 
regulation of translation activity. The dendritic translation of a subset of mRNAs 
involved  in  the  protein-synthesis  dependent  induction  of  LTP  is  regulated  by 
mTOR (Raught et al. 2001; Tang et al. 2002; Cammalleri et al. 2003).  mTOR is  a 
target of the immunosuppressant drug, and is inhibited by, rapamycin (Kunz et al. 
1993;  Helliwell  et  al.  1994).    Rapamycin  inhibits  high  frequency  stimulation-
induced protein synthesis, long term facilitation in Aplysia and late-phase LTP in 
the hippocampus (Casadio et al. 1999; Tang et al. 2002; Cammalleri et al. 2003; Donna M McDade, 2007    Chapter 6, 164 
Karpova et al. 2006).  Figure 6.1 depicts a summary of the many ways that mTOR 
can be activated within cells. 
Downstream  targets  of  mTOR  mainly  comprise  those  proteins  involved  in 
ribosome recruitment to mRNA.  4E-BP1 (eIF4E-binding protein) is a repressor of 
mRNA translation until it becomes phosphorylated, an enzymatic action carried out 
by mTOR.  eIF4E, a eukaryotic initiation factor that binds to the 5‘cap of mRNA 
allowing the 40S ribosomal subunit to bind (Gingras et al. 1999), is inhibited when 
bound by 4E-BP1 (Schmelzle & Hall 2000).  Phosphorylation of 4E-BP1, initially at 
Thr37 and Thr46 (Gingras et al. 1999), by mTOR releases it from eIF4E, allowing 
the initiation factor to bind with eIF4G, form a complex in association with eIF4A 
and permit translation (Haghighat et al. 1995; Marcotrigiano et al. 1999; Gingras et 
al. 1999). 
mTOR also phosphorylates and activates p70 ribosomal S6 kinase (S6K), which 
leads to translational activation and ultimately, cell growth (Montagne et al. 1999; 
Radimerski et al. 2002). p70 S6K phosphorylates the 40S ribosomal protein S6 
and  allows  the  increased  translation  of  mRNAs  coding  for  components  of  the 
translational  machinery,  specifically  the  5‘TOP  (terminal  oligopyrimidine  tract) 
mRNAs, including all the ribosomal proteins and elongation factors (Schwab et al. 
1999; Gingras et al. 2001). 
Rapamycin blocks phosphorylation of mTOR and, therefore, 4E-BP1 and p70 S6K 
inactivation and activation respectively.  It has been demonstrated that both 4E-
BP1 and p70 S6K are inhibited/activated by rapamycin in vivo and phosphorylated 
by mTOR in vitro (Brunn et al. 1997; Burnett et al. 1998).  P70S6K or 4E-BP1 
phosphorylation can be used as an in vivo readout of mTOR activity. 
Utilising yeast di-hybrid systems, it has been found that mTOR interacts with both 
ubiquilin and gephyrin (Sabatini et al. 1999; Wu et al. 2002).  We reasoned that in 
PC-12  cells,  containing  no  GABAARs,  gephyrin  and  ubiquilin  may  modulate 
cellular signalling through mTOR.  To this end we monitored levels of phospho-4E-
BP1 and phospho-p70 S6K as an indication of mTOR activity. 
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Figure  6.1:  A  simplified  diagram  of  the  activation  and  downstream  effects  of  mTOR  on 
protein  synthesis.    Growth  factors  activate  receptors  (R  depicts  the  growth  factor  receptor) 
leading to the activation of many protein kinases and signalling pathways, ultimately culminating in 
the activation of mTOR.  eIF4E, an initiation factor, is inhibited when bound by its repressor 4E-
BP1.  The phosphorylation of 4E-BP1 by mTOR releases eIF4E and activates translation.  mTOR 
also  phosphorylates  the  S6  kinase,  activating  translation.    Diagram  produced  from  information 
reviewed in Hay and Sonenberg (2004) and Asnaghi et al. (2004). 
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6.2  Aims & Objectives 
  Investigate  the  effect  of  NMDA  stimulation  on  the  number  of  GABAA 
receptor  2/3 and  2 subunits localised to the plasma membrane of primary 
cultured cortical neurones. 
  Study the effects of altered zif268 expression on mTOR effectors, p70 S6 
kinase and 4E-BP1. Donna M McDade, 2007    Chapter 6, 167 
6.3  Results 
6.3.1  GABAAR   2/3 numbers are not altered in response to NMDA 
stimulation 
Primary cortical neurones were aged in vitro for 3 weeks as most GABAARs are 
expressed postnatally (Laurie et al. 1992) and inhibitory synapse maturation takes 
approximately 21 days in cultured hippocampal neurones (Craig et al. 1996; Levi 
et al. 2002).  
No effect of NMDA stimulation was found on the density of punctate GABAAR   
chain immunoreactivity when compared to vehicle treated cultured primary cortical 
neurones by immunocytochemistry (p>0.05, 2-way ANOVA, n=6; see figure 6.2 
and 6.3).  Specifically, there was no overall effect of treatment or time and no 
interaction  between  treatment  and  time.    However,  there  was  a  tendency  for 
NMDA treatment to reduce the density of the labelled puncta at later time points.  
For normalisation and resultant statistical analysis, the log value of pixel intensities 
was used.  For graphs, all values are presented as percentages of vehicle treated 
cells. 
 
Figure 6.2: The effect of NMDA stimulation on the density of puncta immunoreactive for the 
GABAAR   chain in cultured cortical neurones.  Graph illustrating the effect of treatment of 3, 6 
or  24  hour  stimulation  of  100μM  NMDA  in  20mM  KCl  or  vehicle  on  GABAA  2/3  subunits 
immunoreactivity  of  21  DIV  primary  cultured  cortical  neurones  as  detected  by 
immunocytochemistry.  Results  are  presented  as  the  number  of  puncta  measured  per  square 
micron and expressed as a mean percentage of the signal in control (vehicle-treated) cells   SEM, 
The effect of treatment, p>0.05, F(1,29)=1.20, 2-way ANOVA, n=6. 
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Figure  6.3:  Images  of  GABAA    chains  within  cultured  neurones  after  6  hours  NMDA 
stimulation.    A  representative  image  comparing  primary  cultured  cortical  neurones  (21  DIV) 
treated for 6 hours with 100 μM NMDA in 20 mM KCl (A) or vehicle (B), probed with anti- GABAA 
2/3 subunit antibody and visualised with a confocal microscope as per the immunocytochemistry 
protocol.  Arrows depict examples of the measured puncta within cells A and B.  Scale bar 15 μm. 
 
6.3.2  GABAA  2 subunits are downregulated in response to NMDA 
stimulation 
Using immunocytochemistry, an overall effect of NMDA treatment was found on 
the density of punctate GABAA  2 subunit immunoreactivity within cultured primary 
cortical neurones when compared to control (vehicle treated) cells (p<0.01 effect 
of treatment, F(1,11) = 9.16, 2-way ANOVA, factors: time and treatment, n=3; see 
figure 6.4).  There was no overall effect of time (p = 0.311, F(2,11) = 1.30) and no 
interaction between treatment and time (p = 0.257, F(2,11) = 1.54).  The log value 
of pixel intensities was used for normalisation and resultant statistical analysis.  
For  graphical  presentation  all  values  are  presented  as  percentages  of  control 
(vehicle treatment).  Figure 6.5 contains representative confocal images of primary 
cortical neurones treated with either vehicle or NMDA for 3 hours. 
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 Figure 6.4: The effect of NMDA stimulation on the density of puncta immunoreactive for 
GABAA  2 subunit in cultured cortical neurones.  Graph illustrating the effect of treatment of 3, 
6 or 24 hour stimulation of 100μM NMDA in 20mM KCl or vehicle on the GABAA  2 subunit 
immunoreactivity of 21 DIV primary cultured cortical neurones as detected by 
immunocytochemistry. Results are presented as the number of puncta measured per square 
micron and expressed as a mean percentage of the signal in control (vehicle-treated) cells   SEM, 
The effect of treatment #p<0.01, F(1,11)=9.16, 2-way ANOVA n=3. 
 
 
Figure 6.5: Images of GABAA  2 subunits within cultured neurones after 3 hours NMDA 
stimulation.  A representative image comparing primary cultured cortical neurones (21 DIV) 
treated for 6 hours with 100 μM in 20 mM KCl (A) or vehicle (B), probed with anti- GABAA  2 and 
visualised with a confocal microscope as per the immunocytochemistry protocol.    Arrows depict 
examples of the measured puncta within cells A and B.  Scale bar 15 μm. 
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6.3.3  Phosphorylation of mTOR targets is not altered in response to 
zif268 overexpression in PC-12 cells 
4E-BP1  and  p70S6K  phospho-protein  levels  within  PC-12  cells  transiently 
transfected with 1  g/mL full-length zif268 pre-treated with 50 ng/mL nerve growth 
factor  show  no  effect  compared  to  control  (truncated)  transfected  cells  as 
determined by western blotting (p>0.05, one sample t-test, n=3; see figures 6.6 A 
& B and 6.7 A & B).  
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Figure  6.6:  The  effect  of  zif268  on  phospho-p70S6K  protein  levels  in  PC-12  cells.    A, 
Representative  western  blot  comparing  phospho-p70S6K  immunoreactivity  in  PC-12  cells 
transiently  transfected  with  either  truncated  or  full-length  zif268.  B,  Graph  comparing  phospho-
p70S6K protein levels from PC-12 cells transiently transfected with either truncated or full-length 
zif268 as determined by western blotting. Results are presented as phospho-p70S6K normalised 
pixel intensity. All data is expressed as a mean percentage of control   SEM, n=3. 
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Figure  6.7:  The  effect  of  zif268  on  phospho-4E-BP1  protein  levels  in  PC-12  cells.    A, 
Representative western blot comparing phospho-4E-BP1 (Thr37/Thr46) immunoreactivity in PC-12 
cells  transiently  transfected  with  either  truncated  or  full-length  zif268.  B,  Graph  comparing 
phospho-4EB-BP1 protein levels from PC-12 cells transiently transfected with either truncated or 
full-length zif268 as determined by western blotting. Results are presented as phospho-4E-BP1 
normalised pixel intensity. All data is expressed as a mean percentage of control   SEM, n=3. 
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6.4  Discussion 
6.4.1  GABAAR density in response to NMDAR stimulation 
This chapter attempted to investigate the joint downstream effects of gephyrin and 
ubiquilin downregulated by an increase in zif268 levels.  Gephyrin is thought to 
mediate clustering and/or synaptic anchoring (Craig et al. 1996; Kneussel et al. 
1999a) and ubiquilin is involved in membrane trafficking of GABAARs (Bedford et 
al. 2001).  Hence it can be postulated that decreased expression of gephyrin and 
ubiquilin following zif268 induction might affect synaptic GABAAR levels.  
The application of NMDA for up to 24 hours produced no significant effect on the 
density of receptors containing the   chain.  However, receptors containing the   
subunit displayed an overall effect of NMDA treatment when compared to vehicle 
treated cells.   
The  co-transfection  of  GABAAR  3  subunits  and  gephyrin  into  HEK293  cells 
causes the intracellular co-localisation of both elements (Kirsch et al. 1995), and 
co-expressing  ubiquilin  with  receptors  containing  the  3  subunit  creates  co-
localised  clusters  below  the  plasma membrane  (Bedford  et  al.  2001).    The  2 
subunit is necessary for GABAA receptor cell surface expression (Connolly et al. 
1996b),  and  therefore  the  extracellular  antibody  against  the  2/3  subunits 
recognizes most GABAA receptor subtypes in cortical neurones and was used by 
Bedford et al. (2001) and Danglot et al. (2003) among many others. 
The   subunit, along with gephyrin, is critical for synaptic targeting (Essrich et al. 
1998), and so  2 subunits were visualised to look specifically at gephyrin clustering 
of GABAAR at synapses.  The antibody was utilised by O‘Sullivan et al. (2005) and 
was directed at extracellular sequences of the subunit and so only visualised those 
receptors at the cell surface.  Without the use of double labelling, we were not able 
to differentiate between synaptic and extrasynaptic GABAAR clusters, however, at 
21 DIV, 82.2% of gamma subunits are synaptically located (Danglot et al. 2003). 
A thorough investigation into the percentage of ubiquilin associated with GABAAR 
within  or  just  below  the  synaptic  membrane  has not  been  published,  however, 
90%  of  gephyrin  clusters  at  21DIV  are  synaptic  and,  although  these  were  not 
always associated with the  3 subunit, only 1.8% of   subunits are localised at the Donna M McDade, 2007    Chapter 6, 173 
synapse without gephyrin (Danglot et al. 2003).  The fact that   2/3 clusters were 
not significantly affected by NMDA, but   subunits were, may be due to the fact 
that  33.4%  of  2/3  clusters  are  extrasynaptic  at  21  DIV  whilst  only  11.6%  of 
clusters  containing  both  gephyrin  and    are  extrasynaptic.    As  gephyrin  and 
ubiquilin are associated predominantly with the synapse, the higher percentage of 
extrasynaptic   2/3 subunits may have negatively affected the measured puncta.  
Alternatively, as   subunit containing GABAARs decreased, there could have been 
compensatory  effects  from  other  GABAARs  containing    (e.g.  1),  but  not   
subunits,  that  served  to  maintain  receptor  numbers  at  the  cell  surface,  and 
remained undetected in this particular experiment.  However, it is interesting to 
note that the GABAAR   subunit graph is strikingly similar to the gephyrin graph for 
NMDAR stimulation over 24 hours (Figures 6.4 and 4.8 respectively).  The results 
are  therefore  consistent  with  induction  of  zif268  following  NMDAR  activation 
leading to reductions in synaptic GABAARs via reduced gephyrin expression. 
Both gephyrin and ubiquilin are significantly downregulated after NMDA treatment 
in cultured cortical neurones (chapters 4 & 5).  As noted above, NMDA treatment 
will  have  many  actions  on  neurones  apart  from  zif268  induction  and  likely 
suppression of gephyrin and ubiquilin levels.  Therefore the reduced density of 
GABAAR-immunoreactive clusters observed (with the   subunit-specific antibody) 
cannot be unequivocally linked to the actions of zif268 via gephyrin and ubiquilin.  
Nevertheless, the hypothesis of reduced synaptic GABAAR density after NMDAR 
stimulation was generated on the basis of detection of gephyrin and ubiquilin as 
zif268 target genes, and the results are certainly consistent with, mediation by this 
pathway. 
It is possible that GABAARs within the cytoplasm after NMDA treatment will be in 
diffuse 'microclusters' throughout the cell and not ordered into synaptic clusters by 
gephyrin (Kneussel et al. 1999a).  It is known that the inhibition of gephyrin leads 
to dramatic decreases in GABAAR clusters (Essrich et al. 1998; Feng et al. 1998; 
Kneussel et al. 1999a).  Image J was used to detect immunoreactivity and allowed 
the enforcement of a threshold for relative optical density and mean puncta size, 
which was found empirically for each z-stacked image.  This makes it unlikely that 
micro-clusters would have been measured as they would be below the minimum 
size.    Although  the  assumption  is  that  internalised  receptors  have  not  been 
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skew the results.  This would mean that the results presented are a global count of 
GABAARs, though they would still be in favour of receptor downregulation after 
NMDA induced zif268 activation.  In addition, immunocytochemistry can produce 
artefacts from the paraformaldehyde fixation of immunofluorescence procedures, 
and it is known that extracellular antibodies can have difficulty gaining access to 
synapses.  However, all the results presented were investigated blind, and the 
result  for  GABAAR    subunits  show  a  significant  (p<0.01)  effect  of  NMDA 
treatment, suggesting that there is a genuine reduction in clustered GABAARs after 
NMDA treatment. 
A  number  of  further  experiments  were  planned  to  test  whether  zif268  can  be 
unequivocally linked to the regulation of GABAAR density.  In particular,   subunit 
immunoreactive cluster density was to be assessed after transfection of cortical 
neurones  with  active  or  inactive  zif268  and  in  cortical  neurones  cultured  from 
wildtype or zif268 knockout mice.  However, following various technical problems, 
there was insufficient time for these studies. 
6.4.2  mTOR in response to changes in zif268 expression levels 
4E-BP1 and p70 S6K are downstream effectors of mTOR, promote cell growth 
(Schmelzle  &  Hall  2000),  and  are  implicated  in  diseases  such  as  cancer  and 
diabetes (Vogt 2001).  Both are found at postsynaptic sites (Tang et al. 2002) and 
can be activated by the ERK pathway activating mTOR (Kelleher et al. 2004).  In 
addition,  both  are  phosphorylated  during  hippocampal  LTP.    Therefore,  mTOR 
could be part of pathway that regulates protein synthesis during LTP.   
Phosphorylation  of  4E-BP1  by  mTOR  dissociates  it  from  eIF-4E,  relieving  the 
translational  block;  the  concurrent  phosphorylation  of  p70  S6K  also  increases 
protein synthesis.  Transient transfection of full-length zif268 in PC-12 cells had no 
effect  on  either  phospho-4E-BP1  or  phospho-p70  S6K  when  compared  to 
truncated  (control)  zif268.    Transient  transfection  of  zif268  in  PC-12  cells 
significantly reduces mRNA levels of gephyrin and ubiquilin; in addition, 4E-BP1 
and p70 S6K have both been detected and activated in PC-12 cells in previous 
studies (Kleijn & Proud 2000).   
In  rat  embryos  mTOR  and  gephyrin  are  expressed  widely,  with  large  amounts 
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presynaptic  membranes.    Sequence  similarity  between  mTOR  and  the  glycine 
receptor means that gephyrin can bind mTOR in this region.  Mutations in the 
mTOR binding region cannot bind gephyrin and subsequently do not activate 4E-
BP1 or p70 S6K, suggesting that gephyrin may be necessary for mTOR function in 
HEK293 cells.  In addition, gephyrin may control the localisation of mTOR in HeLa 
cells to cellular membranes (Sabatini et al. 1999).  We found no evidence to link 
decreased gephyrin levels with the mTOR effectors, 4E-BP1 or p70 S6K, in PC-12 
cells. 
Ubiquilin  was  found  to  bind  to  mTOR  through  a  yeast  2-hybrid  experiment, 
however, there seemed to be no evidence of cellular co-localisation, although both 
proteins  were  found  to  co-sediment  in  some  fractions  of  membrane  proteins.  
mTOR did not phosphorylate ubiquilin in vitro, ubiquilin does not effect mTORs 
phosphorylation of 4E-BP1 or p70S6K and therefore the functional activity remains 
unclear (Wu et al. 2002).  Our results also showed no effect of ubiquilin on mTOR, 
via 4E-BP1 or p70 S6K, in PC-12 cells. 
Rapamycin  has  been  shown  to  inhibit  zif268  expression  in  rat  myoblast  cells 
(Sarker & Lee 2004), and so mTOR can increase zif268 expression by activating 
p70 S6K. This suggests that zif268 is in fact a target of mTOR and may explain 
why  we  witnessed  no  effect  of  altering  zif286  levels.    mTOR  may  activate  its 
downstream effector, p70 S6K, and activate zif268 which would then decrease the 
levels of gephyrin and ubiquilin within the cells.  Bypassing mTOR activation by 
artificially increasing zif268 levels through transient transfection would then explain 
why no changes in mTOR were detected. 
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7.1   Introduction  
Bioinformatics is a vital discipline that provides the computational management of 
all kinds of biological information.  It has revolutionised our understanding of basic 
biological  processes,  and  is  a  valuable  tool  capable  of  turning  data  into 
knowledge.    Database  technologies  and  software  tools  enable  the  collection, 
display, storage and retrieval of large volumes of detailed and complex gene and 
protein sequence data which, when combined with molecular function, results in a 
considerable amount of information.  Bioinformatics can include DNA and protein 
sequences,  genotype,  expression  microarray,  protein  structure  and  many  other 
kinds  of  genetic  and  genomic  data,  which  can  be  compared,  interpreted  and 
analysed through the use of a computer.  With genomics technologies generating 
experimental data ranging from gene sequences,  to gene expression levels, to 
protein-protein  interactions,  it  is  possible  to  delineate  preparatory  functional 
genomics before physical experimentation. 
Known genes found on existing biological databases are derived from a range of 
expressed genes.  Undiscovered genes are expressed at very low levels, and only 
occur at certain developmental stages or are cell type specific.  The identification 
of  these  genes  can  include  the  approach  of  Expressed  Sequence  Tag  (EST) 
analysis, whereby partial cDNA clones are sequenced from mRNA, ensuring the 
partial capture of expressed genes.  EST sequences can be found on the NCBI 
website  (http://www.ncbi.nlm.nih.gov/)  and  generally  represent  200–800  bp  of 
sequence information extending towards the gene origin, usually from the mRNA 
3' end. 
Within microarrays, thousands of expressed gene cDNA tags are arrayed on a 
glass slide and incubated with labelled first-strand cDNA produced from cellular 
mRNA.    The  subsequent  hybridisation  of  the  endogenous  sequence  to  the 
complementary array-based sequence allows relative quantitation of expression 
levels  within  a  given  paradigm.  This  technology  allows  widespread  changes  in 
expression patterns to be probed in a single experiment. 
In 2005, James et al. published data from a microarray experiment performed on 
PC-12  cells  and  verified  in  primary  hippocampal  neurones.    Increased  zif268 
protein  levels  were  induced  in  a  cell  line  by  transfecting  a  plasmid  construct 
containing the zif268 gene, whilst primary cultured neurones received NMDA in Donna M McDade, 2007    Chapter 7, 178 
the  presence  of  KCl.    Known  genes  from  the  Affymetrix  GeneChip
®  A  were 
monitored,  categorised,  investigated  and  reported  as  downstream  targets  of 
zif268.    In  addition  to  the  published  data,  there  were  also  GeneChips
®  B  & C 
which, in contrast to the defined genes on GeneChip
® A, mainly contained ESTs.  
Those tags affected by experimentation were subsequently identified as parts of 
known, or unknown, genes by bioinformatics (please see appendix). 
This chapter looks at two of these ESTs in greater detail as downstream targets of 
zif268 and presents one of them, AI169020, as a potential novel gene, named 
urma (from the Gaelic for ‗brand new‘). Donna M McDade, 2007    Chapter 7, 179 
7.2  Aims & Objectives 
  Investigate all of the ESTs significantly altered in the microarray experiment 
performed by James et al. (2005). 
  Select interesting ESTs for further investigation as potential novel genes. 
  Determine the exact locus and sequence of any prospective novel gene 
candidates. 
  Complete  bench  work  performed  on  PC-12  cells  and  primary  cortical 
neurons to validate any predictions. Donna M McDade, 2007    Chapter 7, 180 
7.3  Results 
7.3.1  Microarray results present 144 ESTs as downstream targets of 
zif268 
Significant  Analysis  of  Microarrays  (SAM)  software  (Tusher  et  al.  2001)  was 
utilised  to  calculate  the  expression  levels  of  mRNA  extracted  from  full-length 
zif268  transfected  PC-12  cells  compared  to  a  transfections  with  a  control 
(truncated) form of zif268 (as published by James et al. (2005)).  SAM allows the 
false positive rate to be set by the user, permitting the selection of the number of 
candidate genes with respect to the likelihood of false positives.  On Genechips B 
& C, 72 ESTs were selected on each chip with a false discovery rate of 7.02 and 
1.26  respectively.    This  means  that,  of  the  144  ESTs  affected  by  treatment, 
approximately 8 of them are likely to be false positives. 
Each  of  the  ESTs  was  investigated  in  turn  and  the  results  are  detailed  in  the 
appendix.    After  the  retrieval  of  EST  sequence  data  from  NCBI 
(www.ncbi.nim.nih.gov/), tags were compared to the Rattus norvegicus genome as 
detailed  on  Ensembl  in  January  2004  (www.ensembl.org)  by  BLAST  analysis.  
Criteria were set allowing the identity of ESTs to be revealed as part of a known 
and annotated gene or as an unknown transcript as detailed in Chapter 2.  From 
this  list,  AI169020  and  AI176839  were  highlighted  as  potentially  interesting.  
AI176839 is found on  Rattus norvegicus chromosome 3q42, which shows high 
synteny with Homo sapiens chromosome 20q13, whilst AI169020 is located on 
Rattus  norvegicus  chromosome  4q13,  which  shows  high  synteny  with  Homo 
sapiens chromosome 7q21.2.  Furthermore, ESTs AA998964 and AI112362 were 
also highlighted, due to minimal information regarding their origin and their close 
proximity to one another (4q13, between 27.98MB and 28.16MB), suggesting that 
they may be part of one transcript.  AA998964 and AI112362 are currently under a 
separate investigation and will not be dealt with in this thesis. 
7.3.2  AI176839 is down regulated in PC-12 cells after transient 
transfection of full-length zif268 
In the first instance, results from the microarray were verified in PC-12 cells by 
repeating the transient transfection performed by James et al. (2005).  mRNA was 
harvested  and  primers  designed  against  the  EST  were  used  to  produce  an 
amplicon  of  approximately  209  bps.    The  sequence  of  AI176839  is detailed in Donna M McDade, 2007    Chapter 7, 181 
figure  7.1  along  with  the  primer  locations.    RNA  expression  is  significantly 
downregulated in PC-12 cells transiently transfected with 1  g/mL full-length zif268 
when compared to cells transiently transfected with 1  g/mL of a control truncated 
zif268 (one sample t-test, p<0.001, n=5; see figure 7.2).  A single cycle within the 
logarithmic linear phase was taken and GAPDH values were used to normalise the 
data.    This  gave  a  50%  reduction  in  AI176839  RNA in  PC-12  cells  transiently 
transfected with full-length zif268 compared to control. 
 
Figure 7.1:  cDNA sequence data for EST AI176839.  This data was detailed in and retrieved 
from the NCBI website (http://www.ncbi.nlm.nih.gov/).  Sequence data in bold represents the 
forward primer location and underlined sequences represent reverse primer targets. 
  
Figure  7.2:    The  effect  of  zif268  transfection  on  AI176839  RNA  in  PC-12  cells.    Graph 
comparing EST AI176839 RNA from PC-12 cells transiently transfected with either truncated or full-
length zif268, as assessed by signal intensities at a single RT-PCR cycle.  Results are presented 
as AI176839 normalised pixel intensity after normalisation to the corresponding GAPDH value.  All 
data is expressed as a mean percentage of control   SEM, **p<0.001, one sample t-test, n=5. 
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7.3.3  AI176839 is downregulated in primary cortical neurones after 
NMDA stimulation to induce zif268 
NMDA  stimulation  (100µM  NMDA  in  20mM  KCl)  of  cultured  primary  cortical 
neurones  for  6  hours  displayed  a  statistically  significant  downregulation  of 
approximately 10% in EST AI176839 RNA levels when compared to vehicle as 
determined by RT-PCR (ANCOVA, p<0.05, F(1,16)=6.48, n=4; see figure 7.3).  A 
window of 5 PCR cycles within the logarithmic phase of the PCR reaction was 
established empirically for both AI176839 and the co-variate, GAPDH.   
In  contrast,  evaluating  RNA  levels  after  24-hour  stimulation  of  primary  cortical 
neurones  with  NMDA,  EST  AI176839  RNA  is  not  significantly  different  from 
primary cortical neurones treated with vehicle for 24 hours (p=0.606, F(1, 16) = 
0.28, n=3, see figure 7.4). 
 
Figure 7.3:  The effect of 6 hour NMDA stimulation on AI176839 RNA levels in primary 
cortical neurones.  Graph illustrating AI176839 ln pixel intensity as a function of GAPDH ln pixel 
intensity, as determined by RT-PCR of cultured primary cortical neurones stimulated for 6 hours 
with either 100µM NMDA in 20mM KCl or Vehicle.  ANCOVA, #p<0.05, F(1, 16) = 6.48, n=4. Donna M McDade, 2007    Chapter 7, 183 
 
Figure  7.4:  The  effect  of  24  hour  NMDA  stimulation  on  AI176839  RNA  levels  in  primary 
cortical neurones.  Graph illustrating AI176839 ln pixel intensity as a function of GAPDH ln pixel 
intensity as determined by RT-PCR of cultured primary cortical neurones stimulated for 24 hours 
with either 100µM NMDA in 20mM KCl or Vehicle.  ANCOVA, p>0.05, F(1, 16) = 0.28, n=3. 
 
7.3.4  AI169020 may be part of novel predicted transcript 
ENSRNOT00000012253 
AI169020 is found on chromosome 4 between genomic locations 27305926 and 
27306502 bases.  In 2005, further investigation of AI169020 with Ensembl version 
34  suggested  that  it  might  be  part  of  the  novel  predicted  transcript 
ENSRNOT00000012253,  which  was  a  transcript  of  gene 
ENSRNOG00000009163.  This was due to the fact that many ESTs were found in 
the  area  of  the  genome  between  and  including  EST  AI169020  and  transcript 
ENSRNOT00000012253, with very little known annotated data (see figure 7.5).  In 
addition, a genscan prediction (Burge & Karlin 1997) was present within the same 
genomic  contig.    Data  mining  Ensembl  for  all  the  orthologue  predictions  of 
ENSRNOT00000012253  led  to  the  Mus  musculus  gene  prediction  NM_026583 
(ensembl  gene  identifier  ENSMUSG00000058503)  on  chromosome  5A1,  which 
led  to  Homo  sapiens  gene  XP_376148.1  (Ensembl  known  gene  prediction 
ENSG00000183055,  transcript  ENST00000332869)  on  chromosome  5q12.1, 
which  in  turn  was  linked  to  protein  reference  sequence  NP_690002.1.    This 
referred to a hypothetical protein LOC257415 isoform 1 [Homo sapiens] from gene 
"MGC40405". Donna M McDade, 2007    Chapter 7, 184 
In order to find the reference and original data from which this information was 
derived, NCBI was consulted and 'Homo sapiens hypothetical protein MGC40405 
(MGC40405),  mRNA'  (744  bp)  found.    However,  this  had  the  gene  identifier 
NM_152789  and  the  nucleotide  sequence  for  translation  to  predicted  protein 
LOC257415  (XP_376148.1,  Ensembl  gene  identifier  ENSG00000183055; 
transcript  ENST00000332869)  is  not  the  same  nucleotide  sequence  as 
NM_152789.  In addition, the nucleotide sequence was placed on Homo sapiens 
chromosome 7 (7q21.1) by NCBI and not 5 (5q12.1) as per Ensembl.  However, 
on  UniProt  (www.ebi.uniprot.org)  hypothetical  protein  MGC40405  (their  entry 
name and accession number Q8N0W8) was placed on chromosome 7q21.3.  
 
Figure  7.5:  BLAST  analysis  of  AI169020  on  Ensembl.      A  screengrab  of  the  genomic  area 
surrounding EST AI169020.  Of note are the highlighted ESTs and GENSCAN gene.  In addition, 
the predicted transcript ENSRNOT00000012253 is also of interest.  
 
Further investigation uncovered a protein LOC257415 isoform 2, which displayed 
a marked similarity to the predicted protein of transcript ENSRNOT00000012253 
and to protein MGC40405 (see figure 7.6). 
The information for hypothetical protein MGC40405 was derived from human brain 
tissue mRNA and submitted to EMBL/GenBank/DDBJ databases and published by 
Strausberg et al. (2002) and Scherer et al. (2003).  The nucleic acid records are 
supported  by  experimental  data  however  the  protein  sequence  is  predicted.  
Performing a BLAST search with MGC40405 nucleotide sequence against the rat 
AI169020 
ENSRNOT00000012253 
ESTs 
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genome places it in the same vicinity as AI169020 and ENSRNOT00000012253, 
highlighting  this  genomic  area of  interest  (see  figure  7.7).    In  addition,  BLAST 
searching the MGC40405 nucleotide sequence against the human genome places 
it on chromosome 7q21.2.  
 
Figure 7.6: Sequence data for transcript ENSRNOT00000012253, LOC257415 and MGC40405.  
A  list  of  information  presented  for  transcript  ENSRNOT00000012253  and  its  predicted  protein 
along  with  the  information  it  was  derived  from,  LOC257415  isoform  1  (as  found  on 
www.ensemble.org).   In addition, the  sequence  data for protein  LOC257415 isoform 2 and  the 
nucleotide and predicted protein sequence of MGC40405 (as found on www.ncbi.nim.nih.gov/). Donna M McDade, 2007    Chapter 7, 186 
 
Figure 7.7: A BLAST search of the MGC40405 nucleotide sequence.  A screen grab from an 
Ensembl BLAST search of MGC40405 places the sequence in the same genomic area (4q13) as 
the EST AI169020 and the transcript of interest, ENSRNOT00000012253. 
The  accumulation  of  contradictory  evidence  suggested  that,  in  contrast  to  the 
information  presented  by  Ensembl,  the  protein  sequence  was  actually  that  of 
LOC257415 variant 2, not variant 1 and the MGC40405 protein was localised to 
chromosome 7.  Overall, there is the implication that this is indeed an area of 
interest with little verified data, warranting further investigation. 
7.3.5  AI169020 is not significantly downregulated in PC-12 cells after 
transient transfection with zif268 
The microarray transient transfections were repeated in PC-12 cells by replicating 
the experiments performed by James et al. (2005).  The sequence of AI169020 is 
detailed in figure 7.8 along with the primer locations.  RNA expression was not 
significantly affected in PC-12 cells transiently transfected with 1  g/mL full-length 
AI169020 
ENSRNOT00000012253 
MGC40405 
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zif268 when compared to cells transiently transfected with 1  g/mL of a control 
truncated  zif268  (n=5;  see  figure  7.9)  although  there  was  a  tendency  for 
decreased expression in the zif268-transfected cells. 
7.3.6  AI169020 and ENSRNOT00000012253 primers produce an 
amplicon from PC-12 cells RNA 
Using  RNA  extracted  from  PC-12  cells,  several  reactions  were  simultaneously 
monitored via PCR for 45 cycles.  EST AI169020 forward and  reverse primers 
produced a predicted amplicon of 148 bps and ENSRNOT00000012253 forward 
and reverse primers (Tr12253 Fwd and Rev) produced a predicted amplicon of 
371 bps, with the addition of minor products, when electrophoresed on a 1.5% 
agarose gel.   
 
Figure 7.8: cDNA sequence data for EST AI169020.  This data was detailed and retrieved from 
the NCBI website (http://www.ncbi.nlm.nih.gov/).  Sequence data in bold represents the forward 
primer location and underlined sequences represent reverse primer targets. 
 
 
Figure 7.9: The effect of zif268 transfection on AI169020 RNA in PC-12 cells.  Graph 
comparing EST AI169020 RNA from PC-12 cells transiently transfected with either truncated or full-
length zif268, as assessed by signal intensities at a single RT-PCR cycle.  Results are presented 
as AI169020 normalised pixel intensity after normalisation to the corresponding GAPDH value.  All 
data is expressed as a mean percentage of control   SEM, n=5. Donna M McDade, 2007    Chapter 7, 188 
In addition, the forward primer of AI169020 and Tr12253 Fwd (the sequences are 
presented  on  opposite  strands)  produced  an  amplicon  of  approximately  1,200 
base pairs with a minor product at approximately 570 bps.  As negative controls, 
the Tr12253 Fwd and Rev primers and the AI169020 Fwd and Tr12253 Fwd were 
also  investigated  with  no  cDNA  present.    The  Tr12253  Fwd  and  Rev  primers 
produced no bands (see figure 7.10), however, the AI169020 Fwd and Tr12253 
Fwd produced a minor band of a few tens of bases, which is likely to be primer-
dimers.   
 
Figure 7.10: Agarose gel image of the novel product PCR fragment.  PCR amplified products 
electrophoresed  on  a  1.5%  agarose  gel  after  45  cycles.    M,  100  bp  DNA  marker  (Promega, 
Southampton, UK), 1, EST AI169020 forward & reverse primers, 2, Tr12253 forward & reverse 
primers,  3,  EST  AI169020  forward  &  Tr12253  forward  primers,  4,  ENSRNOT12253  forward  & 
reverse primers, no cDNA, 5, EST AI169020 forward & Tr12253 forward primers, no cDNA. 
 
7.3.7  AI169020 and ENSRNOT00000012253 primers produce a novel 
transcript from adult rat cerebral cortex mRNA 
cDNA  was  generated  from  rat  cerebral  cortex  tissue  using  Oligo(dT),  which 
hybridises to 3‘ poly(A) tails, ensuring that only expressed mRNAs were used as 
template.  The cDNA was then amplified with AI169020 and Tr12253 Fwd primers 
for 45 cycles in order to generate enough product to sequence.  Previous attempts 
at PCR had unfortunately necessitated such a high number of cycles in order to 
achieve  the  cDNA  concentration  required.    Primers  were  designed  utilising  a 
predicted sequence of the novel gene ascertained from EST and predicted gene 
information.    Firstly,  all  the  ESTs  present  between  AI169020  and  transcript 
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ENSRNOT00000012253 were collated in order from 5‘ to 3‘ (using the AI169020 
sense  strand  to  orientate).    This  comprised  ESTs  BF542993,  CF977261, 
CB765971,  BF288214  and  BF522287,  none  of  which  were  present  on  the 
Affymetrix  GeneChips  and  therefore  were  not  present  in  the  microarray 
experiment (James et al. 2005).  Sequential BLAST analyses were performed to 
find overlapping regions of sequence, allowing all 6 ESTs (including AI169020) 
and ENSRNOT00000012253 to form a coherent single theoretical cDNA strand.  
This created 1414 bps of theoretically expressed sequence, which was used as 
the basis of the novel transcript (see figure 7.11 A & B).  Primers were designed 
using this information and sequenced from AI169020 as the lead primer (as this 
was the originally affected transcript from the microarray experiment).  The actual 
sequence  returned  contained  a  number  of  bases  denoted  ‗N‘,  which  were 
manually identified by scrutinising the chromatogram and verifying with the details 
found on NCBI (see figure 7.12 A & B).  However, the sequencing company only 
provided  a  single  read  and,  combined  with  any  PCR-introduced  errors,  it  is 
possible that the DNA sequence may contain some inaccuracies.  The sequence 
returned comprised 1477 bases and showed approximately 90% homology to the 
predicted  sequence  (figure  7.12  C),  suggesting  the  discovery  of  a  novel  gene 
which I propose to call urma.   
7.3.8  Urma may code for a novel transcription factor of unknown 
function 
With the addition of the AI169020 EST and Transcript ENSRNOT00000012253 
sequences outwith the primers, the total length of urma identified is 1879 bases.  
As AI169020 is a 3‘ EST, the correct orientation is on the complementary strand to 
that sequenced. 
By running the entire nucleotide sequence through two different websites ExPASy 
and  ATGpr  (Nishikawa  et  al.  2000)  (http://ca.expasy.org/tools/dna.html  and 
http://www.hri.co.jp/atgpr/ respectively; see figure 7.13) the results returned were 
exactly the same and therefore, the predicted protein sequence of urma is: 
MNPIAMARSRGPIQSSGPTIQDYLNRPRPTWEEVKEQLEKKKKGSKALAEFEEKMNENWKKELEKH
REKLLSGNESSSKKRQKKKKEKKKSGRYSSSSSSSSDSSSSSSDSEEEDKKQTKRRKKKKSHCHKS
PETSVSDSDSDSKDGSKKKKKSKDITEREKDTKGLSKKRKMYEDKPLSSESLSESDCGEVQAKKKK
SGEERERTTDKAKKRRKHKKHSKKKKKKAASSSSDSP Donna M McDade, 2007    Chapter 7, 190 
 
A 
1. AI169020 
AAAACAAGTG TTTACTAAAA TTCTGGCAAT AGCTTTATGT AACAAGATAC AGCATACCAG 
GCCTGCCACT CAACTTGTTT GTGGTAAGTC TCAGCTTCAA ATGAAGCCGT AAAAACAAAA 
ACCAAAAGTC TGCTTTTTAA TGCTAAATAT TTGAAAGTGT CCATTAAACA AGTTATGAAC 
TTAAGACAGA AGAGTTAGTA AAAGCTAAAC CTGCAGCCTA ACAAAGTTTA ACAAAACATG 
AAGTGTCTAC ACTGGCTACT AAAAATCTCC GACTGGTTAA ACTTGTGTAA ACATGCGCTT 
TACAACTGTA GCTGTCAAGT CAGAAAGTAC AGTGTCTACT AACCATCCCT TCCAAAGCCA 
AGTGTAGTCA AAATGAATTA AATGACGCAA ACAACGTAAC CTAAAAACAT CAGTTATTAT 
TGATGTGGAG TAATTCCAGG CTTTGGGGGC TTCTCATGCT CAAAGGGCCG GTACCTCTGG 
TTCATTCCAA GCAGCTTACG ACAAAGTCTA AGGATGTCAT TAACCTCAGT CAGGGCAGGA  
CTGAC  
 
2. BF542993 
CACGAGGTTT GACTACACTT TGGCTTTGGA GAGGGATGGT TTAGTACACA CTGGTACTTT 
CTGAGCTTGA CAGCTGACAG TTGTAAAGCG CATGTGTTAC ACAAGTTTTA ACCAGTCAGG 
AGATTTCTAC GTAGCCAGTG ATAGACACTT CATGTTTTGT ATAAACTTTG TTTAGGCTGC 
AGTGTTTAGC TTTTAACTAA CTCTTGCTGT CTTAAGTTCA TAACTATGTT TAATGGCACA 
CTTTCAAGAT ATTTAGCATG TAAAAAGCAG GACTTTTGGT TTTTGTTTTT AACGGCTTCA 
TATTGAAGCT GAGACTTACC ACAAACAAGT TGAGTGGCAG GCCTGGTATG CTGTATCTTG 
TTACATAAAG CTATTGCCA 
 
3. CF977261 
GGGGAACTGA ATCTGGATCC ATCTTTTAAG ATGTAACCAG AAATAACGAG TAAAGATTTT 
CAAAGTAGGG ATTTCATTAA TATTTCAAAA TCCTTACTCT GTAGATAAGT ATATTTTAAT 
TTTTCCCCAC GTATGCTTTG ATTTACTTGG GGAAGGAGCT TTTAAAGAGG GGGTGGTTTG 
CTATCTCTTT AGCTACCAGA ACAGCGTGCC TTTGATCTCA CACATCCTAC TTTTGTGGAC 
ACAGTAGCCA TGCTTCCTGG GAGGACAGAG CTGGGCACGG TCAGTCCTGC CCTGACTGAG 
GTTAATGACA TCCTTAGACT TTGTCGTATG CTGCTTGGAA TGAACCAGAG GTACCCGGCC 
CTTTGCAGCA TGAGAAAGCC CCCAAAGCTC TGGAATTACC TCCACATCAA TAATAACTGA 
ATGTTTTTAG GGTTACGTTG TGTTGCGTCA TTTGAATTCA TTTTGACTAC ACTTTGGCTT 
TGGAGAGGGA TGGTTTAGTA AACACTGGTA CTTTCTGAGC TTGACAGCTG ACAGTTGTAA 
AGCGCATGTG TTACACAAGT TTTAACCAGT CAG 
 
4. CB765971 
CGTAGCATCC AGAAGACCAG GGTCCTTACA GAGTGCAATG TCAAAGGAGC TCTCAACTGT 
GAAGATTATG ACTTACTTAG TAACGTGCAT GAATCCCCTT GTTTTTAGAC TTGTCCTGGA 
CTAGTCAGTA GTCACTTGGA TTCCGCTGTG TGAAGGGCCA TGAATGTTGC CTGCTGCTTG 
AACACCTTTT CCTCTTCCAG TGCTTGGTGA CTCTGGGAGA TAGTACTTTG CAGTCATACT 
AGTGGTTAAG ATATTTGGAA TAAAGCTAAT ATTTTTTACT AGAAGTACTT AAGAATAAAT 
CAACAGGAAC TGAATCTGGA TCCATCTTTT AAGATGTAAC CAGAAATAAC GAGATGACTC 
TAGTAAAGAT TTTCAAAGTA TGGATTTCAT TAATATTTCA AAATCCTTAC TCTGTAGA 
 
5. BF288214    
CAGTTCCTGT TAATTTATTC TTAAGTACTT CTAGTAAAAA ATATTAGCTT TATTCCAAAT 
ATCTTAACCA CTAGTATGAC TGCAAAGTAC TATCTCCCAG AGTCACCAAG CACTGGAAGA 
GGAAAAGGTG TTCAAGCAGC AGGCAACATT CATGGCCCTT CACACAGCGG AATCCAAGTG 
ACTACTGACT AGTCCAGGAC AAGTCTAAAA ACAAGGGGAT TCATGCACGT TACTAAGTAA 
GTCATAATCT TCACAGTTGA GAGCTCCTTT GACATTGCAC TCTGTAAGGA CCCTGGTCTT 
CTGGATGCTA CGGCGAGTCT GAGCTTGAAC TGGCAGCCTT CTTTTTCTTC TTCTTGCTGG 
GTTTCTTATG CTTCCTTCTC TTTTTAGCTT TGTCTGTTGT TCTCTCTCGC TCTTCACCGC 
TTTTCTTCTT TTTCGCTTGC ACCTCTCCAC AGTCTGACTC TGACAATGAC TCANC 
 
6. BF522287 
CACGAGGGCT TTGTTGAGCT TTTGTGGGAG GGAAATGGCT TTGATATTTT AGTTTCTAAA 
TCCTGTGAAT ATGGCATCTG TTTCTTAGAC ACTAGATTGA TTTCACTAAG TGCTTGAGAG 
ACTTAGTAAA AGAAACCAAT TCCTGCATCT CACAAGCTTT AATTGTTTTG TGCTTGGTCA 
AGTATTCATC TTCTTCTTCA TCGAGCTCTG ATTCTTCCAG CAGTTCTTCA GATTCTGAGG 
AGGAGGATAA AAAGCAAACA AAAAGAAGGA AGAAAAAGAA GAGCCATTGC CATAAGTCTC 
CGGAGACCTC CGTGTCGGAT TCAGACTCAG ACAGCAAGGA CACTAAAGGA CTCAGCAAAA 
AGAGAAAGAT GTATGAGGAT AAACCTTTGT CATCTGAGTC ATTGTCAGAG TCAGACTGTG 
GAGAGGTGCA AGCGAAAAAG AAGAAAAGCG GTGAAGAGCG AGAGAGAACA AC 
 
7. ENSRNOT00000012253 
ATGGGGAAGC GAGACAATCG CGTGGCCTAC ATGAATCCAA TAGCAATGGC TCGGTCAAGG  Donna M McDade, 2007    Chapter 7, 191 
GGTCCAATCC AGTCTTCAGG ACCAACAATC CAGGATTATC TGAATCGACC AAGGCCTACC 
TGGGAGGAAG TGAAGGAGCA GCTGGAAAAG AAAAAGAAGG GCTCCAAGGC TTTGGCTGAG 
TTTGAAGAGA AAATGAATGA GAATTGGAAG AAAGAACTAG AAAAACATAG AGAAAAACTA 
TTAAGTGGAA ATGAGAGCTC ATCCAAAAAG CGACAGAAAA AGAAAAAAGA AAAGAAGAAA 
TCTGGTAGGT ATTCATCTTC TTCTTCATCG AGCTCTGATT CTTCCAGCAG TTCTTCAGAT 
TCTGAGGAGG AGGATAAAAA GCAAACAAAA AGAAGGAAGA AAAAGAAGAG CCATTGCCAT 
AAGTCTCCGG AGACCTCCGT GTCGGATTCA GACTCAGACA GCAAGGTGAG ACTCAGCCCT 
GGACTGCTGA GAGCAAAAAC AGCCATTTTC CTGTCTGCTT TTCCTGTCTA GCGCTTCAGT 
TAGAAAGCAC ATTTGATTTC ATTTTTGGAT TTTTGAGACA GAGTTTTTCT CTGTATAGAC 
CTAGATCAGG CTGGCCTCAA AGTCACTGAG ATCCAACCTG CCTTCCTGTG CAGCCTGAGT 
GCTGGCACTA AAGGGGTGCA CTAGCACCAC CACTCCCAGC CACATTTGAC TTTTGTACTT 
TGAGGTTCTG CACCAGTCGA CAGGTGTATT TAATATTGTA CATGTAGCAT CTTTTTATCC 
TTTATTCTTC ATATGCATGT TTGTATGATT CCATGATAGT GTTTCCTTTG TTTGTAAAAT  
AATATTTGCA ATTCTAGGTT 
 
B 
 
 
Figure 7.11: Sequence data for the predicted transcript of urma.  A, The sequences of ESTs 
AI169020, BF542993, CF977261, CB765971, BF288214, BF522287 and transcript 
ENSRNOT00000012253 in genomic order.  B, The collated sequence of the predicted urma 
transcript after sequential BLAST analyses of the ESTs presented in A.  Primer locations of 
AI169020 forward and Tr12253 forward are in bold.  Additional primers for sequencing are 
underlined.  
 
This protein sequence is 86% homologous to the protein sequence detailed for 
ENSRNOT00000012253 on Ensembl and 86% homologous to that of MGC40405 
as  detailed by  NCBI  (with  areas  of  similarity  differing  slightly).    Upstream  EST 
sequences to that of urma (CF977260 and BF393377) were collated and added to 
the 5‘end and the extended sequence run through both protein prediction websites 
again.  This did not alter the translation start site of the protein, suggesting that the 
true translational start site has indeed been located. Donna M McDade, 2007    Chapter 7, 192 
As a control, the Rattus norvegicus gephyrin genome sequence (as detailed on 
NCBI, accession number NM_022865) was entered into the ATGpr website.  A 
protein  sequence  with  99%  homology  to  the  experimentally  derived  protein 
sequence detailed on NCBI, accession number NP_074056, and with the correct 
translational start site, was retrieved. 
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C 
1 _________________________NNNNNNNNNNNNNANNANNTTNN 
1 CAAAATGAATTCAAATGACGCAACACAACGTAACCCTAAAAACATTCA 
 
GTTATTATTGATGTGGAGGTAATTCCAGAGCTTTGGGGGCTTTCTCATGCTGCAAAGGGCCGGGTACCT 
GTTATTATTGATGTGGAGGTAATTCCAGAGCTTTGGGGGCTTTCTCATGCTGCAAAGGGCCGGGTACCT 
 
CTGGTTCATTCCAAGCAGCATACGACAAAGTCTAAGGATGTCATTAACCTCAGTCAGGGCAGGACTGAC 
CTGGTTCATTCCAAGCAGCTTACGACAAAGTCTAAGGATGTCATTAACCTCAGTCAGGGCAGGACTGAC 
 
CGTGCCCAGCTCTGTCCTCCCAGGAAGCATGGCTACTGTGTCCACAAAAGTAGGATGTGTGAGATCAAA 
CGTGCCCAGCTCTGTCCTCCCAGGAAGCATGGCTACTGTGTCCACAAAAGTAGGATGTGTGAGATCAAA 
 
GGCACGCTGTTCTGGTAGCTAAAGAGATAGCAAACCACCCCCTCTTTAAAAGCTCCTTCCCCAAGTAAA 
GGCACGCTGTTCTGGTAGCTAAAGAGATAGCAAACCACCCCCTCTTTAAAAGCTCCTTCCCCAAGTAAA 
 
TCAAAGCATACGTGGGGAANAATTAAAATATACTTATCTACAGAGTAAGGATTTTGAAATATTAATGAA 
TCAAAGCATACGTGGGGAAAAATTAAAATATACTTATCTACAGAGTAAGGATTTTGAAATATTAATGAA 
 
ATCCCTACTTTGAAAATCTTTACTAGAGTCATCTCGTTATTTCTGGTTACATCTTAAAAGATGGATCCA 
ATCCCTACTTTGAAAATCTTTA__________CTCGTTATTTCTGGTTACATCTTAAAAGATGGATCCA 
 
GATTCAGT_________TCCTGTTGATTTATTCTTAAGTACTTCTAGTAAAAAATATTAGCTTTATTCC 
GATTCAGTTCCCCCAGTTCCTGTTAATTTATTCTTAAGTACTTCTAGTAAAAAATATTAGCTTTATTCC 
 
AAATATCTTAACCACTAGTATGACTGCAAAGTACTATCTCCCAGAGTCACCAAGCACTGGAAGAGGAAA 
AAATATCTTAACCACTAGTATGACTGCAAAGTACTATCTCCCAGAGTCACCAAGCACTGGAAGAGGAAA 
 
AGGTGTTCAAGCAGCAGGCAACATTCATGGCCCTTCACACAGCGGAATCCAAGTGACTACTGACTAGTC 
AGGTGTTCAAGCAGCAGGCAACATTCATGGCCCTTCACACAGCGGAATCCAAGTGACTACTGACTAGTC 
 
CAGGACAAGTCTAAAAACAAGGGGATTCATGCACGTTACTAAGTAAGTCATAATCTTCACAGTTGAGAG 
CAGGACAAGTCTAAAAACAAGGGGATTCATGCACGTTACTAAGTAAGTCATAATCTTCACAGTTGAGAG 
 
CTCCTTTGACATTGCACTCTGTAAGGACCCTGGTCTTCTGGATGCTACGGCGAGTCTGAGCTTGAACTG 
CTCCTTTGACATTGCACTCTGTAAGGACCCTGGTCTTCTGGATGCTACGGCGAGTCTGAGCTTGAACTG 
 
GCAGCCTTCTTTTTCTTCTTCTTGCTGTGTTTCTTATGCTTCCTTCTCTTTTTAGCTTTGTCTGTTGTT 
GCAGCCTTCTTTTTCTTCTTCTTGCTGGGTTTCTTATGCTTCCTTCTCTTTTTAGCTTTGTCTGTTGTT 
 
CTCTCTCGCTCTTCACCGCTTTTCTTCTTTTTCGCTTGCACCTCTCCACAGTCTGACTCTGACAATGAC 
CTCTCTCGCTCTTCACCGCTTTTCTTCTTTTTCGCTTGCACCTCTCCACAGTCTGACTCTGACAATGAC 
 
TCAGATGACAAAGGTTTATCCTCATACATCTTTCTCTTTTTGCTGAGTCCTTTAGTGTCCTTTTCTCTT 
TCAGATGACAAAGGTTTATCCTCATACATCTTTCTCTTTTTGCTGAGTCCTTTAGTGTCCTT_______ 
 
TCNNTTATATCCTTTGACTTCTTTTTCTTTTTTGAACCATCCTTGCTGTCTGAGTCTGAATCCGACACG 
____________________________________________GCTGTCTGAGTCTGAATCCGACACG 
 
GAGGTCTCCGGANACTTATGGNANTGGCTCTTCTTTTTCTTCCTTCTTTTTGTTTGCTTTTTATCCTCC 
GAGGTCTCCGGAGACTTATGGCAATGGC__________________________________ATCCTCC 
 
TCCTCAGAATCTGAAGAACTGCTGGAAGAATCAGAGCTCGATGAAGAAGAAGATGAATACCTACCAGAT 
TCCTCAGAATCTGAAGAACTGCTGGAAGAATCAGAGCTCGATGAAGAAGAAGATGAATACCTACCAGAT 
 
TTCTTCTTTTCTTTTTTCTTTTTCTGTCGCTTTTTGGATGAGCTCTCATTTCCACTTAATAGTTTTTCT 
TTCTTCTTTTCTTTTTTCTTTTTCTGTCGCTTTTTGGATGAGCTCTCATTTCCACTTAATAGTTTTTCT 
 
CTATGTTTTTCTAGTTCTTTCTTCCAATTCTCATTCATTTTCTCTTCAAACTCAGCCAAAGCCTTGGAG 
CTATGTTTTTCTAGTTCTTTCTTCCAATTCTCATTCATTTTCTCTTCAAACTCAGCCAAAGCCTTGGAG 
 
CCCTTCTTTTTCTTTTCCAGCTGCTCCTTCACTTCCTCCCAGGTAGGCCTTGGTCGATTCAGATAATCC 
CCCTTCTTTTTCTTTTCCAGCTGCTCCTTCACTTCCTCCCAGGTAGGCCTTGGTCGATTCAGATAATCC 
 
TGGATTGTTGGTCCTGAAGACTGGATTGGACCCCTTGACCGAGCCATTGCTATTGGATTCATGTAGGCC 
TGGATTGTTGGTCCTGAAGACTGGATTGGACCCCTTGACCGAGCCATTGCTATTGGATTCATGTAGGCC 
 
ACGCGATTGTCTAA 
ACGCGATTGTCT 
Figure 7.12: Sequencing data from urma transcript. A, The collated sequence returned from 
Geneservice (Cambridge, UK). B, Sequence information of urma once the N‘s have been replaced 
with bases derived from the chromatograms and NCBI.  C, Alignment of the predicted sequence 
(from figure 7.11B) (in red text) and the actual sequence (from A) (in black text).  Donna M McDade, 2007    Chapter 7, 194 
 
Figure 7.13: Predicted protein sequence of urma.  A, The predicted protein sequence of urma 
as returned from ExPASy.  B, The predicted protein sequence of urma as returned from ATGpr.   
The urma protein sequence is not predicted to span the cell membrane nor be 
secreted,  as  per  the  Centre  for  Biological  Sequence  Analysis 
(http://www.cbs.dtu.dk/services/TMHMM/).    Presumably,  this  implies  that  urma 
does not contain a hydrophobic membrane-spanning domain.  Furthermore, when 
investigated using the PredictProtein website (http://www.predictprotein.org), urma 
is  predicted  to  contain  7  cAMP-  and  cGMP-dependent  protein  kinase 
phosphorylation sites and 7 PKC phosphorylation sites.  In addition, it may be 
localised to the nucleus and bind to DNA, as various nuclear localisation signals Donna M McDade, 2007    Chapter 7, 195 
and  DNA  binding  domains  were  identified  throughout  the  protein  sequence.  
These data suggest that urma may be a transcription factor. 
Although the translation start site is predicted, the transcription initiation site has 
still to be elucidated.  However, by examining 11,000 base pairs of the rat genome 
upstream of the translation start site, we reasoned that any exons, introns and the 
promoter  region  would  be  included.    Using  Signal  Scan 
(http://thr.cit.nih.gov/molbio/signal/) to investigate, we found evidence of 3 TATA 
boxes, 2 CAAT boxes, 1 CREB site and 1 zif268 binding site with an overlapping 
Sp-1 recognition sequence, all within 2000 base pairs of each other (see figure 
7.14). 
7.3.9  Urma is significantly downregulated in primary cortical neurons 
after zif268 induction by NMDA stimulation 
The predicted protein results were used to design primers within the coding region 
of urma.  These were used to monitor effects within that part of the transcript that 
may  have  direct,  or  indirect,  actions  on  other  cellular  components.    Evaluating 
RNA levels after 6-hour stimulation of primary cortical neurones with NMDA, urma 
mRNA levels are not significantly different from those in primary cortical neurones 
treated with vehicle for 6 hours (p=0.09, F(1, 11) = 3.46, n=3, see figure 7.15). In 
contrast,  NMDA  stimulation  (100µM  NMDA  in  20mM  KCl)  of  cultured  primary 
cortical neurones for 24 hours induced a statistically significant downregulation in 
mRNA levels when compared to vehicle as determined by RT-PCR (ANCOVA, 
p<0.05, F(1,11) = 4.93, n=3; see figure 7.16).  A window of 3 PCR cycles within 
the logarithmic phase of the PCR reaction was established empirically for both 
urma and the co-variate, GAPDH.   
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Figure 7.14: A diagram of the DNA recognition sequences upstream of the urma translation 
start site.  Positions of some of the possible binding sites for CREB, Zif268 and Sp1, as well as 
TATA and CAAT box locations are presented.  Note that distances in kb are to the translation start 
site as the transcription start site is not known. 
 
 
 
Figure 7.15:  The effect of 6 hour NMDA stimulation on urma mRNA levels in primary cortical 
neurones. Graph illustrating urma coding amplimer ln pixel intensity as a function of GAPDH ln 
pixel intensity, as determined by RT-PCR of cultured primary cortical neurones stimulated for 6 
hours with either 100µM NMDA in 20mM KCl or vehicle (control).  ANCOVA, p>0.05, F(1, 11) = 
3.46, n=3. Donna M McDade, 2007    Chapter 7, 197 
 
Figure  7.16:  The  effect  of  24  hour  NMDA  stimulation  on  urma  mRNA  levels  in  primary 
cortical  neurones.   Graph illustrating urma coding  amplimer ln  pixel intensity  as a function  of 
GAPDH  ln  pixel  intensity,  as  determined  by  RT-PCR  of  cultured  primary  cortical  neurones 
stimulated for 24 hours with either 100µM NMDA in 20mM KCl or vehicle (control).  ANCOVA, 
*p<0.05, F(1, 11) = 4.93, n=3. 
 
7.3.10  Urma is significantly down regulated in zif268 knockout 
mice 
Urma mRNA is significantly downregulated by 7% in cerebral cortex tissue from 
zif268 knockout mice compared to their counterpart wildtype mice as determined 
by RT-PCR (p<0.01 F(1,13) = 9.61, ANCOVA, n=9; see figure 7.17). 
 
 
Figure 7.17:  The effect of genotype on urma RNA levels.  Graph illustrating urma log pixel 
intensity as a function of GAPDH log pixel intensity, as determined by RT-PCR of adult cerebral 
cortex tissue from either wildtype or zif268 knockout mice.  ANCOVA, #p<0.01 F(1,13) = 9.61, n=9. Donna M McDade, 2007    Chapter 7, 198 
7.3.11  Updated Bioinformatics for Urma  
On the 25
th November 2004, both Ensembl and NCBI were contacted to clarify the 
mismatched information regarding the whereabouts of protein MGC40405.  Both 
organisations replied that they would investigate and update their databases.  In 
Ensembl version 42 (December 2006), AI169020 is lined up with Ensembl known 
protein  coding  NP_001019970.1  (Ensembl  Gene  ENSRNOG00000009163, 
transcript ENSRNOT00000012253), which still has no functional description, but 
has an orthologue prediction straight to an MGC40405 fragment (although this is 
still  placed  on  chromosome  5)  (see  figure  7.18).    The  NP_001019970.1 
information is described as 'hypothetical protein LOC362320 [Rattus norvegicus]', 
which now has no variants and presents data that was originally associated with 
isoform 1.  The updated predicted protein sequence of ENSRNOT00000012253 
matches  this,  although  our  results  suggest  that  the  transcript  had  a  greater 
similarity to their, now missing, isoform 2.  The information is from the Sanger 
Institute  and  was  updated  in  December  2005.    This  Ensembl  entry 
NP_001019970.1 corresponds to the Rat Genome database RGD1306302 (Rattus 
norvegicus similar to RIKEN cDNA 5830415L20). 
In  contrast,  the  entry  on  NCBI  regarding  MGC40405  now  has  2  variants:  
MGC40405 isoform 1, described as 'hypothetical protein LOC257415 isoform 1' 
and MGC40405 isoform 2, described as 'hypothetical protein LOC257415 isoform 
2'.  This information was updated in November 2006.  Our predicted protein results 
for urma are similar to MGC40405 isoform 2 protein results. 
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Figure  7.18  Updated  BLAST  search  of  urma,  using  only  the  sequenced  nucleotide 
information returned from Geneservice.  Highlighted are the BLAST results for urma, Ensembl 
Known Protein Coding NP_001019970.1 and EST AI169020. 
AI169020 
Urma 
BLAST 
result 
Known protein 
NP_001019970.1 Donna M McDade, 2007    Chapter 7, 200 
7.4  Discussion 
This chapter is a first introduction to the novel gene urma and describes it as a 
downstream target of zif268 and predicted transcription factor.  Increasing levels of 
zif268 in PC-12 cells shows a tendency to suppress urma mRNA levels, NMDA 
stimulation in cortical neurones decreases urma mRNA levels, and the absence of 
zif268  altogether  significantly  decreases  urma  levels  in  the  cerebral  cortex  in 
zif268 knockout mice.  
Microarrays  can  produce  enormous  amounts  of  information,  which  can  be 
effectively interpreted with the use of SAM analysis.  The use of this statistical 
package provides an accurate estimate of the percentage of genes identified by 
chance,  and  hence  is  superior  to  the  performance  of  multiple  uncorrected 
statistical  tests.    Of  the  144  ESTs  affected,  only  4  were  nominated  for  further 
investigation.  The remaining 140 ESTs, mainly of known origin, warrant further 
investigation to determine their potential role in plasticity via the transcription factor 
zif268.  Gene identification is one of the major tasks of bioinformatics and the 
comparison of ESTs to each other and to genome sequences is useful for gene 
discovery.  ESTs are characteristically redundant and naturally error prone due to 
the fact that they are single-read sequences, however, they are generated from 
oligo(dT)-primed cDNA libraries and can therefore identify authentic mRNAs, even 
when there are long 3‘UTRs.   
More than half of the genes within the genome of an organism can be located 
through  their  homology  to  other  known  proteins.    In  order  to  determine  the 
remaining genes, genefinder programs can be utilised.  GENSCAN, in the most 
basic of explanations, is a probabilistic HMM-based
2 program that searches for 
consensus sequences on both strands of DNA, allowing for occurrences of 
multiple genes.  In general it scans for features recognised by transcriptional, 
splicing and translational machinery which process all of the protein coding genes; 
therefore  it  locates  such  characteristics  as  exons,  introns,  splice  sites  and 
promoters.  It was chosen as a benchmark model for locating areas of interest as, 
in 1997, it could identify 75-80% of exons completely (Burge & Karlin 1997) and is 
                                         
 
2 Hidden Markov Model - A probabilistic model used to align and analyze sequence datasets by 
generalization from a sequence profile 
 Donna M McDade, 2007    Chapter 7, 201 
currently  recommended  by  others  (Nadershahi  et  al.  2004).    GENSCAN  can 
predict about 65% of translation initiation sites and 76% of termination codons 
exactly,  whilst  correctly  identifying  90%  of  internal  splice  sites  (Burge  &  Karlin 
1997). 
EST AI176839 is significantly downregulated by an increase in zif268 levels as 
determined by RT-PCR within a cell line and verified in primary neurones.  The 
effect within cultured primary neurones may be time dependent as RNA levels of 
the EST were significantly downregulated at 6 hours, an effect that had diminished 
by 24 hours.  These results indicate that an area of interest has been identified.  
There  is  now  an  ‗Ensembl  known  protein  coding‘  (transcript 
ENSRNOT00000055127,  NP_001041325.1,  gene  ENSRNOG00000008194, 
similar to known gene NFX1-type zinc finger-containing protein 1 (ZNFX1)) in this 
area however, AI176839 does not line up with any of the exons and is situated at 
the 5‘ end, suggesting that it may not be part of the annotated gene.  Additional 
exploration  of  the  genomic  region  is  warranted  to  determine  the  full-length 
sequence of this mRNA, investigate the presence of a novel gene, and locate the 
transcription  and  translation  start  sites,  the  open  reading  frame  and  overall 
function. 
The generation of a product from oligo(dT) primed cDNA by pooling the primers 
designed for EST AI169020 and transcript ENSRNOT00000012253 shows that an 
actual transcript can be recovered from this area of the genome.  In addition to 
this, knitting together other expressed transcripts in the form of ESTs produced the 
information for the overall sequenced product returned from Geneservice.  This 
suggested that the predicted transcript ENSRNOT00000012253 was in fact a real 
transcript  with  an  extended,  only  just  discovered,  3‘  UTR.    Once  the  coding 
sequence of urma had been predicted by two separate programs, and delivered 
very similar results to those published for transcript ENSRNOT00000012253 and 
MGC40405 on Ensembl and NCBI respectively, primers were designed to monitor 
effects  within  this  region  only.    This  assumes  that  any  effects  noted  are  true 
responses  of  a  novel  gene  modulated  by  the  transcription  factor  zif268.    An 
increase  in  zif268  by  NMDA  stimulation  in  cultured  primary  cortical  neurones 
caused RNA levels of urma to decrease after 24 hours, an effect that seems slow 
acting as there was no difference in RNA levels between NMDA stimulated cells 
and controls after only 6 hours.  This may imply that zif268 has an indirect effect 
on  urma,  whereby  an  unknown  transcription  factor  gene  could  mediate  the Donna M McDade, 2007    Chapter 7, 202 
activation of urma.  However, the presence of a zif268 binding site in the proposed 
'promoter' area may argue a direct interaction.  
The likely translation start site was identified using the software ATGpr, which is 
the most sensitive and accurate of the various approaches available (Nadershahi 
et  al.  2004).    The  optimal  context  for  initiation  of  translation  is  GCCRCCaugG 
whereby  R  denotes  a  purine  (adenine  or  guanine).   Within  this  sequence,  the 
purine  (-3)  and  the  G  (+4)  (the  only  effective  base  in  this  position)  are  most 
important  for  strong  activation  of  the  start  codon  (Kozak  1986;  Kozak  1997).  
When both of these are intact, the AUG is in its strongest context and can function 
more than 10 times more efficiently than any gene with the start codon in a weak 
context  (Kozak  1987).    Urma  has  a  kozak  sequence  of  GCCTACatgA,  where 
underlined letters indicate the important bases, and in both cases it can be seen 
that  the  environment  is  less  than  optimal.    When  the  context  is  less  than 
favourable and translation is not strongly stimulated, some protein synthesis may 
occur but most will start at the next downstream AUG codon.  This means that 
some ribosomes may bypass the weak context AUG codon in favour of a stronger 
context further downstream, in a manner termed leaky scanning  (Kozak 2005).  
This can enable the generation of long and short forms of the protein, if they are in 
the same frame, or completely different proteins if they are in different frames.  
However, less than 10% of all eukaryotic mRNAs do not use the first ATG for the 
start  codon  (Kozak  1989).    Additional  possible  effects  may  be  an  alteration  in 
mRNA stability or splicing (Kozak 2003).  Indeed, it is reported that 35-59% of 
human genes display evidence of at least one splice variant (Modrek & Lee 2002).  
Further experimentation is required to determine whether the suboptimal context 
of the kozak rule within urma has any effect on protein length, number, sequence 
and/or function.  
Analysing  gene  promoters  bioinformatically  to  identify  transcription  factor 
consensus  sequences  has  aided  the  detection  of  functional  transcription factor 
binding sites (Tullai et al. 2004; Chowdhary et al. 2005; Kamalakaran et al. 2005; 
Xie et al. 2005).  The difficulty in this instance is that we have not definitively 
identified a transcriptional start site and it is very difficult to  obtain data on the 
average length of 5‘UTRs in the Rattus norvegicus genome.  However, a statistical 
analysis in 1999  (Deutsch & Long 1999) of 74 genes with descriptive 5‘UTRs, 
taken  from  10  eukaryotic  model  organisms,  records  a  range  of  96  to  8214 
nucleotides for intron length in this area.  Eukaryotic genes tend to have very long Donna M McDade, 2007    Chapter 7, 203 
genes with very short exons (e.g. Arabidopsis has exons of 3 bps) and long introns 
(e.g. the human dystrophin gene has introns of >100 kbs) (Mathe et al. 2002).  In 
fact, first introns in the human genome were found to be longer than median length 
introns more often than expected at random (Kalari et al. 2006).  In addition, it has 
been  shown  that  transcripts  with  an  optimal  start  codon  context  tend  to  have 
shorter 5' UTRs, whereas an increased length of 5' UTR correlates with a 'weak' 
start  codon  context  (Rogozin  et  al.  2001).    Overall,  this  therefore  led  to  the 
analysis of a large genomic area. 
The urma promoter may contain a TATA box, CAAT box, CREB site and a zif268 
binding site with an overlapping Sp-1 recognition sequence.  An interesting feature 
of these consensus sequences is that they are all located within 2000 base pairs 
of each other.  The TATA box to cap site is 30 to 36 bps from the first T of the 
TATA box matrix to the cap site (start of transcription), and the CAAT is generally 
found upstream at –60 to –100.  However, the TATA box only seems to be present 
in about 70% of human promoters, and  the CAAT box found in about 50% of 
vertebrate promoters (Fickett & Hatzigeorgiou 1997).  The presence of a zif268 
binding site located close to recognition sites that may signal the immediacy of the 
transcriptional start site is very encouraging.  In many known zif268 targets the 
consensus  sequence(s)  are  in  proximal  promoter  regions  (James  et  al.  2006).  
The presence of a zif268 binding site does not prove an interaction with urma but 
does  increase  the  likelihood  that  it  is  a  direct  target.    Interestingly,  the  zif268 
binding site is overlapped by an Sp-1 binding site.  It has been reported that the 
competitive  binding  between  Sp-1  and  zif268  at  overlapping  sites  leads  to  a 
suppression in transcription mediated by zif268 as it blocks the binding of Sp-1 to 
its  recognition  sequence  (Ackerman  et  al.  1991;  Bahouth  et  al.  2002).  
Furthermore, additional studies suggest that displaced Sp1 binds to and activates 
the  endogenous  zif268  gene,  thereby  leading  to  "facilitated  inhibition"  of  Sp1 
function by the resulting increased zif268 (Liu et al. 1996).   
The  bioinformatically-derived  localisation  of  urma  to  the  nucleus,  with  the 
prediction that it will bind to DNA, suggests that urma may be transcription factor.  
The  presence  of  many  PKA/PKC/PKG  phosphorylation  sites  within  the  protein 
sequence  are  also  typical  of  a  transcription  factor  responding  to  extracellular 
signals, to rapidly induce or suppress gene expression.  This allows several layers 
of control with overlapping functions to tightly regulate the activity of transcription 
factors and therefore, their downstream targets. Donna M McDade, 2007    Chapter 7, 204 
Within zif268 knockout mice, urma levels are significantly downregulated.  As with 
the  ubiquilin  results,  this  is  surprising  as  the  expected  result  would  be  an 
upregulation in the absence of zif268, however, it does identify urma as a genuine 
downstream target.  It was planned to determine the distribution of urma mRNA 
throughout  the  whole  mouse  brain,  as  well  as  comparing  mRNA  levels  in  the 
striatum of zif268 knockout and wildtype mice after haloperidol administration, by 
in  situ  hybridisation.    However,  there  was  not  enough  time  to  optimise  these 
experiments. 
Evidence that urma could be involved in synaptic plasticity comes from a paper 
published recently describing a girl of 10.5 years of age with mental retardation.  
This has been located to an interstitial deletion of chromosome 7q21.1-q22 and is 
the third case of its kind (Young et al. 1984; Chitayat et al. 1988; Manguoglu et al. 
2005).  In addition a case of a 7q21.2 to q22.1 duplication resulted in moderate 
mental retardation (Lukusa & Fryns 1998), and a proximal interstitial deletion of 7q 
(q11.23q22) produced severe mental retardation (McElveen et al. 1995).  In all of 
the above cases, many other symptoms were also reported, most frequently of 
which  is  ectrodactyly  (split  hand/split  foot  malformation),  which  appears  to  be 
localised between 7q21.2 and 7q22.1.  While clearly there are many genes located 
in  this  region  that  could  be  responsible  for  the  mental  retardation,  the  above 
evidence linking urma to neuronal plasticity makes urma an interesting candidate. 
Biological  websites  are  updated  continuously  but  the  annotation  of  all  the 
information presented by researchers is not keeping pace with the volume of raw 
sequence data.  In addition, the multitude of databases, each with their specific 
accession numbers, can be very confusing.  However, as each part of genome is 
investigated  and  interpreted,  the  situation  should  become  more  manageable.  
Experimental  approaches  remain  necessary  in  order  to  confirm  the  exact 
locations,  transcriptional  activity  and  splicing  patterns  of  novel  genes  and  the 
existence of virtual proteins, their biological functions and condition of expression 
within an organism.  Although the complete gene structure and physical evidence 
of  the  protein  have  not  been  elucidated  yet,  urma  may  be  a  rarely  expressed 
transcription factor that can target genes involved in plasticity.  
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8.1  Discussion 
8.1.1  Significance of Investigation 
This thesis introduces gephyrin, ubiquilin and a novel gene, urma, as downstream 
targets of the plasticity-related immediate early gene, zif268.  It also proposes that 
zif268, activated during neuronal plasticity, transcriptionally downregulates gene 
expression of gephyrin and ubiquilin, which impacts on the number of GABAARs 
localised to the synapse.  This effect may also indirectly influence proteasome 
activity and the cytoskeleton at inhibitory synapses. 
8.1.2  Plasticity 
It  is  assumed  that  memories  are  represented  in  the  brain  as  spatio-temporal 
patterns of cellular activity within a neural network, with adaptations occurring at a 
cellular level  to  store  experiences.    LTP  is  the  pairing  of  input  stimulation  and 
postsynaptic depolarisation, with a resulting long-term increase in the strength and 
efficiency of the synaptic connection.  Stable LTP has been produced in the medial 
and  lateral  perforant  pathways  for  up  to  a  year  (Abraham  et  al.  2002).    It  is 
therefore studied as a possible cellular correlate of learning and memory. 
Several  protein  kinases,  including  Src,  ERK,  CaMKII,  PKC,  cGMP-dependent 
kinase  (PKG)  and  PKA  are  downstream  effectors  of  synaptic  signalling,  as 
selectively  inhibiting  their  actions  can  prevent  hippocampal  LTP  induction.  
Interactions  between  kinase  pathways  suggests  that  ERK  may  be  a  point  of 
convergence integrating CaMK, PKA and PKC signals (Impey et al. 1998).  These 
kinases  are  thought  to  play  a  role  in  the  early  phases  of  LTP,  leading  to  the 
changes  necessary  for  the  slower,  more  sustained  phases  requiring  increased 
gene transcription and new protein synthesis which occur after approximately 3 
hours of LTP maintenance (Krug et al. 1984; Otani et al. 1989; Fazeli et al. 1993). 
Many  articles  cite  the  effects  that  plasticity  have  on  excitatory  synapses.  
Seventeen to twenty percent of the neurones in the brain are GABAergic, each of 
which receives approximately 6000 connections (Somogyi et al. 1998).  Seventeen 
percent of these cells innervate other GABAergic cells (Freund & Buzsaki 1996).  
This body of work looks at inhibitory synapses found on cells that are involved in 
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contain synapses that are activated by GABA, leading to a suppression of their 
activity. 
8.1.3  The transcription factor, zif268 
Zif268 is one of the few proteins consistently implicated in many different forms of 
plasticity.  Within 1 hour of LTP induction, zif268 mRNA is increased (Cole et al. 
1989;  Wisden  et  al.  1990;  Richardson  et  al.  1992).    It  is  also  induced  during 
periods  of  learning,  whilst  the  threshold  and  duration  of  hippocampal  LTP 
correlates with the degree of zif268 induction (Richardson et al. 1992; Worley et al. 
1993).    Sustained  changes  in  neuronal  activity  with  a  concurrent  induction  of 
zif268 has been recorded in the hippocampus, visual or temporal cortex and spinal 
cord, in diverse species from primates to songbirds (Cole et al. 1989; Wisden et al. 
1990; Jarvis et al. 1998; Kaczmarek et al. 1999; Mello et al. 2004; Morris, 2004). 
Zif268 knockout mice show an intact short-term memory but display deficits in late 
phase LTP, whilst long term memory is significantly impaired (Jones et al. 2001), 
confirming the importance of zif268 induction for long term plasticity.  With training 
however, these mice can overcome deficits in memory as illustrated by a number 
of memory tasks (Jones et al. 2001).  This may suggest that other mechanisms 
can  compensate  for  the  lack  of  zif268  in  certain  behavioural  conditions.    For 
instance,  egr-2  mRNA  is  upregulated  and  returns  to  basal  levels  within  a 
timeframe  similar  to  that  of  zif268.    However,  the  corresponding  egr-2  protein 
increase outlasts that of zif268 by approximately 16 hours (Williams et al. 1995).  
In  addition,  certain  binding  sites  on  the  promoter  region  of  zif268  are  equally 
present on egr-2 and egr-4, as well as other IEGs such as c-fos and arg3.1 (Davis 
et al. 2003), and egr-2 and egr-3 are induced during periods of synaptic activity in 
the CNS (Yamagata et al. 1994; Beckmann et al. 1997).  This may go some way 
to explain our results for gephyrin, ubiquilin and urma in the knockout mouse.  A 
preferable  paradigm  would  have  included  a  targeted  deletion  that  could  be 
induced  in  the  adult  mouse  and  knock  down  the  zif268  gene  in  a  controlled 
manner. 
Within this thesis both primary cortical neurones and PC-12 cells were utilised.  
Zif268 has been identified within the PC-12 cell line, and although it is activated by 
the addition of 50ng/mL NGF (Milbrandt 1987), this returns to basal level within 
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elapse after NGF treatment of PC-12 cells before transient transfection of the full-
length  or  truncated  zif268  constructs.    In  addition,  NMDA  stimulation  with  a 
depolarising  agent  induced  zif268  in  primary  cultured  cortical  cells  in  a 
physiologically relevant manner.  However, zif268 is also activated during cellular 
stress & pathology (Jones & Agani 2003; Pignatelli et al. 2003; Quinones et al. 
2003) which could feasibly occur through in vitro cell culture work.  We performed 
the majority of experiments on aged cultures, when presumably, any stress-related 
IEG activation has returned to basal levels.  If time had allowed, gephyrin, ubiquilin 
and  urma  would  have  been  monitored  with  an  in  vivo  LTP  model;  haloperidol 
administration to zif268 knockout mice in order to block striatal D2 receptors.  This 
induces  glutamate  release  from  corticostriatal  neurones,  and  produces  LTP  at 
corticostriatal synapses, whilst increasing protein levels of zif268 (Nguyen et al. 
1992;  Simpson  &  Morris  1994;  Keefe  &  Gerfen  1995;  Calabresi  et  al.  1997; 
Cepeda et al. 2001). 
8.1.4  Urma as a neuronal target of zif268 
A full characterisation of urma is still required to elucidate many aspects of this 
potential  neuronal  plasticity  gene.    However,  this  thesis  has  presented  a 
transcribed sequence that is downregulated in response to an increase in zif268 
as determined by microarray and NMDA stimulation of primary cortical neurones.  
In addition, urma mRNA levels are downregulated in zif268 knockout mice.  This 
information was collected after the design of unique primers using an EST and 
closely  located  predicted  transcript.    The  sequence  provided  from  this  product 
after only amplifying the transcriptome was used to locate a putative translation 
start site.  This information drove the design of further primers to examine the 
translated region of the gene after experimental manipulation.  The likelihood of a 
novel gene within this area of the genome is increased by the annotations now 
found  on  regularly  used  bioinformatic  websites.    Although  the  descriptions  on 
these websites are currently blank, the presence of a known gene symbol adds to 
the probability that urma is a newly discovered transcript.  The submission of urma 
to genomic databases will officially flag this locus as a zif268-modulated gene.  
Urma may be a transcription factor involved in learning and memory, as it has 
putative  sites  for  nuclear  localisation,  DNA  binding,  contains  multiple 
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8.1.5  Gephyrin as a neuronal target of zif268 
The downstream target genes of zif268 in neurones were recently discovered and 
published by James et al. (2005).  In their microarray experiment, gephyrin mRNA 
was suggested to be downregulated by 26% in response to an increase in zif268 
expression.    A  downregulation  of  gephyrin  in  response  to  elevated  zif268 
expression was confirmed within this thesis.  
8.1.5.1  Gephyrin and the cytoskeleton 
Gephyrin has a tendency to assemble into highly structured complexes both in 
vitro and in transfected cells (Schmitt et al. 1987; Kirsch & Betz 1995; Meyer et al. 
1995), which can occur without the aid of additional proteins (Choquet & Triller 
2003) to form a submembraneous scaffold.  It is highly enriched at the cytoplasmic 
face of inhibitory postsynaptic membrane differentiations and is proposed to recruit 
membrane  receptors  and  subsynaptic  structural  and  signalling  proteins  to 
inhibitory  synapses.    In  only  one  study  however,  gephyrin  clusters  have  been 
found opposite glutamate synapses in cultured hippocampal neurones (Brunig et 
al. 2002). 
Gephyrin,  a  major  structural  component  of  inhibitory  postsynaptic  membranes, 
localises  and  anchors  inhibitory  receptors  at  the  synapse,  minimising  receptor 
diffusion.    Although  individual  GABAA  receptors  at  the  synapse  are  continually 
recycled and exchanged between the cell surface and intracellular compartments 
the  number  of  receptors  at  the  plasma  membrane  is  generally  a  stable 
arrangement.    The  exception  is  during  periods  of  intense  activity,  like  that 
encountered during long-term potentiation and synaptic plasticity.  It is thought that 
synaptic  activity  could  control  the  cytoskeleton  to  influence  the  number  of 
receptors at synapses.  Cytoskeleton disruption has been shown to induce rapid 
variations  in  GlyR  numbers  at  synapses,  decreasing  receptor  dwell  times  and 
causing a rapid diffusion of receptors in the extrasynaptic membrane (Kirsch & 
Betz 1995; van Zundert et al. 2002; van Zundert et al. 2004; Charrier et al. 2006). 
Cytoskeletal anchoring of inhibitory receptors may be mediated by an interaction 
of  gephyrin  with  tubulin  (Kirsch  et  al.  1991)  as  evidence  shows  that  alkaloids, 
which disrupt the microtubular network, cause a loss of gephyrin from synaptic 
sites in cultured spinal cells (Kirsch & Betz 1995; van Zundert et al. 2004).  In 
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protein at the early stages of synaptogenesis (Zhang & Benson 2001).  Gephyrin 
may be laid down at GABAAR containing membrane domains by an interaction 
with actin, as microfilaments are essential for gephyrin scaffold formation during 
postsynaptic membrane development.  However this interaction could be transient, 
as disruption of the actin cytoskeleton and microtubule network in differentiated 
cells has no effect on the number of postsynaptic GABAAR and gephyrin clusters 
(Allison et al. 2000).  This may suggest that the receptor and scaffold complex, 
once  formed,  remains  clustered  independently  without  the  aid  of  conventional 
cytoskeletal proteins. 
Mena/VASP acts as an adaptor between actin and gephyrin (Bausen et al. 2006) 
and, along with profilin, is considered an essential and ubiquitous component of 
the cortical microfilament web,  linking gephyrin and GlyRs to the microfilament 
system (Mammoto et al. 1998; Giesemann et al. 2003).  Profilin, which stimulates 
actin  polymerisation  (Mammoto  et  al.  1998),  is  a  gephyrin  ligand  that  may 
contribute to the activity dependent processes underlying synaptic plasticity, as 
both  profilin  I and  II  are  redistributed  to dendritic  spines  after synaptic  activity, 
which, in the case of profilin II, occurs after calcium influx (Ackermann & Matus 
2003; Neuhoff et al. 2005). 
Gephyrin mRNA and protein levels were downregulated by increased zif268 levels 
in PC-12 cells, and following NMDA treatment of primary cortical neurones, as 
determined by reverse transcription PCR, western blotting, immunocytochemistry 
and  ELISA.    A  zif268-mediated  downregulation  of  gephyrin  therefore  could 
decrease cytoskeletal elements at the cell membrane either directly, or indirectly, 
decreasing the number of receptors at the synapse.  The sub-synaptic scaffolds in 
general  govern  the  mobility  of  many  membrane-associated  or  transmembrane 
proteins.    As  synaptic  gephyrin  appears  to  restrict  the  mobility  of  inhibitory 
receptors  diffusing  in  the  plane  of  the  plasma membrane,  the  loss  of  gephyrin 
would  decrease  the  protein  availability  for  interaction  with  the  cortical 
microfilament web, resulting in a reduced size and low packing density of gephyrin 
scaffolds, alleviating restrictions on the lateral mobility of neuronal receptors.  This 
would  directly  influence  the  number  of  postsynaptic  receptors  localised  to  the 
synapse,  and  therefore  the  size  of  the  synaptic  response  and  ultimately  the 
synaptic efficacy (Lim et al. 1999; Meier et al. 2001).  Gephyrin, via a plasticity-
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converts  alterations  in  synaptic  activity  into  morphological  changes  of  synaptic 
structure.   
In  addition  to  the  static  gephyrin  lattices  located  to  the  postsynaptic  cell 
membrane,  there  are  a  number  of  small  mobile  gephyrin  particles  located 
throughout the cytoplasm.  These represent approximately 2% of the total clusters 
(Lorenzo et al. 2004; Maas et al. 2006), and seem to combine and dissociate with 
the bigger clusters.  This mechanism could increase, and reduce, the size of pre-
existing gephyrin scaffolds.  This infers that 98% of gephyrin locates at plasma 
membrane regions (Lorenzo et al. 2004), and confirms our immunocytochemical 
results as depicting gephyrin immunoreactivity at the membrane.  However, if the 
2% of mobile gephyrin has been included in the immunocytochemistry result, it 
would illustrate a reduction of global gephyrin, therefore depleting the available 
pool of gephyrin protein that seems to be reserved for maintaining large gephyrin 
clusters,  or  represents  the  gephyrin  molecules  transportation  from  their  site  of 
production in the cytoplasm.  Global gephyrin levels were detected by  western 
blotting  and  showed  a  significant  downregulatory  effect  of NMDA  treatment  on 
protein levels within primary cultured cortical neurones. 
8.1.5.2  Gephyrin and the GABAA Receptor 
During plastic processes, the lateral diffusion of neurotransmitter receptors in and 
out  of  synapses  rapidly  alters  receptor  numbers  and  is  a  key  component  of 
receptor  renewal  and  concentration  as  shown  by  electrophysiology  (Tovar  & 
Westbrook  2002;  Adesnik  et  al.  2005;  Thomas  et  al.  2005)  and  imaging 
techniques (Dahan et al. 2003; Tardin et al. 2003; Groc et al. 2004).  This serves 
to  swiftly  restore  synaptic  function  during  periods  of  intense  activity,  whereby 
lateral diffusion reduces once the receptor reaches the postsynaptic specialisation 
(Jacob et al. 2005).   
Gephyrin  colocalises  with  both GlyRs  and  GABAARs  in  spinal cord,  retina  and 
various brain regions (Triller et al. 1985; Sassoe-Pognetto et al. 1995; Todd et al. 
1996; Sassoe-Pognetto et al. 2000).  GABAA and glycine receptors together with 
gephyrin  can  also  accumulate  at  the  same  postsynaptic  sites  (Dumoulin  et  al. 
2001) indicating that gephyrin can provide a common anchoring scaffold for both 
types  of  inhibitory  neurotransmitter  receptors,  although  glycine  receptors  are 
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mobility  of  diffusing  hetero-oligomeric  GlyRs  (Meier  et  al.  2001),  and  regulates 
their  packing  density  at  the  postsynaptic  membrane  (Kirsch  &  Betz  1995).    In 
addition,  gephyrin  has  a  strong  association  with  the  2  subunit  of  GABAAR, 
restricts lateral mobility and regulates clustering and cluster stability of GABAAR at 
postsynaptic sites (Essrich et al. 1998, Kneussel et al. 1999; Jacob et al. 2005). 
Gephyrin knockout mice display a total loss of postsynaptic GABAAR  2 and  2 
immunoreactivities  (Kneussel  et  al.  1999),  and  the  targeted  deletion  of  the  2 
subunit of GABAARs prevents postsynaptic clustering (Essrich  et al. 1998).  In 
addition, gephyrin KO mice have a marked increase in the number of intracellular 
aggregates of GABAARs (Kneussel et al. 1999).  Therefore, clusters of GABAARs 
at the synapse may be formed by the intracellular loop of the  2 subunit interacting 
with gephyrin, as part of a postsynaptic scaffold, which then increases their half-
life at the synapse and prevents internalisation (Kneussel et al. 1999).  LTP driven 
gephyrin  protein  downregulation  would  therefore  decrease  the  number  of 
GABAARs  at  the  postsynaptic  membrane.    Indeed,  decreasing  gephyrin 
expression by RNAi does not modify the total cell surface expression levels of 
GABAARs,  but  significantly  reduces  the  number  of  synaptic  receptor  clusters 
(Jacob et al. 2005).  Our results displayed a significant reduction in  2 containing, 
but  not    containing,  GABAARs  in  cortical  neurones  after  NMDA  treatment.  
Although  the  neurones  were  not  simultaneously  stained  with  anti-gephyrin  and 
anti-GABAAR, the experimental procedures in all treatment groups were identical 
and  therefore  a  relationship  can  be  drawn  between  the  decrease  in  gephyrin 
immunoreactivity and corresponding decrease in  2 subunit containing GABAARs.  
It has been suggested that gephyrin and GABAARs are not stably organised with 
the cytoskeleton and instead rely on the  2 subunit for long term maintenance at 
the synapse and recycling at post synaptic sites  (Schweizer et al. 2003).  Our 
results specifically monitored and reported a significant decrease in the  2 subunit 
of GABAARs.  Although a significant fraction of GABAARs at postsynaptic sites are 
not  accessible  to  antibodies  in  intact  cells  (van  Rijnsoever  et  al.  2005),  and 
GABAARs can gephyrin-independently cluster at non-synaptic sites (Christie et al. 
2002; Scotti & Reuter 2001), the cultured cells were permeabilised with triton X-
100 (Sigma-Aldrich, Dorset, UK) and therefore may have allowed the labelling of 
the majority of the 82% of  2 subunits that are localised to the synapse (Danglot et 
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A prerequisite for fast and efficient synaptic transmission is a high concentration of 
neurotransmitter-gated  ion  channels located directly  opposite  presynaptic  nerve 
terminals.  Inhibitory synaptic currents are significantly affected by the number of 
synaptic GABAARs at the plasma membrane (Otis et al. 1994; Nusser et al. 1997; 
Nusser  et  al.  1998),  so  a  reduction  of  GABAARs  at  the  synapse  by  a  zif268-
induced  downregulation  of  gephyrin  would  decrease  the  likelihood  of  receptor 
activation and therefore inhibitory currents entering the cell.  GABAARs are located 
to and exert their effects preferentially in the neuronal dendrites (Miles et al. 1996; 
Allison  et  al.  2000;  Megias  et  al.  2001),  whilst  gephyrin  immunoreactivity  is 
localised mainly to the dendrites after 3 weeks in culture (Craig et al. 1996).  As 
mechanisms that regulate the density and localisation of GABAARs on the surface 
of  cortical  neurones  influence  neuronal  excitability  and  inhibitory  GABAergic 
networks are known to adapt to changes in the strength of their excitatory inputs 
(Nusser et al. 1998; Ives et al. 2002; Leroy et al. 2004; Suzuki et al. 2005), it is 
therefore likely  that this adaptation could include a downregulation of inhibitory 
receptors at synapses. 
It  is  possible  that  the  downstream  effects  of  LTP  directly  interact  with  the 
GABAARs at the synapse as they are phosphorylated by PKA, PKC, PKG, CaMKII 
and  Src,  an  interaction  that  is  thought  to  cause  enhancement  or  inhibition  of 
inhibitory currents (Moss & Smart 2001; Smart 1997; McDonald et al. 1998).  After 
PKC activation, receptors containing the  2 subunit are reduced at the plasma 
membrane  (Connolly  et  al.  1999b)  as  this  prevents  internalised  receptors  from 
returning to the surface, although conflicting evidence has been reported (Chapell 
et al. 1998; Cinar & Barnes 2001).  Although this may be the case, this thesis 
presents evidence that zif268 activation directly downregulates gephyrin levels in 
neurones in the first instance and that this downregulation is remarkably mirrored 
in the downregulation of GABAARs, a receptor that gephyrin has been linked with 
on many occasions.   
Circumstantial  evidence  has  previously  linked  gephyrin  and  zif268  within  a 
learning and memory paradigm.  It was reported that kainic acid-induced plasticity 
and  fear  conditioning  by  light  shock  treatment  and  odour-shock  associative 
learning,  induces  an  upregulation  of  zif268  mRNA  after  0  to  60  minutes  and 
extensive  downregulation  of  gephyrin  after  30  –  120  minutes,  implying  that 
gephyrin may be involved in the long-term storage of fear memory (Resslar et al. 
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the  basolateral  amygdala,  the  piriform  cortex,  perirhinal  cortex  and  habenula.  
Strikingly,  in  the  areas  displaying  no  changes  in  zif268  mRNA  levels,  the 
investigators also found that gephyrin levels were unaffected (Ressler et al. 2002). 
8.1.6  Ubiquilin as a neuronal target of zif268 
The decrease of gephyrin, which causes a decrease of GABAARs localised to the 
synapse  could  increase  the  number  of  intracellular  receptor  microclusters 
throughout  the  cell,  as  reported  in  gephyrin  knockout  mice  (Feng  et  al.  1998).  
These microclusters would either be recycled or require clearance from the cell.  
Ubiquilin, found to be downregulated in the microarray experiment (James et al. 
2005) and in this thesis, has been linked to the GABAAR and the proteasome.  
Ubiquilin therefore may play a role in receptor degradation. 
8.1.6.1  Ubiquilin and GABAARs  
GABAARs are constantly removed from the cell surface by endocytosis and cycled 
between  synaptic  sites  and  intracellular  endocytic  structures,  in  a  ‗holding  and 
recycling‘ pattern (Tehrani & Barnes 1993; Kittler et al. 2000).  This allows the 
quick  recovery  and  reinsertion  of  receptors  into  the  plasma  membrane  during 
periods  of  intense  synaptic  activity.    Ubiquilin  is  associated  with  the  plasma 
membrane (N'Diaye & Brown 2003) and is found in clathrin-coated vesicles as well 
as on intracellular membranes, so is well placed to stabilise recycled and de novo 
synthesised  receptors  (Bedford  et  al.  2001).    It  can  modulate  the  membrane 
insertion of GABAAR, by binding its UBA domain to GABAAR   and   subunits, 
which has a profound effect on the efficacy of synaptic transmission by inhibiting 
GABAAR  polyubiquitylation,  reducing  receptor  targeting  to  the  proteasome  and 
promoting  their  recruitment  to  the  cell  surface.    Importantly,  blocking  the 
interaction of ubiquilin with GABAAR reduces the number of receptors at the cell 
surface (Bedford et al. 2001). 
Ubiquilin  possesses  an  N-terminal  ubiquitin  like  domain,  which  interacts  with 
subunits of the 19S complex, and a C-terminal UBA domain that interacts with 
K48-linked polyubiquitin chains (Funakoshi et al. 2002; Ko et al. 2002; Raasi & 
Pickart 2003), interfering with the degradation of ubiquitin-dependent proteasome 
substrates  in-vivo,  increasing  their  half-life  (Kleijnen  et  al.  2000).    Ubiquilin 
interacts  with  the  ubiquitin  ligase  E6-AP  and  proteasomes  in  large  complexes 
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containing the E4 enzymes cdc48/p97 and ubiquitin-fusion degradation 2 enzyme 
(Ufd2).  Ufd2 extends the ubiquitin chain by a few ubiquitin residues and recruits 
Dsk2, an ubiquilin homologue, which may bind to the ubiquitin-protein conjugate 
and interact with the proteasome via Rpn1/S2 (Funakoshi et al. 2002; Kim et al. 
2004; Richly et al. 2005).  This could suggest that ubiquilin delivers the substrate 
to the proteasome.  However, evidence that increasing ubiquilin levels increases 
GABAAR immunoreactivity (Bedford et al. 2001) suggests that the interaction with 
the  proteasome  blocks  the  degradation  of  ubiquilin-bound  polyubiquitylated 
proteins, at least in the case of GABAAR at the synapse. 
This thesis reports a reduction in ubiquilin mRNA and protein levels in PC-12 cells 
and primary neurones as determined by RT-PCR and immunocytochemistry after 
treatment upregulating zif268 levels.  In addition, ubiquilin mRNA is downregulated 
in zif268 mice compared to wildtypes.  As we did not look at proteasome activity 
directly,  this  leads  to  a  purely  theoretical  relationship  between  LTP,  zif268, 
ubiquilin,  GABAAR  and  the  proteasome.    Thus,  a  zif268 mediated  decrease in 
ubiquilin could increase the degradation of the GABAAR, as ubiquilin would no 
longer be able to 'protect' the GABAAR from the proteasome.  This in turn would 
decrease the size of the intracellular pool of inhibitory receptors in GABA receptive 
synapses  available  for  membrane  insertion.    It  has  been  shown  that  PKC 
activation  prevents  the  recycling  of  receptors  back  to  the  cell  surface  after 
endocytosis (Connolly et al. 1999b; Kittler & Moss 2001), though this does not 
seem to be due to a direct phosphorylation of the receptor.  It is feasible therefore 
that  this  effect  could  be  induced  via  zif268  and  a  resultant  decrease  in  the 
availability of ubiquilin protein. 
Ubiquilin interacts with the   and   subunits of GABAAR, subunits that are found 
throughout the cell and not specifically localised to synapses.  In fact,   and   
subunits are preferentially extrasynaptic (Fritschy et al. 1998; Sassoe-Pognetto et 
al.  2000)  suggesting  that  ubiquilin  may  play  a  role  in  the  regulation  of  global 
GABAAR, rather than synapse specific receptors.  Although Bedford et al. (2001) 
localised  ubiquilin  to  subsynaptic  spaces  and  internal  structures,  there  is  the 
capacity for ubiquilin to exert its effects on extrasynaptic GABAAR and therefore 
influence tonic inhibition.  Extrasynaptic receptors are not in a cluster formation 
and therefore the threshold setting for measuring the immunocytochemistry results 
may  have  overlooked  those  receptors  that  did  not  meet  the  minimum  size 
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reduction in   subunit containing GABAARs throughout the cell, although there was 
a trend for a reduction of these subunits after NMDA treatment.  A reduction of 
GABAARs involved in tonic inhibition would lower the threshold needed for action 
potentials, allowing the cell to act more responsively to afferent excitatory input. 
8.1.6.2  Plasticity and the proteasome 
James et al. (2005) were the first to discover that many downstream targets of 
zif268  are  either  subunits  of  the  proteasome  or  proteins  that  function  with  the 
proteasome within the CNS.  This is additional evidence that LTP and neuronal 
plasticity are dependent on protein degradation, as well as protein formation, and 
that  regulation  of  the  proteasome  could  be  essential  for  normal  CNS  function.  
Zif268 is involved in the suppression of these genes, leading to a corresponding 
decrease in proteasome activity, whereas the absence of zif268 by gene knockout 
is associated with elevated cerebral cortex proteasome activity.  These alterations 
may be subtle but prolonged, as CNS plasticity has been associated with long-
term modifications of proteasome gene expression.  
The levels of proteins involved in synaptic communication are regulated by the 
proteasome  (Boehmer  et  al.  2003;  Colledge  et  al.  2003;  Ehlers  2003;  Pak  & 
Sheng 2003; Boehmer et al. 2004), and the altered expression of a number of 
proteasome genes has been observed in a variety of plasticity models (El-Khodor 
et al. 2001; Becker et al. 2003; Blalock et al. 2003; Cirelli et al. 2004).  In addition, 
NMDAR activation leads to proteasome sequestration to synaptic spines (Bingol & 
Schuman 2004) however, APV does not block HFS-induced protein degradation 
(Karpova et al. 2006).  HFS-induced phosphorylation of the transcription factor 
CREB (Leutgeb et al. 2005) depends on a functional proteasome system (Ehlers 
2003), and therefore the activity of postsynaptic glutamate receptors may regulate 
the  expression  of  proteasome  subunits  via  zif268  and  possibly  other  inducible 
transcription factors. 
In light of these findings, the activation of zif268, which decreases ubiquilin levels 
and therefore potentially increases proteasome activity, seems contradictory.  It is 
possible that a zif268 mediated decrease in ubiquilin and in proteasome subunits 
may not increase GABAAR degradation, but the GABAARs are spatially restricted 
from returning to the membrane or that the downregulation of gephyrin means 
internalised  GABAARs  cannot  be  re-localised  and  anchored  to  the  synapse.  Donna M McDade, 2007    Chapter 8, 217 
However,  our  immunocytochemistry  results  display  a  decrease  in  GABAAR 
immunoreactivity in response to NMDA treatment.  An explanation therefore could 
be that GABAAR subunits interact with the AP2 complex (Marsh & McMahon 1999; 
Kittler et al. 2000),  which in turn interacts  with Eps-15 (Benmerah et al. 1995; 
Morgan  et  al.  2003).  Eps-15  also  interacts  with  polyubiquitinated  receptors, 
possibly  to  sort  them  into  endocytic  compartments  (Polo  et  al.  2002;  Riezman 
2002;  Bache  et  al.  2003;  de  Melker  et  al.  2004).    Ubiquilin  binds  to  GABAAR 
(Bedford et al. 2001) and can interact with Eps-15 (Regan-Klapisz et al. 2005).  
During  periods  of  proteasome  downregulation,  ubiquilin  forms  cytoplasmic 
aggresomes that are highly enriched in polyubiquitinated proteins.  The GABAAR, 
through its interaction with Eps-15, ubiquilin, and its possible ubiquitination as a 
signal for endocytosis, could be recruited to cytoplasmic aggregates after a zif268-
induced  downregulation  of  the  proteasome.    Antibodies  would  encounter 
difficulties  in  trying  to  penetrate  the  aggresome  and  could  therefore  give  the 
impression of reduced proteins levels of GABAAR and could explain our western 
blotting results for ubiquilin.   
A  simpler  explanation  could  be  that  the  proteasome  is  indeed  upregulated  at 
inhibitory synapses in response to LTP, an effect that would not be identified using 
the techniques of James et al. (2005), which looked at global proteasome activity.  
Excitatory  synapses  along  the  dendrites  of  cultured  hippocampal  neurones 
outnumber  inhibitory  synapses  by  4:1  (Liu  et  al.  2004).    An  overriding 
downregulation at excitatory synapses would therefore overshadow any specific 
effect at inhibitory synapses when monitored at the cellular level. 
The  role  of  the  proteasome  within  LTP  therefore  remains  controversial  and  is 
probably due to the precise balance of proteins required throughout the cell to 
provide alterations in neural network properties. 
8.1.7  Inhibitory transmission and Long Term Potentiation 
Normal brain function relies on tightly controlled synaptic inhibition to influence 
neuronal  excitability.    GABA  ensures  that  neurones  avoid  overexcitation, 
preventing the development of pathological states of network activity; experimental 
animal models of temporal lobe epilepsy often involve impaired dendritic inhibition 
(Cossart et al. 2001).  Clinically, GABAARs deal with disorders of excitability and Donna M McDade, 2007    Chapter 8, 218 
are  the  site  of  action  for  benzodiazepines,  barbiturates  and  neurosteroids  to 
combat such conditions as stress, anxiety, epilepsy and pain (McKernan & Whiting 
1996; Moss & Smart 2001). 
Regulating  the  number  of  receptors  at  the  postsynaptic  membrane  allows 
alterations  in  the  efficacy  of  inhibitory  synaptic  transmission.    A  decrease  in 
inhibition may  be  required  for  the  potentiated  activation  of  excitatory  synapses 
allowing the encoding of new information.  To this end, it has been reported that 
interneurones display a reduced level of activity during novel spatial experiences 
as  determined  by  electrophysiology  (Wilson  &  McNaughton  1993;  Fyhn  et  al. 
2002).  Enhancing  network  activity  in  hippocampal  slices  leads  to  increased 
internalisation  of  GABAARs  (Blair  et  al.  2004).    Decreasing  GABAAR  at  the 
synapse would increase the probability of neuronal firing as the cell would be more 
receptive to repeated action potentials due to a decrease in the voltage threshold 
for firing. This may play some part in the strengthening of synapses that occurs 
during  LTP  implying  that  changes  in  excitability  could  be  secondary  to,  or 
facilitated by, changes in inhibitory synaptic transmission.   
Synaptic scaling, a form of homeostatic plasticity, has been described for both 
AMPAR  and  NMDAR  (Watt  et  al.  2000).    This  phenomenon  affects  all  the 
synapses  of  a  cell,  proceeds  over  long  periods  of  time  and  scales  synapses 
proportionally to their synaptic strength (Turrigiano et al. 1998). As all neurones in 
the CNS appear to be responsive to GABA (Peran et al. 2001), this could imply 
that changes in synaptic efficacy at excitatory synapses would result in a cellular 
decrease in GABAARs. 
The site of action for benzodiazepines, a treatment for anxiety and stress, is the   
subunit  of  the  GABAAR,  suggesting  that  GABAA  receptor–mediated  inhibitory 
currents  are  most  likely  involved  in  fear  and  associated  behaviours.    The 
frontotemporal  amygdala  has  been  implicated  in  fear  memory  acquisition 
(Fanselow & Gale 2003), and contains a powerful GABA inhibitory circuit within 
the  basolateral  amygdala  complex  (Takagi  &  Yamamoto  1981;  Washburn  & 
Moises 1992a, b).  The formation of new fear memories displays a requirement for 
reduced GABA inhibitory neurotransmission (Rodriguez et al. 2005).  Zif268 has 
also  been  implicated  in  fear  conditioning  and  behavioural  learning  (Malkani  & 
Rosen 2000; Hall et al. 2000). Donna M McDade, 2007    Chapter 8, 219 
There  is  evidence  to  suggest  that  synaptic  GABAARs  may  be  downregulated 
during  forms  of  plasticity  involving  zif268  induction.    Hippocampal  LTP  is 
associated with the suppression of GABAergic synaptic events (Lu et al. 2000).  
Similarly BDNF treatment or epileptogenesis cause a downregulation of synaptic 
GABAARs (Brunig et al. 2001; Blair et al. 2004).  Activity dependent modulation of 
GABAergic transmission may therefore contribute to long-lasting plasticity.  The 
potential suppression by zif268 by gephyrin and/or ubiquilin expression provides a 
molecular substrate for this phenomenon. 
8.1.8  Summary 
In  summary,  neuronal  plasticity  can  stimulate  the  activation  of  the  inducible 
transcription  factor  zif268.    Zif268  in  turn  suppresses  the  transcription  of  the 
neuronal  proteins  gephyrin,  ubiquilin  and  also  the  novel  gene  urma.    This 
downregulation  is  accompanied  by  a  downregulation  of  synaptically  located 
GABAARs.    Postsynaptic  receptor  accumulation  is  likely  to  depend  on  several 
highly  regulated  processes,  such  as  receptor  synthesis,  intracellular  trafficking, 
membrane  insertion,  lateral  diffusion,  internalisation  and  degradation.    Each 
neurone in the mammalian brain receives, on average, 10
3-10
4 synaptic inputs 
from  other  nerve  cells.    In  cultured  hippocampal  neurones,  neural  output  is 
determined by the dynamic balance of active excitatory and inhibitory synapses 
(Liu 2004).  The neurone therefore must act as a whole entity, with the nucleus 
directing  overall  protein  movement;  subsequently,  orchestrated  local  protein 
synthesis would be briefly outsourced to the dendrites during periods of intense 
activity.  Thus, zif268 may play a role in inhibitory synapse receptor clustering 
during synaptic plasticity. Donna M McDade, 2007    Chapter 8, 220 
8.2  Future Studies 
  Double  stained  immunocytochemistry  of  gephyrin  with  GABAARs  or  with 
synapse  specific  proteins  VIAAT,  synapsin  or  the  GABA  synthesising 
enzyme GAD-65 would confirm a relationship between the gephyrin and 
GABAARs after zif268 activation. 
  The  elucidation  of  endocytosis  at  the  membrane  driven  by  direct  LTP 
induced  phosphorylation  of  GABAAR  or  lack  of  gephyrin  could  prove 
interesting in ascertaining zif268 actions at inhibitory synapses.  Therefore, 
co-immunofluorescence  with  endogenous,  constitutively  recycling, 
transferrin receptors in permeabilised cells could be informative. 
  In order to determine the full sequence of urma, rapid amplification of cDNA 
ends (RACE) or a primer extension reaction could be performed. 
  A yeast 2 hybrid assay would determine the binding partners of urma and 
enable further characterisation of the function of the urma protein. 
  To characterise urma further, the gene could be cloned into a FLAG-tagged 
vector  (or  equivalent),  transfected  into  neurones,  or  a  cell  line  and 
immunocytochemistry performed to determine the subcellular localisation, 
as well as any physical effects.  In addition, western blotting could also be 
performed to find the molecular mass of the protein and in situ hybridisation 
would determine the neuro-anatomical expression pattern. 
  Transient transfection of zif268 into cultured neurones would elucidate the 
specific effect of this transcription factor on gephyrin, ubiquilin and a tagged 
urma by immunocytochemistry.   
  Culturing cortical tissue from zif268 knockout mice could verify the effect of 
zif268  on  gephyrin,  ubiquilin  and  urma  protein  levels  as  determined  by 
immunocytochemistry. Donna M McDade, 2007    Chapter 8, 221 
  CAT  reporter  assays  could  be  performed  for  ubiquilin  and  urma  to 
investigate promoter regulation by zif268.  In addition, an interaction with, 
and  direct  binding  of,  zif268  with  the  promoters  of  the  genes  encoding 
gephyrin, ubiquilin and urma could be determined by EMSA.   
  A behavioural paradigm of synaptic plasticity, in which gephyrin, ubiquilin 
and urma mRNA levels are monitored after zif268 induction in the striatum, 
could be examined by in situ hybridisation. 
  Hippocampal  tissue,  where  LTP  has  been  induced  3  hours  previously, 
could be scrutinized relative to control tissue for alterations in mRNA levels 
of gephyrin, ubiquilin and urma. 
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The  details of  the  results for  GeneChips
®  B  & C in  the microarray  experiment 
(James et al. 2005), whereby PC-12 cells were transiently transfected with either a 
full-length zif268 or a truncated control, as described in Chapter 7, are tabulated 
on the following pages. 
In each table, the individual ESTs are listed with the fold change reported by the 
microarray experiment (Fold Change) and length of the EST (Length (bp)).  In 
addition,  the  results  from  the  BLAST  analysis  (www.ensembl.org)  are  detailed.  
The percentage of similarity to that area of the genome (BLAST Similarity (%)), 
how many base pairs are involved in this percentage (Length Similarity) and the 
precise location of the genomic area are all presented (Chromosome Location).  
Then follows a database reference for any known gene within the vicinity of the 
BLAST hit (Database Reference), the description that accompanies this reference 
(Description)  and  whether  a  known  gene  is  annotated  within  the  area  (Known 
Gene?).  
 
Table Key: 
mm   Mus musculus 
hs  Homo sapiens 
rn  Rattus norvegicus  
B  EST Name  Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference  Description  Known Gene? 
1  AA851237  5.697356  494  97.65  383  4q42        rn: predicted (EST) (genscan 
exon) 
2  AA850583  6.775527  391  99.74  391  12q16  hs: Q15646  hs&mm: 2' 5' oligoadenylate synthetase  rn: predicted (ensembl, genscan, 
NCBI) 
                  mm: NM_145209  like protein (P59OASL) (Thyroid R   hs: OASL or TRIP14     
                    interacting protein 14) (TRIP14)  mm: OASL1 or OASL2 
3  AA899109  4.858614  430  100  413  10q32.3  hs: Q98HCL8  NCBI: similar to chromosome 17 open   rn: predicted (ensembl) (genscan, 
NCBI exons) 
                    reading frame 27  hs: Q98HCL8 
                       mm: predicted 
4  AA849827  3.290448  446  96.71  243  9q22  rn: NM_032612  rn: Signal transducer and   rn: NM_032612 
                  hs: P42224  activator of transcription 1  hs: STAT1 
                  mm: P42225     mm: Stat1 
                       *** 4kbp away from BLAST 
5  AA998964  4.615527  511  99.8  496  4q13  hs: NM_0152703  no description  rn: predicted (ensembl, genscan) 
                     mm: AA175286     hs: NM_0152703 (BRH) 
                           mm: AA175286 (RHS) 
6  AI014130  6.250391  431  100  431  6q16  hs: Q96AL8  mm: Thymidylate Kinase family LPS   rn: predicted (ensembl, EST, 
genscan, NCBI) 
                  mm: NM_020557  inducible member; thymidylate kinase  hs: Q96AL8 
                    homologue  mm: Tyki 
7  AI030615  4.981072  278  81.25  160  11q12  rn: P18589  rn: interferon-induced GTP-binding   rn: MX2_RAT 
                  hs: P20591  protein MX2  hs: MX1 (BRH) 
                  mm: NM_13606     mm: MX2 
8  AA945915  2.41762  671  100  434  11q22  hs: NM_138287  hs: Rhysin 2  rn: predicted (ensembl, EST, 
genscan) 
                       hs: NM_138287 
                       mm: predicted 
                             
                    
B  EST Name  Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference  Description  Known Gene? 
9  AA943147  5.983724  437  99.31  437  4q24  hs: NM_017912   mm: HECT domain and RLD3  rn: predicted (ensembl, EST, 
genscan, NCBI) 
                  mm: NM_028075     hs: NM_017912 (RHS) 
                       mm: Herc3 (RHS) 
10  AA965186  6.084946  525  100  340  1q37  hs: Q92985  hs&mm: Interferon regulatory protein 7  rn: predicted (ensembl, genscan, 
NCBI) 
                  mm: P704434     hs: IRF7    
                        mm: Irf7 
                  opposite direction:  rn: CTD-binding SR-like protein rA9  rn: NM_139093 
                  rn: NM_139093     hs: Q9P1Y6 
                     hs: Q9P1Y6     mm: predicted 
11  AA999171  2.617801  403  99.74  386  9q22     rn: Signal transducer and   rn: NM_032612 
                  hs: P42224  activator of transcription 1  hs: STAT1 
                  mm: P42225     mm: Stat1 
                       *** 4kbp away from BLAST 
12  AA924764  2.489172  520  98.82  169  8q24        ***closest prediction 6kbp away 
from BLAST 
                           ***no other EST's in vicinity 
13  AA997288  2.962963  417  99.74  388  4q22  hs: NM_02275  NCBI: similar to 9930021O16 protein  rn: predicted (ensembl, EST, 
genscan, NCBI) 
                  mm: NM_172893     hs: NM_02275 
                       mm: NM_172893 
14  AA955246  6.131208  249  94.83  232  10q21  rn: NM_172019   rn: Interferon gamma inducible   rn: NM_172019  
                  mm: NM_008330  protein 1  mm: Ifi47 
15  AA997077  2.701461  367  100  350  8q32  mm: NM_011637  mm: three prime repair exonuclease 1;    rn: predicted (ensembl, EST, 
genscan, NCBI) 
                     trophoblast expressed 1; three prime   mm: Trex1 
                     exonuclease 1    
                          
                    
B  EST Name  Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference  Description  Known Gene? 
16  AI012235  1.991437  636  98.58  636  14p22  hs: O14625  hs&mm: Small inducible cytokine b11   rn: predicted (ensembl, EST, 
NCBI) (genscan exon)  
                 mm:Q9JHH5  precursor (cxcl11) (interferon-inducible   hs: CXCL11     
                   t-cell alpha chemoattractant) (i-tac)   mm: Cxcl11 
                   (interferon-gamma-inducible protein-9)     
                   (ip-9) (h174) (beta-r1).     
17  AA946088  1.675014  493  97.57  493  1q55  rn: NM_022260   rn: Caspase-7  rn: NM_022260  
                  hs: P55210     hs: CASP7 
                  mm: P97864     mm: Casp7 
18  AA946160  1.572179  430  93.49  430  20p12  hs: Q12899  hs&mm: Zinc finger protein 173   rn: predicted (ensembl, genscan, 
NCBI) 
                  mm: Q9WUH5  (tripartite motif-containing protein 26)   hs: TRIM26 or ZNF173 
                    (acid finger protein) (AFP)  mm: Trim26 or RNF9 or HERF1 
19  AI008397  1.774528  485  75.49  102  18q12.2        rn: predicted (genscan exon) 
                             
20  AA998576  2.128611  457  99.78  457  4q22       removed from further distribution  
                      at the submitters request 
21  AA851040  1.602795  494  92.42  396  20p12        *** closest exon 5kbp away from 
BLAST 
                      *** EST clusters 
22  AA945683  2.032149  411  95.39  412  1q54  hs: NM_031212  hs&mm: Putative mitochondrial solute   rn: predicted (ensembl, EST, 
genscan, NCBI) 
                 mm: NM_145156  carrier; hypothetical protein NPD016;  hs: NM_031212 
                   putative mitochondrial solute carrier  mm: Mrs3/4-pending 
23  AI045789  3.264773  388  100  376  7q34  hs: NM_032789  NCBI: similar to Plec1 protein  rn: predicted (ensembl, EST, 
genscan, NCBI) 
                 mm: Q8R133     hs: NM_032789 
                       mm: Q8R133 
                   
                          
B  EST Name  Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference  Description  Known Gene? 
24  AI029217  2.097755  389  97.3  370  12q16  hs: Q9Y6K5  hs&mm: 2'-5'-oligoadenylate synthetase   rn: OAS1_RAT 
                  mm: P11928  3 (ec 2.7.7.-) ((2-5')oligo(a) synthetase 3) 
(2-5a synthetase 3)   hs: OAS3 (BRH) 
                     (p100 OAS) (p100oas)  mm: Oas1g (BRH) 
25  AI009156  1.931285  493  98.51  403  3q42  hs: Q9Y508  hs&mm: zinc finger protein 313  rn: predicted (ensembl, EST, 
genscan, NCBI) 
                 mm: Q9ET26     hs: ZNF313 
                      mm: Zfp313 
26  AA955213  1.867483  496  99.79  471  18q12.1  mm: Q8R5D8  NCBI: similar to interferon-inducible   rn: predicted (ensembl, EST, 
genscan, NCBI) 
                   GTPase  mm: Q8R5D8 (BRH) 
27  AI045075  2.888838  395  92.1  367  1q31  hs: NM_002201  hs&mm: interferon stimulated gene  rn: predicted (ensembl, EST, 
genscan, NCBI) 
                 mm: NM_020583  (20kDa)  hs: ISG20     
                      mm: Isg20 
28  AI070325  2.959543  280  98.09  262  7q34  hs: O95236  hs: apoliprotein L3 (apolipoprotein L-III)   rn: predicted (ensembl, EST, 
genscan) 
                  mm: Q8VDU3  (APOL-III) (TNF-inducible protein CG12-
1)  hs: APOL3 (RHS) 
                     (CG12_1)  mm: Q8VDU3 
29  AI070313  2.453626  543  87.5  384  9q35  hs: Q9HB58  hs: nuclear body protein (speckled 110  rn: predicted (ensembl, EST, 
NCBI) 
                   kDa) (transcriptional co-activator  hs: SP110     
                   SP110) (interferon induced protein   mm: predicted 
                        41/75)    
30  AI012552  1.743102  565  98.22  561  1q32  hs: NM_033034  hs&mm: tripartite motif protein trim5  rn: predicted (ensembl, genscan, 
NCBI) 
                 mm: P15533  isoform alpha; tripartite motif protein   hs: TRIM5 
                    trim5; tripartite motif protein 5  mm: TRIM30 
                    (down regulatory protein of interleukin     
                        2 receptor)     
B  EST Name  Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference  Description  Known Gene? 
31  AA848811  1.542258  367  92.16  255  3q35  hs: P01884  hs&mm: Beta-2-microglobulin precursor  rn: B2MG_RAT 
                 mm: P01887     hs: BM2 
                      mm: Bm2 
32  AA945204  1.845121  587  85.56  374  6q32  rn: NM_130743  rn: Interferon, alpha-inducible protein  rn: NM_130743  
                 hs: Q96BMO  27-like  hs: FAM14A or TLH29 (RHS)  
                 hs: Q9H2X8     hs: FAM14B (RHS) 
                       mm: D12Ertd647e 
33  AI044879  1.970482  410  99.72  355  9q33  hs: NM_005444  hs&mm: RCD1 required for cell   rn: predicted (ensembl, EST, 
genscan, NCBI) 
                 mm: NM_021383  differentiaton 1 homolog; protein involved hs: RQCD1    
                   in sexual development   mm: Rqcd1 (or FL10) 
34  AI044792  1.807697  429  76.46  429  11q21  rn: NM_019195  rn: integrin-associated protein  rn: NM_019195 
                  hs: Q08722    hs: CD47     
                  mm: NM_010581    mm: Cd47  
35  AA955249  1.488516  298  100  281  5q22  hs: Q14142  hs: Tripartite motif protein TRIM14  rn: predicted (ensembl, genscan, 
NCBI) 
                      hs: TRIM14 
                      mm: 5830400N10Rik 
                           *** ensembl 4kbp away from 
BLAST 
36  AI011981  1.443584  476  99.58  239  15p13  rn: Q63798  lines up with exon of  rn: PSE2_RAT 
                  hs: Q9UL46  Proteosome activator complex  hs: PSME2 
                    mm: P97372  subunit 2  mm: PSE2_MOUSE 
           99.52  208  17p14  rn: NM_017257     RGD: Psme2 
37  AI059254  1.860603  436  89.86  148  3q42  hs: Q9Y508  hs&mm: Zinc finger protein 313  rn: predicted (ensembl, EST, 
genscan, NCBI) 
                  mm: Q9ET26     hs: ZNF313 
                       mm: Zfp313 
                             
                    
B  EST Name  Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference  Description  Known Gene? 
38  AA997015  1.732952  476  99.13  460  1q43        rn: predicted (EST, genscan) 
39  AA849015  1.491958  623  99.7  334  10q11  rn: Q9QX78  hs&mm: suppressor of cytokine   rn: SOC1_RAT 
                  hs: O15524  signalling(Jak binding protein) (STAT   hs: SOCS1 or SSI1 or TIP3 
                  mm: O35716  induced STAT inhibitor 1) (tec-  mm: Socs1 
                        interacting protein 3)     
40  AA944197  1.272005  537  98.08  260  10q24  rn: NM_023092  rn: unconventional myosin MYR2 1   rn: NM_023092 
                  hs: O00159  heavy chain  hs: MYO1C 
                  mm: Q9WT17     mm: Myo1c 
41  AA850552  1.242266  496  100  496  4q24        genscan prediction (approx. 3kbp 
upstream) 
42  AA963884  1.517473  504  99.66  296  3q42        genscan prediction  
                           (& EST in opposite direction) 
43  AI010116  1.394991  528  98.3  528  8q12  hs: Q9NVC6  hs&mm: co-factor required for SP1   rn: predicted (ensembl, EST, 
genscan, NCBI) 
                  mm: NM_144933  transcriptional activation subunit 6  hs: CRSP6 or DRIP80 or 
                    (transcriptional co-activator CRSP77)  TRAP80 or ARC77 
                    (vitamin D3 receptor-interacting protein   mm: Crsp6 
                    complex 80kDa component DRIP80)    
                    (thyroid hormone receptor-assoc.protein    
                    complex 80kDa component TRAP80)    
44  AA851265  1.736533  230  76.21  227  20p12  rn: P15978  rn: Class 1 histocompatibility antigen   rn: HA11_RAT 
                  hs: P30460  non-RT1.A Alpha-1 chain precursor  hs: HLA-B or HLAB 
45  AI043759  1.964945  429  93.45  412  8q13  hs: NM_018381  no description  rn: predicted (ensembl) 
                  mm: NM_175687     hs: NM_018381 
                           mm: NM_175687 
                  opposite direction:       
                  hs: NM_031917  hs&mm: angiopoietin-related protein 5  rn: predicted (ensembl, EST, 
genscan, NCBI) 
                  mm: NM_145154     hs: ANGPTL6 
                           mm: 6330404E11Rik  
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46  AA850907  1.372024  560  95.72  561  1p12    no description  rn: predicted (ensembl, genscan 
exon) 
47  AI060296  1.213283  345  92.75  207  3q21  hs: NM_172070  hs: similar to F10G7.10.P (KIAA2024)  rn: predicted (ensembl, EST, 
genscan, NCBI 
                       exons) 
                       hs: NM_172070 
                           mm: predicted 
48  AI012340  1.930762  512  97.57  288  20p12  rn: P28077  rn: proteasome subunit beta type 9   rn: PSB9_RAT 
                  hs: P28065  precursor (proteasome chain 7)   hs: PSMB9 
                  mm: P28076  (macropain chain 7) (multicatalytic   mm: Psmb9 
                    endopeptidase complex chain 7) (ring     
                        12 protein) (low mol. mass protein 2)    
49  AI044795  2.022081  359  99.65  286  3q43  rn: Q9QXY4  rn: opioid growth factor receptor (OGFR)  rn: OGFR_RAT 
                  hs: Q9NZT2  (zeta type opioid receptor)  hs: OGFR 
                  mm: Q99PG2     mm: Ogfr 
50  AA851169  1.450284  403  80.49  287  15p13  rn: Q63798  Proteosome activator complex  rn: PSE2_RAT 
                  hs: Q9UL46  subunit 2 (proteasome activator 28-beta  hs: PSME2 
                  mm: P97372  subunit) (PA28BETA) (PA28B) (activator  mm: PSE2_MOUSE 
                    of multicatalytic protease subunit 2)    
                    (11S regulator complex beta subunit)     
                        (reg-beta)    
51  AI058400  1.292373  351  99.05  316  2q45  hs: O14772  hs: Fucose-1-phosphate guanalyl   rn: predicted (ensembl, EST, 
genscan, NCBI) 
                    tansferase (GDP-L-
Fucosepyrophosphor-  hs: FPGT or GFPP 
                    ylase) (GDP-L-Fucosediphosphorylase)    
                         
52  AA850608  1.464707  556  100  277  6q16        no predictions within 2kbp 
                           *** Ensembl & genscan approx 
3kbp away  
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53  AA851017  1.244911  423  99.21  253  2q14     NCBI:similar to Molybdenum cofactor   rn: predicted (EST, genscan, 
NCBI) 
                    synthesis protein 2 large subunit     
                    (Molybdopterin synthase large subunit)     
                    (MPT synthase large subunit) (MOCS2B)     
                        (MOCO1-B    
54  AA900198  1.350785  400  100  383  1q21        rn: predicted (EST & genscan) 
55  AI059449  1.450641  515  92.4  500  1q34  hs: NM_002645  hs&mm: phosphoinositide-3-kinase,   rn: predicted (ensembl, EST, 
genscan, NCBI) 
                  mm: O11083  class 2, alpha polypeptide; C2-containing hs: PIK3C2A 
                    phosphatidylinositol kinase   mm: Pik3c2a 
56  AI070270  1.392079  400  99.74  381  7q34  hs: Q14106  hs: TOB2 protein (transducer of ERBB-2  rn: predicted (ensembl, EST, 
genscan, NCBI)  
                  mm: Q9JM55  2)  hs: TOB2 or TOB4 or KIAA1663 
                       mm: Tob2 
57  AA848487  1.516116  539  96.1  539  17q12.1     NCBI : similar to proteasome  rn: predicted (ensembl, genscan, 
NCBI) 
                    activator complex unit 1    
                   
Proteasome activator 28-alpha subunit) 
(PA28alpha) (PA28a) (Activator of 
multicatalytic protease subunit 1) (11S 
regulator complex alpha subunit) (REG-
alpha) 
  
58  AA850501  1.569242  620  92.59  486  5q22  rn: NM_138871  rn: Tudor repeat associator with pctaire 2 rn: NM_138871 
                  hs: NM_014290     hs: NM_014290 
                  mm: AI447170     mm: AI447170 
59  AA956379  1.311905  456  99.76  421  15p14  hs: NM_153331  NCBI: similar to hypothetical protein   rn: predicted (ensembl, NCBI, 
genscan) 
                    MGC27385  hs: NM_153331 
                       mm: predicted  
B  EST Name  Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference  Description  Known Gene? 
60  AA849560  1.633453  442  99.1  442  3p12  rn: NM_153303  rn: dystonia 1, torsin (autosomal   rn: NM_153303 
                  hs: O14657  dominant; torsin A)  hs: TOR1B or DQ1 or FKSG18 
                  mm: Q9ER41  hs&mm: Torsin B precursor (torsin family mm: Tor1b 
                        1 member B)    
                  opposite direction       
                  hs: O14656  hs&mm: Torsin A precursor (torsin family rn: predicted (ensembl, EST, 
genscan, NCBI) 
                  mm: Q9ER39  1 member A) dystonia 1 protein  hs: DYT1 or TOR1A or DQ2 
                           mm: Dyt1 
61  AA998506  2.112735  419  98.01  402  18q12.1  mm: Q8R5D8  NCBI: similar to interferon-inducible   rn: predicted (ensembl, EST, 
genscan, NCBI) 
                    GTPase  mm: Q8R5D8 (BRH also several 
RHS) 
62  AA850909  1.415247  641  96.72  641  1q21  hs: Q92692  hs&mm: poliovirus receptor related  rn: predicted (ensembl, EST, 
genscan, NCBI) 
                  mm: P32507  protein 2 precursor (herpes virus entry  hs: PVRL2 (BRH) or PRR2 or 
HVEB 
                    mediator B) (HVEB) (nectin 2) (CD112  mm: Pvrl2 
                        antigen)    
63  AA942995  1.338276  461  99.69  320  5q36  hs: NM_018715  hs: RCC1-like (TD-60)  rn: predicted (ensembl, EST, 
genscan, NCBI) 
                    NCBI: similar to CG9135-PA  hs: NM_018715 
                       mm: predicted 
64  AA800994  1.455138  489  99.8  489  2q41  hs: NM_021190  hs&mm: polypyrimidine tract binding   rn: predicted (ensembl, EST, 
NCBI) 
                  mm: NM_019550  protein 2; neural polypyrimidine tract  hs: PTBP2 
                    binding protein; ptb-like protein  mm: NM_019550 
65  AA943011  1.277416  595  99.13  461  8q22  hs: Q9H270  hs&mm: vacuolar protein sorting 11  rn: predicted (ensembl, EST, 
genscan, NCBI) 
                  mm: Q91W86  (HVSP11) (APP3476)  hs: VPS11 
                       mm: Vps11  
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66  AI059844  1.856010  424  99.43  351  12q16  rn: Q99MM4  rn: Traf-interacting zinc finger protein  rn: Q99MM4 
                  hs: NM_006700  fln29 (fragment)  hs: NM_006700 
                  mm: NM_172275  hs&mm: FLN29 gene product  mm: NM_172275 
67  AA849028  1.410556  657  97.87  957  6q24  hs: P25788  hs&mm: proteasome subunit alpha type  rn: predicted (ensembl, EST, 
genscan, NCBI) 
                  mm: O70435  3 (proteasome component C8)  hs: PSMA3 or PSC8 
                    (macropain subunit C8) (multicatalytic  mm: Psma3 
                        endopeptidase complex subunit C8)  ***large EST Cluster  
68  AA955175  1.260318  512  97.58  495  10q26  hs: P52429  hs&mm: diacylglycerol kinase, epsilon  rn: predicted (ensembl, genscan) 
                  mm: Q9R1C6  (diglyceride kinase) (DGK-epsilon) (DAG  hs: DGKE or DAGK5 
                    kinase epsilon)   mm: Dgke 
                           *** 4kbp away from BLAST 
69  AI044222  1.397194  479  99.34  151  14p22  rn: NM_145672  rn: small inducible cytokine B9  rn: NM_145672 
                  hs: Q07325  hs&mm: small inducible cytokine B9  hs: CXCL9 or SCYB9 or MIG 
                  mm: P18340  precursor (gamma interferon induced   mm: Cxc19 
                        monokine) (MIG)    
70  AA900506  1.270857  527  99.17  361  3q36  hs: NM_022662  hs: anaphase-promoting complex 1   rn: predicted (ensembl, EST, 
genscan, NCBI) 
                  mm: P53995  (meiotic checkpoint regulator) (ANAPC1) hs: NM_022662 
                    mm: protein TSG24 (meiotic regulator)  mm: Mcpr 
71  AI070047  1.448225  479  99.57  462  5q36  hs: Q9Y692  hs&mm: glucocorticoid modulatory  rn: predicted (ensembl, genscan) 
                  mm: Q9JL60  element binding protein 1 (GMEB-1)  hs: GMEB1 
                    (parvovirus initiation factor P96) (DNA  mm: Gmeb1 
                        binding protein P96PIF)    
72  AI030755  1.503307  523  99.8  492  17p14     NCBI: similar to 1110064L07Rik protein  rn: predicted (ensembl, EST, 
genscan, NCBI) 
                           mm: predicted  
Table i: Table containing all the information gleaned from www.ensembl.org pertaining to the ESTs significantly affected by zif268 on GeneChip
® B of the 
microarray experiment performed by James et al. (2005).  Please see Chapter 7.  
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1  AI112362  5.812263  440  99.52  417  4q13        rn: predicted (genscan) 
2  AI111492  8.059316  414  92.95  397  6q16  hs: Q96AL8  mm: Thymidylate kinase   rn: predicted (ensembl, EST, 
genscan, NCBI) 
                 mm: NM_020557  family LPS-inducible member;  hs: Q96AL8 
                   thymidylate kinase homologue  mm: Tyki 
3  AI180075  3.419621  423  98.58  423  7q11     NCBI: similar to signal transducer  rn: predicted (EST, genscan, NCBI) 
                   & activator of transcription 2    
4  AI073001  4.377708  463  99.22  383  10q24  hs: NM_153230  NCBI: similar to hypothetical  rn: predicted (ensembl, NCBI exon) 
                   protein MGC35179  hs: NM_153230 
                      mm: predicted 
5  AA819679  2.725092  554  99.44  537  11q22  hs: NM_031458  B aggressive lymphoma gene (BAL)  rn: predicted (ensembl, genscan 
exon, NCBI) 
                      hs: NM_031458 
                      mm: BC003281 
6  AI169624  4.349338  602  84.72  458  12q16  rn: Q05961  rn: 2'-5' oligoadenylate synthetase 1  rn: OAS1_RAT 
                 hs: Q9Y6K5     hs: OAS3   
                 mm: P11928      mm: Oas1g  
7  AI176721  2.242152  599  100  599  1q32  hs: Q8NH66  hs: seven transmembrane helix  rn: predicted (ensembl, genscan) 
                 mm: NM_147079   receptor  hs: Q8NH66   
                   mm: olfactory receptor Mor31-4  mm: NM_147079  
8  AI137038  2.667022  495  98.76  483  13q21  hs: NM_022371  hs&mm: torsin family 3, member A;  rn: predicted (ensembl, genscan, 
NCBI) 
                 mm: NM_023141  ATP-dependent interferon response  hs: TOR_3A 
                   protein 1; ATP-dependent interferon  mm: Tor3a 
                   Responsive, NCBI: similar to ADIR1  EST cluster close with no predictions 
9  AA799298  1.964366  593  99.42  515  1q52  hs: P09913  hs&mm: interferon induced protein  rn: predicted (ensembl, genscan, 
NCBI) 
                 mm: Q64112  with tetratricopeptide repeats 2   hs: IFIT2 
                   (glucocorticoid-attenuated response  mm: Ifit2 
                        gene 39 protein GARG-39)     
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10  AI236003  2.399980  529  87.95  332  14q22  hs: NM_033109  hs&mm: 3'-5' RNA exonuclease;   rn: predicted (ensembl, EST, NCBI) 
                 mm: NM_027869  polynucleotide phosphorylase-like  hs: PNPT1 
                   (polyribonucleotide 
nucleotidyltransferase 1)  mm: 1200003F12Rik 
11  AA858505  2.177984  558  98.7  539  7q34  hs: O95236  hs: apoliprotein L3 (APOL-III)  rn: predicted (ensembl, EST, 
genscan, NCBI) 
                    (TNF-inducible protein CG12-1)  hs: APOL3 
                      mm: 9130022K13Rik 
12  AI102236  2.117253  518  98.84  518  3q42  hs: Q9Y3Z3  hs&mm: sam domain & HD domain-  rn: predicted (ensembl) 
                 mm: Q60710  containing protein 1 (dendritic cell-
derived   hs: SAMHD1 or MOP5 
                   IFNG-induced protein DCIP) (monocyte   mm: Samhd1 
                   protein 5 MOP_5) (interferon-gamma    
                     inducible protein MGII)    
                   in opposite direction    
                   NCBI: similar to dJ132F21.2 - contains a  rn: predicted (EST, genscan, NCBI) 
                   novel protein similar to the L82E from     
                        drosophila    
13  AA819034  2.945161  458  100  209  6q32  hs: Q9H2X8  hs: protein fam14a precursor (TLH29 
protein) 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
                 mm: NM_145449  (pif127-like protein)  hs: FAM14A (BRH) or TLH29 
                      mm: NM_145449 
14  AI169676  1.785363  583  100  572  7q13  hs: Q9NV91  NCBI: similar to CGi3957-PA  rn: predicted (EST, genscan, NCBI) 
                      hs: Q9NV91 
                      mm: predicted  
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15  AI178800  1.937421  568  100  559  3q24  hs: O14933  hs&mm: ubiquitin-conjugating enzyme 
E2- 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
                   mm: NM_19949  18kDa UBCH8 (ubiquitin-protein ligase)  hs: UBE2L6 or UBCH8 
                     (ubiquitin carrier protein) (retinoic acid   mm: Ubce8 
                     induced gene B protein) (RIG-B)    
                       riken cDNA 2810489121    
                      opposite direction    
                     NCBI: similar to RIKEN cDNA 
1110030K22 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
                        hs: predicted 
                           mm: 1110030K22Rik 
16  AI105268  2.842362  514  100  367  9q22  rn: NM_032612  rn: signal transducer and activator of   rn: NM_032612 
                 hs: P42224  transcription 1   hs: STAT1 
                 mm: P42225     mm: Stat1 
                           *** 4kbp away from BLAST 
17  AI071868  1.642953  271  100  254  1q32  hs: P19474  hs&mm: 52kDa RO protein (SJOGREN    rn: predicted (ensembl, genscan, 
NCBI) 
                 mm: Q62191  syndrome type A antigen) (RO(SS-A))   hs: SSA1 (BRH) 
                   (52kDa ribonucleoprotein autoantigen   mm: Trim 21 
                        ro/ss-A) (SS-A) (tripartite motif protein 2)    
18  AI177755  1.818049  590  99.83  590  6q16  rn: NM_177928  rn: pre-B-cell colony-enhancing factor  rn: NM_177928 
                 hs: P43490     hs: PBEF_Human 
                 mm: NM_021524     mm: NM_021524 
19  AA818937  3.017592  394  99.47  377  20p12  rn: P15978  rn: Class 1 histocompatibility antigen, B-
8  rn: HAII_RAT 
                 hs: P30460  B*0801 alpha chain precursor  hs: HLA-B 
                             
20  AA818055  1.651773  594  100  457  15q12  rn: NM_053520  rn: E74-like factor 1 (ETS domain   rn: NM_053520 
                 hs: P32519  transcription factor)   hs: ELF1 
                 mm: Q60775     mm: Elf1  
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21  AI178386  1.867204  443  96.06  254  9q21  hs: NM_138798  NCBI: similar to hypothetical protein   rn: predicted (ensembl, EST, NCBI) 
                   BC018453  hs: NM_138798 
                      mm: 1500032H18Rik 
22  AI229172  2.188327  319  97.48  318  8q13  hs: NM_018381  no description  rn: predicted (ensembl)  
                 mm: NM_175687     hs: NM_018381 
                       mm: NM_175687 
                 hs: NM_031917  hs&mm: angiopoietin-related protein 5  rn: predicted (ensembl, EST, 
genscan, NCBI)  
                 mm: NM_145154     hs: ANGPTL6 
                      rn:6330404E11Rik 
23  AI171280  1.831267  628  71.92  146  4q34  hs: NM_014497  hs&mm: NP220 nuclear protein; CTCL  rn: predicted (EST) (ensembl, NCBI 
exons) 
                 mm: NM_008717  tumour antigen SE33-1  hs: NM_014497 
                      mm: Np220 
                           *** >2kbp away 
24  AI231086  1.518925  541  99.6  252  2q43  rn: Q9QXN1  rn: lymphoid enhancer binding factor 1  rn: LEF1_RAT 
                 hs: Q9UJU2     hs: LEF1 
                 mm: P27782     mm: Lef1 
25  AI171480  1.517404  519  100  519  1q32        rn: predicted (genscan) 
26  AI102643  1.612565  496  92.14  496  15p13  hs: Q00978  hs&mm: transcriptional regulator ISGF3  rn: predicted (ensembl, EST, 
genscan, NCBI)  
                 mm: Q61179  gamma subunit (IFN-alpha responsive  hs: ISGF3G 
                   transcription factor subunit) (interferon   mm: Isgf3g 
                   stimulated gene factor 3 gamma) (ISGF3     
                        P48 subunit) (ISGF-3 gamma)    
27  AA818887  1.712270  522  99.79  477  20p12  rn: NM_012646  rn: RTI class 1B gene, H2-TL-like, GRC  rn: NM_012646 
                 hs: P30460  region  hs: HLA-B 
                 mm: P14432     mm: H2-T10 
28  AI071755  1.261304  263  100  146  9q31        rn: predicted (genscan)   
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29  AI227666  1.651391  573  96.86  573  11q21  rn: NM_019195  rn: integrin-associated protein  rn: NM_019195 
                 hs: Q08722     hs: CD47 
                 mm: NM_010581     mm: Cd47 
30  AI234967  1.793207  416  100  376  20p12  hs: Q9C019  hs&mm: tripartite motif protein 15 (zinc   rn: predicted (ensembl, EST, 
genscan, NCBI)  
                 mm: Q8R096  finger protein B7)  hs: Trim15 or ZNFB7 
                      mm: Q8R096 (BRH) 
31  AI103500  1.616213  519  87.35  304  20p1  rn: P15978  rn: Class 1 histocompatibility antigen, 
non-  rn: HAII_RAT 
                 hs: P30460  rH.A alpha-1 chain precursor  hs: HLA-B 
32  AI177396  1.819174  507  9137  241  8q32     NCBI: similar to ubiquitin-activating 
enzyme 
rn: predicted (EST) (genscan, NCBI 
exons) 
                   E1-like; ubiquitin-activating enzyme-2;     
                   ubiquitin-activating enzyme E1 like    
33  AA818849  2.103757  417  86.8  250  10q32.1  hs: NM_024119  NCBI: similar to hypothetical protein   rn: (ensembl, genscan, NCBI) 
                   FLJ11354  hs: NM_024119 
                      mm: DIILgp2e 
34  AA819788  1.878639  517  99.8  503  11q23     NCBI: similar to 5830458k16Rik protein  rn: predicted (EST, genscan, NCBI) 
35  AI177481  2.160807
28  457  97.92  289  20p12  rn: P28077  rn: proteasome subunit beta type 9   rn: PSB9_RAT 
                 hs: P28065  precursor (proteasome chain 7)   hs: PSMB9 
                 mm: P28076  (macropain chain 7) (multicatalytic   mm: Psmb9 
                   endopeptidase complex chain 7) (ring     
                        12 protein) (low mol. mass protein 2)    
36  AI170410  1.436327  638  99.84  638  11p12  hs: NM_173824  NCBI: similar to 4930453N24Rik  rn: predicted (ensembl, EST, 
genscan, NCBI)  
                      hs: NM_173824 
                      mm: predicted 
37  AI176839  1.853808  478  97.63  211  3q42        rn: predicted (EST, genscan) 
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38  AI228291  1.841349  461  98.26  287  1q22  hs: NM_031448  NCBI: similar to cDNA 160001410  rn: predicted (ensembl, genscan, 
NCBI) 
                      hs: NM_031448 
                      mm: 1600014C10Rik 
39  AA819629  1.460664  529  98.82  510  2.fragment  hs: NM_006820  hs: histocompatibility 28  rn: predicted (ensembl, EST) 
(genscan exon) 
                      hs: Clorf29 
40  AI179939  1.917067  398  100  268  20p12  rn: NM_033098  rn: Tapasin  rn: NM_033098 
                 hs: O15533     hs: TAPBP or TAPA or NGS17 
                 mm: Q9R233     mm: TPSN_MOUSE 
                 hs: O15211  hs&mm: RAL guanine nucleotide   rn: predicted (ensembl, EST, NCBI) 
                 mm: Q61193  dissociation stimulator-like 2 (RALGDS-
like  hs: RAB2L or RGL2 
                        factor (ras-associated protein rab21)  mm: RGL2_Mouse 
41  AI235748  1.819836  537  98.19  497  9q12     NCBI: similar to cDNA 0610009D16  rn: predicted (ensembl, genscan, 
EST, NCBI) 
                      hs: MAD2LIBP 
                      mm: 0610009D16Rik 
42  AI113020  1.588865  503  97.94  486  20p12  hs: NM_015050  NCBI: similar to Riken cDNA 
1300018105 
rn:predicted(ensembl,EST,genscan)(
NCBI exon) 
                      hs: NM_015050 
                       mm: 1300018105Rik 
                        no description  rn: predicted (EST, genscan) 
43  AI071800  1.292724  259  99.08  109  14q21  rn: NM_031352  rn: Drebrin-like  rn: NM_031352 (Ensembl exon) 
                 hs: NM_014063     hs: NM_014063 
                 mm: NM_013810     mm: Dbn1 
44  AA818912  1.701085  615  95.32  598  1q41  hs: NM_022466  hs: zinc finger protein, subfamily 1A,5; 
zinc 
rn: predicted (ensembl, genscan, 
NCBI) 
                   finger transcription factor pegasus  hs: NM_022466 
                      mm: predicted  
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45  AI178869  1.717091  408  99.65  289  3p12  rn: NM_153303  rn: dystonia 1, torsin (autosomal   rn: NM_153303 
                 hs: O14657  dominant; torsin A)  hs: TOR1B or DQ1 or FKSG18 
                 mm: Q9ER41  hs&mm: Torsin B precursor (torsin family mm: Tor1b 
                        1 member B)    
46  AI177734  1.334543  550  99.64  551  11q11     NCBI: similar to hypothetical protein   rn: predicted (NCBI) (genscan exon) 
                        KIAA0136    
47  AI145609  1.800893  528  98.79  495  18q11  hs: P23508  hs: Colorectal mutant cancer protein 
(MCC 
rn: predicted (ensembl, genscan, 
EST, NCBI) 
                   protein  hs: MCC 
                      mm: predicted 
                      *** 4kbp away from Blast 
                           ***Large EST Cluster 
48  AA817937  1.683501  360  100  343  16p14  rn: Q811A2  rn: DAMP-1 protein  rn: Q811A2 
                 hs: Q10589     hs: BST2 
                 mm: Q8R2Q8     mm: Q8R2Q8 
49  AI104907  1.432870  587  99.63  534  14q22  rn: NM_023986  mm: similar to TEMO (fragment)  rn: NM_023986 
                 mm: Q8K0K0  NCBI: TEMO (WITHDRAWN)  hs: PSME4 
                      mm: AA409398 (BRH) 
50  AA684879  1.729296  326  93.19  235  20p12  rn: Q8V1B2  rn: death domain-associated protein 6   rn: DAXX_RAT 
                 hs: Q9UER7  (DAXX)  hs: DAXX or BING2 
                 mm: O35613     mm: DAXX_MOUSE 
51  AA858877  1.501456  487  100  459  2q43  rn: Q9QXN1  rn: lymphoid enhancer binding factor 1  rn: LEF1_RAT 
                  hs: Q9UJU2     hs: LEF1 
                  mm: P27782     mm: Lef1 
52  AA818264  1.760532  494  100  402  12q12  hs: NM_006989  hs: Ca++-promoted Ras inactivator; 
GTPase 
rn: predicted (ensembl, genscan, 
EST, NCBI) 
                   activating protein-like; Ca++-promoted 
ras  hs: NM_006989 
                   inactivator (Rasp21 protein activator 4  mm: predicted 
                        (RASA4))     
C  EST Name  Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference  Description  Known Gene? 
53  AI176976  1.369938  510  98.2  501  3q24  hs: NM_15308  hs&mm: formin binding protein 4 (or 30)  rn: predicted (ensembl, genscan, 
EST, NCBI) 
                 mm: NM_018828     hs: FNBP4 
                      mm: Fnbp4 
54  AI231494  1.518741  588  98.13  588  15p14  rn: P22288  rn: GTP cyclohydrolase 1 precursor 
(GTP-  rn: GCH1_RAT 
                 hs: P30793  CH-1)  hs: GCH1 or GCH or DYT5 
                 mm: Q05915     mm: Gch 
55  AI178629  1.641470  438  98.97  290  20p12  rn: P28064  rn: proteasome subunit beta type 8   rn: PSB8_RAT 
                 hs: P28062  precursor (proteasome component C13)  hs: PSMB8 or LMP7 or RING10 or 
Y2 
                 mm: P28063  (multicatalytical endopeptidase complex   mm: Psmb8 
                        subunit C13) (fragment)    
56  AI176183  1.350876  453  97.57  453  Xq34  hs: P06280  hs&mm: alpha galactosidase A precursor   rn: predicted (ensembl, genscan, 
NCBI) 
                 mm: P51569  (melibiase) (alpha-D-galactoside 
galactohyd-  hs: GLA 
                   rolase) (alpha-D-galactosidase A)  mm: Gla 
57  AI176479  1.341039  416  100  261  1q41  rn: P26376  rn: interferon-inducible protein  rn: INIB_RAT 
                 hs: Q01628     hs: IFITM3 
                 mm:NM_0285378     mm: Fgls - pending (BRH) 
                             
58  AI072951  1.363177  516  94.44  216  10q26  hs: NM_144975  NCBI: similar to hypothetical protein   rn: predicted (ensembl, EST, NCBI) 
                   FLJ34922  hs: NM_144975 
                      mm: predicted (RHS only) 
59  AI071534  1.292306  464  97.54  447  11p12  hs: NM_173824  NCBI: similar to 4930453N24Rik protein  rn: predicted (ensembl, EST, 
genscan, NCBI) 
                      hs: NM_173824 
                      mm: predicted (BRH) 
                    
C  EST Name  Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference  Description  Known Gene? 
60  AI179403  1.560792  541  99.81  532  20q13  hs: NM_022091  hs: DJ467N11.1 protein  rn: predicted (ensembl, EST, 
genscan, NCBI) 
                   NCBI: similar to RNA helicase family  hs: NM_006828 
                      mm: Q8K292 
61  AI232313  1.628982  575  97.91  575  4q11  hs: Q9Y5A7  hs&mm: BS4 protein (NY-REN-18 
antigen) 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
                 mm: P54729  (NEDD8 ultimate buster-1)  hs: BS4_Human or NUB1 or NYREN 
18 
                      mm: Nyren 18 - pending 
62  AI112633  1.272086  446  96.74  429  12p12     NCBI: similar to proteasome subunit 
alpha  
rn: predicted (genscan) (ensembl 
pseudogene) 
                   type 6 (proteasome iota 
chain)(macropain iota chain)    
                   (multicatalytic endopeptidase    
                   complex iota chain)(27kDa prosomal 
protein) (PROS-27) (p27k)    
63  AI176007  1.695461  653  99  400  4q44        rn: predicted (EST) 
64  AI137689  1.272232  457  98.44  384  14q22  rn: NM_173147  rn: VPS54-like  rn: NM_173147 
                 hs: NM_016516  hs&mm: Tumour antigen SLP-8P   hs: VPS54 
                 mm: NM_139061     mm: Vps54 
66  AI071570  1.220613  429  100  118  20p12  hs: P00751  hs&mm: complement factor B precursor  rn: predicted (ensembl, EST, 
genscan, NCBI) 
                 mm: P04186  (C3/C5 convertase) (properdin factor B)   hs: BF 
                   (glycine-rich beta 
glycoprotein)(GBG)(PBF2)  mm: CFAB_Mouse 
67  AI171503  1.436843  479  74.31  432  2q11  rn: Q9JJ22  rn: adipocyte-derived leucine 
aminopeptidase  rn: ART1-RAT 
                 hs: Q9NZ08  precursor (A-lap) (ARTS-1) 
(aminopeptidase  hs: ART1-HUMAN 
                 mm: Q9EQH2  pils) (puromycin-insensitive leucyl-
specific  mm: Arts-1 pending 
                        aminopeptidase) (pils-AP)     
C  EST Name  Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference  Description  Known Gene? 
68  AI227647  1.227656  339  80.07  301  19p12  rn: O55145  rn: fractalkaline precursor (CX3CLI)   rn: SYD1-RAT 
                 hs: P78423  (neurotactin) (CX3C membrane-
anchored  
hs: CX3CLI or SCYDI or FKN or NTT 
or A-152E5.2 
                 mm: O35188  chemokine) (small inducible cytokine D1) mm: AB030188 
69  AI169020  1.420293  577  99.31  577  4q13     no description  rn: predicted (ensembl) 
                           mm: 1700109H08Rik 
                     hs: NM_152789  no description  rn: predicted (ensembl) 
                           hs: NM_152789 (BRH) 
                           mm: 5830415L20Rik (RHS only) 
70  AI227994  1.487453  569  94.76  572  11q21  rn: NM_019195  rn: integrin-associated protein  rn: NM_019195 
                 hs: Q08722     hs: CD47 
                 mm: NM_010581     mm: Cd47 
71  AI071265  1.489646  443  99.29  424  15p13  hs: Q00978  hs&mm: transcriptional regulator ISGF3  rn: predicted (ensembl, EST, 
genscan, NCBI)  
                  mm: Q61179  gamma subunit (IFN-alpha responsive  hs: ISGF3G 
                    transcription factor subunit) (interferon   mm: Isgf3g 
                    stimulated gene factor 3 gamma) (ISGF3     
                        P48 subunit) (ISGF-3 gamma)    
72  AI178746  1.400854  542  97.42  542  8q32     NCBI: similar to TGF-beta induced 
apoptosis  rn: predicted (EST, genscan, NCBI)  
                   protein 3    
Table ii: Table containing all the information gleaned from www.ensembl.org pertaining to the ESTs significantly affected by zif268 on GeneChip
® C of the 
microarray experiment performed by James et al. (2005).  Please see Chapter 7.244 
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